200,000+ products from a single source!

sales@angenechem.com

Home > Imidazoles > 95382-33-5

95382-33-5

95382-33-5 | Magnesium,bis[5-methoxy-2-[[(4-methoxy-3,5-dimethyl-2-pyridinyl)methyl]sulfinyl-kO]-1H-benzimidazolato-kN1]-, (T-4)-

CAS No: 95382-33-5 Catalog No: AG01CBWN MDL No:MFCD06798050

Product Description

Catalog Number:
AG01CBWN
Chemical Name:
Magnesium,bis[5-methoxy-2-[[(4-methoxy-3,5-dimethyl-2-pyridinyl)methyl]sulfinyl-kO]-1H-benzimidazolato-kN1]-, (T-4)-
CAS Number:
95382-33-5
MDL Number:
MFCD06798050
IUPAC Name:
magnesium;6-methoxy-2-[(4-methoxy-3,5-dimethylpyridin-2-yl)methylsulfinyl]-1H-benzimidazole
InChI:
InChI=1S/C17H19N3O3S.Mg/c1-10-8-18-15(11(2)16(10)23-4)9-24(21)17-19-13-6-5-12(22-3)7-14(13)20-17;/h5-8H,9H2,1-4H3,(H,19,20);
InChI Key:
MQEUGMWHWPYFDD-UHFFFAOYSA-N

Properties

Complexity:
453  
Compound Is Canonicalized:
Yes
Covalently-Bonded Unit Count:
2  
Defined Atom Stereocenter Count:
0
Defined Bond Stereocenter Count:
0
Exact Mass:
369.1g/mol
Formal Charge:
0
Heavy Atom Count:
25  
Hydrogen Bond Acceptor Count:
6  
Hydrogen Bond Donor Count:
1  
Isotope Atom Count:
0
Molecular Weight:
369.722g/mol
Monoisotopic Mass:
369.1g/mol
Rotatable Bond Count:
5  
Topological Polar Surface Area:
96.3A^2
Undefined Atom Stereocenter Count:
1  
Undefined Bond Stereocenter Count:
0

Literature

Title Journal
Hesperidin protects against stress induced gastric ulcer through regulation of peroxisome proliferator activator receptor gamma in diabetic rats. Chemico-biological interactions 20180801
Omeprazole induces heme oxygenase-1 in fetal human pulmonary microvascular endothelial cells via hydrogen peroxide-independent Nrf2 signaling pathway. Toxicology and applied pharmacology 20161115
Fasting-Induced Changes in Hepatic P450 Mediated Drug Metabolism Are Largely Independent of the Constitutive Androstane Receptor CAR. PloS one 20160101
Apocynin protects against ethanol-induced gastric ulcer in rats by attenuating the upregulation of NADPH oxidases 1 and 4. Chemico-biological interactions 20151205
Omeprazole Attenuates Pulmonary Aryl Hydrocarbon Receptor Activation and Potentiates Hyperoxia-Induced Developmental Lung Injury in Newborn Mice. Toxicological sciences : an official journal of the Society of Toxicology 20151101
TCDD and omeprazole prime platelets through the aryl hydrocarbon receptor (AhR) non-genomic pathway. Toxicology letters 20150519
Omeprazole Inhibits Pancreatic Cancer Cell Invasion through a Nongenomic Aryl Hydrocarbon Receptor Pathway. Chemical research in toxicology 20150518
Omeprazole, a gastric proton pump inhibitor, inhibits melanogenesis by blocking ATP7A trafficking. The Journal of investigative dermatology 20150301
The pharmacokinetics and pharmacodynamics of danirixin (GSK1325756)--a selective CXCR2 antagonist --in healthy adult subjects. BMC pharmacology & toxicology 20150101
CYP2C19 polymorphisms account for inter-individual variability of drug metabolism in cynomolgus macaques. Biochemical pharmacology 20140915
Aggregate culture of human embryonic stem cell-derived hepatocytes in suspension are an improved in vitro model for drug metabolism and toxicity testing. Toxicological sciences : an official journal of the Society of Toxicology 20140701
Safety profile of enantiomers vs. racemic mixtures: it's the same? British journal of clinical pharmacology 20121101
Gastroprotective effects of extracts and guttiferone A isolated from Garcinia achachairu Rusby (Clusiaceae) against experimentally induced gastric lesions in mice. Naunyn-Schmiedeberg's archives of pharmacology 20121101
The influence of omeprazole on platelet inhibition of clopidogrel in various CYP2C19 mutant alleles. Genetic testing and molecular biomarkers 20121101
Inhibition of gastric perception of mild distention by omeprazole in volunteers. World journal of gastroenterology 20121021
Blindness following severe midfacial trauma--case report and review. Journal of cranio-maxillo-facial surgery : official publication of the European Association for Cranio-Maxillo-Facial Surgery 20121001
Effects of omeprazole consumption on serum levels of trace elements. Journal of trace elements in medicine and biology : organ of the Society for Minerals and Trace Elements (GMS) 20121001
Comparative study of novel spectrophotometric methods manipulating ratio spectra: an application on pharmaceutical ternary mixture of omeprazole, tinidazole and clarithromycin. Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy 20121001
Thalidomide-induced acute cholestatic hepatitis: case report and review of the literature. Gastroenterologia y hepatologia 20121001
Partial symptom-response to proton pump inhibitors in patients with non-erosive reflux disease or reflux oesophagitis - a post hoc analysis of 5796 patients. Alimentary pharmacology & therapeutics 20121001
Greater than 95% success with 14-day bismuth quadruple anti- Helicobacter pylori therapy: a pilot study in US Hispanics. Helicobacter 20121001
Novel formulations of dipyridamole with microenvironmental pH-modifiers for improved dissolution and bioavailability under hypochlorhydria. International journal of pharmaceutics 20120915
Symmetrical drug-related intertriginous and flexural exanthema (Baboon syndrome) induced by omeprazole. International journal of dermatology 20120901
Prospective randomized controlled trial to compare the effects of omeprazole and famotidine in preventing delayed bleeding and promoting ulcer healing after endoscopic submucosal dissection. Journal of gastroenterology and hepatology 20120901
Evaluation of six proton pump inhibitors as inhibitors of various human cytochromes P450: focus on cytochrome P450 2C19. Drug metabolism and disposition: the biological fate of chemicals 20120901
Risk factors associated with a decrease ≥2 g/dL in haemoglobin and/or ≥10% haematocrit in osteoarthritis patients taking celecoxib or a nonselective NSAID plus a PPI in a large randomised controlled trial (CONDOR). Alimentary pharmacology & therapeutics 20120901
Efficacy and safety of celecoxib versus diclofenac and omeprazole in elderly arthritis patients: a subgroup analysis of the CONDOR trial. Current medical research and opinion 20120901
Variation in omeprazole pharmacokinetics in a random Iranian population: a pilot study. Biopharmaceutics & drug disposition 20120901
Increase in gastric pH reduces hypotensive effect of oral sodium nitrite in rats. Free radical biology & medicine 20120815
Cytoprotective effect of benzyl N'-(5-chloro-indol-3-yl-methylidene)-hydrazinecarbodithioate against ethanol-induced gastric mucosal injury in rats. Molecules (Basel, Switzerland) 20120803
In with the new: the determinants of prescribing innovation by general practitioners in Ireland. The European journal of health economics : HEPAC : health economics in prevention and care 20120801
Cocktail approach for in vivo phenotyping of 5 major CYP450 isoenzymes: development of an effective sampling, extraction, and analytical procedure and pilot study with comparative genotyping. Journal of clinical pharmacology 20120801
Omeprazole impairs the absorption of mycophenolate mofetil but not of enteric-coated mycophenolate sodium in healthy volunteers. Journal of clinical pharmacology 20120801
¹³¹I gastric uptake with and without omeprazole in patients undergoing radioiodine therapy for differentiated thyroid carcinoma. European journal of nuclear medicine and molecular imaging 20120801
The role of proton pump inhibitors in adenoid hypertrophy in children. Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery 20120801
Efficacy of omeprazole paste in the prevention of gastric ulcers in 2 years old Thoroughbreds. The Journal of veterinary medical science 20120801
Hydroxylation of R(+)- and S(-)-omeprazole after racemic dosing are different among the CYP2C19 genotypes. Pharmaceutical research 20120801
Suspected methotrexate toxicity from omeprazole: a case review of carboxypeptidase G2 use in a methotrexate-experienced patient with methotrexate toxicity and a review of the literature. Journal of pharmacy practice 20120801
Randomised clinical trial: simvastatin as adjuvant therapy improves significantly the Helicobacter pylori eradication rate--a placebo-controlled study. Alimentary pharmacology & therapeutics 20120801
Respiratory response to proton pump inhibitor treatment in children with obstructive sleep apnea syndrome and gastroesophageal reflux disease. Sleep medicine 20120801
Helicobacter pylori infection: sequential therapy followed by levofloxacin-containing triple therapy provides a good cumulative eradication rate. Helicobacter 20120801
[Impact of proton pump inhibitor omeprazole on the antiplatelet effect of clopidogrel in individuals with various CYP2C19*2 genotypes]. Zhonghua yi xue yi chuan xue za zhi = Zhonghua yixue yichuanxue zazhi = Chinese journal of medical genetics 20120801
Antiulcerogenic activity of hydroalcoholic fruit extract of Pithecellobium dulce in different experimental ulcer models in rats. Journal of ethnopharmacology 20120713
Lycopene an adjunctive therapy for Helicobacter pylori eradication: a quasi-control trial. Journal of complementary & integrative medicine 20120702
The cholecystokinin CCK2 receptor antagonist, JNJ-26070109, inhibits gastric acid secretion and prevents omeprazole-induced acid rebound in the rat. British journal of pharmacology 20120701
Tigecycline-resistant Enterococcus faecalis associated with omeprazole use in a surgical patient. The Journal of antimicrobial chemotherapy 20120701
A mechanistic pharmacokinetic model to assess modified oral drug bioavailability post bariatric surgery in morbidly obese patients: interplay between CYP3A gut wall metabolism, permeability and dissolution. The Journal of pharmacy and pharmacology 20120701
Factors modulating the outcome of treatment for the eradication of Helicobacter pylori infection. The new microbiologica 20120701
[Effects of omeprazole on the proliferation and apoptosis of hepatoma cell line HepG2]. Sichuan da xue xue bao. Yi xue ban = Journal of Sichuan University. Medical science edition 20120701
Effects of selective COX-2 inhibitor and Helicobacter pylori eradication on precancerous gastric lesions. Gut 20120601
Inhibitors of acid secretion can benefit gastric wound repair independent of luminal pH effects on the site of damage. Gut 20120601
The elegance of the gastric mucosal barrier: designed by nature for nature. Gut 20120601
Effect of a traditional Chinese medicine Liu Wei Di Huang Wan on the activities of CYP2C19, CYP2D6 and CYP3A4 in healthy volunteers. Xenobiotica; the fate of foreign compounds in biological systems 20120601
Effect of the proton pump inhibitor omeprazole on the gastrointestinal bacterial microbiota of healthy dogs. FEMS microbiology ecology 20120601
A difficult diagnosis: drug-induced subacute cutaneous lupus erythematosus (SCLE) triggered by omeprazole in a patient with pre-existing idiopathic SCLE. Clinical and experimental dermatology 20120601
Enantioseparation of omeprazole--effect of different packing particle size on productivity. Journal of chromatography. A 20120601
Diminished mycophenolic acid exposure caused by omeprazole may be clinically relevant in the first week posttransplantation. Therapeutic drug monitoring 20120601
Co-treatment of dichloroacetate, omeprazole and tamoxifen exhibited synergistically antiproliferative effect on malignant tumors: in vivo experiments and a case report. Hepato-gastroenterology 20120601
Modulation of microenvironment acidity reverses anergy in human and murine tumor-infiltrating T lymphocytes. Cancer research 20120601
Recurrence of Helicobacter pylori After Eradication in Patients with Peptic Ulcer. Southern medical journal 20120601
Ultrastructure of ECL cells in Mastomys after long-term treatment with H2 receptor antagonist loxtidine. Medical molecular morphology 20120601
Gastroprotective activities of Turnera diffusa Willd. ex Schult. revisited: Role of arbutin. Journal of ethnopharmacology 20120507
Comparison of the protective effects of various antiulcer agents alone or in combination on indomethacin-induced gastric ulcers in rats. Experimental and toxicologic pathology : official journal of the Gesellschaft fur Toxikologische Pathologie 20120501
Suboptimal response to ferrous sulfate in iron-deficient patients taking omeprazole. American journal of therapeutics 20120501
Evaluation of lansoprazole as a probe for assessing cytochrome P450 2C19 activity and genotype-phenotype correlation in childhood. European journal of clinical pharmacology 20120501
Mucosal barrier defects in gastric intestinal metaplasia: in vivo evaluation by confocal endomicroscopy. Gastrointestinal endoscopy 20120501
The effect of once daily omeprazole and succinic acid (VECAM) vs once daily omeprazole on 24-h intragastric pH. Neurogastroenterology and motility : the official journal of the European Gastrointestinal Motility Society 20120501
High-sensitivity liquid chromatography-tandem mass spectrometry for the simultaneous determination of five drugs and their cytochrome P450-specific probe metabolites in human plasma. Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20120501
Conservative long-term treatment of children with eosinophilic esophagitis. Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology 20120501
Relative bioavailability and pharmacokinetic comparison of two different enteric formulations of omeprazole. Journal of Zhejiang University. Science. B 20120501
[A pilot trial on the treatment of gastroesophageal reflux-related cough in infants]. Zhongguo dang dai er ke za zhi = Chinese journal of contemporary pediatrics 20120501
Improved dissolution and pharmacokinetic behavior of dipyridamole formulation with microenvironmental pH-modifier under hypochlorhydria. International journal of pharmaceutics 20120415
A randomized, 2-period, crossover design study to assess the effects of dexlansoprazole, lansoprazole, esomeprazole, and omeprazole on the steady-state pharmacokinetics and pharmacodynamics of clopidogrel in healthy volunteers. Journal of the American College of Cardiology 20120403
Omeprazole limited sampling strategies to predict area under the concentration-time curve ratios: implications for cytochrome P450 2C19 and 3A phenotyping. European journal of clinical pharmacology 20120401
Enantioselective disposition of omeprazole, pantoprazole, and lansoprazole in a same Brazilian subjects group. Chirality 20120401
Non-steroidal anti-inflammatory drugs and gastroprotection with proton pump inhibitors: a focus on ketoprofen/omeprazole. Clinical drug investigation 20120401
Control of intra-oesophageal pH in patients with Barrett's oesophagus on omeprazole-sodium bicarbonate therapy. Alimentary pharmacology & therapeutics 20120401
Low dose or high dose of proton pump inhibitor for ulcer bleeding? European journal of internal medicine 20120401
[Effect of omeprazole on gene expression profile of human umbilical vein endothelial cell line and bioinformatics analysis]. Nan fang yi ke da xue xue bao = Journal of Southern Medical University 20120401
Ask the doctor. I recently switched from Prilosec to its generic form omeprazole, and it doesn't relieve my heartburn as well as Prilosec. Aren't generics supposed to be the same as the brand-name drugs? Harvard women's health watch 20120401
Fifteen-year effects of Helicobacter pylori, garlic, and vitamin treatments on gastric cancer incidence and mortality. Journal of the National Cancer Institute 20120321
Gastroprotective effect of Senecio candicans DC on experimental ulcer models. Journal of ethnopharmacology 20120306
Effects of Pithecellobium jiringa ethanol extract against ethanol-induced gastric mucosal injuries in Sprague-Dawley rats. Molecules (Basel, Switzerland) 20120306
Influence of different proton pump inhibitors on activity of cytochrome P450 assessed by [(13)C]-aminopyrine breath test. Journal of clinical pharmacology 20120301
[Clinical importance of the clopidogrel - omeprazole interaction: a question to solve]. Atencion primaria 20120301
In vitro evaluation of phototoxic properties of proton pump inhibitors, H2-receptor antagonists and statins. Acta dermato-venereologica 20120301
The safety of fetal exposure to proton-pump inhibitors during pregnancy. Digestive diseases and sciences 20120301
Induction of CYP2C19 and CYP3A activity following repeated administration of efavirenz in healthy volunteers. Clinical pharmacology and therapeutics 20120301
Comparison of adjuvant therapies by an H2-receptor antagonist and a proton pump inhibitor after endoscopic treatment in hemostatic management of bleeding gastroduodenal ulcers. Digestive endoscopy : official journal of the Japan Gastroenterological Endoscopy Society 20120301
Pneumatosis cystoides intestinalis in scleroderma-related conditions. Internal medicine journal 20120301
I've taken aspirin for years to prevent heart attack, and now I've developed an ulcer. My doctor told me to keep taking aspirin along with Prilosec. Why keep taking aspirin if it caused my ulcer? Mayo Clinic health letter (English ed.) 20120301
Ligand-based design of a potent and selective inhibitor of cytochrome P450 2C19. Journal of medicinal chemistry 20120209
Low levels of adherence with proton pump inhibitor therapy contribute to therapeutic failure in gastroesophageal reflux disease. Diseases of the esophagus : official journal of the International Society for Diseases of the Esophagus 20120201
Repeated administration of berberine inhibits cytochromes P450 in humans. European journal of clinical pharmacology 20120201
Clopidogrel and PPI interaction: clinically relevant or not? Current cardiology reports 20120201
Long-term maintenance treatment with omeprazole in children with healed erosive oesophagitis: a prospective study. Alimentary pharmacology & therapeutics 20120201
Effects of proton pump inhibitors on platelet function in patients receiving clopidogrel: a systematic review. Drug safety 20120201
Calcium [¹³C]carbonate breath test for quantitative measurement of total gastric acid in rats. Scandinavian journal of gastroenterology 20120201
Evolution of GERD over 5 years. Alimentary pharmacology & therapeutics 20120201
Recent safety concerns with proton pump inhibitors. Journal of clinical gastroenterology 20120201
Acid inhibition effect of ilaprazole on Helicobacter pylori-negative healthy volunteers: an open randomized cross-over study. Journal of digestive diseases 20120201
Imperative to consider multiple initiatives to maximize prescribing efficiency from generic availability: case history from Abu Dhabi. Expert review of pharmacoeconomics & outcomes research 20120201
Multiple initiatives continue to enhance the prescribing efficiency for the proton pump inhibitors and statins in Scotland. Expert review of pharmacoeconomics & outcomes research 20120201
Combatting the cough that won't quit. The Journal of family practice 20120201
A new model of gastric bleeding induced in rats by aspirin plus clopidogrel under stimulation of acid secretion. Prophylactic effects of antiulcer drugs. Journal of physiology and pharmacology : an official journal of the Polish Physiological Society 20120201
[Effect of high altitude hypoxia on the activity and protein expression of CYP2C9 and CYP2C19]. Yao xue xue bao = Acta pharmaceutica Sinica 20120201
Treatment with histamine-type 2 receptor antagonists and omeprazole increase the risk of diarrhoea in neonatal foals treated in intensive care units. Equine veterinary journal. Supplement 20120201
Precision improvement for omeprazole determination through stability evaluation. Drug testing and analysis 20120101
Increasing the duration of dual amoxicillin plus omeprazole Helicobacter pylori eradication to 6 weeks: a pilot study. Journal of gastroenterology and hepatology 20120101
Anti-carcinogenic properties of omeprazole against human colon cancer cells and azoxymethane-induced colonic aberrant crypt foci formation in rats. International journal of oncology 20120101
[The efficiency of drug prescription: impact of a therapeutic exchange program]. Gaceta sanitaria 20120101
Effects of omeprazole and genetic polymorphism of CYP2C19 on the clopidogrel active metabolite. Drug metabolism and disposition: the biological fate of chemicals 20120101
Prediction of relative in vivo metabolite exposure from in vitro data using two model drugs: dextromethorphan and omeprazole. Drug metabolism and disposition: the biological fate of chemicals 20120101
Ilaprazole for the treatment of duodenal ulcer: a randomized, double-blind and controlled phase III trial. Current medical research and opinion 20120101
Assessment of the use of clopidogrel associated with gastroprotective medications in outpatients. Farmacia hospitalaria : organo oficial de expresion cientifica de la Sociedad Espanola de Farmacia Hospitalaria 20120101
[Sound therapy in sudden deafness]. Acta otorrinolaringologica espanola 20120101
Seeking an optimal eradication therapy for Helicobacter pylori infection. Journal of gastroenterology and hepatology 20120101
Early effects of oral administration of omeprazole and roxatidine on intragastric pH. Journal of Zhejiang University. Science. B 20120101
Impact of antisecretory treatment on respiratory symptoms of gastroesophageal reflux disease in children. Diseases of the esophagus : official journal of the International Society for Diseases of the Esophagus 20120101
Agranulocytosis induced by proton pump inhibitors. Journal of clinical gastroenterology 20120101
Is quadruple therapy the new triple therapy for H pylori? Canadian family physician Medecin de famille canadien 20120101
Clarithromycin versus metronidazole in first-line Helicobacter pylori eradication. Prospective randomized study of 85 Tunisian adults. La Tunisie medicale 20120101
Yellow brain culinary-medicinal mushroom, Tremella mesenterica Ritz.:Fr. (higher Basidiomycetes), is subjectively but not objectively effective for eradication of Helicobacter pylori: a prospective controlled trial. International journal of medicinal mushrooms 20120101
Gaviscon® vs. omeprazole in symptomatic treatment of moderate gastroesophageal reflux. a direct comparative randomised trial. BMC gastroenterology 20120101
Treatment of laryngopharyngeal reflux: a comparison between domperidone plus omeprazole and omeprazole alone. Journal of the Medical Association of Thailand = Chotmaihet thangphaet 20120101
Methanol extract of Bauhinia purpurea leaf possesses anti-ulcer activity. Medical principles and practice : international journal of the Kuwait University, Health Science Centre 20120101
[Severe hypomagnesemia refractory to oral supplementation associated to omeprazole treatment]. Endocrinologia y nutricion : organo de la Sociedad Espanola de Endocrinologia y Nutricion 20120101
Early effect of oral administration of omeprazole with mosapride as compared with those of omeprazole alone on the intragastric pH. BMC gastroenterology 20120101
Effects of PPIs and an H2 blocker on the antiplatelet function of clopidogrel in Japanese patients under dual antiplatelet therapy. Journal of atherosclerosis and thrombosis 20120101
Gastrointestinal-sparing effects of novel NSAIDs in rats with compromised mucosal defence. PloS one 20120101
Efficacy of omeprazole, famotidine, mosapride and teprenone in patients with upper gastrointestinal symptoms: an omeprazole-controlled randomized study (J-FOCUS). BMC gastroenterology 20120101
Bone remodeling after administration of proton pump (H+/K+-ATPase) inhibitors and alendronate in ovariectomized rats. Acta poloniae pharmaceutica 20120101
Liver tumor promoting effect of omeprazole in rats and its possible mechanism of action. The Journal of toxicological sciences 20120101
Nine cases of allergy to omeprazole. Journal of investigational allergology & clinical immunology 20120101
[Factors affecting efficacy of gastroesophageal reflux disease treatment with proton pump inhibitors]. Terapevticheskii arkhiv 20120101
Omeprazole- and esomeprazole-associated hypomagnesaemia: data mining of the public version of the FDA Adverse Event Reporting System. International journal of medical sciences 20120101
Proton pump (H+/K+-ATPase) inhibitors weaken the protective effect of alendronate on bone mechanical properties in estrogen-deficient rats. Pharmacological reports : PR 20120101
Influence of omeprazole and famotidine on the antiplatelet effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes: a prospective, randomized, multicenter study. Circulation journal : official journal of the Japanese Circulation Society 20120101
In vitro and in vivo protection against indomethacin-induced small intestinal injury by proton pump inhibitors, acid pump antagonists, or indomethacin-phosphatidylcholine. Digestion 20120101
Removal of trace organic chemical contaminants by a membrane bioreactor. Water science and technology : a journal of the International Association on Water Pollution Research 20120101
Inhibitory effects of kale ingestion on metabolism by cytochrome P450 enzymes in rats. Biomedical research (Tokyo, Japan) 20120101
Proton-pump inhibitors could be innocent when used concomitantly with clopidogrel. Circulation journal : official journal of the Japanese Circulation Society 20120101
Late hypersensitivity to omeprazole and other proton pump inhibitors. Acta clinica Belgica 20120101
Enhanced liver tumor promotion but not liver initiation activity in rats subjected to combined administration of omeprazole and β-naphthoflavone. The Journal of toxicological sciences 20120101
Stability of omeprazole in SyrSpend SF Alka (reconstituted). International journal of pharmaceutical compounding 20120101
Differential effects of Cu(II) and Fe(III) on the binding of omeprazole and pantoprazole to bovine serum albumin: toxic effect of metal ions on drugs. Journal of pharmaceutical and biomedical analysis 20111215
Antiprotozoal activity of proton-pump inhibitors. Bioorganic & medicinal chemistry letters 20111215
Aspirin-induced small bowel injuries and the preventive effect of rebamipide. World journal of gastroenterology 20111214
Pharmacokinetics and antitumor activity of patupilone combined with midazolam or omeprazole in patients with advanced cancer. Cancer chemotherapy and pharmacology 20111201
Pharmacokinetics of two formulations of omeprazole administered through a gastrostomy tube in patients with severe neurodevelopmental problems. British journal of clinical pharmacology 20111201
Sequential therapy versus tailored triple therapies for Helicobacter pylori infection in children. Journal of pediatric gastroenterology and nutrition 20111201
Effect of multiple doses of omeprazole on the pharmacokinetics, pharmacodynamics, and safety of a single dose of rivaroxaban. Journal of cardiovascular pharmacology 20111201
[Primary antibiotic resistance of Helicobacter pylori strains and eradication rate according to gastroduodenal disease in Korea]. The Korean journal of gastroenterology = Taehan Sohwagi Hakhoe chi 20111201
Inhibitors of gastric acid secretion increase the risk of prion infection in mice. Scandinavian journal of gastroenterology 20111201
Assessment and treatment of gastroesophageal reflux in healthy infants with apneic episodes: a retrospective analysis of 87 consecutive patients. Clinical pediatrics 20111201
Novel stably transfected gene reporter human hepatoma cell line for assessment of aryl hydrocarbon receptor transcriptional activity: construction and characterization. Environmental science & technology 20111201
Pharmacodynamic evaluation of clopidogrel plus PA32540: the Spaced PA32540 With Clopidogrel Interaction Gauging (SPACING) study. Clinical pharmacology and therapeutics 20111201
Bioavailability of omeprazole 20 mg capsules containing omeprazole 22.5% enteric coated pellets versus a reference product in healthy Bangladeshi male subjects: an open-label, single-dose, randomized-sequence, two-way crossover study. International journal of clinical pharmacology and therapeutics 20111201
[Gastric MALT lymphoma: anatomo-clinical data and outcome of early stage H. pylori-associated gastric MALT-lymphoma resistant to treatment]. La Tunisie medicale 20111201
To compare the efficacy of triple therapy with furazolidone, amoxicillin and omeprazole for two weeks and three weeks in the eradication of Helicobacter pylori in Bangladeshi duodenal ulcer patients. Bangladesh Medical Research Council bulletin 20111201
Helicobacter pylori eradication in functional dyspepsia: HEROES trial. Archives of internal medicine 20111128
Omeprazole attenuates hyperoxic injury in H441 cells via the aryl hydrocarbon receptor. Free radical biology & medicine 20111115
Warfarin. BMJ (Clinical research ed.) 20111102
Interaction of sorafenib and cytochrome P450 isoenzymes in patients with advanced melanoma: a phase I/II pharmacokinetic interaction study. Cancer chemotherapy and pharmacology 20111101
Response of unexplained chest pain to proton pump inhibitor treatment in patients with and without objective evidence of gastro-oesophageal reflux disease. Gut 20111101
Formulation of multiparticulate systems as lyophilised orally disintegrating tablets. European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V 20111101
The proton pump inhibitor, omeprazole, but not lansoprazole or pantoprazole, is a metabolism-dependent inhibitor of CYP2C19: implications for coadministration with clopidogrel. Drug metabolism and disposition: the biological fate of chemicals 20111101
Small-molecular virulence inhibitors show divergent and immunomodulatory effects in infection models of Salmonella enterica serovar Typhimurium. International journal of antimicrobial agents 20111101
Duodenal ulceration in a patient with celiac disease and plasminogen I deficiency: coincidence or cofactors? Pediatrics 20111101
A randomized study comparing levofloxacin, omeprazole, nitazoxanide, and doxycycline versus triple therapy for the eradication of Helicobacter pylori. The American journal of gastroenterology 20111101
Clinical update on nursing home medicine: 2011. Journal of the American Medical Directors Association 20111101
Gastric antral diverticulum with heterotopic pancreas in a teenage patient. Journal of pediatric gastroenterology and nutrition 20111101
Discontinuation of unnecessary medications in older adults. The Consultant pharmacist : the journal of the American Society of Consultant Pharmacists 20111101
Comparison of the efficacy and safety between generic intravenous omeprazole (Zefxon) and original omeprazole (Losec) in the adjunct treatment of non-variceal upper gastrointestinal bleeding in Siriraj Hospital. Journal of the Medical Association of Thailand = Chotmaihet thangphaet 20111101
[Severe hypomagnesemia related to omeprazole]. Revista clinica espanola 20111001
Proton pump inhibitors exacerbate NSAID-induced small intestinal injury by inducing dysbiosis. Gastroenterology 20111001
Omeprazole attenuates hyperoxic lung injury in mice via aryl hydrocarbon receptor activation and is associated with increased expression of cytochrome P4501A enzymes. The Journal of pharmacology and experimental therapeutics 20111001
Relationship between cardiovascular outcomes and proton pump inhibitor use in patients receiving dual antiplatelet therapy after acute coronary syndrome. Pharmacoepidemiology and drug safety 20111001
Proton pump inhibitors omeprazole, lansoprazole and pantoprazole induce relaxation in the rat lower oesophageal sphincter. The Journal of pharmacy and pharmacology 20111001
Does BMI affect the clinical efficacy of proton pump inhibitor therapy in GERD? The case for rabeprazole. European journal of gastroenterology & hepatology 20111001
Fixed drug eruption caused by three unrelated drugs: promethazine, pethidine and omeprazole. Clinical and experimental dermatology 20111001
Prescribing proton pump inhibitor and clopidogrel together: current state of recommendations. Current opinion in gastroenterology 20111001
Expression of albumin and cytochrome P450 enzymes in HepG2 cells cultured with a nanotechnology-based culture plate with microfabricated scaffold. The Journal of toxicological sciences 20111001
Combination of PPI with a prokinetic drug in gastroesophageal reflux disease. Acta medica Indonesiana 20111001
Effects of melatonin and tryptophan on healing of gastric and duodenal ulcers with Helicobacter pylori infection in humans. Journal of physiology and pharmacology : an official journal of the Polish Physiological Society 20111001
Elusive cause of hypomagnesaemia. BMJ (Clinical research ed.) 20110930
Does laryngopharyngeal reflux cause intraoral burning sensations? A preliminary study. European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery 20110901
A rare association of inlet patch with laryngospasm: a report of two children and literature review. Pediatric pulmonology 20110901
Sequential therapy versus standard triple drug therapy for eradication of Helicobacter pylori in patients with perforated duodenal ulcer following simple closure. Scandinavian journal of gastroenterology 20110901
Inhibition of monoacylglycerol lipase attenuates nonsteroidal anti-inflammatory drug-induced gastric hemorrhages in mice. The Journal of pharmacology and experimental therapeutics 20110901
Whole-cell oxidation of omeprazole sulfide to enantiopure esomeprazole with Lysinibacillus sp. B71. Bioresource technology 20110901
Effectiveness of the proton pump inhibitor omeprazole associated with calcium hydroxide as intracanal medication: an in vivo study. Journal of endodontics 20110901
Correlation between creatinine clearance and Helicobacter pylori infection eradication with sequential and triple therapeutic regimens: A randomised clinical trial. Arab journal of gastroenterology : the official publication of the Pan-Arab Association of Gastroenterology 20110901
The effect of St John's wort (hypericum perforatum) on cytochrome p450 1a2 activity in perfused rat liver. Biomedical papers of the Medical Faculty of the University Palacky, Olomouc, Czechoslovakia 20110901
Chiral assay of omeprazole and metabolites and its application to a pharmacokinetics related to CYP2C19 genotypes. Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20110815
Ulcerative cystitis associated with phenylbutazone administration in two horses. Journal of the American Veterinary Medical Association 20110815
Helicobacter pylori associated with chronic urticaria. Journal of infection in developing countries 20110812
Mitochondrial dependent apoptosis: ameliorative effect of flunarizine on ischemia-reperfusion of celiac artery-induced gastric lesions in the rat. Digestive diseases and sciences 20110801
Assessment of a novel β2-adrenoceptor agonist, trantinterol, for interference with human liver cytochrome P450 enzymes activities. Toxicology in vitro : an international journal published in association with BIBRA 20110801
Influence of esomeprazole on hypoglycemic activity of oral antidiabetic agents in rats and rabbits. Molecular and cellular biochemistry 20110801
Race affects healing of erosive oesophagitis in patients treated with proton pump inhibitors. Alimentary pharmacology & therapeutics 20110801
Occupational contact allergy to omeprazole and fluoxetine. Contact dermatitis 20110801
The reason for failure of on-demand PPI therapy in NERD patients. Neurogastroenterology and motility : the official journal of the European Gastrointestinal Motility Society 20110801
Reducing the risk of gastroduodenal ulcers with a fixed combination of esomeprazole and low-dose acetyl salicylic acid. Expert review of gastroenterology & hepatology 20110801
The potential inhibitory effect of revaprazan, an acid pump antagonist, on anticoagulation with warfarin. The Tohoku journal of experimental medicine 20110801
Hoarseness and chronic cough: would you suspect reflux? The Journal of family practice 20110801
Second-line levofloxacin-based triple therapy's efficiency for Helicobacter pylori eradication in patients with peptic ulcer. Southern medical journal 20110801
Effect of Helicobacter pylori eradication therapy in iron deficiency anaemia of pregnancy - a pilot study. The Indian journal of medical research 20110801
Effects of intrarectally administered omeprazole paste on gastric fluid pH in healthy adult horses. The Veterinary record 20110730
Buspirone, fexofenadine, and omeprazole: quantification of probe drugs and their metabolites in human plasma. Journal of pharmaceutical and biomedical analysis 20110715
Differential ligand-dependent activation and a role for Y322 in aryl hydrocarbon receptor-mediated regulation of gene expression. Biochemical and biophysical research communications 20110715
Cure of alopecia areata after eradication of Helicobacter pylori: a new association? World journal of gastroenterology 20110714
[Hypomagnesemia related to the use of omeprazole with negative result for mutation in the TRPM6 gene]. Medicina clinica 20110709
Sequential therapy compared with standard triple therapy for Helicobacter pylori eradication in children: a double-blind, randomized, controlled trial. The Journal of pediatrics 20110701
Helicobacter pylori chronic gastritis in children: to eradicate or not to eradicate? The Journal of pediatrics 20110701
Black tea and theaflavins suppress various inflammatory modulators and i-NOS mediated nitric oxide synthesis during gastric ulcer healing. Free radical research 20110701
Efficacy of Lactobacillus casei treatment on small bowel injury in chronic low-dose aspirin users: a pilot randomized controlled study. Journal of gastroenterology 20110701
[The effects of pronase on drugs concentrations for treatment of Helicobacter pylori infection in gastric tissue]. Zhonghua nei ke za zhi 20110701
The usefulness of the original questionnaire in the evaluation of quality of life in patients with gastroesophageal reflux disease. Polski przeglad chirurgiczny 20110701
A newly developed DNA microarray is useful to assess induction of cytochromes p450 in the cynomolgus monkey. Drug metabolism and pharmacokinetics 20110601
Anti-ulcer constituents of Annona squamosa twigs. Fitoterapia 20110601
Melatonin and steroid hormones activate intermembrane Cu,Zn-superoxide dismutase by means of mitochondrial cytochrome P450. Free radical biology & medicine 20110601
[Omeprazole and hypomagnesemia]. Revista clinica espanola 20110601
Intravenous esomeprazole: a pharmacoeconomic profile of its use in the prevention of recurrent peptic ulcer bleeding. PharmacoEconomics 20110601
Effects of different proton pump inhibitors on cardiac contractility in isolated human failing myocardium. The Journal of cardiovascular surgery 20110601
High eradication rates of Helicobacter pylori infection following sequential therapy: the Israeli experience treating naïve patients. Helicobacter 20110601
Helicobacter pylori eradication: A new, single-capsule bismuth-containing quadruple therapy. Nature reviews. Gastroenterology & hepatology 20110601
Efficacy of levofloxacin and rifaximin based quadruple therapy in Helicobacter pylori associated gastroduodenal disease: a double-blind, randomized controlled trial. Journal of Korean medical science 20110601
Helicobacter pylori infection: is sequential therapy superior to standard triple therapy? A single-centre Italian study in treatment-naive and non-treatment-naive patients. Canadian journal of gastroenterology = Journal canadien de gastroenterologie 20110601
Role of the COX-independent pathways in the ulcer-healing action of epigallocatechin gallate. Food & function 20110601
[Gastric acid suppression of a new oral powder omeprazole suspension for infants with gastroesophageal reflux disease. A pilot study]. Acta gastroenterologica Latinoamericana 20110601
Separate dosing of clopidogrel and omeprazole may improve platelet inhibition on dual antiplatelet therapy. International journal of cardiology 20110519
Internal standard tracked dilution to overcome challenges in dried blood spots and robotic sample preparation for liquid chromatography/tandem mass spectrometry assays. Rapid communications in mass spectrometry : RCM 20110515
Confounding factors for variation of clozapine plasma levels: drug interactions with proton pump inhibitor or infectious etiologies? European journal of clinical pharmacology 20110501
Randomized controlled trial of standard versus high-dose intravenous omeprazole after endoscopic therapy in high-risk patients with acute peptic ulcer bleeding. The British journal of surgery 20110501
Evaluation of the effects of 20 nonsynonymous single nucleotide polymorphisms of CYP2C19 on S-mephenytoin 4'-hydroxylation and omeprazole 5'-hydroxylation. Drug metabolism and disposition: the biological fate of chemicals 20110501
Proton pump inhibitors reduce interferon-γ-induced neurotoxicity and STAT3 phosphorylation of human astrocytes. Glia 20110501
Melatonin or L-tryptophan accelerates healing of gastroduodenal ulcers in patients treated with omeprazole. Journal of pineal research 20110501
Efficacy of proton-pump inhibitors in children with gastroesophageal reflux disease: a systematic review. Pediatrics 20110501
Omeprazole, but not pantoprazole, reduces the antiplatelet effect of clopidogrel: a randomized clinical crossover trial in patients after myocardial infarction evaluating the clopidogrel-PPIs drug interaction. European journal of gastroenterology & hepatology 20110501
Long-term follow-up of a child with primary lymph node gastrinoma and Zollinger-Ellison syndrome. Journal of pediatric surgery 20110501
Coadministration of clopidogrel and proton pump inhibitors. Cleveland Clinic journal of medicine 20110501
Sex and CYP3A5 genotype influence total CYP3A activity: high CYP3A activity and a unique distribution of CYP3A5 variant alleles in Ethiopians. The pharmacogenomics journal 20110401
A new PPI, ilaprazole compared with omeprazole in the treatment of duodenal ulcer: a randomized double-blind multicenter trial. Journal of clinical gastroenterology 20110401
Drug-induced subacute cutaneous lupus erythematosus associated with omeprazole. Clinical and experimental dermatology 20110401
Patients with gastroesophageal reflux disease and respiratory manifestations do not present lung function disorders during cardiopulmonary exercise test. Diseases of the esophagus : official journal of the International Society for Diseases of the Esophagus 20110401
'War and Peace' with Barrett's esophagus. Digestive diseases and sciences 20110401
Effect of omeprazole on the pharmacokinetics and toxicities of irinotecan in cancer patients: a prospective cross-over drug-drug interaction study. European journal of cancer (Oxford, England : 1990) 20110401
Clinical outcomes in patients with the concomitant use of clopidogrel and proton pump inhibitors after percutaneous coronary intervention: an analysis from the Guthrie Health Off-Label Stent (GHOST) investigators. Circulation. Cardiovascular interventions 20110401
Five-year examination of utilization and drug cost outcomes associated with benefit design changes including reference pricing for proton pump inhibitors in a state employee health plan. Journal of managed care pharmacy : JMCP 20110401
What is the evidence? Portosystemic shunt in a dog. Journal of the American Veterinary Medical Association 20110401
False elevation of chromogranin A due to proton pump inhibitors. The Netherlands journal of medicine 20110401
Eosinophilic esophagitis in patients with typical gastroesophageal reflux disease symptoms refractory to proton pump inhibitor. Clinics (Sao Paulo, Brazil) 20110401
Omeprazole decreases magnesium transport across Caco-2 monolayers. World journal of gastroenterology 20110328
Proton pump inhibitor step-down therapy for GERD: a multi-center study in Japan. World journal of gastroenterology 20110321
Quadruple or triple therapy to eradicate H pylori. Lancet (London, England) 20110312
Helicobacter pylori eradication with a capsule containing bismuth subcitrate potassium, metronidazole, and tetracycline given with omeprazole versus clarithromycin-based triple therapy: a randomised, open-label, non-inferiority, phase 3 trial. Lancet (London, England) 20110312
Gastroesophageal reflux disease management according to contemporary international guidelines: a translational study. World journal of gastroenterology 20110307
Effect of low-dose omeprazole (20 mg daily) on the pharmacokinetics of multiple-dose atazanavir with ritonavir in healthy subjects. Journal of clinical pharmacology 20110301
Proton pump inhibitor treatment for congenital chloride diarrhea. Digestive diseases and sciences 20110301
Gastrin-releasing peptide receptor antagonist or N-acetylcysteine combined with omeprazol protect against mitochondrial complex II inhibition in a rat model of gastritis. Basic & clinical pharmacology & toxicology 20110301
Proton pump inhibitor co-therapy with clopidogrel: is there GI benefit or cardiovascular harm? Gastroenterology 20110301
Role of omeprazole dosage and cytochrome P450 2C19 genotype in patients receiving omeprazole-amoxicillin dual therapy for Helicobacter pylori eradication. Pharmacotherapy 20110301
Clinical usefulness of limited sampling strategies for estimating AUC of proton pump inhibitors. Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan 20110301
The efficacy of a 1-week triple therapy for eradication of Helicobacter pylori infection in children. Arab journal of gastroenterology : the official publication of the Pan-Arab Association of Gastroenterology 20110301
Omeprazole affects clopidogrel efficacy but not ischemic events in patients with acute coronary syndrome undergoing elective percutaneous coronary intervention. Chinese medical journal 20110301
Impact of a bleeding care pathway in the management of acute upper gastrointestinal bleeding. Indian journal of gastroenterology : official journal of the Indian Society of Gastroenterology 20110301
Clopidogrel with or without omeprazole in coronary disease. The New England journal of medicine 20110217
Clopidogrel with or without omeprazole in coronary disease. The New England journal of medicine 20110217
Effect of eradication of Helicobacter pylori in children with chronic immune thrombocytopenia: a prospective, controlled, multicenter study. Pediatric blood & cancer 20110201
Randomised clinical trial: efficacy of the addition of a prokinetic, mosapride citrate, to omeprazole in the treatment of patients with non-erosive reflux disease - a double-blind, placebo-controlled study. Alimentary pharmacology & therapeutics 20110201
The efficacy and safety of long-term Helicobacter species quadruple therapy in asymptomatic cats with naturally acquired infection. Journal of feline medicine and surgery 20110201
Intragastric acidity during administration of generic omeprazole or esomeprazole - a randomised, two-way crossover study including CYP2C19 genotyping. Alimentary pharmacology & therapeutics 20110201
GERD in 2010: diagnosis, novel mechanisms of disease and promising agents. Nature reviews. Gastroenterology & hepatology 20110201
It is difficult to discontinue PPI treatment in patients with GERD. The American journal of gastroenterology 20110201
[About a case of multiple endocrine neoplasia type 1. Review of some clinical manifestations and treatment controversies]. Endocrinologia y nutricion : organo de la Sociedad Espanola de Endocrinologia y Nutricion 20110201
Remission of high-grade B-cell lymphoma in a pediatric patient following Helicobacter pylori eradication. Pediatrics international : official journal of the Japan Pediatric Society 20110201
[Strategy to manage low dose aspirin-induced gastrointestinal injury]. Nihon rinsho. Japanese journal of clinical medicine 20110201
Does antireflux surgery prevent progression of Barrett's esophagus? Minerva chirurgica 20110201
Furazolidone, amoxicillin and omeprazole with or without bismuth for eradication of Helicobacter pylori in peptic ulcer disease. The Turkish journal of gastroenterology : the official journal of Turkish Society of Gastroenterology 20110201
[Severe hypomagnesaemia due to long-term treatment with omeprazole]. Medicina clinica 20110129
Double-dose clopidogrel in patients undergoing PCI for ACS. Lancet (London, England) 20110122
Anaphylaxis to omeprazole. Cross-reactivity with the other proton pump inhibitors. Allergologia et immunopathologia 20110101
Zinc salts provide a novel, prolonged and rapid inhibition of gastric acid secretion. The American journal of gastroenterology 20110101
Differential effects of omeprazole and pantoprazole on the pharmacodynamics and pharmacokinetics of clopidogrel in healthy subjects: randomized, placebo-controlled, crossover comparison studies. Clinical pharmacology and therapeutics 20110101
Rebamipide has the potential to reduce the intensity of NSAID-induced small intestinal injury: a double-blind, randomized, controlled trial evaluated by capsule endoscopy. Journal of gastroenterology 20110101
Efficacy of oral famotidine and 2 omeprazole formulations for the control of intragastric pH in dogs. Journal of veterinary internal medicine 20110101
Should prophylactic low-dose aspirin therapy be continued in peptic ulcer bleeding? Drugs 20110101
Effects of omeprazole on symptoms and quality of life in Japanese patients with reflux esophagitis: final results of OMAREE, a large-scale clinical experience investigation. BMC gastroenterology 20110101
[Confounding bias due to indication and severity in observational studies]. Gaceta sanitaria 20110101
Prophylactic use of omeprazole associated with a reduced risk of peptic ulcer disease among maintenance hemodialysis patients. Renal failure 20110101
Effects of intravenously administered esomeprazole sodium on gastric juice pH in adult female horses. Journal of veterinary internal medicine 20110101
[Correction of negative influence of long-term hypergastrinemia on gastric acid secretion]. Fiziolohichnyi zhurnal (Kiev, Ukraine : 1994) 20110101
Does a proton pump inhibitor cause hypokalemia? Internal medicine (Tokyo, Japan) 20110101
Epigallocatechin gallate accelerates healing of indomethacin-induced stomach ulcers in mice. Pharmacological reports : PR 20110101
Omeprazole inhibits proliferation and modulates autophagy in pancreatic cancer cells. PloS one 20110101
[Toxic epidermal necrolysis with fatal ending due to the concurrent use of carbamazepine, cilostazol and omeprazol: a case report]. Farmacia hospitalaria : organo oficial de expresion cientifica de la Sociedad Espanola de Farmacia Hospitalaria 20110101
Ca2+ activated K+ channel Kca3.1 as a determinant of gastric acid secretion. Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology 20110101
[Cardiac invasive aspergillosis in a heart transplant recipient]. Revista iberoamericana de micologia 20110101
Healing effects of rebamipide and omeprazole in Helicobacter pylori-positive gastric ulcer patients after eradication therapy: a randomized double-blind, multinational, multi-institutional comparative study. Digestion 20110101
[Interaction between clopidogrel and proton pump inhibitors]. Nederlands tijdschrift voor geneeskunde 20110101
Proton pump inhibitors inhibit metformin uptake by organic cation transporters (OCTs). PloS one 20110101
Effect of proton pump inhibitors on platelet inhibition activity of clopidogrel in Chinese patients with percutaneous coronary intervention. Vascular health and risk management 20110101
Comparison of the effects of omeprazole and rabeprazole on ticlopidine metabolism in vitro. Journal of pharmacological sciences 20110101
[Changes of NO-ergic activity in the salivary glands of rats under conditions of omeprazole-induced hypergastrinemia]. Fiziolohichnyi zhurnal (Kiev, Ukraine : 1994) 20110101
Efficacy of Helicobacter pylori eradication therapy in cirrhotic patients with peptic ulcer disease. Revista medico-chirurgicala a Societatii de Medici si Naturalisti din Iasi 20110101
[Characteristics of duodenogastric reflux in duodenal ulcer patients and its dynamics after Helicobacter pylori eradication]. Eksperimental'naia i klinicheskaia gastroenterologiia = Experimental & clinical gastroenterology 20110101
Kinetics of omeprazole degradation in solid state. Acta poloniae pharmaceutica 20110101
Improvement in health-related quality of life after therapy with omeprazole in patients with coronary artery disease and recurrent angina-like chest pain. A double-blind, placebo-controlled trial of the SF-36 survey. Health and quality of life outcomes 20110101
The effect of omeprazole on gastric myoelectrical activity and emptying. Journal of smooth muscle research = Nihon Heikatsukin Gakkai kikanshi 20110101
Evaluation of antiulcerogenic activity of aqueous extract of Brassica oleracea var. capitata (cabbage) on Wistar rat gastric ulceration. Arquivos de gastroenterologia 20110101
Clopidogrel and proton pump inhibitors: is there a significant drug-drug interaction? Canadian journal of cardiovascular nursing = Journal canadien en soins infirmiers cardio-vasculaires 20110101
[Drug-induced tubulointerstitial nephritis]. Nederlands tijdschrift voor geneeskunde 20110101
Omeprazole does not change the oral bioavailability or pharmacokinetics of vinpocetine in rats. Pharmacological reports : PR 20110101
[Chronic pancreatitis: microbe-intestinal tissue complex and systemic inflammatory response]. Eksperimental'naia i klinicheskaia gastroenterologiia = Experimental & clinical gastroenterology 20110101
[Prevention of acute stress ulcer and gastrointestinal bleeding in patients with acute necrotizing pancreatitis]. Anesteziologiia i reanimatologiia 20110101
[Effect of acidophilic multiprobiotic symbiter on pathological changes in bone periodontal tissue under hypo-acidic condition]. Fiziolohichnyi zhurnal (Kiev, Ukraine : 1994) 20110101
Iatrogenic gastric wall abscess infected with Enterobacter cloacae after biopsy. Gastrointestinal endoscopy 20101201
Maintenance treatment with proton pump inhibitors for reflux esophagitis in pediatric patients: a systematic literature analysis. Journal of pediatric gastroenterology and nutrition 20101201
Novel approaches to inhibition of gastric acid secretion. Current gastroenterology reports 20101201
Review article: combination of clopidogrel and proton pump inhibitors: implications for clinicians. Journal of cardiovascular pharmacology and therapeutics 20101201
Identifying, evaluating, and controlling bioanalytical risks resulting from nonuniform matrix ion suppression/enhancement and nonlinear liquid chromatography-mass spectrometry assay response. Analytical chemistry 20101201
Effect of omeprazole on the expression of transcription factors in osteoclasts and osteoblasts. International journal of molecular medicine 20101201
The effect of cytochrome P2C19 and interleukin-1 polymorphisms on H. pylori eradication rate of 1-week triple therapy with omeprazole or rabeprazole, amoxycillin and clarithromycin in Chinese people. Journal of clinical pharmacy and therapeutics 20101201
Enantioseparation of rabeprazole and omeprazole by nonaqueous capillary electrophoresis with an ephedrine-based ionic liquid as the chiral selector. Biomedical chromatography : BMC 20101201
Effect of omeprazole on the concentration of interleukin-6 and transforming growth factor-β1 in patients receiving dual antiplatelet therapy after percutaneous coronary intervention. European cytokine network 20101201
Esomeprazole for the treatment of peptic ulcer bleeding. Expert review of gastroenterology & hepatology 20101201
A comprehensive development strategy in buccal drug delivery. AAPS PharmSciTech 20101201
Warfarin therapy: how the less interesting half just got interesting. Journal of thrombosis and haemostasis : JTH 20101201
Late-onset omeprazole-associated acute interstitial nephritis. Journal of the American Geriatrics Society 20101201
Haematological side effect of Helicobacter pylori eradication. Journal of the Egyptian Society of Parasitology 20101201
[Atypical manifestations of acute posterior placoid pigment epitheliopathy]. Archivos de la Sociedad Espanola de Oftalmologia 20101201
Comparative healing property of kombucha tea and black tea against indomethacin-induced gastric ulceration in mice: possible mechanism of action. Food & function 20101201
In brief: Clopidogrel and omeprazole. The Medical letter on drugs and therapeutics 20101129
Clarithromycin-based triple therapy for Helicobacter pylori treatment in peptic ulcer patients. Journal of infection in developing countries 20101124
Clopidogrel with or without omeprazole in coronary artery disease. The New England journal of medicine 20101111
Interaction of clopidogrel and omeprazole. The New England journal of medicine 20101111
Clinical problem-solving. Bitter pills. The New England journal of medicine 20101104
Efficacy of standard triple therapy in the treatment of Helicobacter pylori infection: experience from Kuwait. Digestive diseases and sciences 20101101
The proton pump inhibitor test for gastroesophageal reflux disease: optimal cut-off value and duration. Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver 20101101
A dispensing error resulting in possible fluoxetine overdose and subsequent discontinuation syndrome in a child. Clinical pediatrics 20101101
[Dilemma between gastroprotection and cardiovascular prevention]. Deutsche medizinische Wochenschrift (1946) 20101101
Treatment strategies for acid reflux: EncomPASSing practical solutions for primary care. The American journal of gastroenterology 20101101
Utility of dried blood spot sampling and storage for increased stability of photosensitive compounds. Bioanalysis 20101101
Endoscopic jejunal biopsy culture: a simple and effective method to study jejunal microflora. Indian journal of gastroenterology : official journal of the Indian Society of Gastroenterology 20101101
Interactive medical case. Bitter pills. The New England journal of medicine 20101014
Liquid chromatographic resolution of proton pump inhibitors including omeprazole on a ligand exchange chiral stationary phase. Journal of chromatography. A 20101008
Effect of Helicobacter pylori infection and its eradication on reflux esophagitis and reflux symptoms. The American journal of gastroenterology 20101001
Helicobacter pylori eradication with a 7-day low-dose triple therapy in hemodialysis patients. Clinical and experimental nephrology 20101001
Discontinuation of long-term proton pump inhibitor therapy in primary care patients: a randomized placebo-controlled trial in patients with symptom relapse. European journal of gastroenterology & hepatology 20101001
Comparison between the effect of omeprazole and rabeprazole on the antiplatelet action of clopidogrel. Circulation journal : official journal of the Japanese Circulation Society 20101001
Racemization of the gastrointestinal antisecretory chiral drug esomeprazole magnesium via the pyramidal inversion mechanism: A theoretical study. Chirality 20101001
Stress-related mucosal disease: incidence of bleeding and the role of omeprazole in its prophylaxis. European journal of internal medicine 20101001
Pharmacodynamic effects of concomitant versus staggered clopidogrel and omeprazole intake: results of a prospective randomized crossover study. Circulation. Cardiovascular interventions 20101001
Considerable use of furazolidone in Iran. Saudi journal of gastroenterology : official journal of the Saudi Gastroenterology Association 20101001
Risk factors and prevention of upper gastrointestinal hemorrhage after a coronary artery bypass grafting operation. Surgery today 20101001
Comparison of the efficacy of triple versus quadruple therapy on the eradication of Helicobacter pylori and antibiotic resistance. Journal of digestive diseases 20101001
Infection: Bismuth improves PPI-based triple therapy for H. pylori eradication. Nature reviews. Gastroenterology & hepatology 20101001
Intermittent use of pantoprazole and famotidine in severe hypomagnesaemia due to omeprazole. The Netherlands journal of medicine 20101001
[Effects of Helicobacter pylori, omeprazole and gastrin on the proliferation and apoptosis of gastric epithelial cell]. Zhonghua yi xue za zhi 20100928
Proton pump inhibitors and acute interstitial nephritis. BMJ (Clinical research ed.) 20100922
Standard triple, bismuth pectin quadruple and sequential therapies for Helicobacter pylori eradication. World journal of gastroenterology 20100914
Direct HPLC enantioseparation of omeprazole and its chiral impurities: application to the determination of enantiomeric purity of esomeprazole magnesium trihydrate. Journal of pharmaceutical and biomedical analysis 20100905
The effect of acid reduction with a proton pump inhibitor on the pharmacokinetics of lopinavir or ritonavir in HIV-infected patients on lopinavir/ritonavir-based therapy. Journal of clinical pharmacology 20100901
Regression of immunoproliferative small intestinal disease after eradication of Helicobacter pylori. Journal of gastrointestinal cancer 20100901
Nonpigmented fixed drug eruption induced by esomeprazole. Cutaneous and ocular toxicology 20100901
Antioxidant pre-treatment prevents omeprazole-induced toxicity in an in vitro model of infectious gastritis. Free radical biology & medicine 20100901
Diagnostic exercise: chronic vomiting in a dog. Veterinary pathology 20100901
Clinically significant CYP2C inhibition by noscapine but not by glucosamine. Clinical pharmacology and therapeutics 20100901
Role of cytochrome P450 2C19 genetic polymorphisms in the therapeutic efficacy of omeprazole in Iranian patients with erosive reflux esophagitis. Archives of Iranian medicine 20100901
[On-demand treatment of nonerosive reflux disease: omeprazole plus bicarbonate powder versus omeprazole capsules]. Acta gastroenterologica Latinoamericana 20100901
[37-year old patient with fever, diarrhea and lymphadenopathy]. Der Internist 20100801
Gastroprotection in trauma patients receiving non-steroidal anti-inflammatory drugs. The surgeon : journal of the Royal Colleges of Surgeons of Edinburgh and Ireland 20100801
Efficacy and safety of Levofloxacin, Clarithromycin and Esomeprazol as first line triple therapy for Helicobacter pylori eradication in Middle East. Prospective, randomized, blind, comparative, multicenter study. European journal of internal medicine 20100801
Novel application of proton pump inhibitor for the prevention of colitis-induced colorectal carcinogenesis beyond acid suppression. Cancer prevention research (Philadelphia, Pa.) 20100801
Pharmacokinetics of intrarectal omeprazole in alpacas. Journal of veterinary pharmacology and therapeutics 20100801
A one-year economic evaluation of six alternative strategies in the management of uninvestigated upper gastrointestinal symptoms in Canadian primary care. Canadian journal of gastroenterology = Journal canadien de gastroenterologie 20100801
Hyperprolactinaemia induced by proton pump inhibitor. JPMA. The Journal of the Pakistan Medical Association 20100801
[Impact of different proton pump inhibitors on the antiplatelet activity of clopidogrel in combination with aspirin for patients undergoing coronary stent implantation]. Zhongguo ying yong sheng li xue za zhi = Zhongguo yingyong shenglixue zazhi = Chinese journal of applied physiology 20100801
[Active pharmacosurveillance of patients affiliated to the Colombian general social security/health system]. Revista de salud publica (Bogota, Colombia) 20100801
NSAIDs and risk of lower gastrointestinal bleeding. Lancet (London, England) 20100717
Celecoxib versus omeprazole and diclofenac in patients with osteoarthritis and rheumatoid arthritis (CONDOR): a randomised trial. Lancet (London, England) 20100717
Omeprazole-induced cough in a patient with gastroesophageal reflux disease. European journal of gastroenterology & hepatology 20100701
Gedunin and photogedunin of Xylocarpus granatum show significant anti-secretory effects and protect the gastric mucosa of peptic ulcer in rats. Phytomedicine : international journal of phytotherapy and phytopharmacology 20100701
Pantoprazole does not influence the antiplatelet effect of clopidogrel-a whole blood aggregometry study after coronary stenting. Journal of cardiovascular pharmacology 20100701
Investigation of the anti-inflammatory effect of Curcuma longa in Helicobacter pylori-infected patients. International immunopharmacology 20100701
Efficacy and safety of modified sequential three-step empirical therapy for chronic cough. Respirology (Carlton, Vic.) 20100701
Editorial: just how 'difficult' is it to withdraw PPI treatment? The American journal of gastroenterology 20100701
Comparative study of Nigella Sativa and triple therapy in eradication of Helicobacter Pylori in patients with non-ulcer dyspepsia. Saudi journal of gastroenterology : official journal of the Saudi Gastroenterology Association 20100701
Peptic ulcer bleeding outcomes adversely affected by end-stage renal disease. Gastrointestinal endoscopy 20100701
Role of 7,8-dimethoxycoumarin in anti-secretary and anti-inflammatory action on pyloric ligation-induced gastritis in rats. Journal of Asian natural products research 20100701
Omeprazole preferentially inhibits the metabolism of (+)-(S)-citalopram in healthy volunteers. British journal of clinical pharmacology 20100701
A column-switching method for quantification of the enantiomers of omeprazole in native matrices of waste and estuarine water samples. Talanta 20100630
Postoperative pneumonia in elderly patients receiving acid suppressants: a retrospective cohort analysis. BMJ (Clinical research ed.) 20100621
Hemifacial paralysis in a child treated for leukemia: unusual side effect of omeprazole? Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners 20100601
Effect of soybean administration on the pharmacokinetics of carbamazepine and omeprazole in rats. Fundamental & clinical pharmacology 20100601
Recurrent cytomegalovirus infection in ileal pouch-anal anastomosis for ulcerative colitis. Inflammatory bowel diseases 20100601
Impact of the CYP2C19*17 allele on the pharmacokinetics of omeprazole and pantoprazole in children: evidence for a differential effect. Drug metabolism and disposition: the biological fate of chemicals 20100601
Cadmium inhibits acid secretion in stimulated frog gastric mucosa. Toxicology and applied pharmacology 20100601
Effect of glycyrrhizin on CYP2C19 and CYP3A4 activity in healthy volunteers with different CYP2C19 genotypes. Xenobiotica; the fate of foreign compounds in biological systems 20100601
Distribution of small intestinal mucosal injuries as a result of NSAID administration. European journal of clinical investigation 20100601
Influence of CYP2C19 on the relationship between pharmacokinetics and intragastric pH of omeprazole administered by successive intravenous infusions in Chinese healthy volunteers. European journal of clinical pharmacology 20100601
High efficacy of 14-day triple therapy-based, bismuth-containing quadruple therapy for initial Helicobacter pylori eradication. Helicobacter 20100601
Second-line and rescue therapies for Helicobacter pylori eradication in clinical practice. Journal of gastrointestinal and liver diseases : JGLD 20100601
Early postoperative care of liver transplantation for infants with biliary atresia during pediatric intensive care unit stay. Transplantation proceedings 20100601
Quadruple therapy with ecabet sodium, omeprazole, amoxicillin and metronidazole is effective for eradication of Helicobacter pylori after failure of first-line therapy (KDOG0201 Study). Journal of clinical pharmacy and therapeutics 20100601
[Does dual antiplatelet therapy always require gastroprotection? Gastroprotection with proton pump inhibitors is advisable for all patients who need dual antiplatelet therapy]. Giornale italiano di cardiologia (2006) 20100601
Is the prevalence of CYP2C19 genetic variants different in Pacific people than in New Zealand Europeans? The New Zealand medical journal 20100528
Use of (S)-BINOL as NMR chiral solvating agent for the enantiodiscrimination of omeprazole and its analogs. Chirality 20100515
Diagnosis of gastroesophageal reflux disease. American family physician 20100515
[Prevalence of rebleeding from peptic ulcer in patients treated with proton pump inhibitors]. Medicina clinica 20100508
Omeprazole induces gastric permeability to digoxin. Digestive diseases and sciences 20100501
Influence of number of calibration standards within a defined range on pharmacokinetic disposition-case studies with omeprazole and clopidogrel carboxylic acid. Biomedical chromatography : BMC 20100501
A placebo-controlled trial of 10-day bismuth-based quadruple therapy to eradicate Helicobacter pylori infection; a pilot study for the large Linqu County trial. European journal of gastroenterology & hepatology 20100501
Proton pump inhibitor lansoprazole is a nuclear liver X receptor agonist. Biochemical pharmacology 20100501
Impact of oesophagitis classification in evaluating healing of erosive oesophagitis after therapy with proton pump inhibitors: a pooled analysis. European journal of gastroenterology & hepatology 20100501
Clinical trial: clarithromycin vs. levofloxacin in first-line triple and sequential regimens for Helicobacter pylori eradication. Alimentary pharmacology & therapeutics 20100501
If I take the blood thinner Plavix, should I avoid using Prilosec or other heartburn medications? Mayo Clinic women's healthsource 20100501
Simultaneous determination of tolbutamide, omeprazole, midazolam and dextromethorphan in human plasma by LC-MS/MS--a high throughput approach to evaluate drug-drug interactions. Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20100501
Gastric acid-reducing medications and clopidogrel: what are the latest FDA recommendations? The American journal of gastroenterology 20100501
Rescue therapy using a rifabutin-based regimen is effective for cure of Helicobacter pylori infection. Canadian journal of gastroenterology = Journal canadien de gastroenterologie 20100501
Omeprazole-induced acute interstitial nephritis is not related to CYP2C19 genotype or CYP2C19 phenotype. British journal of clinical pharmacology 20100501
Protective effect of lafutidine, a histamine H2 receptor antagonist, against loxoprofen-induced small intestinal lesions in rats. Journal of gastroenterology and hepatology 20100501
Eradication of Helicobacter spp. by using medicated diet in mice deficient in functional natural killer cells and complement factor D. Journal of the American Association for Laboratory Animal Science : JAALAS 20100501
Evidence for interaction between clopidogrel and proton-pump inhibitors. American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists 20100415
Gastrin release: Antrum microdialysis reveals a complex neural control. Regulatory peptides 20100409
Helicobacter pylori first-line treatment and rescue option containing levofloxacin in patients allergic to penicillin. Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver 20100401
The prokinetic effect of mosapride citrate combined with omeprazole therapy improves clinical symptoms and gastric emptying in PPI-resistant NERD patients with delayed gastric emptying. Journal of gastroenterology 20100401
Pharmacokinetics of intravenous omeprazole in critically ill paediatric patients. European journal of clinical pharmacology 20100401
Omeprazole-Mg 20.6 mg is superior to lansoprazole 15 mg for control of gastric acid: a comparison of over-the-counter doses of proton pump inhibitors. Alimentary pharmacology & therapeutics 20100401
The efficacy and safety of proton pump inhibitors vs histamine-2 receptor antagonists for stress ulcer bleeding prophylaxis among critical care patients: a meta-analysis. Critical care medicine 20100401
Interaction study between levofloxacin and omeprazole using urinary pharmacokinetic data. Pakistan journal of pharmaceutical sciences 20100401
Upregulation of the esophago-UES relaxation response: a possible pathophysiological mechanism in suspected reflux laryngitis. Neurogastroenterology and motility : the official journal of the European Gastrointestinal Motility Society 20100401
A randomized controlled trial: efficacy and safety of azithromycin, ofloxacin, bismuth, and omeprazole compared with amoxicillin, clarithromycin, bismuth, and omeprazole as second-line therapy in patients with Helicobacter pylori infection. Helicobacter 20100401
Omeprazole-induced subacute cutaneous lupus erythematosus. Clinical and experimental dermatology 20100401
Modification of gastric pH in the fasted dog. The Journal of pharmacy and pharmacology 20100401
[Evaluation of the effect of ilaprazole on intragastric pH in patients with duodenal ulcer]. Zhonghua nei ke za zhi 20100401
Omeprazole induces gastric transmucosal permeability to the peptide bradykinin. World journal of gastroenterology 20100307
PPI-delayed diagnosis of gastrinoma: oncologic victim of pharmacologic success. Pathology oncology research : POR 20100301
Inappropriate use of proton pump inhibitors. Irish journal of medical science 20100301
Wernicke encephalopathy complicating hyperemesis gravidarum: a case report. European journal of obstetrics, gynecology, and reproductive biology 20100301
Stable expression, activity, and inducibility of cytochromes P450 in differentiated HepaRG cells. Drug metabolism and disposition: the biological fate of chemicals 20100301
A bio-analytical hydrophilic interaction LC-MS/MS method for the simultaneous quantification of omeprazole and lansoprazole in human plasma in support of a pharmacokinetic omeprazole study in children. Journal of separation science 20100301
The role of L-arginine in inclusion complexes of omeprazole with cyclodextrins. AAPS PharmSciTech 20100301
Treating silent reflux disease does not improve poorly controlled asthma. Cleveland Clinic journal of medicine 20100301
Sensitivity and proportionality assessment of metabolites from microdose to high dose in rats using LC-MS/MS. Bioanalysis 20100301
Clinical and cost impact of intravenous proton pump inhibitor use in non-ICU patients. World journal of gastroenterology 20100227
Proton pump inhibitors. British dental journal 20100227
Development of a pH-responsive drug delivery system for enantioselective-controlled delivery of racemic drugs. Journal of controlled release : official journal of the Controlled Release Society 20100225
Pharmacokinetic profile of immediate-release omeprazole in patients with gastro-oesophageal reflux associated with gastroparesis. Alimentary pharmacology & therapeutics 20100215
Stimulatory effect of N-methyltyramine, a congener of beer, on pancreatic secretion in conscious rats. Alcoholism, clinical and experimental research 20100201
Follow-up to the pre-validation of a harmonised protocol for assessment of CYP induction responses in freshly isolated and cryopreserved human hepatocytes with respect to culture format, treatment, positive reference inducers and incubation conditions. Toxicology in vitro : an international journal published in association with BIBRA 20100201
Latin american consensus on gastroesophageal reflux disease: an update on therapy. Gastroenterologia y hepatologia 20100201
Combined treatment of achalasia - botulinum toxin injection followed by pneumatic dilatation: long-term results. Diseases of the esophagus : official journal of the International Society for Diseases of the Esophagus 20100201
Interleukin-1beta promotes gastric atrophy through suppression of Sonic Hedgehog. Gastroenterology 20100201
Omeprazole and clopidogrel: Should clinicians be worried? Cleveland Clinic journal of medicine 20100201
The impact of treatment with omeprazole on the effectiveness of clopidogrel drug therapy during the first year after successful coronary stenting. The Canadian journal of cardiology 20100201
Controversial warning on Plavix and stomach-protecting medications. Harvard heart letter : from Harvard Medical School 20100201
Generics offer pharmacy plans specific benefits. Managed care (Langhorne, Pa.) 20100201
CYP1A inhibition in fish gill filaments: a novel assay applied on pharmaceuticals and other chemicals. Aquatic toxicology (Amsterdam, Netherlands) 20100131
Effectiveness of voice therapy in reflux-related voice disorders. Diseases of the esophagus : official journal of the International Society for Diseases of the Esophagus 20100101
Eltrombopag, an oral thrombopoietin receptor agonist, has no impact on the pharmacokinetic profile of probe drugs for cytochrome P450 isoenzymes CYP3A4, CYP1A2, CYP2C9 and CYP2C19 in healthy men: a cocktail analysis. European journal of clinical pharmacology 20100101
Identification of the human cytochrome P450 enzymes involved in the two oxidative steps in the bioactivation of clopidogrel to its pharmacologically active metabolite. Drug metabolism and disposition: the biological fate of chemicals 20100101
Effects of Kollicoat IR and hydroxypropyl-beta-cyclodextrin on the dissolution rate of omeprazole from its microparticles and enteric-coated capsules. Pharmaceutical development and technology 20100101
Proton pump inhibitor and clopidogrel interaction: fact or fiction? The American journal of gastroenterology 20100101
Current standings of the proton pump inhibitor and clopidogrel co-therapy: review on an evolving field with the eyes of the gastroenterologist. Digestion 20100101
Short-duration furazolidone therapy in combination with amoxicillin, bismuth subcitrate, and omeprazole for eradication of Helicobacter pylori. Saudi journal of gastroenterology : official journal of the Saudi Gastroenterology Association 20100101
The potential therapeutic effect of melatonin in Gastro-Esophageal Reflux Disease. BMC gastroenterology 20100101
Efficacy of omeprazole versus high-dose famotidine for prevention of exercise-induced gastritis in racing Alaskan sled dogs. Journal of veterinary internal medicine 20100101
[Proton pump inhibitors and calcium absorption?]. Medizinische Monatsschrift fur Pharmazeuten 20100101
Immediate-release oral proton pump inhibitors: Panacea or a flash in the pan? Journal of gastroenterology and hepatology 20100101
Effects of omeprazole on the antiplatelet activity of clopidogrel. International heart journal 20100101
Toxic tacrolimus blood levels with rifampin administration in a renal transplant recipient. Annals of transplantation 20100101
Can omeprazole reduce the incidence of hypercalcemia in dialysis patients using calcium containing phosphate binders? Journal of nephrology 20100101
Short-term antibiotic treatment has differing long-term impacts on the human throat and gut microbiome. PloS one 20100101
Effect of eradication of Helicobacter pylori and iron supplementation on the iron status of children with iron deficiency. Archives of medical research 20100101
Improved HPLC method for determination of four PPIs, omeprazole, pantoprazole, lansoprazole and rabeprazole in human plasma. Journal of pharmacy & pharmaceutical sciences : a publication of the Canadian Society for Pharmaceutical Sciences, Societe canadienne des sciences pharmaceutiques 20100101
Study of cross-reactivity between proton pump inhibitors. Journal of investigational allergology & clinical immunology 20100101
[Modeling osteoporosis]. Vestnik Rossiiskoi akademii meditsinskikh nauk 20100101
Clopidogrel and proton pump inhibitor (PPI) interaction: separate intake and a non-omeprazole PPI the solution? European journal of medical research 20100101
Nutcracker esophagus: an acid related disease or a primary motor disorder? Gastroenterologie clinique et biologique 20100101
Proton pump inhibitor-induced neutropenia: possible cross-reactivity between omeprazole and pantoprazole. Clinical drug investigation 20100101
Osteogenic activity of locally applied small molecule drugs in a rat femur defect model. Journal of biomedicine & biotechnology 20100101
Stability-indicating high-performance thin-layer chromatographic method for quantitative determination of omeprazole in capsule dosage form. Journal of AOAC International 20100101
[Polypectomy and endoscopic management of a giant gastric polyp]. Revista de gastroenterologia del Peru : organo oficial de la Sociedad de Gastroenterologia del Peru 20100101
Randomized controlled trial: roxatidine vs omeprazole for non-erosive reflux disease. Hepato-gastroenterology 20100101
[Omeprazole of limited value in crying babies]. Nederlands tijdschrift voor geneeskunde 20100101
Liver fibrosis impairs hepatic pharmacokinetics of liver transplant drugs in the rat model. Drug metabolism and pharmacokinetics 20100101
Spectrophotometric determination of peptic ulcer sulfur-containing drugs in bulk form and in tablets. Drug testing and analysis 20100101
[Duodenal involvement in Henoch-Schonlein purpura. Report of a case]. Revista de gastroenterologia del Peru : organo oficial de la Sociedad de Gastroenterologia del Peru 20100101
Relationship between the acid-inhibitory effects of two proton pump inhibitors and CYP2C19 genotype in Japanese subjects: a randomized two-way crossover study. The Journal of international medical research 20100101
A case of gastric polyposis in antral area of stomach following prolonged proton-pump therapy. German medical science : GMS e-journal 20100101
De novo erosive esophagitis in duodenal ulcer patients related to pre-existing reflux symptoms, smoking, and patient age, but not to Helicobacter pylori eradication: a one-year follow-up study. Medicina (Kaunas, Lithuania) 20100101
Myocardium functional recovery protection by omeprazole after ischemia-reperfusion in isolated rat hearts. Revista brasileira de cirurgia cardiovascular : orgao oficial da Sociedade Brasileira de Cirurgia Cardiovascular 20100101
[Dynamics of regeneration of epitheliocytes from gastric mucosa at different modes of antirelapse treatment of ulcer disease]. Klinicheskaia meditsina 20100101
Role of intravenous omeprazole on non-variceal upper gastrointestinal bleeding after endoscopic treatment: a comparative study. Medicinski arhiv 20100101
[Dynamics of inflammatory periodontal diseases under the influence of gastroesophageal reflux disease therapy]. Eksperimental'naia i klinicheskaia gastroenterologiia = Experimental & clinical gastroenterology 20100101
Antibiotic susceptibility patterns of Helicobacter pylori and triple therapy in a high-prevalence area. British journal of biomedical science 20100101
Ultra-fast gradient LC method for omeprazole analysis using a monolithic column: assay development, validation, and application to the quality control of omeprazole enteric-coated pellets. Journal of AOAC International 20100101
Benign intermittent gastric outlet obstruction in an elderly: endoscopic management and brief review. Nigerian journal of medicine : journal of the National Association of Resident Doctors of Nigeria 20100101
Helicobacter pylori eradication and histopathological esophagitis in dyspeptic patients. Tropical gastroenterology : official journal of the Digestive Diseases Foundation 20100101
[Drug UDCA (Ursosan) in therapeutic management of patients Barrett's esophagus]. Eksperimental'naia i klinicheskaia gastroenterologiia = Experimental & clinical gastroenterology 20100101
A randomized trial comparing four Helicobacter pylori eradication regimens: standard triple therapy, ciprofloxacin based triple therapy, quadruple and sequential therapy. Tropical gastroenterology : official journal of the Digestive Diseases Foundation 20100101
Clinical practice. Barrett's esophagus. The New England journal of medicine 20091224
[Risky to combine clopidogrel with proton pump inhibitor?]. Lakartidningen 20091222
An academic perspective on the APPEs' educational significance. American journal of pharmaceutical education 20091217
LC-UV and LC-MS evaluation of stress degradation behaviour of tenatoprazole. Journal of pharmaceutical and biomedical analysis 20091205
Comparison of outcomes twelve years after antireflux surgery or omeprazole maintenance therapy for reflux esophagitis. Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association 20091201
[Prevention of GI bleeding due to antiplatelet agents: a labyrinth!]. Presse medicale (Paris, France : 1983) 20091201
Pharmacokinetic assessment of a five-probe cocktail for CYPs 1A2, 2C9, 2C19, 2D6 and 3A. British journal of clinical pharmacology 20091201
[Delayed hypersensitivity to sodium lauryl sulphate in omeprazole]. Annales de dermatologie et de venereologie 20091201
[Anti-Helicobacter pylori treatment in patients with idiopathic thrombocytopenic purpura]. Zhong nan da xue xue bao. Yi xue ban = Journal of Central South University. Medical sciences 20091201
Stool transplantation for older patients with Clostridium difficile infection. Journal of the American Geriatrics Society 20091201
[Acid suppression capacity of omeprazole, sodium bicarbonate and alginic acid in an oral powder combination]. Acta gastroenterologica Latinoamericana 20091201
[Effect of yiqi huoxue formula on healing quality and recurrence rate of peptic ulcer]. Zhongguo Zhong xi yi jie he za zhi Zhongguo Zhongxiyi jiehe zazhi = Chinese journal of integrated traditional and Western medicine 20091201
Identification of new CYP2C19 variants exhibiting decreased enzyme activity in the metabolism of S-mephenytoin and omeprazole. Drug metabolism and disposition: the biological fate of chemicals 20091101
Case reports--resolution of Barrett's disease and esophageal epithelial atypia after gastric bypass and LAP-BAND. Obesity surgery 20091101
Involvement of cytochrome P450 3A4 and P-glycoprotein in first-pass intestinal extraction of omeprazole in rabbits. Acta pharmacologica Sinica 20091101
Interaction between liquid protein solution and omeprazole suspension. American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists 20091101
Simple and sensitive LC-ESI-MS method for the quantitation of sildenafil in plasma samples. Journal of separation science 20091101
[Medical case of successful therapy of polymyositis by high doses of glucocorticoid]. Voenno-meditsinskii zhurnal 20091101
Missed opportunities in the trial on proton-pump inhibitor therapy in bleeding peptic ulcers. Annals of internal medicine 20091020
Missed opportunities in the trial on proton-pump inhibitor therapy in bleeding peptic ulcers. Annals of internal medicine 20091020
Missed opportunities in the trial on proton-pump inhibitor therapy in bleeding peptic ulcers. Annals of internal medicine 20091020
Long-term treatment with proton pump inhibitor is associated with undesired weight gain. World journal of gastroenterology 20091014
Early use of omeprazole benefits patients with acute myocardial infarction. Journal of thrombosis and thrombolysis 20091001
Effects of Angelicae tenuissima radix, Angelicae dahuricae radix and Scutellariae radix extracts on cytochrome P450 activities in healthy volunteers. Basic & clinical pharmacology & toxicology 20091001
In vitro inhibition and induction of human liver cytochrome p450 enzymes by milnacipran. Drug metabolism and disposition: the biological fate of chemicals 20091001
Comparison of azithromycin and metronidazole in a quadruple-therapy regimen for Helicobacter pylori eradication in dyspepsia. Saudi journal of gastroenterology : official journal of the Saudi Gastroenterology Association 20091001
Recurrent peptic ulcer disease in a pediatric patient with type 1 neurofibromatosis and primary ciliary dyskinesia. Minerva pediatrica 20091001
The effect of omeprazole on oesophageal pH in dogs during anaesthesia. The Journal of small animal practice 20091001
Nanoparticulation of poorly water soluble drugs using a wet-mill process and physicochemical properties of the nanopowders. Chemical & pharmaceutical bulletin 20091001
[Prostaglandin E(2) and omeprazole in treating poisoning related acute mucosal lesion]. Zhong nan da xue xue bao. Yi xue ban = Journal of Central South University. Medical sciences 20091001
Importance of CYP2C19 genetic polymorphism in the eradication of Helicobacter pylori in north Indians. The Indian journal of medical research 20091001
[Omeprazole increases the risk of myocardial infarction in patients treated with clopidogrel]. Lakartidningen 20091001
Hypersensitivity to generic drugs with soybean oil. The New England journal of medicine 20090924
Comparison of omeprazole and pantoprazole influence on a high 150-mg clopidogrel maintenance dose the PACA (Proton Pump Inhibitors And Clopidogrel Association) prospective randomized study. Journal of the American College of Cardiology 20090922
Systematic review: standard- and double-dose proton pump inhibitors for the healing of severe erosive oesophagitis -- a mixed treatment comparison of randomized controlled trials. Alimentary pharmacology & therapeutics 20090915
Does Helicobacter pylori eradication therapy for peptic ulcer prevent gastric cancer? World journal of gastroenterology 20090914
Aspirin in the primary prevention of vascular disease. Lancet (London, England) 20090912
Effect of rebamipide on quality of peptic ulcer healing in rat. Digestive diseases and sciences 20090901
The efficacy of Helicobacter pylori eradication regimen with and without vitamin C supplementation. Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver 20090901
Seven-day intravenous low-dose omeprazole infusion reduces peptic ulcer rebleeding for patients with comorbidities. Gastrointestinal endoscopy 20090901
The pharmacology of esomeprazole and its role in gastric acid related diseases. Expert opinion on drug metabolism & toxicology 20090901
Omeprazole inhibits IL-4 and IL-13 signaling signal transducer and activator of transcription 6 activation and reduces lung inflammation in murine asthma. The Journal of allergy and clinical immunology 20090901
Oesophageal acid hypersensitivity is not a contraindication to Nissen fundoplication. The British journal of surgery 20090901
Pylera for the eradication of Helicobacter pylori infection. Expert review of anti-infective therapy 20090901
Effect of a proton pump inhibitor on the pharmacokinetics of imatinib. British journal of clinical pharmacology 20090901
Effects of omeprazole on the pharmacokinetic profiles of lisdexamfetamine dimesylate and extended-release mixed amphetamine salts in adults. Postgraduate medicine 20090901
[The administration of proton-pump inhibitors in little children or patients with difficulties in deglutition]. Journal de pharmacie de Belgique 20090901
Efficacy of an intravenous proton pump inhibitor after endoscopic therapy with epinephrine injection for peptic ulcer bleeding in patients with uraemia: a case-control study. Alimentary pharmacology & therapeutics 20090815
Lichenoid drug eruption. Dermatology online journal 20090815
Off-label use of medicines in children: can available evidence avoid useless paediatric trials? The case of proton pump inhibitors for the treatment of gastroesophageal reflux disease. European journal of clinical pharmacology 20090801
Efficacy of the standard quadruple therapy versus triple therapies containing proton pump inhibitor plus amoxicillin and clarithromycin or amoxicillin-clavulanic acid and metronidazole for Helicobacter pylori eradication in children. Digestive diseases and sciences 20090801
Comparison of the degree of duodenogastroesophageal reflux and acid reflux between patients who failed to respond and those who were successfully treated with a proton pump inhibitor once daily. The American journal of gastroenterology 20090801
Parotid mucosa-associated lymphoid tissue lymphoma regression after Helicobacter pylori eradication. The Laryngoscope 20090801
Effect of a gastrin-releasing peptide receptor antagonist and a proton pump inhibitor association in an animal model of gastritis. Peptides 20090801
Generic omeprazole delayed-release capsules: in vitro performance evaluations. Drug development and industrial pharmacy 20090801
A biodegradable esophageal stent in the treatment of a corrosive esophageal stenosis in a child. Journal of pediatric gastroenterology and nutrition 20090801
CYP2C19 haplotypes in Koreans as a marker of enzyme activity evaluated with omeprazole. Journal of clinical pharmacy and therapeutics 20090801
Toxic epidermal necrolysis and neutropaenia: complications of omeprazole. The Australasian journal of dermatology 20090801
It is premature to recommend low-dose intravenous proton pump inhibition after endoscopic hemostasis in patients with bleeding ulcers. The American journal of gastroenterology 20090801
Long-term use of proton pump inhibitors: are they really safe? A case of delayed acute interstitial nephritis. Journal of the American Geriatrics Society 20090801
Sevelamer reduces the efficacy of many other drugs. Prescrire international 20090801
Transmucosal gastric leak induced by proton pump inhibitors. Digestive diseases and sciences 20090701
Microscopic colitis associated with omeprazole and esomeprazole exposure. Journal of clinical gastroenterology 20090701
Simultaneous estimation of four proton pump inhibitors--lansoprazole, omeprazole, pantoprazole and rabeprazole: development of a novel generic HPLC-UV method and its application to clinical pharmacokinetic study. Biomedical chromatography : BMC 20090701
Drug-drug interaction between clopidogrel and the proton pump inhibitors. The Annals of pharmacotherapy 20090701
Evidence that proton-pump inhibitor therapy induces the symptoms it is used to treat. Gastroenterology 20090701
Do the association of cytochrome P450 interacting drugs, influence clopidogrel efficacity? American heart journal 20090701
Management of acute peptic ulcers: how ethnicity, different proton pump inhibitors and mechanism of delivery alter the equation. Journal of gastroenterology and hepatology 20090701
Comparison of p.o. or i.v. proton pump inhibitors on 72-h intragastric pH in bleeding peptic ulcer. Journal of gastroenterology and hepatology 20090701
Phytochemical analyses and gastroprotective effects of Eugenia umbelliflora (Myrtaceae) on experimental gastric ulcers. Natural product communications 20090701
Diverse chemicals including aryl hydrocarbon receptor ligands modulate transcriptional activity of the 3'immunoglobulin heavy chain regulatory region. Toxicology 20090630
The anti-ulcer activities of bisabolangelone from Angelica polymorpha. Journal of ethnopharmacology 20090622
Interaction between clopidogrel and proton pump inhibitors. CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne 20090609
Determination of tenatoprazole enantiomers and their enantioselective pharmacokinetics in rats. Chirality 20090601
The use of neem for controlling gastric hyperacidity and ulcer. Phytotherapy research : PTR 20090601
Effects of allicin on CYP2C19 and CYP3A4 activity in healthy volunteers with different CYP2C19 genotypes. European journal of clinical pharmacology 20090601
Prevention of nonsteroidal anti-inflammatory drug-induced small-intestinal injury by prostaglandin: a pilot randomized controlled trial evaluated by capsule endoscopy. Gastrointestinal endoscopy 20090601
Proton pump inhibitors and clopidogrel: a difficult dilemma. American heart journal 20090601
Effect of gastric ulceration on physiologic responses to exercise in horses. American journal of veterinary research 20090601
[Clinical observation on transcutaneous electrical acupoint stimulation for treatment of functional dyspepsia]. Zhongguo zhen jiu = Chinese acupuncture & moxibustion 20090601
[Pharmacy compounding of an omeprazole suspension]. Journal de pharmacie de Belgique 20090601
Case report: peptic ulcer disease in a professional athlete. The Physician and sportsmedicine 20090601
Cytochrome P-450 polymorphisms and response to clopidogrel. The New England journal of medicine 20090521
Inactivation by omeprazole of the carnitine transporter (OCTN2) reconstituted in liposomes. Chemico-biological interactions 20090515
Regulation of glycolytic oscillations by mitochondrial and plasma membrane H+-ATPases. Biophysical journal 20090506
The bioavailability of bromazepam, omeprazole and paracetamol given by nasogastric feeding tube. European journal of clinical pharmacology 20090501
Proton pump inhibitors exert anti-inflammatory effects and decrease human microglial and monocytic THP-1 cell neurotoxicity. Experimental neurology 20090501
Eradication of Helicobacter pylori may be beneficial in the management of Alzheimer's disease. Journal of neurology 20090501
Clopidogrel inhibits CYP2C19-dependent hydroxylation of omeprazole related to CYP2C19 genetic polymorphisms. Journal of clinical pharmacology 20090501
Delayed-type hypersensitivity reactions due to sodium lauryl sulphate in omeprazole. Journal of the European Academy of Dermatology and Venereology : JEADV 20090501
Helicobacter pylori infection in patients with chronic urticaria: correlation with pathologic findings in gastric biopsies. International journal of dermatology 20090501
Effects of omeprazole treatment on nucleoside transporter expression and adenosine uptake in rat gastric mucosa. Canadian journal of physiology and pharmacology 20090501
Pneumomediastinum, stomach wall and hepatic portal vein gas secondary to partial necrosis of the stomach wall. Singapore medical journal 20090501
[Eosinophilic esophagitis: report of three cases]. Revista medica de Chile 20090501
Esophageal candidiasis in an immunocompetent girl. World journal of pediatrics : WJP 20090501
Silent acid reflux and asthma control. The New England journal of medicine 20090409
Control of 24-hour intragastric acidity with morning dosing of immediate-release and delayed-release proton pump inhibitors in patients with GERD. Journal of clinical gastroenterology 20090401
Highly sensitive method for the determination of omeprazole in human plasma by liquid chromatography-electrospray ionization tandem mass spectrometry: application to a clinical pharmacokinetic study. Biomedical chromatography : BMC 20090401
Levofloxacin, Amoxicillin, and Omeprazole as first-line triple therapy for Helicobacter pylori eradication. Journal of clinical gastroenterology 20090401
Effect of Helicobacter pylori eradication on ulcer recurrence after simple closure of perforated duodenal ulcer. International journal of surgery (London, England) 20090401
Impact of intestinal CYP2C19 genotypes on the interaction between tacrolimus and omeprazole, but not lansoprazole, in adult living-donor liver transplant patients. Drug metabolism and disposition: the biological fate of chemicals 20090401
Amoxicillin, clarithromycin, and omeprazole based targeted nanoparticles for the treatment of H. pylori. Journal of drug targeting 20090401
Faster clearance of omeprazole in mutant Nagase analbuminemic rats: possible roles of increased protein expression of hepatic CYP1A2 and lower plasma protein binding. Biopharmaceutics & drug disposition 20090401
Regulation of arginase/nitric oxide synthesis axis via cytokine balance contributes to the healing action of malabaricone B against indomethacin-induced gastric ulceration in mice. International immunopharmacology 20090401
A high-throughput assay using liquid chromatography-tandem mass spectrometry for simultaneous in vivo phenotyping of 5 major cytochrome p450 enzymes in patients. Therapeutic drug monitoring 20090401
Randomized, double-blind, placebo-controlled trial: effect of lactobacillus GG supplementation on Helicobacter pylori eradication rates and side effects during treatment in children. Journal of pediatric gastroenterology and nutrition 20090401
Effects of preoperative administration of omeprazole on bleeding after endoscopic submucosal dissection: a prospective randomized controlled trial. Endoscopy 20090401
Clopidogrel and proton pump inhibitors: gastric protection at expense of vascular benefit? Thrombosis and haemostasis 20090401
Impact of proton pump inhibitors on the antiplatelet effects of clopidogrel. Thrombosis and haemostasis 20090401
The response of Asian patients with functional dyspepsia to eradication of Helicobacter pylori infection. European journal of gastroenterology & hepatology 20090401
Use of gastrointestinal proton pump inhibitors to regulate osteoclast-mediated resorption of calcium phosphate cements in vivo. Current drug delivery 20090401
Effect of alpha-tocopherol, N-acetylcysteine and omeprazole on esophageal adenocarcinoma formation in a rat surgical model. International journal of cancer 20090315
Omeprazole significantly reduces posaconazole serum trough level. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 20090315
Efficacy of a new therapeutic regimen versus two routinely prescribed treatments for eradication of Helicobacter pylori: a randomized, double-blind study of doxycycline, co-amoxiclav, and omeprazole in Iranian patients. Digestive diseases and sciences 20090301
Tuberculosis in a patient on temozolomide: a case report. Journal of neuro-oncology 20090301
Pharmacokinetics and absorption of posaconazole oral suspension under various gastric conditions in healthy volunteers. Antimicrobial agents and chemotherapy 20090301
Experimental oesophagitis in the rat is associated with decreased voluntary movement. Neurogastroenterology and motility : the official journal of the European Gastrointestinal Motility Society 20090301
Using omeprazole to link the components of the post-prandial alkaline tide in the spiny dogfish, Squalus acanthias. The Journal of experimental biology 20090301
Effect of proton pump inhibitors on vitamins and iron. The American journal of gastroenterology 20090301
The Calcium Carbonate Breath Test, a noninvasive test of stimulated gastric acid secretion: preliminary communication. European journal of gastroenterology & hepatology 20090301
Relative bioavailability and pharmacokinetic study of omeprazole 20 mg enteric-coated tablet in healthy Bangladeshi volunteers. International journal of clinical pharmacology and therapeutics 20090301
Evaluation of use of proton pump inhibitors in Greece. European journal of internal medicine 20090301
Acute gastroduodenal injury after ingestion of diluted herbicide pendimethalin. Singapore medical journal 20090301
Oral or intravenous proton pump inhibitor in patients with peptic ulcer bleeding after successful endoscopic epinephrine injection. British journal of clinical pharmacology 20090301
Comparative study of omeprazole, lansoprazole, pantoprazole and esomeprazole for symptom relief in patients with reflux esophagitis. World journal of gastroenterology 20090227
Effects of omeprazole on plasma levels of raltegravir. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 20090215
Analysis of omeprazole and its main metabolites by liquid chromatography using hybrid micellar mobile phases. Analytica chimica acta 20090209
In vitro evaluation of natural and methylated cyclodextrins as buccal permeation enhancing system for omeprazole delivery. European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V 20090201
Helicobacter pylori eradication in patients on long-term treatment with NSAIDs reduces the severity of gastritis: a randomized controlled trial. Journal of clinical gastroenterology 20090201
N-(2-hydroxyethyl)-N,2-dimethyl-8-{[(4R)-5-methyl-3,4-dihydro-2H-chromen-4-yl]amino}imidazo[1,2-a]pyridine-6-carboxamide (PF-03716556), a novel, potent, and selective acid pump antagonist for the treatment of gastroesophageal reflux disease. The Journal of pharmacology and experimental therapeutics 20090201
Nefopam hydrochloride compatibility and stability with selected proton pump inhibitors in bionolyte G5 injection for intravenous infusion. Journal of clinical pharmacy and therapeutics 20090201
Sequential therapy vs. standard triple therapies for Helicobacter pylori infection: a meta-analysis. Journal of clinical pharmacy and therapeutics 20090201
Antiulcerogenic and anti-inflammatory activities of the essential oil from Pterodon emarginatus seeds. The Journal of pharmacy and pharmacology 20090201
Design and in vitro/in vivo evaluation of multi-layer film coated pellets for omeprazole. Chemical & pharmaceutical bulletin 20090201
Proton pump inhibitor omeprazole use is associated with low bone mineral density in maintenance haemodialysis patients. International journal of clinical practice 20090201
Medications as a potential source of exposure to phthalates in the U.S. population. Environmental health perspectives 20090201
[Medical treatment efficient in chronic reflux. Also surgery has a given place in long-term therapy--for certain patients]. Lakartidningen 20090201
[Therapy of gastric acid-induced illnesses in general practice. The first pantoprazole generic drug has arrived]. MMW Fortschritte der Medizin 20090129
Physico-chemical solid-state characterization of omeprazole sodium: thermal, spectroscopic and crystallinity studies. Journal of pharmaceutical and biomedical analysis 20090115
Specific HRQL instruments and symptom scores were more responsive than preference-based generic instruments in patients with GERD. Journal of clinical epidemiology 20090101
Therapy for unhealed gastrocutaneous fistulas in rats as a model for analogous healing of persistent skin wounds and persistent gastric ulcers: stable gastric pentadecapeptide BPC 157, atropine, ranitidine, and omeprazole. Digestive diseases and sciences 20090101
A randomized, open trial evaluating the effect of Saccharomyces boulardii on the eradication rate of Helicobacter pylori infection in children. Acta paediatrica (Oslo, Norway : 1992) 20090101
Impact of CYP2C19 polymorphisms on the clinical action of proton pump inhibitors (PPIs). European journal of clinical pharmacology 20090101
Squamous overgrowth is not a safety concern for photodynamic therapy for Barrett's esophagus with high-grade dysplasia. Gastroenterology 20090101
Increase in vertebral fracture risk in postmenopausal women using omeprazole. Calcified tissue international 20090101
Effects of pantoprazole and esomeprazole on platelet inhibition by clopidogrel. American heart journal 20090101
Proton-pump inhibitor utilization associated with the change to nonpreferred formulary status for esomeprazole in the TRICARE formulary. Journal of managed care pharmacy : JMCP 20090101
Exogenous luminal nitric oxide exacerbates esophagus tissue damage in a reflux esophagitis model of rats. Scandinavian journal of gastroenterology 20090101
Pharmacokinetics and bioequivalence of 20 mg omeprazole capsule in 24 healthy Korean male volunteers. International journal of clinical pharmacology and therapeutics 20090101
APC sensitive gastric acid secretion. Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology 20090101
Second-line treatment for Helicobacter pylori infection based on moxifloxacin triple therapy: a randomized controlled trial. Wiener klinische Wochenschrift 20090101
Spectrophotometric and chromatographic determination of omeprazole in pharmaceutical formulations. Pharmaceutical development and technology 20090101
Does treatment with proton pump inhibitors for gastroesophageal reflux disease (GERD) improve asthma symptoms in children with asthma and GERD? A systematic review. Journal of investigational allergology & clinical immunology 20090101
Nine cases of omeprazole allergy: cross-reactivity between proton pump inhibitors. Journal of investigational allergology & clinical immunology 20090101
Hypersensitivity reaction to omeprazole in a child. Journal of investigational allergology & clinical immunology 20090101
Comparison of the effects of omeprazole and famotidine in treatment of upper abdominal symptoms in patients with reflux esophagitis. Journal of gastroenterology 20090101
Control of esophageal and intragastric pH with compounded and manufactured omeprazole in patients with reflux esophagitis: a pilot study. The Canadian journal of clinical pharmacology = Journal canadien de pharmacologie clinique 20090101
Effect of the cytochrome P450 2C19 inhibitor omeprazole on the pharmacokinetics and safety profile of bortezomib in patients with advanced solid tumours, non-Hodgkin's lymphoma or multiple myeloma. Clinical pharmacokinetics 20090101
[Antisecretory therapy strategy for patients with bleeding and perforated gastroduodenal ulcers]. Khirurgiia 20090101
Randomized, parallel, double-blind comparison of the ulcer-healing effects of ilaprazole and omeprazole in the treatment of gastric and duodenal ulcers. Journal of gastroenterology 20090101
Maintenance therapy of gastroesophageal reflux disease patients with omeprazole. Hepato-gastroenterology 20090101
Application of a stability-indicating thin-layer chromatographic method to the determination of tenatoprazole in pharmaceutical dosage forms. Journal of AOAC International 20090101
Bioequivalence and pharmacokinetic study of two different omeprazole capsule formulations in healthy Bangladeshi volunteers. Arzneimittel-Forschung 20090101
Suppressive effect of sulindac on branch duct-intraductal papillary mucinous neoplasms. Journal of gastroenterology 20090101
[Eradication therapy and processes of proliferation and apoptosis in the stomach of patients with duodenal ulcer]. Klinicheskaia meditsina 20090101
Gastroesophageal reflux leads to esophageal cancer in a surgical model with mice. BMC gastroenterology 20090101
Effect of addition of vitamin C to clarithromycin-amoxicillin-omeprazol triple regimen on Helicobacter pylori eradication. Acta gastro-enterologica Belgica 20090101
[Complex metabolic disorders revealing a gastric ulcer of the bulb. A case report]. Annales de biologie clinique 20090101
[Combined treatment of gastric ulcers induced by nonsteroid antiinflammatory drugs. Results of 4-week population-based controlled trial of efficacy of proton pump inhibitor combination with tripotassium bismuth dicitrate]. Terapevticheskii arkhiv 20090101
[Antihelicobacteric therapy for the patients with recurrent complicated postoperative gastroduodenal ulcer: indications, principles of conduction, efficacy]. Klinichna khirurhiia 20090101
[Effect of eradication therapy on nitrogen oxide activity in the gastric juice of patients with chronic gastritis and ulcer disease]. Klinicheskaia meditsina 20090101
Pioglitazone induced gastric acid secretion. Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology 20090101
[Why some proton pump inhibitors are more equal than others]. Nederlands tijdschrift voor geneeskunde 20090101
Patient satisfaction with switching to esomeprazole from existing proton pump inhibitor therapy for gastro-oesophageal reflux disease: an observational, multicentre study. Clinical drug investigation 20090101
[Esomeprazole based triple therapy for the eradication of helicobacter pylori in patients with non-ulcer dyspepsia]. Revista de gastroenterologia del Peru : organo oficial de la Sociedad de Gastroenterologia del Peru 20090101
[An unknown but potentially serious side effect of proton pump inhibitors: hypomagnesaemia]. Nederlands tijdschrift voor geneeskunde 20090101
Simultaneous determination of omeprazole and domperidone in dog plasma by LC-MS method. Journal of chromatographic science 20090101
Negative chronotropic effect of proton pump inhibitors on frog-heart preparation. Indian journal of gastroenterology : official journal of the Indian Society of Gastroenterology 20090101
Drug-drug interactions with raltegravir. European journal of medical research 20090101
[Comparative evaluation of the omeprasol and pantoprasol efficacy in treatment of gastropathy induced by non-steroid anti-inflammatory drugs in the patients with rheumatoid arthritis]. Likars'ka sprava 20090101
[Omeprazol and ezomeprazol pharmacokinetics, duration of antisecretory effect, and reasons for their probable changes in duodenal ulcer]. Eksperimental'naia i klinicheskaia gastroenterologiia = Experimental & clinical gastroenterology 20090101
[Effect of CYP2C19 gene polymorphism on eradication treatment efficacy of Helicobacter pylori infection]. Eksperimental'naia i klinicheskaia gastroenterologiia = Experimental & clinical gastroenterology 20090101
[Posterior gastric wall ulceration as a complication of percutaneous endoscopic gastrostomy. A report of 2 cases]. Medycyna wieku rozwojowego 20090101
Long-term survival in a patient with carcinoid syndrome receiving treatment for Zollinger-Ellison syndrome. International surgery 20090101
Usefulness of assessment of voice capabilities in female patients with reflux-related dysphonia. Medicina (Kaunas, Lithuania) 20090101
[Effectiveness of Ultop 10 mg using at treatment of functional (nonulcer) dyspepsia syndrome]. Eksperimental'naia i klinicheskaia gastroenterologiia = Experimental & clinical gastroenterology 20090101
[Comparative study of esomeprazole and omeprazole using for initialism therapy for elderly-senile and young-adulthood patients with GERD]. Eksperimental'naia i klinicheskaia gastroenterologiia = Experimental & clinical gastroenterology 20090101
Acute perforated duodenal ulcer in Maiduguri: experience with simple closure and Helicobacter pylori eradication. West African journal of medicine 20090101
Comparative bioavailability of two oral formulations of omeprazole. Proceedings of the Western Pharmacology Society 20090101
A glass of water immediately increases gastric pH in healthy subjects. Digestive diseases and sciences 20081201
Kinetics of omeprazole and escitalopram in relation to the CYP2C19*17 allele in healthy subjects. European journal of clinical pharmacology 20081201
A rapid lateral flow stool antigen immunoassay and (14)C-urea breath test for the diagnosis and eradication of Helicobacter pylori infection in children. Diagnostic microbiology and infectious disease 20081201
Hydroxychloroquine-induced hyperpigmentation: the staining pattern. Journal of cutaneous pathology 20081201
Gastroesophageal scintigraphy in the evaluation of adult patients with chronic cough due to gastroesophageal reflux disease. Nuclear medicine communications 20081201
Myristica malabarica heals stomach ulceration by increasing prostaglandin synthesis and angiogenesis. Planta medica 20081201
Effect of CYP2C19 genetic polymorphisms on the efficacy of proton pump inhibitor-based triple therapy for Helicobacter pylori eradication: a meta-analysis. Helicobacter 20081201
A comparative study between the efficacy of systemic meglumine antimoniate therapy with standard or low dose plus oral omeprazole in the treatment of cutaneous leishmaniasis. Journal of vector borne diseases 20081201
Effect of feeding nitrite, ascorbate, hemin, and omeprazole on excretion of fecal total apparent N-nitroso compounds in mice. Chemical research in toxicology 20081201
[Proton pump inhibition: more than only reflux therapy]. MMW Fortschritte der Medizin 20081113
Development and validation of an improved high-throughput method for the determination of anastrozole in human plasma by LC-MS/MS and atmospheric pressure chemical ionization. Journal of pharmaceutical and biomedical analysis 20081104
Acute gastrointestinal bleeding. Firstly, improve availability of endoscopy. BMJ (Clinical research ed.) 20081103
Symptom-focused results after laparoscopic fundoplication for refractory gastroesophageal reflux disease--a prospective study. Langenbeck's archives of surgery 20081101
Biochemical mechanism of healing activity of the natural phenolic, allylpyrocatechol against indomethacin-induced gastric ulceration in mice. Digestive diseases and sciences 20081101
Enantioseparation of omeprazole and its metabolite 5-hydroxyomeprazole using open tubular capillary electrochromatography with immobilized avidin as chiral selector. Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20081101
[Chronic use of proton-pump inhibitors associated with giardiasis: A rare cause of hypomagnesemic hypoparathyroidism?]. Annales d'endocrinologie 20081101
Cytochrome P450 induction by rifampicin in healthy subjects: determination using the Karolinska cocktail and the endogenous CYP3A4 marker 4beta-hydroxycholesterol. Clinical pharmacology and therapeutics 20081101
Omeprazole alleviates benzo[a]pyrene cytotoxicity by inhibition of CYP1A1 activity in human and mouse hepatoma cells. Basic & clinical pharmacology & toxicology 20081101
Analyses of CYP2C in porcine microsomes. Basic & clinical pharmacology & toxicology 20081101
Towards evidence based emergency medicine: best BETs from the Manchester Royal Infirmary. BET 2. Use of intravenous omeprazole in gastrointestinal patients before endoscopy. Emergency medicine journal : EMJ 20081101
Comparison of inducibility of multidrug resistance (MDR)1, multidrug resistance-associated protein (MRP)1, and MRP2 mRNAs by prototypical microsomal enzyme inducers in primary cultures of human and cynomolgus monkey hepatocytes. Biological & pharmaceutical bulletin 20081101
Triple therapy-based targeted nanoparticles for the treatment of Helicobacter pylori. Journal of drug targeting 20081101
[Streptococcus pneumoniae infection: cause or consequence of pulmonary alveolar proteinosis?]. Archivos de bronconeumologia 20081101
Quadruple therapy with furazolidone for retreatment in patients with peptic ulcer disease. World journal of gastroenterology 20081028
CYP2C19 pharmacogenetics in advanced cancer: compromised function independent of genotype. British journal of cancer 20081021
Discovery of small molecule agonists for the bombesin receptor subtype 3 (BRS-3) based on an omeprazole lead. Bioorganic & medicinal chemistry letters 20081015
Proton-pump inhibitors in peptic ulcer disease. Lancet (London, England) 20081004
[Analysis of actual costs in long-term therapy of reflux disease. Use of pantoprazole counts]. MMW Fortschritte der Medizin 20081002
The effect of Helicobacter pylori eradication treatment on the MUC 1 and Lewis antigens level in human gastric juice: a preliminary study. Digestive diseases and sciences 20081001
A pharmacokinetic study of etravirine (TMC125) co-administered with ranitidine and omeprazole in HIV-negative volunteers. British journal of clinical pharmacology 20081001
[General practitioners' management of gastroesophageal reflux in France in 2005: a pharmacoeconomic study]. Presse medicale (Paris, France : 1983) 20081001
Meta-analysis: high-dose proton pump inhibitors vs. standard dose in triple therapy for Helicobacter pylori eradication. Alimentary pharmacology & therapeutics 20081001
Heterogeneity of acid secretion induced by carbachol and histamine along the gastric gland axis and its relationship to [Ca2+]i. American journal of physiology. Gastrointestinal and liver physiology 20081001
Effects of helicobacter pylori eradication on chronic nonspecific pharyngeal symptoms. Journal of otolaryngology - head & neck surgery = Le Journal d'oto-rhino-laryngologie et de chirurgie cervico-faciale 20081001
Compatibility studies between mannitol and omeprazole sodium isomers. Journal of pharmaceutical and biomedical analysis 20080929
Esophageal ulceration from high-intensity focused US catheter ablation for pulmonary vein isolation: a novel complication in the treatment of symptomatic refractory atrial fibrillation. Gastrointestinal endoscopy 20080901
Investigation of the in vivo activity of CYP3A in Brazilian volunteers: comparison of midazolam and omeprazole as drug markers. European journal of clinical pharmacology 20080901
Physical and chemical stability of esomeprazole sodium solutions. The Annals of pharmacotherapy 20080901
What is new in the management of Helicobacter pylori? Irish journal of medical science 20080901
IgE-mediated anaphylaxis to proton pump inhibitors - cross-reacting study. Allergy 20080901
Acetaminophen-induced, not desflurane-induced, hepatotoxicity. Anesthesiology 20080901
Treatment of non-cardiac chest pain. Disease-a-month : DM 20080901
Laparoscopic partial posterior (Toupet) fundoplication improves esophageal bolus propagation on scintigraphy. Surgical endoscopy 20080801
Severe hypomagnesaemia in long-term users of proton-pump inhibitors. Clinical endocrinology 20080801
Primary prevention of adverse gastroduodenal effects from short-term use of non-steroidal anti-inflammatory drugs by omeprazole 20 mg in healthy subjects: a randomized, double-blind, placebo-controlled study. Digestive diseases and sciences 20080801
Interaction between methotrexate and omeprazole in an adolescent with leukemia: a case report. Pharmacy world & science : PWS 20080801
Minimal-change esophagitis on narrow-band imaging. Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association 20080801
Inhibition of H+/K+ ATPase in the gastroprotective effect of Baccharis illinita DC. The Journal of pharmacy and pharmacology 20080801
Is there a role for intravenous omeprazole in patients with duodenal diverticular bleeding after successful initial endoscopic hemostasis? Gastrointestinal endoscopy 20080801
[Extraesophageal manifestations of gastroesophageal reflux disease]. The Korean journal of gastroenterology = Taehan Sohwagi Hakhoe chi 20080801
[Comparison of Helicobacter pylori eradication rate in patients with non-ulcer dyspepsia and peptic ulcer diseases according to proton pump inhibitors]. The Korean journal of gastroenterology = Taehan Sohwagi Hakhoe chi 20080801
Effects of a one-week treatment with acid gastric inhibitors on Helicobacter pylori-infected mice. Scandinavian journal of gastroenterology 20080801
Effect of quercetin, flavonoids and alpha-tocopherol, an antioxidant vitamin, on experimental reflux oesophagitis in rats. European journal of pharmacology 20080728
Validation of a conscious rat model for the discovery of novel agents that inhibit gastric acid secretion. European journal of pharmacology 20080728
Dilated intercellular spaces in gastroesophageal reflux disease patients and the changes of intercellular spaces after omeprazole treatment. Chinese medical journal 20080720
Omeprazole and refractory hypomagnesaemia. BMJ (Clinical research ed.) 20080719
Endoscopic findings and Helicobacter pylori in children on long-term hemodialysis. Pakistan journal of biological sciences : PJBS 20080715
The effect of double dose of omeprazole on the course of angina pectoris and treadmill stress test in patients with coronary artery disease--a randomised, double-blind, placebo controlled, crossover trial. International journal of cardiology 20080704
'Poppy seeds' in stomach aspirates: is oral omeprazole extemporaneous dispersion bioavailable? European journal of pediatrics 20080701
Angiogenic and cell proliferating action of the natural diarylnonanoids, malabaricone B and malabaricone C during healing of indomethacin-induced gastric ulceration. Pharmaceutical research 20080701
Effect of Helicobacter pylori eradication and antisecretory maintenance therapy on peptic ulcer recurrence in cirrhotic patients: a prospective, cohort 2-year follow-up study. Journal of clinical gastroenterology 20080701
Postoperative severe uvular edema following tonsillectomy in a child with a history of obstructive sleep apnea. Paediatric anaesthesia 20080701
Effect of some natural products either alone or in combination on gastritis induced in experimental rats. Digestive diseases and sciences 20080701
Protective effects of vitamin E and omeprazole on the hypoxia/reoxygenation induced intestinal injury in newborn rats. Pediatric surgery international 20080701
Predictable prolonged suppression of gastric acidity with a novel proton pump inhibitor, AGN 201904-Z. Alimentary pharmacology & therapeutics 20080701
Ninety-six-hour wireless oesophageal pH monitoring following proton pump inhibitor administration in NERD patients. Alimentary pharmacology & therapeutics 20080701
Omeprazole transactivates human CYP1A1 and CYP1A2 expression through the common regulatory region containing multiple xenobiotic-responsive elements. Biochemical pharmacology 20080701
Mass defect profiles of biological matrices and the general applicability of mass defect filtering for metabolite detection. Rapid communications in mass spectrometry : RCM 20080701
Rapid screening of glutathione-trapped reactive metabolites by linear ion trap mass spectrometry with isotope pattern-dependent scanning and postacquisition data mining. Chemical research in toxicology 20080701
Faster clearance of omeprazole in rats with acute renal failure induced by uranyl nitrate: contribution of increased expression of hepatic cytochrome P450 (CYP) 3A1 and intestinal CYP1A and 3A subfamilies. The Journal of pharmacy and pharmacology 20080701
Acid reflux detection and symptom-reflux association using 4-day wireless pH recording combining 48-hour periods off and on PPI therapy. The American journal of gastroenterology 20080701
Omeprazole, lansoprazole and pantoprazole had no effect on blood pressure and electrocardiogram of anesthetized rat. Pharmacological research 20080701
By the way, doctor. I was treated for two weeks with antibiotics and a proton pump inhibitor when I had an H.pylori infection. I've continued with the proton inhibitor to cut down on stomach acid. Could that be harmful? Harvard health letter 20080701
Pharmacokinetics and safety of saquinavir/ritonavir and omeprazole in HIV-infected subjects. Clinical pharmacology and therapeutics 20080601
Omeprazole-associated changes in the gastric mucosa of children. Journal of clinical pathology 20080601
Clinical review: gastrointestinal bleeding after percutaneous coronary intervention: a deadly combination. QJM : monthly journal of the Association of Physicians 20080601
Effects of the CYP3A5 genotype on omeprazole sulfoxidation in CYP2C19 PMs. European journal of clinical pharmacology 20080601
Standardization of surgical technique in antireflux surgery: the LOTUS Trial experience. World journal of surgery 20080601
Cost-effectiveness analysis of high-dose omeprazole infusion before endoscopy for patients with upper-GI bleeding. Gastrointestinal endoscopy 20080601
Anaphylactic reaction to omeprazole. The American journal of gastroenterology 20080601
The role of cytochrome P2C19 in R-warfarin pharmacokinetics and its interaction with omeprazole. Therapeutic drug monitoring 20080601
[Upper gastrointestinal bleeding of infrequent cause]. Acta gastroenterologica Latinoamericana 20080601
[High intestinal haemorrhage in patient with Schöelin-Henoch purpura]. Anales de medicina interna (Madrid, Spain : 1984) 20080601
Is a 7-day Helicobater pylori treatment enough for eradication and inactivation of gastric inflammatory activity? World journal of gastroenterology 20080514
Helicobacter pylori recurrence and infection rate in Israeli adults. Digestive diseases and sciences 20080501
Effect of eradication of Helicobacter pylori on platelet recovery in patients with chronic idiopathic thrombocytopenic purpura: a controlled trial. American journal of hematology 20080501
Effect of CYP2C19*2 and *17 mutations on pharmacodynamics and kinetics of proton pump inhibitors in Caucasians. British journal of clinical pharmacology 20080501
Less small-bowel injury with lumiracoxib compared with naproxen plus omeprazole. Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association 20080501
Generation of mice transgenic for human CYP2C18 and CYP2C19: characterization of the sexually dimorphic gene and enzyme expression. Drug metabolism and disposition: the biological fate of chemicals 20080501
Increased omeprazole metabolism in carriers of the CYP2C19*17 allele; a pharmacokinetic study in healthy volunteers. British journal of clinical pharmacology 20080501
Biochemical and histopathologic effects of omeprazole and vitamin E in rats with corrosive esophageal burns. Pediatric surgery international 20080501
Randomised comparison of the FerX Ella antireflux stent and the ultraflex stent: proton pump inhibitor combination for prevention of post-stent reflux in patients with esophageal carcinoma involving the esophago-gastric junction. Journal of gastroenterology and hepatology 20080501
Proton pump inhibitor-induced rhabdomyolysis and hyponatremic delirium. The American journal of emergency medicine 20080501
Effects of acid antisecretory drugs on mucus barrier of the rat against 5-fluorouracil-induced gastrointestinal mucositis. Scandinavian journal of gastroenterology 20080501
Omeprazole promotes gastric epithelial cell migration. The Journal of pharmacy and pharmacology 20080501
Effects of acid-reducing agents on the pharmacokinetics of lopinavir/ritonavir and ritonavir-boosted atazanavir. Journal of clinical pharmacology 20080501
Helicobacter pylori eradication prevents progression of gastric cancer in hypergastrinemic INS-GAS mice. Cancer research 20080501
Effect of a community screening for Helicobacter pylori: a 5-Yr follow-up study. The American journal of gastroenterology 20080501
[Acute generalized exanthematous pustulosis induced by omeprazole]. Gastroenterologia y hepatologia 20080501
[Stress ulcer prophylaxis in septic patients. Evidence-based overview]. Anasthesiologie, Intensivmedizin, Notfallmedizin, Schmerztherapie : AINS 20080501
Use of physician education and computer alert to improve targeted use of gastroprotection among NSAID users. The American journal of gastroenterology 20080501
[Effectiveness of 10 day-sequential therapy for Helicobacter pylori eradication in Korea]. The Korean journal of gastroenterology = Taehan Sohwagi Hakhoe chi 20080501
[Spontaneous resolution of multiple fundic gland polyps after cessation of treatment with omeprazole]. The Korean journal of gastroenterology = Taehan Sohwagi Hakhoe chi 20080501
The alternating current polarographic behavior and determination of lansoprazole and omeprazole in dosage forms and biological fluids. Journal of biochemical and biophysical methods 20080424
[Palpable purpura with severe pruritus]. MMW Fortschritte der Medizin 20080424
Endoscopic analysis of gastric ulcer after one week's treatment with omeprazole and rabeprazole in relation to CYP2C19 genotype. Digestive diseases and sciences 20080401
Upper gastrointestinal bleeding in patients with acute coronary syndromes: clinical predictors and prophylactic role of proton pump inhibitors. Journal of clinical gastroenterology 20080401
Influence of CYP2C19*18 and CYP2C19*19 alleles on omeprazole 5-hydroxylation: in vitro functional analysis of recombinant enzymes expressed in Saccharomyces cerevisiae. Basic & clinical pharmacology & toxicology 20080401
Idiopathic tracheal stenosis: successful outcome with antigastroesophageal reflux disease therapy. The Annals of thoracic surgery 20080401
[Cost comparative analysis of drug therapy for non-steroidal anti-inflammatory drug (NSAID)-induced gastric ulcer in Japan]. Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan 20080401
Cyclooxygenase-2 selective non-steroidal anti-inflammatory drugs (etodolac, meloxicam, celecoxib, rofecoxib, etoricoxib, valdecoxib and lumiracoxib) for osteoarthritis and rheumatoid arthritis: a systematic review and economic evaluation. Health technology assessment (Winchester, England) 20080401
[Effect of Helicobacter pylori eradication on iron deficiency anemia of unknown origin]. Gastroenterologia y hepatologia 20080401
Chronic urticaria and Helicobacter pylori. Indian journal of medical sciences 20080401
Bioavailability of two single-dose oral formulations of omeprazole 20 mg: an open-label, randomized sequence, two-period crossover comparison in healthy Mexican adult volunteers. Clinical therapeutics 20080401
Effect of H pylori infection and its eradication on hyperammo-nemia and hepatic encephalopathy in cirrhotic patients. World journal of gastroenterology 20080328
CYP2C19 inhibition: the impact of substrate probe selection on in vitro inhibition profiles. Drug metabolism and disposition: the biological fate of chemicals 20080301
Omeprazole stimulates the induction of human insulin-like growth factor binding protein-1 through aryl hydrocarbon receptor activation. The Journal of pharmacology and experimental therapeutics 20080301
Systematic and simultaneous gene profiling of 84 drug-metabolizing genes in primary human hepatocytes. Journal of biomolecular screening 20080301
Effect of omeprazole on the plasma concentrations of indinavir when administered alone and in combination with ritonavir. American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists 20080301
Case of the month. Gastroesophageal reflux disease (GERD), heart failure, valvular heart disease. JAAPA : official journal of the American Academy of Physician Assistants 20080301
[Effect of combined therapy with Kangyanling and Omeprazole on digestive dysfunction in burned patients]. Zhongguo Zhong xi yi jie he za zhi Zhongguo Zhongxiyi jiehe zazhi = Chinese journal of integrated traditional and Western medicine 20080301
Empirical rescue therapy after Helicobacter pylori treatment failure: a 10-year single-centre study of 500 patients. Alimentary pharmacology & therapeutics 20080215
Hypergastrinemia increases gastric epithelial susceptibility to apoptosis. Regulatory peptides 20080207
Omeprazole inhibits natural killer cell functions. Digestive diseases and sciences 20080201
Long-term proton pump inhibitor use in children: a retrospective review of safety. Digestive diseases and sciences 20080201
The anti-secretory and anti-ulcer activities of esomeprazole in comparison with omeprazole in the stomach of rats and rabbits. Molecular and cellular biochemistry 20080201
EMANCIPATE study: drawing conclusions may be difficult in the absence of fundamental information. European journal of gastroenterology & hepatology 20080201
EMANCIPATE versus EXPO: different results can be explained by differing study designs. European journal of gastroenterology & hepatology 20080201
Evaluation of three different proton pump inhibitors with amoxicillin and metronidazole in retreatment for Helicobacter pylori infection. Journal of clinical gastroenterology 20080201
[Sequential therapy regimen for Helicobacter pylori infection in children]. Archives de pediatrie : organe officiel de la Societe francaise de pediatrie 20080201
[Esophageal Crohn's disease]. Gastroenterologia y hepatologia 20080201
Influence of omeprazole on the antiplatelet action of clopidogrel associated with aspirin: the randomized, double-blind OCLA (Omeprazole CLopidogrel Aspirin) study. Journal of the American College of Cardiology 20080122
Omeprazole: a possible new candidate influencing the antiplatelet effect of clopidogrel. Journal of the American College of Cardiology 20080122
Healing properties of malabaricone B and malabaricone C, against indomethacin-induced gastric ulceration and mechanism of action. European journal of pharmacology 20080114
Second-line rescue therapy with levofloxacin after H. pylori treatment failure: a Spanish multicenter study of 300 patients. The American journal of gastroenterology 20080101
An alternative salvage regimen for Helicobacter pylori-resistant patients with heart failure. Cardiology 20080101
The effect of omeprazole paste on intragastric pH in clinically ill neonatal foals. Equine veterinary journal 20080101
Significant decrease in nelfinavir systemic exposure after omeprazole coadministration in healthy subjects. Pharmacotherapy 20080101
Response to Ray and colleagues: the called-for large clinical trial is already ongoing. Gastroenterology 20080101
Clarithromycin- and omeprazole-containing gliadin nanoparticles for the treatment of Helicobacter pylori. Journal of drug targeting 20080101
Subacute cutaneous lupus erythematosus induced or exacerbated by proton pump inhibitors. Acta dermato-venereologica 20080101
Validation of a four-graded scale for severity of heartburn in patients with symptoms of gastroesophageal reflux disease. Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research 20080101
Blockage of intracellular proton extrusion with proton extrusions with proton pump inhibitor induces apoptosis in gastric cancer. Cancer science 20080101
Gastrointestinal bleeding in a toddler secondary to chronic renal failure and hyper-gastrinemia. Indian journal of pediatrics 20080101
Antiulcerogenic activity of fractions and 3,15-dioxo-21alpha-hydroxy friedelane isolated from Maytenus robusta (Celastraceae). Archives of pharmacal research 20080101
Preoperative treatment with a non-steroidal anti-inflammatory drug (NSAID) increases tumor tissue infiltration of seemingly activated immune cells in colorectal cancer. Cancer immunity 20080101
No increased bone formation around alendronate or omeprazole loaded bioactive bone cements in a femoral defect. Tissue engineering. Part A 20080101
Omeprazole induces apoptosis in normal human polymorphonuclear leucocytes. International journal of immunopathology and pharmacology 20080101
[Role of anti-secretory treatment in addition to Helicobacter pylori eradication triple therapy in the treatment of peptic ulcer]. The Korean journal of gastroenterology = Taehan Sohwagi Hakhoe chi 20080101
High grade B-cell gastric lymphoma with complete pathologic remission after eradication of Helicobacter pylori infection: report of a case and review of the literature. World journal of surgical oncology 20080101
Safety profile of esomeprazole: results of a prescription-event monitoring study of 11 595 patients in England. Drug safety 20080101
Effect of age, feeding, and omeprazole administration on gastric tonometry in healthy neonatal foals. Journal of veterinary internal medicine 20080101
Furazolidone, tetracycline and omeprazole: a low-cost alternative for Helicobacter pylori eradication in children. Jornal de pediatria 20080101
Stereoselective disposition of proton pump inhibitors. Clinical drug investigation 20080101
Gastroesophageal reflux disease after Helicobacter pylori eradication in gastric ulcer patients: a one-year follow-up study. Medicina (Kaunas, Lithuania) 20080101
[Medicamentous bezoar following pancreaticoduodenectomy: the combined use of cholestyramine and antisecretory medications as a risk factor in pancreatic surgery]. Journal de chirurgie 20080101
Symptomatic response to blocked and unblocked pentagastrin stimulation in functional dyspepsia. Comparison of responders and non-responders to omeprazole identified in a single-subject trial model. Digestive diseases (Basel, Switzerland) 20080101
Pylera plus omeprazole: quadruple treatment for Helicobacter pylori. Reviews in gastroenterological disorders 20080101
Time esophageal pH < 4 overestimates the prevalence of pathologic esophageal reflux in subjects with gastroesophageal reflux disease treated with proton pump inhibitors. BMC gastroenterology 20080101
Prevalence of A2143G mutation of H. pylori-23S rRNA in Chinese subjects with and without clarithromycin use history. BMC microbiology 20080101
Short-term triple therapy with azithromycin for Helicobacter pylori eradication: low cost, high compliance, but low efficacy. BMC gastroenterology 20080101
Effect of Roux-en-Y surgery and medical intervention on Barrett's-type changes: an in vivo model. Diseases of the esophagus : official journal of the International Society for Diseases of the Esophagus 20080101
A search for Helicobacter pyloriin localized vulvodynia. Gynecologic and obstetric investigation 20080101
The influence of a newly developed quinolone: antofloxacin, on CYP activity in rats. European journal of drug metabolism and pharmacokinetics 20080101
Activation and stabilization of drugs by supramolecular pKa shifts: drug-delivery applications tailored for cucurbiturils. Angewandte Chemie (International ed. in English) 20080101
Occurrence of community-acquired respiratory tract infection in patients receiving esomeprazole: retrospective analysis of adverse events in 31 clinical trials. Drug safety 20080101
[Gastroduodenal ulcers in the practice of joint endoprosthesis]. Klinichna khirurhiia 20080101
Melatonin for the treatment of gastroesophageal reflux disease. Alternative therapies in health and medicine 20080101
[Eosinophilic esophagitis in 29 pediatric patients]. Arquivos de gastroenterologia 20080101
Esomeprazole: a review of its use in the management of gastric acid-related diseases in adults. Drugs 20080101
[Acute pancreatitis as a complication of diagnostic gastroduodenal endoscopy at 10 years old girl--case report]. Polski merkuriusz lekarski : organ Polskiego Towarzystwa Lekarskiego 20080101
Nocturnal gastroesophageal reflux disease: issues, implications, and management strategies. Reviews in gastroenterological disorders 20080101
Late and fatal deterioration of an intracerebral hemorrhage attributable to the onset of a high titer of acquired factor V inhibitor. European neurology 20080101
Efficacy and safety of omeprazole in Japanese patients with nonerosive reflux disease. Journal of gastroenterology 20080101
Bioequivalence study of two capsule formulations of omeprazole in healthy volunteers. Arzneimittel-Forschung 20080101
The effect of omeprazole on asthmatic adolescents with gastroesophageal reflux disease. Allergy and asthma proceedings 20080101
Effect of proton pump inhibitors on gastric juice volume, gastric pH and gastric intramucosal pH in critically ill patients : a randomized, double-blind, placebo-controlled study. Clinical drug investigation 20080101
I was recently diagnosed with 'dyspepesia.' Is this a fancy term for heartburn? Are there other ways of preventing and easing symptoms besides yoga classes to reduce stress and Prilosec for reflux? DukeMedicine healthnews 20080101
Gastroesophageal reflux detected on the myocardial perfusion scan with (99m)Tc-MIBI. Hellenic journal of nuclear medicine 20080101
Role of PDK1 in regulation of gastric acid secretion. Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology 20080101
Salmonella panama and acute respiratory distress syndrome in a traveler taking a proton pump inhibitor. Journal of travel medicine 20080101
The influence of Helicobacter pylori patients' treatment on MUC 1 content in gastric juice. Hepato-gastroenterology 20080101
[Topical issues of paediatric gastroenterology]. Eksperimental'naia i klinicheskaia gastroenterologiia = Experimental & clinical gastroenterology 20080101
[NSAID-gastropathy: state-of-the-art therapy optimization capabilities in outpatient practice]. Eksperimental'naia i klinicheskaia gastroenterologiia = Experimental & clinical gastroenterology 20080101
[Interleukin-1beta gene polymorphism as a predictor of eradication treatment efficacy in gastric and duodenal ulcer associated with Helicobacter pylori]. Eksperimental'naia i klinicheskaia gastroenterologiia = Experimental & clinical gastroenterology 20080101
A primary Helicobacter pylori infection does not protect against reinfection in children after eradication therapy. Revista de investigacion clinica; organo del Hospital de Enfermedades de la Nutricion 20080101
Methanolic extract of Tetracera potatoria, an antiulcer agent increases gastric mucus secretion and endogenous antioxidants. Nigerian journal of physiological sciences : official publication of the Physiological Society of Nigeria 20080101
Staving off death: a case study of the pharmaceutical industry's strategies to protect blockbuster franchises. Food and drug law journal 20080101
[Therapeutic innovations in gastroesophageal reflux]. Presse medicale (Paris, France : 1983) 20071201
Quantification of tenatoprazole in rat plasma by HPLC: validation and its application to pharmacokinetic studies. Biomedical chromatography : BMC 20071201
A comparison of community pharmacists' views of over-the-counter omeprazole and simvastatin. Pharmacoepidemiology and drug safety 20071201
Pharmacokinetic interaction between oltipraz and omeprazole in rats: Competitive inhibition of metabolism of oltipraz by omeprazole via CYP1A1 and 3A2, and of omeprazole by oltipraz via CYP1A1/2, 2D1/2, and 3A1/2. European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences 20071201
Stability of partial doses of omeprazole-sodium bicarbonate oral suspension. The Annals of pharmacotherapy 20071201
Effects of a one-week treatment with acid gastric inhibitors on Helicobacter pylori-infected mice. Scandinavian journal of gastroenterology 20071201
Double-dose, new-generation proton pump inhibitors do not improve Helicobacter pylori eradication rate. Helicobacter 20071201
Failure of sequential therapy to eradicate Helicobacter pylori in previously treated subjects. Helicobacter 20071201
Use of acid-suppressing drugs and the risk of bacterial gastroenteritis. Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association 20071201
Distinct effects of omeprazole and rabeprazole on the tacrolimus blood concentration in a kidney transplant recipient. Drug metabolism and pharmacokinetics 20071201
[Duodenal ulcer and helicobacter pylori]. Gastroenterologie clinique et biologique 20071201
Development of the 'Inje cocktail' for high-throughput evaluation of five human cytochrome P450 isoforms in vivo. Clinical pharmacology and therapeutics 20071101
Estimation of CYP2C19 activity by the omeprazole hydroxylation index at a single point in time after intravenous and oral administration. European journal of clinical pharmacology 20071101
The aerial parts of Guazuma ulmifolia Lam. protect against NSAID-induced gastric lesions. Journal of ethnopharmacology 20071101
Clinical trial: the effects of adding ranitidine at night to twice daily omeprazole therapy on nocturnal acid breakthrough and acid reflux in patients with systemic sclerosis--a randomized controlled, cross-over trial. Alimentary pharmacology & therapeutics 20071101
Clinical trial: knowledge of negative Helicobacter pylori status reduces subsequent dyspepsia-related resource use. Alimentary pharmacology & therapeutics 20071101
A quintuple therapy for H. pylori eradication. The American journal of gastroenterology 20071101
Gastroprotective properties of Myristica malabarica against indometacin-induced stomach ulceration: a mechanistic exploration. The Journal of pharmacy and pharmacology 20071101
[Evidence based treatment strategy for dyspeptic symptoms]. Nihon Shokakibyo Gakkai zasshi = The Japanese journal of gastro-enterology 20071101
Collagenous gastritis: a rare cause of abdominal pain and iron-deficiency anemia. Journal of pediatric gastroenterology and nutrition 20071101
[Drug treatment and surgical indications in gastroesophageal reflux]. Revista de gastroenterologia de Mexico 20071101
[Clinical value of 24-hour pH monitoring in patients with laryngopharyngeal reflux disease]. Zhonghua er bi yan hou tou jing wai ke za zhi = Chinese journal of otorhinolaryngology head and neck surgery 20071101
Acid-suppressive effects of various regimens of omeprazole in Helicobacter pylori-negative CYP2C19 homozygous extensive metabolizers: which regimen has the strongest effect? Digestive diseases and sciences 20071001
Enantioselective quantification of omeprazole and its main metabolites in human serum by chiral HPLC-atmospheric pressure photoionization tandem mass spectrometry. Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20071001
Eradication of Helicobacter pylori does not reduce the incidence of gastroduodenal ulcers in patients on long-term NSAID treatment: double-blind, randomized, placebo-controlled trial. Helicobacter 20071001
Eradication of Helicobacter pylori infection favourably affects altered gastric mucosal MMP-9 levels. Helicobacter 20071001
Eradication of Helicobacter pylori infection equally improves chronic urticaria with positive and negative autologous serum skin test. Helicobacter 20071001
Garlic, vitamin, and antibiotic treatment for Helicobacter pylori: a randomized factorial controlled trial. Helicobacter 20071001
Steady-state pharmacokinetics of once-daily fosamprenavir/ritonavir and atazanavir/ritonavir alone and in combination with 20 mg omeprazole in healthy volunteers. HIV medicine 20071001
Effects of CYP2C19 genetic polymorphism on the pharmacokinetics and pharmacodynamics of omeprazole in Chinese people. Journal of clinical pharmacy and therapeutics 20071001
Herbal medicine yin zhi huang induces CYP3A4-mediated sulfoxidation and CYP2C19-dependent hydroxylation of omeprazole. Acta pharmacologica Sinica 20071001
The ghrelin system in acinar cells: localization, expression, and regulation in the exocrine pancreas. Pancreas 20071001
The role of sildenafil citrate in the protection of gastric mucosa from nonsteroidal anti-inflammatory drug-induced damage. Ulusal travma ve acil cerrahi dergisi = Turkish journal of trauma & emergency surgery : TJTES 20071001
Influence of sulfobutylether-beta-cyclodextrin on the stability of S- and R- omeprazole. Current drug discovery technologies 20071001
Proton pump inhibitor utilization patterns in infants. Journal of pediatric gastroenterology and nutrition 20071001
[Endoscopic changes in the stomach and duodenal mucosa caused by minidose acetylsalicylic acid therapy and their prevention]. Vnitrni lekarstvi 20071001
Evidence for the role of gastric mucosa at the secretion of soluble triggering receptor expressed on myeloid cells (strem-1) in peptic ulcer disease. World journal of gastroenterology 20070914
Comparison of four proton pump inhibitors for the short-term treatment of esophagitis in elderly patients. World journal of gastroenterology 20070907
Evaluation of the antiulcerogenic activity of Maytenus robusta (Celastraceae) in different experimental ulcer models. Journal of ethnopharmacology 20070905
Proton pump inhibitors suppress absorption of dietary non-haem iron in hereditary haemochromatosis. Gut 20070901
Preparative chiral chromatography and chiroptical characterization of enantiomers of omeprazole and related benzimidazoles. Chirality 20070901
[Helicobacter pylori infection and eradication are not related to glycosylated hemoglobin levels (HbA1c) in young patients with type 1 diabetes]. Presse medicale (Paris, France : 1983) 20070901
Oral erythromycin accelerates impaired gastrointestinal motility after endoscopic mucosal resection. Digestive diseases and sciences 20070901
Solid-state characterization and dissolution profiles of the inclusion complexes of omeprazole with native and chemically modified beta-cyclodextrin. European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V 20070901
Five-year efficacy and safety of photodynamic therapy with Photofrin in Barrett's high-grade dysplasia. Gastrointestinal endoscopy 20070901
[Toxic epidermal necrolysis induced by phenytoin and whole brain radiotherapy]. Actas dermo-sifiliograficas 20070901
Reflux oesophagitis in children; the role of endoscopy. A multicentric Italian survey. Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver 20070901
Duodenogastro-esophageal reflux in children with refractory gastro-esophageal reflux disease. The Journal of pediatrics 20070901
Columnar-lined esophagus: lessons learnt from children. The American journal of gastroenterology 20070901
Treatment interruptus: the need for withdrawal. The American journal of gastroenterology 20070901
CYP2C19 pharmacogenomics associated with therapy of Helicobacter pylori infection and gastro-esophageal reflux diseases with a proton pump inhibitor. Pharmacogenomics 20070901
[Chiral separation of tenatoprazole enantiomers using high performance liquid chromatography on vacomycin-bonded chiral stationary phase]. Se pu = Chinese journal of chromatography 20070901
High-grade dysplasia in Barrett's oesophagus. The case against oesophageal resection. Annals of the Royal College of Surgeons of England 20070901
[Acid pump inhibitor before before gastroscopy for upper gastrointestinal bleeding]. Ugeskrift for laeger 20070827
High-performance liquid chromatographic separation of rolipram, bupivacaine and omeprazole using a tartardiamide-based stationary phase influence of flow rate and temperature on the enantioseparation. Journal of chromatography. A 20070824
Analytical methodologies for the determination of omeprazole: an overview. Journal of pharmaceutical and biomedical analysis 20070815
Banding without resection (endoscopic mucosal ligation) as a novel approach for the ablation of short-segment Barrett's epithelium: results of a pilot study. The American journal of gastroenterology 20070801
Influence of omeprazole on pharmacokinetics of domperidone given as free base and maleate salt in healthy Chinese patients. Acta pharmacologica Sinica 20070801
Reversal of migraine symptoms by Helicobacter pylori eradication therapy in patients with hepatitis-B-related liver cirrhosis. Helicobacter 20070801
Recent advances in chirally pure proton pump inhibitors. Journal of the Indian Medical Association 20070801
Omeprazole before endoscopy in patients with gastrointestinal bleeding. The New England journal of medicine 20070719
Omeprazole before endoscopy in patients with gastrointestinal bleeding. The New England journal of medicine 20070719
Validation of chromatographic methods: evaluation of detection and quantification limits in the determination of impurities in omeprazole. Journal of chromatography. A 20070713
Proton pump inhibitors improve acid-related dyspepsia in gastroesophageal reflux disease patients. Digestive diseases and sciences 20070701
CYP1A induction and human risk assessment: an evolving tale of in vitro and in vivo studies. Drug metabolism and disposition: the biological fate of chemicals 20070701
Pyramidal inversion mechanism of simple chiral and achiral sulfoxides: a theoretical study. Chirality 20070701
Effect of baseline symptom severity on patient-reported outcomes in gastroesophageal reflux disease. European journal of gastroenterology & hepatology 20070701
Omeprazole for gastroesophageal reflux disease in the first 2 years of life: a dose-finding study with dual-channel pH monitoring. Journal of pediatric gastroenterology and nutrition 20070701
Duodenal gastric metaplasia and Helicobacter pylori infection in patients with diffuse nodular duodenitis. Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas 20070701
I was recently diagnosed with 'dyspepsia'. Is this just a fancy term for heartburn? Are there other ways of preventing and easing symptoms besides yoga classes to reduce stress and Prilosec for reflux? DukeMedicine healthnews 20070701
[Morphological observation on gastric mucosa membrane of patients with gastric ulcer treated with combined use of Qifang Weitong Powder and omeprazole]. Zhongguo Zhong xi yi jie he za zhi Zhongguo Zhongxiyi jiehe zazhi = Chinese journal of integrated traditional and Western medicine 20070701
Optimal length of triple therapy for H pylori eradication in a population with high prevalence of infection in Chile. World journal of gastroenterology 20070607
Dexamethasone damages the rat stomach but not small intestine during inhibition of COX-1. Digestive diseases and sciences 20070601
Rapid determination of omeprazole in human plasma by protein precipitation and liquid chromatography-tandem mass spectrometry. Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20070601
Maintenance therapy for erosive esophagitis in children after healing by omeprazole: is it advisable? The American journal of gastroenterology 20070601
Letter to the editor, re: Nylaende M, Abdelnoor M, Stranden E, Morken B, Sandbaek G, Risum O, et al. The Oslo balloon angioplasty versus conservative treatment study (OBACT)--the 2-years results of a single centre, prospective, randomised study in patients with intermittent claudication. Eur J Vasc Endovasc Surg. 2007;33:3-12. European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery 20070601
One week of esomeprazole triple therapy vs 1 week of omeprazole triple therapy plus 3 weeks of omeprazole for duodenal ulcer healding in Helicobacter pylori-positive patients. Digestive diseases and sciences 20070601
Severe systemic adverse reaction to proton pump inhibitors in an infant. Pediatric pulmonology 20070601
Effect of cranberry juice on eradication of Helicobacter pylori in patients treated with antibiotics and a proton pump inhibitor. Molecular nutrition & food research 20070601
The crucial role of the therapeutic window in understanding the clinical relevance of the poor versus the ultrarapid metabolizer phenotypes in subjects taking drugs metabolized by CYP2D6 or CYP2C19. Journal of clinical psychopharmacology 20070601
Can famotidine and omeprazole be combined on a once-daily basis? Scandinavian journal of gastroenterology 20070601
Type I allergic reaction to benzimidazole antihelmintics. Allergy 20070601
Effects of short-term light to heavy exercise on gastric ulcer development in horses and efficacy of omeprazole paste in preventing gastric ulceration. Journal of the American Veterinary Medical Association 20070601
Proton pump inhibitors induce apoptosis of human B-cell tumors through a caspase-independent mechanism involving reactive oxygen species. Cancer research 20070601
[Protonic pump inhibitors in kidney transplant patients: efficacy and safety]. Minerva urologica e nefrologica = The Italian journal of urology and nephrology 20070601
Suppression of gastric acid with intravenous esomeprazole and omeprazole: results of 3 studies in healthy subjects. International journal of clinical pharmacology and therapeutics 20070601
Comparison of inducibility of CYP1A and CYP3A mRNAs by prototypical inducers in primary cultures of human, cynomolgus monkey, and rat hepatocytes. Drug metabolism and pharmacokinetics 20070601
Potential effect of over-the-counter sales on omeprazole calls to Texas poison centers. Texas medicine 20070601
Eradication rates of helicobacter pylori infection with second-line treatment: non-ulcer dyspepsia compared to peptic ulcer disease. Hepato-gastroenterology 20070601
[Structure-function relationship of gastric proton pump]. Seikagaku. The Journal of Japanese Biochemical Society 20070601
[Gastroesophageal reflux as a cause of night sweating]. Anales de medicina interna (Madrid, Spain : 1984) 20070601
Tautomeric polymorphism in omeprazole. Chemical communications (Cambridge, England) 20070528
[Anaphylaxis to proton pump inhibitors]. Medicina clinica 20070526
Small bowel mucosal injury is reduced in healthy subjects treated with celecoxib compared with ibuprofen plus omeprazole, as assessed by video capsule endoscopy. Alimentary pharmacology & therapeutics 20070515
Development of pancreatic acinar cell metaplasia after successful administration of omeprazole for 6 months in rats. Digestive diseases and sciences 20070501
Pathogenic importance of pepsin in ischemia/reperfusion-induced gastric injury. Life sciences 20070501
The effect of omeprazole on the bioavailability and safety of garenoxacin in healthy volunteers. Journal of clinical pharmacology 20070501
Single-session, graded esophageal dilation without fluoroscopy in outpatients with lower esophageal (Schatzki's) rings: a prospective, long-term follow-up study. Journal of gastroenterology and hepatology 20070501
Argon plasma coagulation for non-dysplastic Barrett's epithelium: a hard act to follow. The American journal of gastroenterology 20070501
Getting categorical on GERD. The American journal of gastroenterology 20070501
Quantitative analysis of in vitro compatibility of binary and ternary mixtures of nitroimidazole and macrolides in combination with omeprazole using a calorimetric technique. Die Pharmazie 20070501
Effects of allyl isothiocyanate from horseradish on several experimental gastric lesions in rats. European journal of pharmacology 20070430
Omeprazole before endoscopy in patients with gastrointestinal bleeding. The New England journal of medicine 20070419
Pattern of proton pump inhibitor calls to Texas poison centers, 1998-2004. Journal of toxicology and environmental health. Part A 20070415
Continuous infusion of high-dose omeprazole is more effective than standard-dose omeprazole in patients with high-risk peptic ulcer bleeding: a retrospective study. Alimentary pharmacology & therapeutics 20070415
Comparison of 1 and 2 weeks of omeprazole, amoxicillin and clarithromycin treatment for Helicobacter pylori eradication: the HYPER Study. Gut 20070401
Determination of esomeprazole and its two main metabolites in human, rat and dog plasma by liquid chromatography with tandem mass spectrometry. Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20070401
Results from the pediatric European register for treatment of Helicobacter pylori (PERTH). Helicobacter 20070401
Rebamipide contributes to reducing adverse effects of long-term administration of omeprazole in rats. Digestive diseases and sciences 20070401
Post-tonsillectomy bleeding. Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery 20070401
[A case of gastroesophageal reflux disease with marked eosinophilia]. Nihon Shokakibyo Gakkai zasshi = The Japanese journal of gastro-enterology 20070401
Baccharis dracunculifolia, the main botanical source of Brazilian green propolis, displays antiulcer activity. The Journal of pharmacy and pharmacology 20070401
Ecabet sodium prevents esophageal lesions induced by the reflux of gastric juice in rats. Inflammopharmacology 20070401
Male breast cancer with mandibular metastasis. A case report. Minerva stomatologica 20070401
Is this medicine really involved in a drug interaction? Southern medical journal 20070401
Omeprazole-associated digoxin toxicity. Southern medical journal 20070401
H. pylori infection in childhood chronic immune thrombocytopenic purpura. Haematologica 20070401
[Clinical pharmacological aspects of the proton pump inhibitor therapy: importance of pharmacogenetic differences in the clinical practice]. Orvosi hetilap 20070325
[The 10-minute-consultation: chronic singultus]. MMW Fortschritte der Medizin 20070322
Anti-ulcer activity of crude alcoholic extract of Toona ciliata Roemer (heart wood). Journal of ethnopharmacology 20070321
Effect of omeprazole and domperidone on adult asthmatics with gastroesophageal reflux. World journal of gastroenterology 20070321
alpha-Amino acid derivatives as proton pump inhibitors and potent anti-ulcer agents. European journal of medicinal chemistry 20070301
Acute kidney injury following proton pump inhibitor therapy. Kidney international 20070301
Effect of omeprazole on the pharmacokinetics of paricalcitol in healthy subjects. Biopharmaceutics & drug disposition 20070301
Intracranial hypotension following motor vehicle accident: an overlooked cause of post-traumatic head and neck pain? Pain practice : the official journal of World Institute of Pain 20070301
Characteristics of children receiving proton pump inhibitors continuously for up to 11 years duration. The Journal of pediatrics 20070301
Chest pain during triple therapy for duodenal ulcer. Internal medicine journal 20070301
Quality of life in laryngopharyngeal reflux patients. The Laryngoscope 20070301
Omeprazole reduces the response to capsaicin but not to methacholine in asthmatic patients with proximal reflux. Scandinavian journal of gastroenterology 20070301
Comparison of two invasive diagnostic tests for Helicobacter pylori after antimicrobial therapy. Scandinavian journal of gastroenterology 20070301
By the way, doctor. I heard that taking a proton-pump inhibitor could cause hip fractures. I've been taking 20 mg of Prilosec every day for a year. Should I be concerned? Harvard women's health watch 20070301
The inhibitory effects of H+ K+ ATPase inhibitors on human neutrophils in vitro: restoration by a K+ ionophore. Inflammation research : official journal of the European Histamine Research Society ... [et al.] 20070301
[Study on integrated Chinese and Western therapy and criterion for efficacy evaluation of gastroesophageal reflux disease--a clinical observation on 116 cases]. Zhongguo Zhong xi yi jie he za zhi Zhongguo Zhongxiyi jiehe zazhi = Chinese journal of integrated traditional and Western medicine 20070301
[Typhoid fever and acute pancreatitis: two cases]. Le infezioni in medicina : rivista periodica di eziologia, epidemiologia, diagnostica, clinica e terapia delle patologie infettive 20070301
Efficacy of low-dose proton pump inhibitor (PPI) in the eradication of Helicobacter pylori following combination PPI/AC therapy in Japan. Hepato-gastroenterology 20070301
Proton pump inhibitors for GERD in children. The Medical letter on drugs and therapeutics 20070226
The management of upper gastrointestinal symptoms: is endoscopy indicated? The Medical journal of Australia 20070219
Omeprazole-based triple therapy with low-versus high-dose of clarithromycin plus amoxicillin for H pylori eradication in Iranian population. World journal of gastroenterology 20070214
Pharmacokinetics of omeprazole after intravenous and oral administration to rats with liver cirrhosis induced by dimethylnitrosamine. International journal of pharmaceutics 20070207
Interaction of omeprazole with a methylated derivative of beta-cyclodextrin: phase solubility, NMR spectroscopy and molecular simulation. Pharmaceutical research 20070201
Absolute bioavailability and metabolism of omeprazole in relation to CYP2C19 genotypes following single intravenous and oral administrations. European journal of clinical pharmacology 20070201
Which has superior acid-suppressive effect, 10 mg omeprazole once daily or 20 mg famotidine twice daily? Effects of single or repeated administration in Japanese Helicobacter pylori-negative CYP2C19 extensive metabolizers. Digestive diseases and sciences 20070201
Pre-endoscopic PPI therapy reduces recurrent adverse outcomes in acute non-variceal upper gastrointestinal bleeding. Alimentary pharmacology & therapeutics 20070201
Comparison of 7-day and 14-day proton pump inhibitor-containing triple therapy for Helicobacter pylori eradication: neither treatment duration provides acceptable eradication rate in Korea. Helicobacter 20070201
Oral health status and oral hygiene practices of patients with peptic ulcer and how these affect Helicobacter pylori eradication from the stomach. Helicobacter 20070201
Seven-year follow-up of a randomized clinical trial comparing proton-pump inhibition with surgical therapy for reflux oesophagitis. The British journal of surgery 20070201
There are more confounders in omeprazole-calcium interaction. The American journal of medicine 20070201
Laser eustachian tuboplasty: two-year results. The Laryngoscope 20070201
Comparative drug effects: the case of GERD therapies. Disease management : DM 20070201
Equine gastric ulcer syndrome in adult horses: a review. New Zealand veterinary journal 20070201
Acid-related disorders and use of antisecretory medication. Danish medical bulletin 20070201
Autoimmune haemolytic anaemia associated with use of omeprazole. British journal of hospital medicine (London, England : 2005) 20070201
Promotion of cutaneous wound healing by famotidine in Wistar rats. The Indian journal of medical research 20070201
Autoimmune haemolytic anaemia due to Omeprazole. Irish medical journal 20070201
[The changes of esophageal epithelial intercellular spaces before and after omeprazole treatment in erosive esophagitis]. Zhonghua nei ke za zhi 20070201
[Proton pump inhibitors in developmental period medicine]. Polski merkuriusz lekarski : organ Polskiego Towarzystwa Lekarskiego 20070201
Comparison of the effects of immediate-release omeprazole oral suspension, delayed-release lansoprazole capsules and delayed-release esomeprazole capsules on nocturnal gastric acidity after bedtime dosing in patients with night-time GERD symptoms. Alimentary pharmacology & therapeutics 20070115
[Platelet inhibition and gastric problems]. Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke 20070104
Impact of malnutrition on gastrointestinal disorders and gross motor abilities in children with cerebral palsy. Brain & development 20070101
Reactions of sulfenic acid with 2-mercaptoethanol: a mechanism for the inhibition of gastric (H+-K+)-adenosine triphosphate by omeprazole. Journal of pharmaceutical sciences 20070101
HPLC determination and pharmacokinetic study of tenatoprazole in dog plasma after oral administration of enteric-coated capsule. Biomedical chromatography : BMC 20070101
Does adding misoprostol to standard intravenous proton pump inhibitor protocol improve the outcome of aspirin/NSAID-induced upper gastrointestinal bleeding?: a randomized prospective study. Digestive diseases and sciences 20070101
Protective effects of proton pump inhibitors against indomethacin-induced lesions in the rat small intestine. Naunyn-Schmiedeberg's archives of pharmacology 20070101
Occupational airborne contact dermatitis from omeprazole. Contact dermatitis 20070101
Improvement of the eradication rate of Helicobacter pylori gastritis in children is by adjunction of omeprazole to a dual antibiotherapy. Acta paediatrica (Oslo, Norway : 1992) 20070101
Systematic review of rosacea treatments. Journal of the American Academy of Dermatology 20070101
Effects of cysteine on the pharmacokinetic parameters of omeprazole in rats with protein-calorie malnutrition: partial restoration of some parameters to control levels by oral cysteine supplementation. JPEN. Journal of parenteral and enteral nutrition 20070101
Effect of omeprazole on acid gastroesophageal reflux and gastric acidity in preterm infants with pathological acid reflux. Journal of pediatric gastroenterology and nutrition 20070101
Comparison of gastric pH with omeprazole magnesium 20.6 mg (Prilosec OTC) o.m. famotidine 10 mg (Pepcid AC) b.d. and famotidine 20 mg b.d. over 14 days of treatment. Alimentary pharmacology & therapeutics 20070101
[Omeprazole-induced acute cholestatic hepatitis]. Gastroenterologia y hepatologia 20070101
[Effect of mucosal protective on the quality of gastric ulcer healing]. Zhejiang da xue xue bao. Yi xue ban = Journal of Zhejiang University. Medical sciences 20070101
Eradication therapy in Helicobacter pylori-positive patients with halitosis: long-term outcome. Medical principles and practice : international journal of the Kuwait University, Health Science Centre 20070101
By the way, doctor. I recently switched from Prilosec to its generic form, omeprazole. The generic form doesn't give me as much relief from heartburn as Prilosec does. Aren't generics supposed to be the same as the brand-name drugs? Harvard women's health watch 20070101
Adverse events reporting. Clinical drug investigation 20070101
Bioequivalence assessment of two capsule formulations of omeprazole in healthy volunteers. Arzneimittel-Forschung 20070101
Adjuvant effect of vitamin C on omeprazole-amoxicillin-clarithromycin triple therapy for Helicobacter pylori eradication. Hepato-gastroenterology 20070101
Cyp2c19 genotype and omeprazole hydroxylation phenotype in Chinese Li population. Clinical and experimental pharmacology & physiology 20070101
[Age and eradication treatment of duodenal ulcer]. Terapevticheskii arkhiv 20070101
[Pharmacological efficacy of bismuth tripotassium dicitrate in peptic ulcer]. Terapevticheskii arkhiv 20070101
Process of measuring in clinical medicine--implications of different definitions in clinical therapeutic studies. Digestion 20070101
[Rabeprazole test and comparison of the effectiveness of course treatment with rabeprazole in patients with gastroesophageal reflux disease and non-coronary chest pain]. Klinicheskaia meditsina 20070101
[Antihelicobacter effects of melatonin]. Klinicheskaia meditsina 20070101
[Characteristics of a combined course of duodenal ulcer and gastroesophageal reflux disease]. Klinicheskaia meditsina 20070101
[The clinical effectiveness of rabeprazole in patients with acid-related gastric and duodenal diseases with various sensitivity of different types of parietal gastric cell receptors]. Klinicheskaia meditsina 20070101
Gynaecomastia associated with proton pump inhibitors: a case series from the Spanish Pharmacovigilance System. Drug safety 20070101
[Experience of treatment of patients with gastropathy induced by non-steroid anti-inflammatory drugs]. Eksperimental'naia i klinicheskaia gastroenterologiia = Experimental & clinical gastroenterology 20070101
Comparative study of proton pump inhibitors for triple therapy in H. pylori eradication. Indian journal of gastroenterology : official journal of the Indian Society of Gastroenterology 20070101
Responsiveness of measures of heartburn improvement in non-erosive reflux disease. Health and quality of life outcomes 20070101
Effect of proton pump inhibitor on amylase release from isolated pancreatic acini. In vitro cellular & developmental biology. Animal 20070101
Cost-effectiveness analysis of two management strategies for dyspepsia. International journal of technology assessment in health care 20070101
Development of an omeprazole parenteral formulation with hydroxypropyl-beta-cyclodextrin. Pharmaceutical development and technology 20070101
Phenotype-genotype analysis of CYP2C19 in Colombian mestizo individuals. BMC clinical pharmacology 20070101
Efficacy of rifabutin-based triple therapy as second-line treatment to eradicate helicobacter pylori infection. BMC gastroenterology 20070101
[Factors affecting efficacy of proton pump inhibitors in NAID-induced gastric ulcers]. Terapevticheskii arkhiv 20070101
Toxic epidermal necrolysis as a dermatological manifestation of drug hypersensitivity syndrome. European journal of dermatology : EJD 20070101
Macrolide resistance in the normal microbiota after Helicobacter pylori treatment. Scandinavian journal of infectious diseases 20070101
Combined garlic-omeprazole versus standard quadruple therapy for eradication of Helicobacter pylori infection. Indian journal of gastroenterology : official journal of the Indian Society of Gastroenterology 20070101
Pregabalin-induced remission in a 62-year-old woman with a 20-year history of vulvodynia. Pain research & management 20070101
[Changes in epithelium transport system function and morphological indexes in the colon mucosa of rats with hypergastrinemia of different duration]. Fiziolohichnyi zhurnal (Kiev, Ukraine : 1994) 20070101
Nerolidol, an antiulcer constituent from the essential oil of Baccharis dracunculifolia DC (Asteraceae). Zeitschrift fur Naturforschung. C, Journal of biosciences 20070101
[A survey of gastroprotective drugs: prescription-indication in hospitalized patients]. Gaceta sanitaria 20070101
Determination of the in vitro susceptibility of feline tritrichomonas foetus to 5 antimicrobial agents. Journal of veterinary internal medicine 20070101
[Clinical guidelines of diagnosis and treatment of gastroesophageal reflux disease]. Revista de gastroenterologia de Mexico 20070101
[Modern attitude towards management of laryngopharyngeal form of gastroesophageal reflux disease. Lithuanian clinical practice guidelines for adults]. Medicina (Kaunas, Lithuania) 20070101
Prospective Acid Reflux Study of Iran (PARSI): methodology and study design. BMC gastroenterology 20070101
The effect of probiotics on Helicobacter pylori eradication. Hepato-gastroenterology 20070101
Changes in omeprazole pharmacokinetics in rats with diabetes induced by alloxan or streptozotocin: faster clearance of omeprazole due to induction of hepatic CYP1A2 and 3A1. Journal of pharmacy & pharmaceutical sciences : a publication of the Canadian Society for Pharmaceutical Sciences, Societe canadienne des sciences pharmaceutiques 20070101
Assessment of the pharmaceutical quality of omeprazole capsule brands marketed in Egypt. Eastern Mediterranean health journal = La revue de sante de la Mediterranee orientale = al-Majallah al-sihhiyah li-sharq al-mutawassit 20070101
[New approach to the treatment and prophylaxis of NSAID-induced gastropathies in ambulatory practics]. Eksperimental'naia i klinicheskaia gastroenterologiia = Experimental & clinical gastroenterology 20070101
[Influence of omeprasole and lansoprasole on Na+, K+ -ATPase and Mg2+ -ATPase activity of the plasmatic membrane of myometrium smooth muscle cells]. Ukrains'kyi biokhimichnyi zhurnal (1999 ) 20070101
A head to head comparison of oral vs intravenous omeprazole for patients with bleeding peptic ulcers with a clean base, flat spots and adherent clots. World journal of gastroenterology 20061228
Semipreparative enantiomeric separation of omeprazole by supercritical fluid chromatography. Journal of chromatography. A 20061222
A simple and sensitive bioanalytical assay for simultaneous determination of omeprazole and its three major metabolites in human blood plasma using RP-HPLC after a simple liquid-liquid extraction procedure. Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20061205
Specific H+/K(+)-ATPase inhibitors decreased contractile responses of isolated rat vas deferens. Pharmacological research 20061201
2-week triple therapy for Helicobacter pylori infection is better than 1-week in clinical practice: a large prospective single-center randomized study. Helicobacter 20061201
A double blind, randomised placebo controlled trial of rifampicin with omeprazole in the treatment of human cutaneous leishmaniasis. Journal of vector borne diseases 20061201
Efficacy of two triple eradication regimens in children with Helicobacter pylori infection. Journal of Korean medical science 20061201
An in vitro comparison of different providers to deliver four proton pump inhibitor products through a feeding tube. Alimentary pharmacology & therapeutics 20061201
Boerhaave syndrome treated conservatively following early endoscopic diagnosis: a case report. Journal of Nippon Medical School = Nippon Ika Daigaku zasshi 20061201
Continuous infusion or repeated intravenous bolus injection of high-dose omeprazole in patients at high risk of rebleeding from peptic ulcers? The American journal of gastroenterology 20061201
[Safety of proton pump inhibitors]. Medicina clinica 20061125
Stability and viscosity of a flavored omeprazole oral suspension for pediatric use. American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists 20061115
Conservative management of esophageal perforation following obesity surgery. Sao Paulo medical journal = Revista paulista de medicina 20061107
[Anaphylaxis caused by omeprazole]. Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete 20061101
Characteristics of the K+-competitive H+,K+-ATPase inhibitor AZD0865 in isolated rat gastric glands. American journal of physiology. Gastrointestinal and liver physiology 20061101
Gastric type H+,K+-ATPase in the cochlear lateral wall is critically involved in formation of the endocochlear potential. American journal of physiology. Cell physiology 20061101
Pharmacokinetics of omeprazole in rats with water deprivation for 72 hours. Biopharmaceutics & drug disposition 20061101
Influence of omeprazol on the antiplatelet action of clopidogrel associated to aspirin. Journal of thrombosis and haemostasis : JTH 20061101
Finasteride 1 mg has no inhibitory effect on omeprazole metabolism in extensive and poor metabolizers for CYP2C19 in Japanese. European journal of clinical pharmacology 20061101
Excessively high doses of omeprazole being used in infants. Journal of paediatrics and child health 20061101
A 59-year-old woman with gastroesophageal reflux disease and barrett esophagus, 4 years later. JAMA 20061101
Anti-ulcer effect of tea catechin in rats. Biological & pharmaceutical bulletin 20061101
Initial 48-hour acid inhibition by intravenous infusion of omeprazole, famotidine, or both in relation to cytochrome P450 2C19 genotype status. Clinical pharmacology and therapeutics 20061101
Prospective trial of laparoscopic nissen fundoplication versus proton pump inhibitor therapy for gastroesophageal reflux disease: Seven-year follow-up. Journal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary Tract 20061101
Molecular mechanisms involved in anti-inflammatory effects of proton pump inhibitors. Inflammation research : official journal of the European Histamine Research Society ... [et al.] 20061101
Treatment of gastroesophageal reflux disease. Jornal de pediatria 20061101
Proton-pump inhibitors and hypomagnesemic hypoparathyroidism. The New England journal of medicine 20061026
Therapeutic ritonavir-boosted atazanavir plasma concentration and concurrent omeprazole use. AIDS (London, England) 20061024
Does delayed gastric emptying shorten the H pylori eradication period? A double blind clinical trial. World journal of gastroenterology 20061021
Expression of HSP72 in the gastric mucosa is regulated by gastric acid in rats-correlation of HSP72 expression with mucosal protection. Biochemical and biophysical research communications 20061020
Pre-endoscopic proton pump inhibitor therapy reduces recurrent adverse gastrointestinal outcomes in patients with acute non-variceal upper gastrointestinal bleeding. Alimentary pharmacology & therapeutics 20061015
An in vitro investigation on acid catalyzed reactions of proton pump inhibitors in the absence of an electrophile. International journal of pharmaceutics 20061012
Enantiomeric separation of omeprazole and its metabolite 5-hydroxyomeprazole using non-aqueous capillary electrophoresis. Journal of chromatography. A 20061006
Endoplasmic reticulum stress response is involved in the pathogenesis of stress induced gastric lesions in rats. Life sciences 20061004
[Long term results of treatment by simple surgical closure of perforated gastroduodenal ulcer followed by eradication of Helicobacter pylori]. Annales de chirurgie 20061001
Detection and characterization of metabolites in biological matrices using mass defect filtering of liquid chromatography/high resolution mass spectrometry data. Drug metabolism and disposition: the biological fate of chemicals 20061001
Effect of acid secretion blockade on acute gastric mucosal lesions induced by Tityus serrulatus scorpion toxin in anaesthetized rats. Toxicon : official journal of the International Society on Toxinology 20061001
Regression of gastroesophageal reflux disease symptoms using dietary supplementation with melatonin, vitamins and aminoacids: comparison with omeprazole. Journal of pineal research 20061001
Urea, fluorofamide, and omeprazole treatments alter helicobacter colonization in the mouse gastric mucosa. Helicobacter 20061001
Lack of pharmacokinetic interaction between omeprazole or lansoprazole and ivabradine in healthy volunteers: an open-label, randomized, crossover, pharmacokinetic interaction clinical trial. Journal of clinical pharmacology 20061001
Effect of rabeprazole and omeprazole on the onset of gastro-oesophageal reflux disease symptom relief during the first seven days of treatment. Scandinavian journal of gastroenterology 20061001
Proton pump inhibitors: indigestion for nephrologists! Nephrology (Carlton, Vic.) 20061001
Proton pump inhibitors and acute interstitial nephritis: report and analysis of 15 cases. Nephrology (Carlton, Vic.) 20061001
Potential relationship between gastroesophageal reflux disease and atrial arrhythmias. Journal of clinical gastroenterology 20061001
The role of proton-pump inhibitor therapy in patients with gastroesophageal reflux disease and difficult-to-control asthma. Expert opinion on pharmacotherapy 20061001
Canine gastrinoma: a case study and literature review of therapeutic options. New Zealand veterinary journal 20061001
Endothelin-1, inducible nitric oxide synthase and macrophage inflammatory protein-1alpha in the pathogenesis of stress ulcer in neurotraumatic patients. The Journal of trauma 20061001
Proton pump inhibitors. Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association 20061001
Interaction studies of omeprazole with mefloquine, pyrimethamine and sulfadoxine. Pakistan journal of pharmaceutical sciences 20061001
[The influence of gastroesophageal reflux on the course and therapy of bronchial asthma]. Polski merkuriusz lekarski : organ Polskiego Towarzystwa Lekarskiego 20061001
Medical treatment of gastro-oesophageal reflux disease. Acta otorhinolaryngologica Italica : organo ufficiale della Societa italiana di otorinolaringologia e chirurgia cervico-facciale 20061001
[Dosaging of proton pumps inhibitors]. Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke 20060921
Discontinuation of proton pump inhibitors in patients on long-term therapy: a double-blind, placebo-controlled trial. Alimentary pharmacology & therapeutics 20060915
Thyroxine in goiter, H. pylori infection, and gastritis. The New England journal of medicine 20060914
Furazolidone-based triple therapy for H pylori gastritis in children. World journal of gastroenterology 20060914
Determination of omeprazole, hydroxyomeprazole and omeprazole sulfone using automated solid phase extraction and micellar electrokinetic capillary chromatography. Journal of pharmaceutical and biomedical analysis 20060911
Physical and thermal characterisation of chiral omeprazole sodium salts. Journal of pharmaceutical and biomedical analysis 20060911
Esophageal pH-impedance monitoring and symptom analysis in GERD: a study in patients off and on therapy. The American journal of gastroenterology 20060901
Proton pump inhibitors reduce gallbladder function. Surgical endoscopy 20060901
Comparison of the efficacy of rabeprazole 10 mg and omeprazole 20 mg for the healing rapidity of peptic ulcer diseases. Journal of gastroenterology and hepatology 20060901
Systematic review: proton pump inhibitors (PPIs) for the healing of reflux oesophagitis - a comparison of esomeprazole with other PPIs. Alimentary pharmacology & therapeutics 20060901
Omeprazole may be superior to famotidine in the management of iatrogenic ulcer after endoscopic mucosal resection: a prospective randomized controlled trial. Alimentary pharmacology & therapeutics 20060901
Intravenous pantoprazole as initial treatment in patients with gastroesophageal reflux disease and a history of erosive esophagitis: a randomized clinical trial. Digestive diseases and sciences 20060901
Monitoring cytochrome P-450 activity during rabeprazole treatment in patients with gastresophageal reflux disease. Digestive diseases and sciences 20060901
Esophageal intramural pseudodiverticulosis with esophageal strictures successfully treated with dilation therapy. The Annals of thoracic surgery 20060901
Treatment of laryngopharyngeal reflux improves asthma symptoms in asthmatics. The Journal of asthma : official journal of the Association for the Care of Asthma 20060901
Efficacy of lower than standard doses of pancreatic enzyme supplementation therapy during acid inhibition in patients with pancreatic exocrine insufficiency. Journal of clinical gastroenterology 20060901
Double-blind, placebo-controlled trial with single-dose pantoprazole for laryngopharyngeal reflux. The American journal of gastroenterology 20060901
Continuous infusion of pantoprazole versus ranitidine for prevention of ulcer rebleeding: a U.S. multicenter randomized, double-blind study. The American journal of gastroenterology 20060901
The effect of CYP2C19 substrate on the metabolism of melatonin in the elderly: A randomized, double-blind, placebo-controlled study. Methods and findings in experimental and clinical pharmacology 20060901
[Influence of CYP2C19 polymorphism and Helicobacter pylori status on the antisecretory effect of omeprazole in gastroesophageal reflux disease]. The Korean journal of gastroenterology = Taehan Sohwagi Hakhoe chi 20060901
Effects of 3-day IV pantoprazole versus omeprazole on 24-hour intragastric acidity at 3 days in Chinese patients with duodenal ulcer: A single-center, prospective, randomized, comparative, pilot trial. Clinical therapeutics 20060901
14-day quadruple therapy with ranitidine bismuth citrate after Helicobacter pylori treatment failure in Thailand. Journal of the Medical Association of Thailand = Chotmaihet thangphaet 20060901
Gastroprotective and ulcer-healing activity of oleanolic acid derivatives: in vitro-in vivo relationships. Life sciences 20060829
Triple, standard quadruple and ampicillin-sulbactam-based quadruple therapies for H. pylori eradication: a comparative three-armed randomized clinical trial. World journal of gastroenterology 20060814
Pharmacodynamic and kinetic effect of rabeprazole on serum gastrin level in relation to CYP2C19 polymorphism in Chinese Hans. World journal of gastroenterology 20060807
Effects of prototypical drug-metabolizing enzyme inducers on mRNA expression of housekeeping genes in primary cultures of human and rat hepatocytes. Biochemical and biophysical research communications 20060804
Acid-suppressive effects of generic omeprazole: comparison of three brands of generic omeprazole with original omeprazole. Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver 20060801
Generic versus brand-name medicinal products: are they really interchangeable? Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver 20060801
Letter to the Editor regarding pediatric postcricoid masses. International journal of pediatric otorhinolaryngology 20060801
Use of omeprazole sulfone in a single plasma sample as a probe for CYP3A4. European journal of clinical pharmacology 20060801
Prevention of NSAID-associated gastrointestinal lesions: a comparison study pantoprazole versus omeprazole. The American journal of gastroenterology 20060801
Silent reflux: ex juvantibus criteria for diagnosis and treatment of laryngeal disorders. Acta oto-laryngologica 20060801
[Neurological manifestations in critically ill patients]. Revista de neurologia 20060801
Efficacy and safety of rabeprazole, amoxicillin, and gatifloxacin after treatment failure of initial Helicobacter pylori eradication. Helicobacter 20060801
Triple levofloxacin-based rescue therapy is an accepted empirical third-line treatment. The American journal of gastroenterology 20060801
Multichannel intraluminal impedance in the evaluation of patients with persistent globus on proton pump inhibitor therapy. The Annals of otology, rhinology, and laryngology 20060801
Regulation of mRNA expression of MDR1, MRP1, MRP2 and MRP3 by prototypical microsomal enzyme inducers in primary cultures of human and rat hepatocytes. Drug metabolism and pharmacokinetics 20060801
Impact of the reclassification of omeprazole on the prescribing and sales of ulcer healing drugs. Pharmacy world & science : PWS 20060801
Continuation of proton pump inhibitors from hospital to community. Pharmacy world & science : PWS 20060801
Pharmacoeconomic comparison of Helicobacter pylori eradication regimens. Pharmacy world & science : PWS 20060801
Effect of omeprazole on markers of performance in gastric ulcer-free standardbred horses. Equine veterinary journal. Supplement 20060801
Azithromycin in one week quadruple therapy for H pylori eradication in Iran. World journal of gastroenterology 20060728
Randomized double-blind factorial trial of three treatments to reduce the prevalence of precancerous gastric lesions. Journal of the National Cancer Institute 20060719
Randomized trial of rifabutin-based triple therapy and high-dose dual therapy for rescue treatment of Helicobacter pylori resistant to both metronidazole and clarithromycin. Alimentary pharmacology & therapeutics 20060715
Beyond gastric acid reduction: proton pump inhibitors induce heme oxygenase-1 in gastric and endothelial cells. Biochemical and biophysical research communications 20060707
Effects of enzyme inducers and inhibitors on the pharmacokinetics of intravenous omeprazole in rats. Biopharmaceutics & drug disposition 20060701
Profiling the hepatic effects of flutamide in rats: a microarray comparison with classical aryl hydrocarbon receptor ligands and atypical CYP1A inducers. Drug metabolism and disposition: the biological fate of chemicals 20060701
Identification of human hepatic cytochrome P450 enzymes involved in the metabolism of 8-prenylnaringenin and isoxanthohumol from hops (Humulus lupulus L.). Drug metabolism and disposition: the biological fate of chemicals 20060701
Can heterotopic gastric mucosa present as globus pharyngeus? The Journal of laryngology and otology 20060701
Optimising the therapy of exocrine pancreatic insufficiency by the association of a proton pump inhibitor to enteric coated pancreatic extracts. Gut 20060701
A proton pump inhibitor, lansoprazole, ameliorates asthma symptoms in asthmatic patients with gastroesophageal reflux disease. The Tohoku journal of experimental medicine 20060701
Can Helicobacter pylori eradication regimens be shortened in clinical practice? An open-label, randomized, pilot study of 4 and 7-day triple therapy with rabeprazole, high-dose levofloxacin, and tinidazole. Journal of clinical gastroenterology 20060701
The effect of CYP2C19 polymorphisms on H. pylori eradication rate in dual and triple first-line PPI therapies: a meta-analysis. The American journal of gastroenterology 20060701
By the way, doctor. I've been taking Prilosec for over a year for GERD. Recently, I read that long-term use of proton pump inhibitors increases the risk of certain gastric cancers. Your opinion? Harvard women's health watch 20060701
Determination and validation of ketoprofen, pantoprazole and valsartan together in human plasma by high performance liquid chromatography. Die Pharmazie 20060701
Effects of rabeprazole or famotidine during cardiac surgery on perioperative gastric and esophageal pH readings. The Japanese journal of thoracic and cardiovascular surgery : official publication of the Japanese Association for Thoracic Surgery = Nihon Kyobu Geka Gakkai zasshi 20060701
Severe laryngeal hyperkeratosis secondaryto laryngopharyngeal reflux. Ear, nose, & throat journal 20060701
Clinical impact of CYP2C19 polymorphism on the action of proton pump inhibitors: a review of a special problem. International journal of clinical pharmacology and therapeutics 20060701
The complete remission concept. Drugs of today (Barcelona, Spain : 1998) 20060701
Interaction or relationship between Helicobacter pylori and non-steroidal anti-inflammatory drugs in upper gastrointestinal diseases. World journal of gastroenterology 20060628
Eradication of H pylori infection in a rural population: one-day quadruple therapy versus 7-day triple therapy. World journal of gastroenterology 20060628
Effect of omeprazole on the pharmacokinetics of saquinavir-500 mg formulation with ritonavir in healthy male and female volunteers. AIDS (London, England) 20060626
Development and validation of a dissolution test for rabeprazole sodium in coated tablets. Journal of pharmaceutical and biomedical analysis 20060607
Determination of omeprazole in rat plasma by high-performance liquid chromatography without solvent extraction. Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20060606
Preparation, characterization, and in vivo anti-ulcer evaluation of pantoprazole-loaded microparticles. European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V 20060601
Solid state interactions between the proton pump inhibitor omeprazole and various enteric coating polymers. Journal of pharmaceutical sciences 20060601
Design and planned analyses of an ongoing randomized trial assessing the preventive effect of Helicobacter pylori eradication on occurrence of new gastric carcinomas after endoscopic resection. Helicobacter 20060601
Switch patterns before and after patent expiry of omeprazole: a case study in The Netherlands. Alimentary pharmacology & therapeutics 20060601
Effect of frequent dosing of an oral proton pump inhibitor on intragastric pH. Alimentary pharmacology & therapeutics 20060601
Reversed-phase high performance liquid chromatographic method for the determination of lansoprazole, omeprazole and pantoprazole sodium sesquihydrate in presence of their Acid-induced degradation products. Chemical & pharmaceutical bulletin 20060601
Enantioselective disposition of lansoprazole and rabeprazole in human plasma. Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan 20060601
Myopathy including polymyositis: a likely class adverse effect of proton pump inhibitors? European journal of clinical pharmacology 20060601
Should we bravo? Gastroenterology 20060601
Proton pump inhibitor or testing for Helicobacter pylori as the first step for patients presenting with dyspepsia? A cluster-randomized trial. The American journal of gastroenterology 20060601
Management of the dyspeptic patient: anything goes? The American journal of gastroenterology 20060601
Gastroesophageal reflux disease and asthma: the role of proton pump inhibitors. Chest 20060601
Identification of a single time-point for plasma lansoprazole measurement that adequately reflects area under the concentration-time curve. Therapeutic drug monitoring 20060601
Porfimer sodium photodynamic therapy for management of Barrett's esophagus with high-grade dysplasia. Lasers in surgery and medicine 20060601
Effect of a therapeutic maximum allowable cost (MAC) program on the cost and utilization of proton pump inhibitors in an employer-sponsored drug plan in Canada. Journal of managed care pharmacy : JMCP 20060601
The effect of luteolin-7-O-beta-D-glucuronopyranoside on gastritis and esophagitis in rats. Archives of pharmacal research 20060601
The pharmacodynamic effect of omeprazole 10 mg and 20 mg once daily in patients with nonerosive reflux disease in Japan. Journal of gastroenterology 20060601
[Effects of proton pump inhibitor on airway hyperresponsiveness in asthmatics with gastroesophageal reflux]. Arerugi = [Allergy] 20060601
Complete regression of low-grade mucosa-associated lymphoid tissue (MALT) lymphoma in the gastric stump after eradication of Helicobacter pylori. Journal of experimental & clinical cancer research : CR 20060601
[Prospective study of 420 biopsies realised in patients with duodenal ulcer with positive Helicobacter pylori]. La Tunisie medicale 20060601
Efficacy of one-day quadruple therapy for H pylori infection in Chinese patients. World journal of gastroenterology 20060521
Sub-optimal proton pump inhibitor dosing is prevalent in patients with poorly controlled gastro-oesophageal reflux disease. Alimentary pharmacology & therapeutics 20060515
Role of CYP3A4 in the regulation of the aryl hydrocarbon receptor by omeprazole sulphide. Cellular signalling 20060501
Degradation of lansoprazole and omeprazole in the aquatic environment. Chemosphere 20060501
Ion flow regulates left-right asymmetry in sea urchin development. Development genes and evolution 20060501
Ritonavir-boosted atazanavir may be efficacious in HIV-infected patients concurrently receiving omeprazole. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 20060501
Evaluation of triple and quadruple Helicobacter pylori eradication therapies in Iranian children: a randomized clinical trial. European journal of gastroenterology & hepatology 20060501
Gastro-oesophageal reflux disease in 'difficult-to-control' asthma: prevalence and response to treatment with acid suppressive therapy. Alimentary pharmacology & therapeutics 20060501
Healing rates for moderate and severe oesophagitis. Alimentary pharmacology & therapeutics 20060501
Proton pump inhibitors and acute interstitial nephritis. Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association 20060501
Evaluation of the drug interaction potential of aplaviroc, a novel human immunodeficiency virus entry inhibitor, using a modified cooperstown 5 + 1 cocktail. Journal of clinical pharmacology 20060501
Lopinavir/ritonavir induces the hepatic activity of cytochrome P450 enzymes CYP2C9, CYP2C19, and CYP1A2 but inhibits the hepatic and intestinal activity of CYP3A as measured by a phenotyping drug cocktail in healthy volunteers. Journal of acquired immune deficiency syndromes (1999) 20060501
A multicenter, randomized, double-blind, 8-week comparative trial of standard doses of esomeprazole (40 mg) and omeprazole (20 mg) for the treatment of erosive esophagitis. Digestive diseases and sciences 20060501
Therapy with gastric acidity inhibitors increases the risk of acute gastroenteritis and community-acquired pneumonia in children. Pediatrics 20060501
Cutaneous hyperpigmentation induced by omeprazole mimicking ashy dermatosis. Journal of the European Academy of Dermatology and Venereology : JEADV 20060501
Primary cutaneous MALT-type lymphoma and Helicobacter pylori: a possible relationship. Journal of the European Academy of Dermatology and Venereology : JEADV 20060501
[Financial restrictions in health care systems could affect treatment quality of GERD-patients]. Zeitschrift fur Gastroenterologie 20060501
Presenting symptoms of nonerosive and erosive esophagitis in pediatric patients. Digestive diseases and sciences 20060501
A multicenter, randomized, double-blind, 8-week comparative trial of low-dose esomeprazole (20 mg) and standard-dose omeprazole (20 mg) in patients with erosive esophagitis. Digestive diseases and sciences 20060501
Hydroxyl radical scavenging reactivity of proton pump inhibitors. Biochemical pharmacology 20060428
Rabeprazole test for the diagnosis of gastro-oesophageal reflux disease: results of a study in a primary care setting. World journal of gastroenterology 20060428
Thyroxine in goiter, Helicobacter pylori infection, and chronic gastritis. The New England journal of medicine 20060427
Comparison of the effects of fasting morning, fasting evening and fed bedtime administration of tenatoprazole on intragastric pH in healthy volunteers: a randomized three-way crossover study. Alimentary pharmacology & therapeutics 20060415
Proton pump inhibitor failure in gastro-oesophageal reflux disease--what about eosinophilic oesophagitis? Alimentary pharmacology & therapeutics 20060415
Diagnostic and management problems of laryngopharyngeal reflux disease in children. International journal of pediatric otorhinolaryngology 20060401
In vitro and in vivo inhibitory effect of stiripentol on clobazam metabolism. Drug metabolism and disposition: the biological fate of chemicals 20060401
Eradication of Helicobacter pylori infection reverses E-cadherin promoter hypermethylation. Gut 20060401
Effect of omeprazole on bioavailability of an oral extended-release formulation of ciprofloxacin. American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists 20060401
Proton pump inhibition prevents gastrointestinal bleeding in ultramarathon runners: a randomised, double blinded, placebo controlled study. British journal of sports medicine 20060401
Pantoprazole-induced thrombocytopenia. The Annals of pharmacotherapy 20060401
Dose-response evaluation of the antisecretory effect of continuous infusion intravenous lansoprazole regimens over 48 h. Alimentary pharmacology & therapeutics 20060401
Lansoprazole regimens that sustain intragastric pH > 6.0: an evaluation of intermittent oral and continuous intravenous infusion dosages. Alimentary pharmacology & therapeutics 20060401
A therapeutic substitution policy for proton pump inhibitors: clinical and economic consequences. Clinical pharmacology and therapeutics 20060401
Gastrin enhances the angiogenic potential of endothelial cells via modulation of heparin-binding epidermal-like growth factor. Cancer research 20060401
Design and evaluation of jingzhiguanxin monolithic osmotic pump tablet. Chemical & pharmaceutical bulletin 20060401
Porfimer: new drug. Endobrachyesophagus: encouraging preliminary results. Prescrire international 20060401
Gastrin increases murine intestinal crypt regeneration following injury. Gastroenterology 20060401
Helicobacter pylori eradication prior to initiation of long-term non-steroidal anti-inflammatory drug therapy in Chinese patients-a cost-effectiveness analysis. International journal of clinical pharmacology and therapeutics 20060401
Chronic diarrhea and weight loss in three horses. The Veterinary clinics of North America. Equine practice 20060401
Cholelithiasis and hepatic fibrosis in a standardbred mare. The Veterinary clinics of North America. Equine practice 20060401
Treatment of oesophageal bile reflux in children: the results of a prospective study with omeprazole. Journal of pediatric gastroenterology and nutrition 20060401
Multicenter, randomized, double-blind study comparing 10, 20 and 40 mg pantoprazole in children (5-11 years) with symptomatic gastroesophageal reflux disease. Journal of pediatric gastroenterology and nutrition 20060401
Pantoprazole infusion as adjuvant therapy to endoscopic treatment in patients with peptic ulcer bleeding: prospective randomized controlled trial. Journal of gastroenterology and hepatology 20060401
Co-prescription of alginate based formulations & proton pump inhibitors (PPIs) in gastro-oesophageal reflux disease: time for rethink? The Indian journal of medical research 20060401
Administration of an alginate based gastric reflux suppressant on the bioavailability of omeprazole. The Indian journal of medical research 20060401
Inhibition of endosomal sequestration of basic anticancer drugs: influence on cytotoxicity and tissue penetration. British journal of cancer 20060327
Effect of drug treatment on hyperplastic gastric polyps infected with Helicobacter pylori: a randomized, controlled trial. World journal of gastroenterology 20060321
Recurrence of Helicobacter pylori infection after several eradication therapies: long-term follow-up of 1000 patients. Alimentary pharmacology & therapeutics 20060315
Continuous treatment of Barrett's oesophagus patients with proton pump inhibitors up to 13 years: observations on regression and cancer incidence. Alimentary pharmacology & therapeutics 20060315
Characterization of the inhibitory activity of tenatoprazole on the gastric H+,K+ -ATPase in vitro and in vivo. Biochemical pharmacology 20060314
[Is the successful eradication of Helicobacter pylori sufficient for the healing of peptic ulcer?]. Orvosi hetilap 20060312
Sensitive determination of omeprazole and its two main metabolites in human plasma by column-switching high-performance liquid chromatography: application to pharmacokinetic study in relation to CYP2C19 genotypes. Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20060307
Frequency of gastroesophageal reflux disease in nonatopic children with asthma-like airway disease. Respiratory medicine 20060301
An amino acid transporter involved in gastric acid secretion. Pflugers Archiv : European journal of physiology 20060301
Disease-modifying anti-rheumatic drugs are only one of a number of potential causes of myelosuppression: a careful drug history is necessary to elucidate the cause of an adverse event. Rheumatology (Oxford, England) 20060301
Omeprazole-induced dermatomyositis. The British journal of dermatology 20060301
The effects of changing temperature correction factors on measures of acidity calculated from gastric and oesophageal pH recordings. Alimentary pharmacology & therapeutics 20060301
Changes of gastric mucosal architecture during long-term omeprazole therapy: results of a randomized clinical trial. Alimentary pharmacology & therapeutics 20060301
Pantoprazole and perinuclear antineutrophil cytoplasmic antibody-associated vasculitis. The Journal of rheumatology 20060301
Review article: the role of acid suppression in patients with non-erosive reflux disease or functional heartburn. Alimentary pharmacology & therapeutics 20060301
Different effects of fluvoxamine on rabeprazole pharmacokinetics in relation to CYP2C19 genotype status. British journal of clinical pharmacology 20060301
Enantioselective disposition of rabeprazole in relation to CYP2C19 genotypes. British journal of clinical pharmacology 20060301
Hydroxylation of lansoprazole in poor metabolizers of CYP2C19. British journal of clinical pharmacology 20060301
Use of omeprazole as a CYP3A probe drug: effect of sex and menstrual cycle phase on CYP3A activity in healthy Caucasian adults. Journal of clinical pharmacology 20060301
Rapid onset of effect of sodium alginate on gastro-oesophageal reflux compared with ranitidine and omeprazole, and relationship between symptoms and reflux episodes. International journal of clinical practice 20060301
Psychological factors as a predictor of treatment response in patients with heartburn: a pooled analysis of clinical trials. Scandinavian journal of gastroenterology 20060301
Inhibition of atazanavir oral absorption by lansoprazole gastric acid suppression in healthy volunteers. Pharmacotherapy 20060301
Long-term results of upper respiratory syndrome surgery and gastrointestinal tract medical treatment in 51 brachycephalic dogs. The Journal of small animal practice 20060301
Hypersensitivity to lansoprazole and rabeprazole with tolerance to other proton pump inhibitors. The Journal of allergy and clinical immunology 20060301
Proton pump inhibitor therapy in atazanavir-treated patients: contraindicated? Journal of acquired immune deficiency syndromes (1999) 20060301
Role of intravenous omeprazole in patients with high-risk peptic ulcer bleeding after successful endoscopic epinephrine injection: a prospective randomized comparative trial. The American journal of gastroenterology 20060301
Omeprazole treatment ameliorates oxyntic atrophy induced by DMP-777. Digestive diseases and sciences 20060301
Efficacy of low-dose lansoprazole in the treatment of non-erosive gastrooesophageal reflux disease. Influence of infection by Helicobacter pylori. Revista espanola de enfermedades digestivas : organo oficial de la Sociedad Espanola de Patologia Digestiva 20060301
Microscopic colitis associated with exposure to lansoprazole. The Medical journal of Australia 20060220
[Gastric protection and treatment with low-dose aspirin]. Medicina clinica 20060218
Proton pump inhibitors omeprazole and lansoprazole induce relaxation of isolated human arteries. European journal of pharmacology 20060215
Healing of lymphocytic gastritis after Helicobacter pylori eradication therapy--a randomized, double-blind, placebo-controlled multicentre trial. Alimentary pharmacology & therapeutics 20060215
Efficacy and safety of rifabutin-containing 'rescue therapy' for resistant Helicobacter pylori infection. Alimentary pharmacology & therapeutics 20060215
Validation of a 7-point Global Overall Symptom scale to measure the severity of dyspepsia symptoms in clinical trials. Alimentary pharmacology & therapeutics 20060215
Interaction between tacrolimus and omeprazole in a pediatric liver transplant recipient. Transplantation 20060215
Omeprazole maintenance therapy prevents recurrent ulcer bleeding after surgery for duodenal ulcer. World journal of gastroenterology 20060207
Sensitive quantification of omeprazole and its metabolites in human plasma by liquid chromatography-mass spectrometry. Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20060202
Obstructive sleep apnoea is improved by a prolonged treatment of gastrooesophageal reflux with omeprazole. Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver 20060201
What is the relationship between gastro-oesophageal reflux and obstructive sleep apnoea? Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver 20060201
Acute severe myopathy following a single infusion of omeprazole. The Annals of pharmacotherapy 20060201
Acid decomposition of omeprazole in the absence of thiol: a differential pulse polarographic study at the static mercury drop electrode (SMDE). Journal of pharmaceutical sciences 20060201
Pharmacokinetics of three proton pump inhibitors in Chinese subjects in relation to the CYP2C19 genotype. European journal of clinical pharmacology 20060201
Lansoprazole, levofloxacin and amoxicillin triple therapy vs. quadruple therapy as second-line treatment of resistant Helicobacter pylori infection. Alimentary pharmacology & therapeutics 20060201
Three-year oral pantoprazole administration is effective for patients with Zollinger-Ellison syndrome and other hypersecretory conditions. Alimentary pharmacology & therapeutics 20060201
Effect of probiotics and triple eradication therapy on the cyclooxygenase (COX)-2 expression, apoptosis, and functional gastric mucosal impairment in Helicobacter pylori-infected Mongolian gerbils. Helicobacter 20060201
Prevalence and treatment of Helicobacter pylori in patients with blepharitis. Investigative ophthalmology & visual science 20060201
Proton-pump inhibitors for upper-gastrointestinal bleeding. American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists 20060201
Proton-pump inhibitors for upper-gastrointestinal bleeding. American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists 20060201
Third-line rescue therapy with levofloxacin after two H. pylori treatment failures. The American journal of gastroenterology 20060201
Determinants of long-term outcome of patients with reflux-related ear, nose, and throat symptoms. Digestive diseases and sciences 20060201
In vitro effects of some drugs on human red blood cell glucose-6-phosphate dehydrogenase enzyme activity. Journal of enzyme inhibition and medicinal chemistry 20060201
Clarithromycin-resistant genotypes and eradication of Helicobacter pylori. Annals of internal medicine 20060117
A study of 4- and 7-day triple therapy with rabeprazole, high-dose levofloxacin and tinidazole rescue treatment for Helicobacter pylori eradication. Alimentary pharmacology & therapeutics 20060115
Rabeprazole containing triple therapy to eradicate Helicobacter pylori infection on the Texas-Mexican border. Alimentary pharmacology & therapeutics 20060115
Proton pump inhibitor treatment of patients with gastroesophageal reflux-related chronic cough: a comparison between two different daily doses of lansoprazole. World journal of gastroenterology 20060107
Analysis of omeprazole and 5-OH omeprazole in human plasma using hydrophilic interaction chromatography with tandem mass spectrometry (HILIC-MS/MS)--eliminating evaporation and reconstitution steps in 96-well liquid/liquid extraction. Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20060102
Attenuation of acid induced oesophagitis in VR-1 deficient mice. Gut 20060101
Altered expression of Skp2, c-Myc and p27 proteins but not mRNA after H. pylori eradication in chronic gastritis. Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 20060101
Conformational spaces of the gastrointestinal antisecretory chiral drug omeprazole: stereochemistry and tautomerism. Chirality 20060101
Fatal toxic epidermal necrolysis due to lansoprazole. Clinical and experimental dermatology 20060101
Lansoprazole, a proton pump inhibitor, reduces the severity of indomethacin-induced rat enteritis. International journal of molecular medicine 20060101
Efficacy of Nissen fundoplication versus medical therapy in the regression of low-grade dysplasia in patients with Barrett esophagus: a prospective study. Annals of surgery 20060101
A comparison of oral omeprazole and intravenous cimetidine in reducing complications of duodenal peptic ulcer. BMC gastroenterology 20060101
A common novel CYP2C19 gene variant causes ultrarapid drug metabolism relevant for the drug response to proton pump inhibitors and antidepressants. Clinical pharmacology and therapeutics 20060101
Acid-suppressive effects of rabeprazole, omeprazole, and lansoprazole at reduced and standard doses: a crossover comparative study in homozygous extensive metabolizers of cytochrome P450 2C19. Clinical pharmacology and therapeutics 20060101
Clinical outcomes of eradication of Helicobacter pylori in nonulcer dyspepsia in a population with a high prevalence of infection: results of a 12-month randomized, double blind, placebo-controlled study. Digestive diseases and sciences 20060101
Reversible edema in a male patient taking parenteral pantoprazole infusion for pyloric stenosis. Digestive diseases and sciences 20060101
Inhibition of pentagastrin-stimulated gastric acid secretion by pantoprazole and omeprazole in healthy adults. Digestive diseases and sciences 20060101
A 30-month evaluation of the effects on the cost and utilization of proton pump inhibitors from adding omeprazole OTC to drug benefit coverage in a state employee health plan. Journal of managed care pharmacy : JMCP 20060101
Duodenal hematoma following endoscopic duodenal biopsy: a case report and review of the existing literature. Canadian journal of gastroenterology = Journal canadien de gastroenterologie 20060101
[A randomized, prospective, comparative, multicenter study of rabeprazole and ranitidine in the treatment of reflux esophagitis]. The Korean journal of gastroenterology = Taehan Sohwagi Hakhoe chi 20060101
[A Case of Cronkhite-Canada syndrome showing resolution with Helicobacter pylori eradication and omeprazole]. The Korean journal of gastroenterology = Taehan Sohwagi Hakhoe chi 20060101
Efficacy of a proton pump inhibitor given in the early postoperative period to relieve symptoms of hiatal hernia after open heart surgery. Surgery today 20060101
Anaphylaxis to omeprazole: diagnosis and desensitization protocol. Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology 20060101
Inlet patch of gastric mucosa in upper esophagus causing chronic cough and vocal cord dysfunction. Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology 20060101
Cholecystoduodenal fistula secondary to penetrating duodenal ulcer: a case of conservative management. Journal of the College of Physicians and Surgeons--Pakistan : JCPSP 20060101
Effectiveness of minocycline-based triple therapy for eradication of Helicobacter pylori infection. Journal of gastroenterology and hepatology 20060101
Pharmacokinetics of tenatoprazole, a newly synthesized proton pump inhibitor, in healthy male Caucasian volunteers. Arzneimittel-Forschung 20060101
Empiric treatment of laryngopharyngeal reflux with proton pump inhibitors: a systematic review. The Laryngoscope 20060101
Helicobacter pylori infection prevents nocturnal gastric acid breakthrough. Hepato-gastroenterology 20060101
'Best practice' for Helicobacter pylori eradication in the primary care setting. Irish medical journal 20060101
Intestinal CYP3A4 is not involved in the enantioselective disposition of lansoprazole. Xenobiotica; the fate of foreign compounds in biological systems 20060101
Effect of Helicobacter pylori eradication on the outcome of reflux esophagitis and chronic gastritis in the elderly. A randomized, multicenter, eight-month study. Gerontology 20060101
[Melatonin in treatment of duodenal ulcer]. Klinicheskaia meditsina 20060101
[Medical, social, and economic effectiveness of treatment of day-case patients with peptic ulcer]. Klinicheskaia meditsina 20060101
[Pseudomembranous colitis after Helicobacter pylori eradication therapy]. Kansenshogaku zasshi. The Journal of the Japanese Association for Infectious Diseases 20060101
[Economic evaluation of the treatment with aspirin plus esomeprazole compared to clopidogrel in gastrointestinal bleeding prevention]. Gaceta sanitaria 20060101
[Comment. Higher safety for patients and lower costs for society]. Gaceta sanitaria 20060101
Increased microvascular permeability in early stage of dextran sulfate sodium-induced colitis: its interaction with lansoprazole binding sites. Clinical hemorheology and microcirculation 20060101
Is omeprazole or misoprostol superior for improving indomethacin-induced delayed maturation of granulation tissue in rat gastric ulcers? Digestion 20060101
Drug injury in the upper gastrointestinal tract: nonsteroidal anti-inflammatory drugs. Gastrointestinal endoscopy clinics of North America 20060101
[Complex evaluation of the action of inhibitors of hydrochloric acid secretion on gastric function in ulcer disease]. Terapevticheskii arkhiv 20060101
Functional complementation of the yeast P-type H-ATPase, PMA1, by the Pneumocystis carinii P-type H-ATPase, PCA1. The Journal of eukaryotic microbiology 20060101
Role of Helicobacter pylori virulence factor and genotypes in non-ulcer dyspepsia. Journal of gastroenterology and hepatology 20060101
Pharmacokinetic and pharmacodynamic population modeling of orally administered rabeprazole in healthy Chinese volunteers by the NONMEM method. European journal of drug metabolism and pharmacokinetics 20060101
Possible interethnic differences in omeprazole pharmacokinetics : comparison of Jordanian Arabs with other populations. Clinical pharmacokinetics 20060101
Omeprazole and misoprostol for preventing gastric mucosa effects caused by indomethacin and celecoxib in rats. Acta cirurgica brasileira 20060101
Anaphylactic reaction to drugs commonly used for gastrointestinal system diseases: 3 case reports and review of the literature. Journal of investigational allergology & clinical immunology 20060101
Effect of proton pump inhibitors on hepatic regeneration. European surgical research. Europaische chirurgische Forschung. Recherches chirurgicales europeennes 20060101
[Symptomatic high chromogranin A level associated with rabeprazole and ranitidine]. Therapie 20060101
Additional bedtime H2-receptor antagonist for the control of nocturnal gastric acid breakthrough: a Cochrane systematic review. Chinese journal of digestive diseases 20060101
A meta-analysis: comparison of esomeprazole and other proton pump inhibitors in eradicating Helicobacter pylori. Digestion 20060101
Quality of life in GERD patients: medical treatment versus antireflux surgery. Journal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary Tract 20060101
Assessment of prescribing information for generic drugs manufactured in the Middle East and marketed in Saudi Arabia. Annals of Saudi medicine 20060101
HPLC determination of omeprazole in human plasma using a monolithic column. Arzneimittel-Forschung 20060101
Late-onset life threatening hemorrhage of omeprazole-resistant duodenal ulcer managed by interventional radiology: report of a case. Internal medicine (Tokyo, Japan) 20060101
[Parotid phlegmon with involvement of both lobes. Report of a case]. Anales otorrinolaringologicos ibero-americanos 20060101
The Efficacy of Helicobacter pylori eradication in the treatment of idiopathic thrombocytopenic purpura--the first study in Turkey. Acta haematologica 20060101
Comparative study of salivary pH and volume in adults with chronic laryngopharyngitis by gastroesophageal reflux disease before and after treatment. Brazilian journal of otorhinolaryngology 20060101
[The effectiveness of SCENAR therapy in complex treatment of duodenal ulcer, and the mechanisms of its action]. Klinicheskaia meditsina 20060101
Pharmacokinetic drug interaction profiles of proton pump inhibitors. Drug safety 20060101
Gastroesophageal reflux disease symptoms on antisecretory therapy: acid, non-acid, or no GERD. Reviews in gastroenterological disorders 20060101
Experimental model in the qualitative and quantitative assessment of non-Helicobacter gastric microflora under proton pump inhibitors action. Acta cirurgica brasileira 20060101
Economic evaluation of empirical antisecretory therapy versus Helicobacter pylori test for management of dyspepsia: a randomized trial in primary care. International journal of technology assessment in health care 20060101
Effects of intravenously administrated omeprazole on gastric juice pH and gastric ulcer scores in adult horses. Journal of veterinary internal medicine 20060101
Gastrin-secreting neoplasia in a cat. Journal of veterinary internal medicine 20060101
Recurrence of upper gastrointestinal bleeding after donepezil administration. Alzheimer disease and associated disorders 20060101
Efficacy and safety of Helicobacter pylori eradication therapy with omeprazole, amoxicillin and high- and low-dose clarithromycin in Japanese patients: a randomised, double-blind, multicentre study. Clinical drug investigation 20060101
Drug interactions. Atazanavir and acid-reducing agents. TreatmentUpdate 20060101
Toxic epidermal necrolysis due to omeprazole. European journal of dermatology : EJD 20060101
[Safety of proton pump inhibitors for long-term application]. Eksperimental'naia i klinicheskaia gastroenterologiia = Experimental & clinical gastroenterology 20060101
Fundic gland polyps and PPI: the Mozart effect of gastrointestinal pathology? Polish journal of pathology : official journal of the Polish Society of Pathologists 20060101
[The course of Helicobacter pylori-associated duodenal ulcer concurrent with chronic opisthorchiasis]. Meditsinskaia parazitologiia i parazitarnye bolezni 20060101
Asthma and gastroesophageal reflux disease: effect of long-term pantoprazole therapy. World journal of gastroenterology 20051228
Comparison of P-glycoprotein-mediated drug-digoxin interactions in Caco-2 with human and rodent intestine: relevance to in vivo prediction. European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences 20051201
Effects of omeprazole or cola beverage on the pharmacokinetics of oral DA-8159, a new erectogenic, in rats. Biopharmaceutics & drug disposition 20051201
Interaction magnitude, pharmacokinetics and pharmacodynamics of ticlopidine in relation to CYP2C19 genotypic status. Pharmacogenetics and genomics 20051201
Effect of a triphasic oral contraceptive on drug-metabolizing enzyme activity as measured by the validated Cooperstown 5+1 cocktail. Journal of clinical pharmacology 20051201
The effect of regular and high doses of omeprazole on the intragastric acidity in patients with bleeding peptic ulcer treated endoscopically: a clinical trial with continuous intragastric pH monitoring. European journal of gastroenterology & hepatology 20051201
Cryoablation of Barrett's esophagus: a pilot study. Gastrointestinal endoscopy 20051201
Clinical implications of immediate-release PPI therapy in the management of GERD and upper GI bleeding. Introduction. Alimentary pharmacology & therapeutics 20051201
Review article: similarities and differences among delayed-release proton-pump inhibitor formulations. Alimentary pharmacology & therapeutics 20051201
Review article: immediate-release proton-pump inhibitor therapy--potential advantages. Alimentary pharmacology & therapeutics 20051201
Review article: putting immediate-release proton-pump inhibitors into clinical practice--improving nocturnal acid control and avoiding the possible complications of excessive acid exposure. Alimentary pharmacology & therapeutics 20051201
Review article: prevention of stress-related mucosal bleeding with proton-pump inhibitors. Alimentary pharmacology & therapeutics 20051201
Review article: the role of antisecretory therapy in the management of non-variceal upper gastrointestinal bleeding. Alimentary pharmacology & therapeutics 20051201
Rabeprazole: the role of proton pump inhibitors in Helicobacter pylori eradication. Expert review of anti-infective therapy 20051201
Impact of Helicobacter pylori eradication on the anti-secretory efficacy of lansoprazole in gastroesophageal reflux disease patients. Journal of gastroenterology and hepatology 20051201
Esomeprazole-induced healing of gastroesophageal reflux disease is unrelated to the genotype of CYP2C19: evidence from clinical and pharmacokinetic data. Clinical pharmacology and therapeutics 20051201
Pharmacokinetics of oral omeprazole in llamas. Journal of veterinary pharmacology and therapeutics 20051201
Pharmacodynamic study of a long-acting parenteral formulation of omeprazole in horses. Journal of veterinary pharmacology and therapeutics 20051201
Rabeprazole experience in Korea; focus on CYP2C19 polymorphism. Journal of gastroenterology and hepatology 20051201
CYP2C19 genotype and the PPIs--focus on rabeprazole. Journal of gastroenterology and hepatology 20051201
Inappropriate use of intravenous pantoprazole: extent of the problem and successful solutions. Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association 20051201
All PPIs equivalent for treatment of GERD. The Journal of family practice 20051201
Acute pancreatitis associated with omeprazole. International journal of clinical pharmacology and therapeutics 20051201
Should we eradicate Helicobacter pylori before prescribing an NSAID? Result of a placebo-controlled study. The American journal of gastroenterology 20051201
[Cytochrome P450 2C19 genotype -based second line therapy with amoxicillin and lansoprazole after failure of initial helicobacter pylori eradication therapy]. Nihon rinsho. Japanese journal of clinical medicine 20051201
Gastrointestinal tract. Medsurg nursing : official journal of the Academy of Medical-Surgical Nurses 20051201
Efficacy of Helicobacter pylori eradication on the chronic mucosal inflammation of the remnant stomach after distal gastrectomy for early gastric cancer. Journal of experimental & clinical cancer research : CR 20051201
[Lipid peroxidation and antioxidant system in treatment dynamics of patients with chronic gastritis]. Likars'ka sprava 20051201
Comparison of pantoprazole- vs. omeprazole- based triple therapy regimens in the treatment of Helicobacter pylori infection and duodenal ulcer healing in a Turkish population. The Turkish journal of gastroenterology : the official journal of Turkish Society of Gastroenterology 20051201
Helicobacter pylori eradication in peptic dyspepsia. East African medical journal 20051201
Idiopathic pure red cell aplasia: case report with review of literature. South Dakota journal of medicine 20051201
Stability of pantoprazole in 0.9% sodium chloride injection in polypropylene syringes. American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists 20051115
Effects of treatment with omeprazole or ranitidine on gastric squamous ulceration in racing Thoroughbreds. Journal of the American Veterinary Medical Association 20051115
Randomized study of Helicobacter pylori eradication therapy and proton pump inhibitor monotherapy for idiopathic thrombocytopenic purpura. Annals of hematology 20051101
Enantiomer/enantiomer interactions between the S- and R- isomers of omeprazole in human cytochrome P450 enzymes: major role of CYP2C19 and CYP3A4. The Journal of pharmacology and experimental therapeutics 20051101
Nasal pain disrupting sleep as a presenting symptom of extraesophageal acid reflux in children. International journal of pediatric otorhinolaryngology 20051101
Proton pump inhibitor formulary considerations in the acutely ill. Part 2: Clinical efficacy, safety, and economics. The Annals of pharmacotherapy 20051101
A randomized trial of triple therapy for pediatric Helicobacter pylori infection and risk factors for treatment failure in a population with a high prevalence of infection. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 20051101
Helicobacter pylori eradication in childhood after failure of initial treatment: advantage of quadruple therapy with nifuratel to furazolidone. Alimentary pharmacology & therapeutics 20051101
Balanced perspective essential in erosive oesophagitis treatment. Alimentary pharmacology & therapeutics 20051101
Proton-pump inhibitor for peptic ulcer bleeding. Alimentary pharmacology & therapeutics 20051101
General practitioners' adoption of new drugs and previous prescribing of drugs belonging to the same therapeutic class: a pharmacoepidemiological study. British journal of clinical pharmacology 20051101
In vivo metabolic activity of CYP2C19 and CYP3A in relation to CYP2C19 genetic polymorphism in chronic liver disease. Journal of clinical pharmacology 20051101
Efficacy of rabeprazole in the treatment of symptomatic gastroesophageal reflux disease. Digestive diseases and sciences 20051101
Development and validation of the Gastroesophageal Reflux Disease Treatment Satisfaction Questionnaire. Digestive diseases and sciences 20051101
Improvement of gastrointestinal quality of life scores in cases of Helicobacter pylori-positive functional dyspepsia after successful eradication therapy. Journal of gastroenterology and hepatology 20051101
Nonsecretory variant of immunoproliferative small intestinal disease: a case report with pathologic, immunophenotypic, and molecular findings. Archives of pathology & laboratory medicine 20051101
Review of immediate-release omeprazole for the treatment of gastric acid-related disorders. Expert opinion on pharmacotherapy 20051101
Four-day Bravo pH capsule monitoring with and without proton pump inhibitor therapy. Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association 20051101
Celecoxib compared with lansoprazole and naproxen to prevent gastrointestinal ulcer complications. The American journal of medicine 20051101
Helicobacter pylori: factors affecting eradication and recurrence. The American journal of gastroenterology 20051101
Improved efficacy of 10-Day sequential treatment for Helicobacter pylori eradication in children: a randomized trial. Gastroenterology 20051101
Intravenous proton pump inhibitors before endoscopy in bleeding peptic ulcer with high-risk stigmata: a multicentre comparative study. Canadian journal of gastroenterology = Journal canadien de gastroenterologie 20051101
[The impact of rabeprazole treatment on the quality of life in patients with reflux esophagitis and non-erosive reflux disease]. Zhonghua nei ke za zhi 20051101
Identification and synthesis of potential impurities of rabeprazole sodium. Die Pharmazie 20051101
'Proton-pump inhibitor-first' strategy versus 'step-up' strategy for the acute treatment of reflux esophagitis: a cost-effectiveness analysis in Japan. Journal of gastroenterology 20051101
Helicobacter pylori treatment. Southern medical journal 20051101
Effect of N-acetyl cysteine on Helicobacter pylori. Southern medical journal 20051101
[Gastroesophageal reflux and obstructive sleep apnea syndrome]. Acta otorrinolaringologica espanola 20051101
[Guidelines in the management of H. pylori infection in Japan]. Nihon rinsho. Japanese journal of clinical medicine 20051101
[Establishment of 2nd line treatment regimen for H. pylori infection--future prospect for the application for national health insurance system in Japan]. Nihon rinsho. Japanese journal of clinical medicine 20051101
[H. pylori motility analysis]. Nihon rinsho. Japanese journal of clinical medicine 20051101
[Cap polyposis and Helicobacter pylori]. Nihon rinsho. Japanese journal of clinical medicine 20051101
[Recent topics on important drugs for H. pylori eradication: Omeprazole]. Nihon rinsho. Japanese journal of clinical medicine 20051101
[Recent topics on important drugs for H. pylori eradication: Lansoprazole]. Nihon rinsho. Japanese journal of clinical medicine 20051101
[Recent topics on important drugs for H. pylori eradication: Rabeprazole]. Nihon rinsho. Japanese journal of clinical medicine 20051101
[Recent topics on important drugs for H. pylori eradication: Pantoprazole sodium]. Nihon rinsho. Japanese journal of clinical medicine 20051101
[H. pylori eradication package set (Lansap)]. Nihon rinsho. Japanese journal of clinical medicine 20051101
[Concomitant dosing of a H2 receptor antagonist (H2RA) with a triple therapy increases the cure rate of Helicobacter pylori infection]. Nihon rinsho. Japanese journal of clinical medicine 20051101
[Quality of ulcer healing and rebamipide]. Nihon rinsho. Japanese journal of clinical medicine 20051101
[Triple therapy for eradication of Helicobacter pylori in Japan]. Nihon rinsho. Japanese journal of clinical medicine 20051101
[Adverse effects of Helicobacter pylori eradication and its prevention]. Nihon rinsho. Japanese journal of clinical medicine 20051101
[Is antimicrobial susceptibility testing necessary before second-line treatment for Helicobacter pylori infection?]. Nihon rinsho. Japanese journal of clinical medicine 20051101
[Second-line eradication therapy for H. pylori infection--PPI+AMPC+MNZ triple therapy]. Nihon rinsho. Japanese journal of clinical medicine 20051101
[High dose dual PPI/AMPC therapy for the treatment of Helicobacter pylori infection after failure of usual standard triple PPI/AMPC/CAM therapy]. Nihon rinsho. Japanese journal of clinical medicine 20051101
[PPI plus bismuth-based quintuple therapy]. Nihon rinsho. Japanese journal of clinical medicine 20051101
[Comparison between one-week and two-week regimens of new triple therapy in H. pylori eradication]. Nihon rinsho. Japanese journal of clinical medicine 20051101
[Cetraxate hydrochloride (Neuer) induces the effectiveness of new triple therapy in H. pylori eradication]. Nihon rinsho. Japanese journal of clinical medicine 20051101
[Investigation about 3rd line eradication of H. pylori]. Nihon rinsho. Japanese journal of clinical medicine 20051101
[Helicobacter pylori eradication therapy for children]. Nihon rinsho. Japanese journal of clinical medicine 20051101
[Eradication therapy for the remnant stomach infected with Helicobacter pylori ]. Nihon rinsho. Japanese journal of clinical medicine 20051101
[Eradication of Helicobacter pylori in patients with end-stage renal disease undergoing dialysis treatment]. Nihon rinsho. Japanese journal of clinical medicine 20051101
[Gastroduodenal erosions observed after Helicobacter pylori eradication]. Nihon rinsho. Japanese journal of clinical medicine 20051101
[Influence of cytochrome P450 2C19 genetic polymorphism on H. pylori eradication therapy]. Nihon rinsho. Japanese journal of clinical medicine 20051101
[Antibacterial activity of a Chinese herbal medicine, Gosyuyu (Wu-Chu-Yu), against Helicobacter pylori]. Nihon rinsho. Japanese journal of clinical medicine 20051101
Interaction between omeprazole and tacrolimus in renal allograft recipients: a clinical-analytical study. Transplantation proceedings 20051101
[Acid inhibitors for asthma patients]. MMW Fortschritte der Medizin 20051020
[What does the H. pylori eradication bring?]. MMW Fortschritte der Medizin 20051020
Gastroprotective effect of the Mapuche crude drug Araucaria araucana resin and its main constituents. Journal of ethnopharmacology 20051003
L-type amino acids stimulate gastric acid secretion by activation of the calcium-sensing receptor in parietal cells. American journal of physiology. Gastrointestinal and liver physiology 20051001
Rabeprazole is equivalent to omeprazole in the treatment of erosive gastro-oesophageal reflux disease. A randomised, double-blind, comparative study of rabeprazole and omeprazole 20 mg in acute treatment of reflux oesophagitis, followed by a maintenance open-label, low-dose therapy with rabeprazole. Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver 20051001
Gastric ulcer despite no acid in a renal allograft recipient: what is the link? Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 20051001
A decade-long sour-taste sensation successfully treated with a proton-pump inhibitor. Journal of oral rehabilitation 20051001
Coadministration of lansoprazole and naproxen does not affect the pharmacokinetic profile of methotrexate in adult patients with rheumatoid arthritis. Journal of clinical pharmacology 20051001
Validity of the Glasgow Aneurysm Score and the Hardman Index in predicting outcome after ruptured abdominal aortic aneurysm repair (Br J Surg 2005; 92: 570-573). The British journal of surgery 20051001
Appropriate choice of proton pump inhibitor therapy in the prevention and management of NSAID-related gastrointestinal damage. International journal of clinical practice 20051001
Pharmacokinetic differences between pantoprazole enantiomers in rats. Pharmaceutical research 20051001
Lack of predictors of normalization of oesophageal acid exposure in Barrett's oesophagus. Alimentary pharmacology & therapeutics 20051001
Treatment of patients with heartburn without endoscopic evaluation: on-demand treatment after effective continuous administration of lansoprazole 15 mg. Alimentary pharmacology & therapeutics 20051001
Long-term follow-up after eradication of Helicobacter pylori with omeprazole, clarithromycin, and tinidazole (OCT regimen) in a Japanese population. Helicobacter 20051001
CagA status and Helicobacter pylori eradication among dyspeptic patients. Gastroenterologia y hepatologia 20051001
Dysphagia associated with gastroesophageal reflux disease is improved by proton pump inhibitor. Digestive diseases and sciences 20051001
The efficacy of preanesthetic proton pump inhibitor treatment for patients on long-term H2 antagonist therapy. Anesthesia and analgesia 20051001
Additional discussions regarding the altered metabolism and transport of omeprazole after long-term use of St John's wort. Clinical pharmacology and therapeutics 20051001
Effects of omeprazole and gentamicin on the biochemical and histopathological alterations of the hypoxia/ reoxygenation induced intestinal injury in newborn rats. Pediatric surgery international 20051001
The effects of inhibiting cytochrome P450 3A, p-glycoprotein, and gastric acid secretion on the oral bioavailability of methadone in dogs. Journal of veterinary pharmacology and therapeutics 20051001
Cost-effectiveness comparison of current proton-pump inhibitors to treat gastro-oesophageal reflux disease in the UK. Current medical research and opinion 20051001
Gastric pH, sevelamer hydrochloride and omeprazole. Clinical nephrology 20051001
Effect of omeprazole on the hydroxylation of warfarin enantiomers in human: in-vitro studies with liver microsomes and cDNA-expressed cytochrome P450 isozymes. Current drug metabolism 20051001
Routine application of the proton-pump inhibitor pantoprazole in patients with gastric lymphoma undergoing chemotherapy. Scandinavian journal of gastroenterology 20051001
Effect of Cimetidine and Phenobarbital on metabolite kinetics of Omeprazole in rats. Archives of pharmacal research 20051001
Analysis of omeprazole, midazolam and hydroxy-metabolites in plasma using liquid chromatography coupled to tandem mass spectrometry. Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20050925
Determination of rabeprazole and its active metabolite, rabeprazole thioether in human plasma by column-switching high-performance liquid chromatography and its application to pharmacokinetic study. Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20050925
Long-term results of anti-Helicobacter pylori therapy in early-stage gastric high-grade transformed MALT lymphoma. Journal of the National Cancer Institute 20050921
Positive inotropic and negative chronotropic effects of proton pump inhibitors in isolated rat atrium. European journal of pharmacology 20050920
Cyclo-oxygenase-2 expression and prostaglandin E2 production in experimental chronic gastric ulcer healing. European journal of pharmacology 20050920
Determination of omeprazole in human plasma by liquid chromatography-electrospray quadrupole linear ion trap mass spectrometry. Journal of pharmaceutical and biomedical analysis 20050915
Does gastro-esophageal reflux provoke the myocardial ischemia in patients with CAD? International journal of cardiology 20050915
[Oesophageal ulcer and doxycycline]. Atencion primaria 20050915
Proton pump inhibitors reduce the bioavailability of dietary vitamin C. Alimentary pharmacology & therapeutics 20050915
The effect of a therapeutic trial of high-dose rabeprazole on symptom response of patients with non-cardiac chest pain: a randomized, double-blind, placebo-controlled, crossover trial. Alimentary pharmacology & therapeutics 20050915
Control of intra-oesophageal and intra-gastric pH with proton pump inhibitors in patients with Barrett's oesophagus. Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver 20050901
Cytochrome P450 mRNA expression in peripheral blood lymphocytes as a predictor of enzyme induction. European journal of clinical pharmacology 20050901
Pantoprazole 20 mg on demand is effective in the long-term management of patients with mild gastro-oesophageal reflux disease. European journal of gastroenterology & hepatology 20050901
Helicobacter pylori eradication decreases the expression of glycosylphosphatidylinositol-anchored complement regulators, decay-accelerating factor and homologous restriction factor 20, in human gastric epithelium. Journal of gastroenterology and hepatology 20050901
Management of symptoms in step-down therapy of gastroesophageal reflux disease. Journal of gastroenterology and hepatology 20050901
Determinants of non-response in Helicobacter pylori eradication trials. Journal of gastroenterology and hepatology 20050901
Primary mucosa-associated lymphoid tissue lymphoma occurring in the rectum. Gastrointestinal endoscopy 20050901
Acid suppression does not change respiratory symptoms in children with asthma and gastro-oesophageal reflux disease. Archives of disease in childhood 20050901
The effect of cimetidine or omeprazole on the pharmacokinetics of escitalopram in healthy subjects. British journal of clinical pharmacology 20050901
Long-term acid suppressive therapy may prevent the relapse of lower esophageal (Schatzki's) rings: a prospective, randomized, placebo-controlled study. The American journal of gastroenterology 20050901
Esomeprazole-based therapy in Helicobacter pylori eradication: any effect by increasing the dose of esomeprazole or prolonging the treatment? The American journal of gastroenterology 20050901
A comparative study on endoscopic ulcer healing of omeprazole versus rabeprazole with respect to CYP2C19 genotypic differences. Digestive diseases and sciences 20050901
Effects of 24 weeks of lansoprazole therapy on asthma symptoms, exacerbations, quality of life, and pulmonary function in adult asthmatic patients with acid reflux symptoms. Chest 20050901
Hepatic penetration of a single large duodenal ulcer. The Ulster medical journal 20050901
Factors influencing the shift of patients from one proton pump inhibitor to another: the effect of direct-to-consumer advertising. Clinical therapeutics 20050901
The effect of gastro-oesophageal reflux and omeprazole on key sleep parameters. Alimentary pharmacology & therapeutics 20050815
Is a long-term ranitidine-based triple therapy against Helicobacter pylori only a heritage of the past? A prospective, randomized clinicopharmacological study. Alimentary pharmacology & therapeutics 20050815
Long-term omeprazole and esomeprazole treatment does not significantly increase gastric epithelial cell proliferation and epithelial growth factor receptor expression and has no effect on apoptosis and p53 expression. World journal of gastroenterology 20050814
Comparative study and optimisation of the administration mode of three proton pump inhibitors by nasogastric tube. International journal of pharmaceutics 20050811
High-performance liquid chromatography method for the quantification of pantoprazole in human plasma. Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20050805
Symptom association probability and symptom sensitivity index: preferable but still suboptimal predictors of response to high dose omeprazole. Gut 20050801
Allergy to lansoprazole: study of cross-reactivity among proton-pump inhibitors. Allergy 20050801
Effect of the proton pump inhibitor omeprazole on the pharmacokinetics of extended-release formulations of oxybutynin and tolterodine. Journal of clinical pharmacology 20050801
Review article: the long-term use of proton-pump inhibitors. Alimentary pharmacology & therapeutics 20050801
Seven versus ten days of rabeprazole triple therapy for Helicobacter pylori eradication: a multicenter randomized trial. The American journal of gastroenterology 20050801
Long-term prevention of erosive or ulcerative gastro-oesophageal reflux disease relapse with rabeprazole 10 or 20 mg vs. placebo: results of a 5-year study in the United States. Alimentary pharmacology & therapeutics 20050801
Helicobacter pylori eradication, CYP2C19 and omeprazole doses. Alimentary pharmacology & therapeutics 20050801
Omeprazole-induced hepatitis. Pediatric emergency care 20050801
[The clinical strategy for the Barrett's esophagus]. Nihon rinsho. Japanese journal of clinical medicine 20050801
Role of chronic infection and inflammation in the gastrointestinal tract in the etiology and pathogenesis of idiopathic parkinsonism. Part 2: response of facets of clinical idiopathic parkinsonism to Helicobacter pylori eradication. A randomized, double-blind, placebo-controlled efficacy study. Helicobacter 20050801
[Comparison of esomeprazole- and omeprazole-based triple therapy regimens for duodenal ulcer with Helicobacter pylori infection]. Di 1 jun yi da xue xue bao = Academic journal of the first medical college of PLA 20050801
Protective effect of melatonin and omeprazole against alendronat-induced gastric damage. Digestive diseases and sciences 20050801
A follow-up study on the effect of Helicobacter pylori eradication on the severity of gastric histology. Digestive diseases and sciences 20050801
Proton-pump-inhibitor-induced hepatitis. Southern medical journal 20050801
[The cause of failure of eradication treatment of Helicobacter pylori]. Rinsho byori. The Japanese journal of clinical pathology 20050801
Mechanisms of action of leptin in preventing gastric ulcer. World journal of gastroenterology 20050721
Allophylus serratus: a plant with potential anti-ulcerogenic activity. Journal of ethnopharmacology 20050714
Lansoprazole prevents experimental gastric injury induced by non-steroidal anti-inflammatory drugs through a reduction of mucosal oxidative damage. World journal of gastroenterology 20050714
Head-to-head comparison of H2-receptor antagonists and proton pump inhibitors in the treatment of erosive esophagitis: a meta-analysis. World journal of gastroenterology 20050714
Omeprazole-induced slowing of gastrointestinal transit in mice can be countered with tegaserod. European journal of pharmacology 20050704
Enhanced ghrelin secretion in rats with cysteamine-induced duodenal ulcers. American journal of physiology. Gastrointestinal and liver physiology 20050701
Antisecretory drugs, Helicobacter pylori infection and symptom relief in GORD: still an unexplored triangle. Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver 20050701
A gene expression fingerprint of mouse stomach ECL cells. Biochemical and biophysical research communications 20050701
Variable omeprazole kinetics in healthy Jordanian adults. Biopharmaceutics & drug disposition 20050701
Cost-effectiveness of a 'score and scope' strategy for the management of dyspepsia. European journal of gastroenterology & hepatology 20050701
The effects of apigenin-7-O-beta-D-glucuronopyranoside on reflux oesophagitis and gastritis in rats. Autonomic & autacoid pharmacology 20050701
Omeprazole delays gastric emptying in healthy volunteers: an effect prevented by tegaserod. Alimentary pharmacology & therapeutics 20050701
Effect of concomitant dosing of famotidine with lansoprazole on gastric acid secretion in relation to CYP2C19 genotype status. Alimentary pharmacology & therapeutics 20050701
Enantioselective disposition of lansoprazole in relation to CYP2C19 genotypes in the presence of fluvoxamine. British journal of clinical pharmacology 20050701
Pharmacodynamic comparison of pantoprazole enantiomers: inhibition of acid-related lesions and acid secretion in rats and guinea-pigs. The Journal of pharmacy and pharmacology 20050701
Apparent anaphylaxis associated with pantoprazole. American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists 20050701
Helicobacter pylori infection influences symptomatic response to anti-secretory therapy in patients with GORD--crossover comparative study with famotidine and low-dose lansoprazole. Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver 20050701
Effect of CYP2C19 and MDR1 polymorphisms on cure rate in patients with acid-related disorders with Helicobacter pylori infection. European journal of clinical pharmacology 20050701
Helicobacter heilmannii infection: clinical, endoscopic and histopathological features in Japanese patients. Pathology international 20050701
A randomized trial comparing omeprazole, ranitidine, cisapride, or placebo in helicobacter pylori negative, primary care patients with dyspepsia: the CADET-HN Study. The American journal of gastroenterology 20050701
Effects of proton pump inhibitors on calcium carbonate absorption in women: a randomized crossover trial. The American journal of medicine 20050701
The healing course of thermal esophageal injury: a case report. Gastrointestinal endoscopy 20050701
Laryngopharyngeal reflux: prospective cohort study evaluating optimal dose of proton-pump inhibitor therapy and pretherapy predictors of response. The Laryngoscope 20050701
Lansoprazole-associated collagenous colitis: a case report. Zeitschrift fur Gastroenterologie 20050701
Pharmacokinetics and pharmacodynamics of pantoprazole in clinically normal neonatal foals. Equine veterinary journal 20050701
Rate-limiting biotransformation of triamterene is mediated by CYP1A2. International journal of clinical pharmacology and therapeutics 20050701
Appropriate use of intravenous proton pump inhibitors in the management of bleeding peptic ulcer. Digestive diseases and sciences 20050701
The efficacy of high- and low-dose intravenous omeprazole in preventing rebleeding for patients with bleeding peptic ulcers and comorbid illnesses. Digestive diseases and sciences 20050701
Acid-suppressive efficacy of a reduced dosage of rabeprazole: comparison of 10 mg twice daily rabeprazole with 20 mg twice daily rabeprazole, 30 mg twice daily lansoprazole, and 20 mg twice daily omeprazole by 24-hr intragastric pH-metry. Digestive diseases and sciences 20050701
Influence of 1-week Helicobacter pylori eradication therapy with rabeprazole, clarithromycin, and metronidazole on 13C-aminopyrine breath test. Digestive diseases and sciences 20050701
Does eradication of Helicobacter pylori infection help normalize serum lipid and CRP levels? Digestive diseases and sciences 20050701
Eradication of Helicobacter spp. from a rat breeding colony. Contemporary topics in laboratory animal science 20050701
Investigations on the thermal behavior of omeprazole and other sulfoxides. Die Pharmazie 20050701
Helicobacter pylori and recurrent pain abdomen. Indian journal of pediatrics 20050701
EC fines AstraZeneca in Losec antitrust case. Nature reviews. Drug discovery 20050701
Mechanisms of protection by pantoprazole against NSAID-induced gastric mucosal damage. Naunyn-Schmiedeberg's archives of pharmacology 20050701
Effects of antisecretory agents on angiogenesis during healing of gastric ulcers. Journal of gastroenterology 20050701
Changes in gastric ECL cells and parietal cells after long-term administration of high-dose omeprazole to patients with Barrett's esophagus. The Tokai journal of experimental and clinical medicine 20050701
Understanding GERD symptoms in the clinical setting. Drugs of today (Barcelona, Spain : 1998) 20050701
Extraesophageal manifestations of GERD: diagnosis and therapy. Drugs of today (Barcelona, Spain : 1998) 20050701
Molecular characterization of rat gastric mucosal response to potent acid inhibition. Physiological genomics 20050616
Meta-analysis: role of Helicobacter pylori eradication in the prevention of peptic ulcer in NSAID users. Alimentary pharmacology & therapeutics 20050615
High rate of Helicobacter pylori eradication with sequential therapy in elderly patients with peptic ulcer: a prospective controlled study. Alimentary pharmacology & therapeutics 20050615
Comparison of the effects of immediate-release omeprazole powder for oral suspension and pantoprazole delayed-release tablets on nocturnal acid breakthrough in patients with symptomatic gastro-oesophageal reflux disease. Alimentary pharmacology & therapeutics 20050615
Quality of gastric ulcer healing evaluated by endoscopic ultrasonography. World journal of gastroenterology 20050614
Effect of clarithromycin on the enantioselective disposition of lansoprazole in relation to CYP2C19 genotypes. Chirality 20050601
Air swallowing can be responsible for non-response of heartburn to high-dose proton pump inhibitor. Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver 20050601
Lack of significant effect of grapefruit juice on the pharmacokinetics of lansoprazole and its metabolites in subjects with different CYP2C19 genotypes. Journal of clinical pharmacology 20050601
CYP35: xenobiotically induced gene expression in the nematode Caenorhabditis elegans. Archives of biochemistry and biophysics 20050601
Proton pump inhibitors: update on their role in acid-related gastrointestinal diseases. International journal of clinical practice 20050601
The effect of rabeprazole on regional gastric acidity and the postprandial cardia/gastro-oesophageal junction acid layer in normal subjects: a randomized, double-blind, placebo-controlled study. Alimentary pharmacology & therapeutics 20050601
Effect of CYP2C19 polymorphism on the safety and efficacy of omeprazole in Japanese patients with recurrent reflux oesophagitis. Alimentary pharmacology & therapeutics 20050601
Effect of orally administered omeprazole on abomasal luminal pH in dairy calves fed milk replacer. Journal of veterinary medicine. A, Physiology, pathology, clinical medicine 20050601
Efficacy of famotidine and omeprazole in healing symptoms of non-erosive gastro-oesophageal reflux disease: randomized-controlled study of gastro-oesophageal reflux disease. Alimentary pharmacology & therapeutics 20050601
Famotidine vs. omeprazole: a prospective randomized multicentre trial to determine efficacy in non-erosive gastro-oesophageal reflux disease. Alimentary pharmacology & therapeutics 20050601
Preventive therapy for non-steroidal anti-inflammatory drug-induced ulcers in Japanese patients with rheumatoid arthritis: the current situation and a prospective controlled-study of the preventive effects of lansoprazole or famotidine. Alimentary pharmacology & therapeutics 20050601
Effect of famotidine on recurrent bleeding after successful endoscopic treatment of bleeding peptic ulcer. Alimentary pharmacology & therapeutics 20050601
A prospective randomized trial of either famotidine or omeprazole for the prevention of bleeding after endoscopic mucosal resection and the healing of endoscopic mucosal resection-induced ulceration. Alimentary pharmacology & therapeutics 20050601
Low-dose rabeprazole, amoxicillin and metronidazole triple therapy for the treatment of Helicobacter pylori infection in Chinese patients. Journal of gastroenterology and hepatology 20050601
Influence of CYP2C19 polymorphism and Helicobacter pylori genotype determined from gastric tissue samples on response to triple therapy for H pylori infection. Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association 20050601
Influence of CYP2C19 pharmacogenetic polymorphism on proton pump inhibitor-based therapies. Drug metabolism and pharmacokinetics 20050601
Desmodium gangeticum: a potent anti-ulcer agent. Indian journal of experimental biology 20050601
Efficacy of local omeprazoles in the treatment of peptic ulcer disease. JPMA. The Journal of the Pakistan Medical Association 20050601
The results of Helicobacter pylori eradication on repeated bleeding in patients with stomach ulcer. Collegium antropologicum 20050601
[Application of the proton pump inhibitors in treatment of an acute gastro-intestinal bleeding of the ulcer etiology]. Klinichna khirurhiia 20050601
The association of consumer cost-sharing and direct-to-consumer advertising with prescription drug use. Research in social & administrative pharmacy : RSAP 20050601
Esomeprazole tablet vs omeprazole capsule in treating erosive esophagitis. World journal of gastroenterology 20050528
Heartburn-dominant, uninvestigated dyspepsia: a comparison of 'PPI-start' and 'H2-RA-start' management strategies in primary care--the CADET-HR Study. Alimentary pharmacology & therapeutics 20050515
Helicobacter pylori eradication does not cause reflux oesophagitis in functional dyspeptic patients: a randomized, investigator-blinded, placebo-controlled trial. Alimentary pharmacology & therapeutics 20050515
Efficacy of omeprazole paste for prevention of gastric ulcers in horses in race training. Journal of the American Veterinary Medical Association 20050515
Efficacy of omeprazole paste for prevention of recurrence of gastric ulcers in horses in race training. Journal of the American Veterinary Medical Association 20050515
Ischemia of rat stomach mobilizes ECL cell histamine. American journal of physiology. Gastrointestinal and liver physiology 20050501
The effect of pharmacologically altered gastric pH on cadmium absorption from the diet and its accumulation in murine tissues. Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association 20050501
Impact of stress ulcer prophylaxis algorithm study. The Annals of pharmacotherapy 20050501
Effects of 5 years of treatment with rabeprazole or omeprazole on the gastric mucosa. European journal of gastroenterology & hepatology 20050501
Pharmacokinetic profile of the oral direct thrombin inhibitor dabigatran etexilate in healthy volunteers and patients undergoing total hip replacement. Journal of clinical pharmacology 20050501
A simple method for differentiation of monoisotopic drug metabolites with hydrogen-deuterium exchange liquid chromatography/electrospray mass spectrometry. European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences 20050501
Has Helicobacter pylori eradication therapy any effect on severity of rosacea symptoms? Journal of the European Academy of Dermatology and Venereology : JEADV 20050501
Treatment regimens for Helicobacter pylori infection in children: is in vitro susceptibility testing helpful? Journal of pediatric gastroenterology and nutrition 20050501
A quantitative analysis of NSAID-induced small bowel pathology by capsule enteroscopy. Gastroenterology 20050501
Proton pump inhibitors to be used more? Drug discovery today 20050501
Effectiveness of omeprazole- versus lansoprazole-based triple therapy for Helicobacter pylori eradication. Digestive diseases and sciences 20050501
Efficacy of triple therapy plus cetraxate for the Helicobacter pylori eradication in partial gastrectomy patients. Digestive diseases and sciences 20050501
[A randomized, comparative study of rabeprazole vs. ranitidine maintenance therapies for reflux esophagitis--multicenter study]. The Korean journal of gastroenterology = Taehan Sohwagi Hakhoe chi 20050501
Rabeprazole controls GERD symptoms in a patient for whom treatment with lansoprazole failed: first report of 'cluster GERD.'. Digestive diseases and sciences 20050501
[Disappearance of gastric adenocarcinoma in hyperplastic polyp after eradication of Heliobacter pylori. Report of a case]. Nihon Shokakibyo Gakkai zasshi = The Japanese journal of gastro-enterology 20050501
Role of autoimmune gastritis, Helicobacter pylori and celiac disease in refractory or unexplained iron deficiency anemia. Haematologica 20050501
Early effects of lafutidine or rabeprazole on intragastric acidity: which drug is more suitable for on-demand use? Journal of gastroenterology 20050501
A new-generation H2 receptor antagonist: quicker and stronger acid inhibition than proton pump inhibitors in the clinical setting? Journal of gastroenterology 20050501
[Role of esophageal motility abnormalities in severe reflux esophagitis]. Zhonghua nei ke za zhi 20050501
Biotransformation of pantoprazole by the fungus Cunninghamella blakesleeana. Xenobiotica; the fate of foreign compounds in biological systems 20050501
Comparison of enantioselective disposition of rabeprazole versus lansoprazole in renal-transplant recipients who are CYP2C19 extensive metabolizers. Xenobiotica; the fate of foreign compounds in biological systems 20050501
Somatostatin inhibits gastric acid secretion more effectively than pantoprazole in patients with peptic ulcer bleeding: a prospective, randomized, placebo-controlled trial. Scandinavian journal of gastroenterology 20050501
What are the effects of cyclooxygenase-2-specific inhibitors on the small bowel? Nature clinical practice. Gastroenterology & hepatology 20050501
Efficacy of omeprazole and amoxicillin with either clarithromycin or metronidazole on eradication of Helicobacter pylori in Chinese peptic ulcer patients. World journal of gastroenterology 20050428
Influence of various proton pump inhibitors on intestinal metaplasia in noneradicated Helicobacter pylori patients. World journal of gastroenterology 20050421
Normalization of oesophageal pH does not guarantee control of duodenogastro-oesophageal reflux in Barrett's oesophagus. Alimentary pharmacology & therapeutics 20050415
Long-term acid suppression by omeprazole in gastro-oesophageal reflux disease patients does not lead to anti-gastric autoantibody production. Alimentary pharmacology & therapeutics 20050415
Minimizing complications from nonsteroidal antiinflammatory drugs: cost-effectiveness of competing strategies in varying risk groups. Arthritis and rheumatism 20050415
Zegerid--immediate-release omeprazole. The Medical letter on drugs and therapeutics 20050411
[Rapidity of pain relief, medication requirement and patient satisfaction with reflux treatment in the physician's office]. MMW Fortschritte der Medizin 20050407
Antimicrobial actions of benzimidazoles against oral streptococci. Oral microbiology and immunology 20050401
Localization of gastrinomas by selective intra-arterial calcium injection in patients on proton pump inhibitor or H2 receptor antagonist therapy. European journal of gastroenterology & hepatology 20050401
Idiopathic gastric acid hypersecretion presenting as a diarrheal disorder and mimicking both Zollinger-Ellison syndrome and Crohn's disease. European journal of gastroenterology & hepatology 20050401
Eradication rate of Helicobacter pylori in dyspeptic patients. Medical science monitor : international medical journal of experimental and clinical research 20050401
Long-term treatment of gastro-oesophageal reflux disease patients with frequent symptomatic relapses using rabeprazole: on-demand treatment compared with continuous treatment. Alimentary pharmacology & therapeutics 20050401
The effect of Bcrp1 (Abcg2) on the in vivo pharmacokinetics and brain penetration of imatinib mesylate (Gleevec): implications for the use of breast cancer resistance protein and P-glycoprotein inhibitors to enable the brain penetration of imatinib in patients. Cancer research 20050401
Helicobacter pylori eradication in the management of patients with idiopathic thrombocytopenic purpura. The American journal of medicine 20050401
Comparison of Prilosec OTC (omeprazole magnesium 20.6 mg) to placebo for 14 days in the treatment of frequent heartburn. Journal of clinical pharmacy and therapeutics 20050401
Randomized, double-blind comparison of immediate-release omeprazole oral suspension versus intravenous cimetidine for the prevention of upper gastrointestinal bleeding in critically ill patients. Critical care medicine 20050401
Ranitidine bismuth citrate-based triple therapies as a second-line therapy for Helicobacter pylori in Turkish patients. Journal of gastroenterology and hepatology 20050401
Cure rate of high dose omeprazole and amoxicillin therapy for treatment-resistant Helicobacter pylori infection. Journal of gastroenterology and hepatology 20050401
Validation of a quality-of-life instrument for laryngopharyngeal reflux. Archives of otolaryngology--head & neck surgery 20050401
FDA notifications. BMS issues letter about omeprazole. AIDS alert 20050401
Comparison of proton pump inhibitor-based triple therapy with losec and the generic drug, Omepradex, for efficacy of Helicobacter pylori eradication. Digestive diseases and sciences 20050401
Effect of high-dose aspirin on Helicobacter pylori eradication. Digestive diseases and sciences 20050401
Severe GERD: effective treatment prevents potentially serious complications. JAAPA : official journal of the American Academy of Physician Assistants 20050401
Effects of rabeprazole on early symptom relief in gastro-oesophageal reflux disease: the Hellenic Rabeprazole Study Group surveillance study. Current medical research and opinion 20050401
Comparison of an increased dosage regimen of rabeprazole versus a concomitant dosage regimen of famotidine with rabeprazole for nocturnal gastric acid inhibition in relation to cytochrome P450 2C19 genotypes. Clinical pharmacology and therapeutics 20050401
[The clinical applications of rabeprazole either alone or combined with anti-Helicobacter pylori agents in peptic ulcer patients]. Zhonghua nei ke za zhi 20050401
[The effect of Helicobacter pylori eradication therapy on bismuth absorption of colloidal bismuth subcitrate]. Zhonghua nei ke za zhi 20050401
Ménétrier's disease in a patient with Helicobacter pylori infection is linked to elevated glucagon-like peptide-2 activity. Scandinavian journal of gastroenterology 20050401
How effective are quadruple therapies as first-line H. pylori eradication therapies? Nature clinical practice. Gastroenterology & hepatology 20050401
'Avoid the crush': hazards of medication administration in patients with dysphagia or a feeding tube. CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne 20050329
Effect of omeprazole on symptoms and ultrastructural esophageal damage in acid bile reflux. World journal of gastroenterology 20050328
[Effect of the Helicobacter pylori eradication in patients with functional dyspepsia: randomised placebo-controlled trial]. Medicina clinica 20050326
Lack of interaction between atazanavir and lansoprazole. AIDS (London, England) 20050324
Sofalcone, a mucoprotective agent, increases the cure rate of Helicobacter pylori infection when combined with rabeprazole, amoxicillin and clarithromycin. World journal of gastroenterology 20050321
One-year follow-up study of Helicobacter pylori eradication rate with 13C-urea breath test after 3-d and 7-d rabeprazole-based triple therapy. World journal of gastroenterology 20050321
First-line eradication therapy for Helicobacter pylori in primary health care based on antibiotic resistance: results of three eradication regimens. Alimentary pharmacology & therapeutics 20050315
New once-daily, highly effective rescue triple therapy after multiple Helicobacter pylori treatment failures: a pilot study. Alimentary pharmacology & therapeutics 20050315
Physical characterization of pantoprazole sodium hydrates. International journal of pharmaceutics 20050303
[Rapidity of pain relief, medication requirement and patient satisfaction with reflux treatment in the physician's office]. MMW Fortschritte der Medizin 20050303
The effect of the CYP2C19 genotype on the hydroxylation index of omeprazole in South Indians. European journal of clinical pharmacology 20050301
Impact of gastric acid suppressants on cytochrome P450 3A4 and P-glycoprotein: consequences for FK506 assimilation. Kidney international 20050301
Influence of antimicrobial treatment for Helicobacter pylori infection on the intestinal microflora in Japanese macaques. Journal of medical microbiology 20050301
Pharmacodynamic effects and kinetic disposition of rabeprazole in relation to CYP2C19 genotype in healthy Chinese subjects. Acta pharmacologica Sinica 20050301
Pantoprazole reduces the size of postbanding ulcers after variceal band ligation: a randomized, controlled trial. Hepatology (Baltimore, Md.) 20050301
Failure of nasogastric omeprazole suspension in pediatric intensive care patients. Pediatric critical care medicine : a journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies 20050301
Prospective randomized trial for optimal prophylactic treatment of the upper gastrointestinal complications after open heart surgery. Circulation journal : official journal of the Japanese Circulation Society 20050301
Helicobacter pylori status and symptom assessment two years after eradication in pediatric patients from a high prevalence area. Journal of pediatric gastroenterology and nutrition 20050301
Efficacy and safety of lansoprazole in adolescents with symptomatic erosive and non-erosive gastroesophageal reflux disease. Journal of pediatric gastroenterology and nutrition 20050301
Simultaneous herpetic and candidal esophagitis in an immunocompetent teenager. Journal of pediatric gastroenterology and nutrition 20050301
Clinical, histological and molecular follow-up of 60 patients with gastric marginal zone lymphoma of mucosa-associated lymphoid tissue. Virchows Archiv : an international journal of pathology 20050301
Reversibility of GERD ultrastructural alterations and relief of symptoms after omeprazole treatment. The American journal of gastroenterology 20050301
Effects of clarithromycin on lansoprazole pharmacokinetics between CYP2C19 genotypes. British journal of clinical pharmacology 20050301
H+/K+-ATPase (proton pump) inhibitors dampen increased cough reflex: more than gastric acid suppression. Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology 20050301
Attenuating effect of H+K+ATPase inhibitors on airway cough hypersensitivity induced by allergic airway inflammation in guinea-pigs. Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology 20050301
Initial-rate method for the determination of pantoprazole in pharmaceutical formulations using 1-fluoro 2,4-dinitrobenzene. Die Pharmazie 20050301
Metabolism of pantoprazole involving conjugation with glutathione in rats. The Journal of pharmacy and pharmacology 20050301
Helicobacter pylori infection in patients with erosive esophagitis is associated with rapid heartburn relief and lack of relapse after treatment with pantoprazole. Digestive diseases and sciences 20050301
Twice-daily standard dose of omeprazole achieves the necessary level of acid inhibition for Helicobacter pylori eradication. A randomized controlled trial using standard and double doses of omeprazole in triple therapy. Digestive diseases and sciences 20050301
Multifocal gastric carcinoid tumor in a patient with pernicious anemia receiving lansoprazole. Digestive diseases and sciences 20050301
On omeprazole and iron replacement. Southern medical journal 20050301
Effects of ranitidine, famotidine, pantoprazole, and omeprazole on intragastric pH in dogs. American journal of veterinary research 20050301
Cost effective prescribing of proton pump inhibitors (PPI's) in the GMS Scheme. Irish medical journal 20050301
Gastroesophageal reflux disease in bronchial asthma and the response to omeprazole. Asian Pacific journal of allergy and immunology 20050301
[Effectiveness of an intervention to improve medical prescription quality in specialized care]. Farmacia hospitalaria : organo oficial de expresion cientifica de la Sociedad Espanola de Farmacia Hospitalaria 20050301
[Omeprazol-associated intersticial nephritis. A case report]. Farmacia hospitalaria : organo oficial de expresion cientifica de la Sociedad Espanola de Farmacia Hospitalaria 20050301
A simultaneous assessment of CYP3A4 metabolism and induction in the DPX-2 cell line. The AAPS journal 20050301
Can lansoprazole, amoxicillin, and clarithromycin combination still be used as a first-line therapy for eradication of helicobacter pylori? The Turkish journal of gastroenterology : the official journal of Turkish Society of Gastroenterology 20050301
High-performance liquid chromatography method for the quantification of rabeprazole in human plasma using solid-phase extraction. Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20050225
Determination of lansoprazole and two of its metabolites by liquid-liquid extraction and automated column-switching high-performance liquid chromatography: application to measuring CYP2C19 activity. Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20050225
The proton pump inhibitor lansoprazole inhibits rhinovirus infection in cultured human tracheal epithelial cells. European journal of pharmacology 20050221
Anti-Helicobacter pylori therapy significantly reduces Helicobacter pylori -induced gastric mucosal damage in Mongolian gerbils. World journal of gastroenterology 20050221
Response of blood endothelin-1 and nitric oxide activity in duodenal ulcer patients undergoing Helicobacter pylori eradication. World journal of gastroenterology 20050221
Effects of killing Helicobacter pylori quadruple therapy on peptic ulcer: a randomized double-blind clinical trial. World journal of gastroenterology 20050221
[Diagnosis of and therapy for peptic ulcer]. Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine 20050220
Evaluation of early gastric mucosal permeability induced by central thyrotropin-releasing hormone administration. American journal of physiology. Gastrointestinal and liver physiology 20050201
Lansoprazole enantiomer activates human liver microsomal CYP2C9 catalytic activity in a stereospecific and substrate-specific manner. Drug metabolism and disposition: the biological fate of chemicals 20050201
Pharmacokinetic interaction between tacrolimus and clarithromycin in a heart transplant patient. Therapeutic drug monitoring 20050201
Effects of the association of lansoprazole, clarithromycin and metronidazole for helicobacter Pylori eradication therapy, measured by the 13C Aminopyrine breath test. Medical science monitor : international medical journal of experimental and clinical research 20050201
Validation of the Reflux Disease Questionnaire for a German population. European journal of gastroenterology & hepatology 20050201
Omeprazole raises somatostatin and motilin in human plasma. Biological & pharmaceutical bulletin 20050201
The safety of proton pump inhibitors in pregnancy: a multicentre prospective controlled study. Alimentary pharmacology & therapeutics 20050201
Esomeprazole 40 mg twice daily in triple therapy and the efficacy of Helicobacter pylori eradication related to CYP2C19 metabolism. Alimentary pharmacology & therapeutics 20050201
Amoxicillin resistance in Helicobacter pylori: studies from Tokyo, Japan from 1985 to 2003. Helicobacter 20050201
Comparison of two management strategies for Helicobacter pylori treatment: clinical study and cost-effectiveness analysis. Helicobacter 20050201
Acute endoscopic intervention in non-variceal upper gastrointestinal bleeding. Postgraduate medical journal 20050201
Video capsule endoscopy to prospectively assess small bowel injury with celecoxib, naproxen plus omeprazole, and placebo. Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association 20050201
Rabeprazole-induced acute interstitial nephritis. Nephrology (Carlton, Vic.) 20050201
[Gastroesophageal reflux disease refractory to esomeprazole]. Gastroenterologia y hepatologia 20050201
Gastroprotective activity of a new semi-synthetic solidagenone derivative in mice. The Journal of pharmacy and pharmacology 20050201
Randomized trial of argon plasma coagulation vs. multipolar electrocoagulation for ablation of Barrett's esophagus. Gastrointestinal endoscopy 20050201
A prospective study of oesophageal 24-h ambulatory pH monitoring in patients with functional dyspepsia. Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver 20050201
Quantification of omeprazole degradation by enteric coating polymers: an UV-VIS spectroscopy study. Die Pharmazie 20050201
Restorative impact of rabeprazole on gastric mucus and mucin production impairment during naproxen administration: its potential clinical significance. Digestive diseases and sciences 20050201
Atazanavir not to be used with proton pump inhibitors. AIDS patient care and STDs 20050201
Evaluation of the effects of anti-secretory drugs on intragastric acidity: is combined therapy with a proton pump inhibitor and an H2 receptor antagonist effective as initial treatment? Journal of gastroenterology 20050201
Effect of adsorbents on the absorption of lansoprazole with surfactant. International journal of pharmaceutics 20050131
Hyponatraemia, fever, vomiting, severe abdominal pain, and weight loss associated with omeprazole. The New Zealand medical journal 20050128
Reducing the risks of gastrointestinal bleeding with antiplatelet therapies. The New England journal of medicine 20050120
The effect of acid suppression on sleep patterns and sleep-related gastro-oesophageal reflux. Alimentary pharmacology & therapeutics 20050115
Rebound acid hypersecretion after long-term inhibition of gastric acid secretion. Alimentary pharmacology & therapeutics 20050115
Cost-effectiveness analysis of NSAIDs, NSAIDs with concomitant therapy to prevent gastrointestinal toxicity, and COX-2 specific inhibitors in the treatment of rheumatoid arthritis. Rheumatology international 20050101
Regulation of aryl hydrocarbon receptor signal transduction by protein tyrosine kinases. Cellular signalling 20050101
Neuropathy associated with lansoprazole treatment. Muscle & nerve 20050101
Adverse reactions during imatinib and lansoprazole treatment in gastrointestinal stromal tumors. The Annals of pharmacotherapy 20050101
A pharmacokinetic study comparing single and repeated oral doses of 20 mg and 40 mg omeprazole and its two optical isomers, S-omeprazole (esomeprazole) and R-omeprazole, in healthy subjects. European journal of clinical pharmacology 20050101
Persistent cough following pulmonary resection: observational and empiric study of possible causes. The Annals of thoracic surgery 20050101
Switching prescription drugs to over the counter. BMJ (Clinical research ed.) 20050101
Standard treatment for Helicobacter pylori infection is suboptimal in non-ulcer dyspepsia compared with duodenal ulcer in Chinese. Alimentary pharmacology & therapeutics 20050101
Clinical outcome using lansoprazole in acid hypersecretors with and without Zollinger-Ellison syndrome: a 13-year prospective study. Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association 20050101
Helicobacter pylori eradication as the sole treatment for gastric and duodenal ulcers. European journal of gastroenterology & hepatology 20050101
Night-time gastro-oesophageal reflux disease: prevalence, hazards, and management. European journal of gastroenterology & hepatology 20050101
Septic complications after variceal cyanoacrylate injection. Gastrointestinal endoscopy 20050101
Helicobacter heilmannii infection in a child after successful eradication of Helicobacter pylori: case report and review of literature. Journal of gastroenterology 20050101
Eradication of Helicobacter pylori decreases mucosal alterations linked to gastric carcinogenesis in Mongolian gerbils. Journal of gastroenterology 20050101
South Dakota Medicaid will now cover OTC Loratadine and OTC Prilosec. South Dakota journal of medicine 20050101
Spillover effects of restrictive drug formularies: a case study of PacifiCare in California. The American journal of managed care 20050101
Probiotics: wanted dead or alive. Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver 20050101
Pantoprazole in severe acid-peptic disease: the effectiveness and safety of 5 years' continuous treatment. Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver 20050101
The early effect of proton pump inhibitor therapy on the accuracy of the 13C-urea breath test. Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver 20050101
Survival of the probiotic, L. plantarum 299v and its effects on the faecal bacterial flora, with and without gastric acid inhibition. Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver 20050101
Pharmacokinetics of rabeprazole following single intravenous and oral administration to healthy subjects. International journal of clinical pharmacology and therapeutics 20050101
Proton pump inhibitors: a survey of prescribing in an Irish general hospital. International journal of clinical practice 20050101
Role of pantoprazole in the treatment of gastro-oesophageal reflux disease. Expert opinion on pharmacotherapy 20050101
[Bronchial asthma and gastroesophageal reflux disease: are they interrelated by chance?]. Klinicheskaia meditsina 20050101
[Is anti-helicobacter therapy a rational approach in treatment of erosive and ulcerous lesions of the gastroduodenal mucosa in patients with inflamatory bowel diseases?]. Klinicheskaia meditsina 20050101
Degradation of omeprazole induced by enteric polymer solutions and aqueous dispersions: HPLC investigations. Drug development and industrial pharmacy 20050101
Experiments to optimize enzyme substitution therapy in pancreatic duct-ligated pigs. Journal of animal physiology and animal nutrition 20050101
Stereoselective inhibition of cytochrome P450 forms by lansoprazole and omeprazole in vitro. Xenobiotica; the fate of foreign compounds in biological systems 20050101
[Esomeprasol and rabeprasol effects on esophageal acidification in patients with gastroesophageal reflux disease, intensively metabolizing inhibitors of proton pump]. Terapevticheskii arkhiv 20050101
Efficacy of a triple therapy with rabeprazole, amoxicillin, and faropenem as second-line treatment after failure of initial Helicobacter pylori eradication therapy. Hepato-gastroenterology 20050101
Why is this woman smiling? The hard sell of bad medicine. Revolution (Oakland, Calif.) 20050101
Pharmacodynamic effects of 3-day intravenous treatment with pantoprazole or ranitidine after 10 days of oral ranitidine. Methods and findings in experimental and clinical pharmacology 20050101
[Prevention and treatment of gastroduodenal hemorrhages in pediatric cardiac surgery]. Anesteziologiia i reanimatologiia 20050101
[Helicobacter pylori infection in patients with chronic hives and asthma]. Klinicheskaia meditsina 20050101
The role of proton pump inhibitors in acute stress ulcer prophylaxis in mechanically ventilated patients. Dimensions of critical care nursing : DCCN 20050101
[Basic principles of successful GERD (gastroesophageal reflux disease) therapy]. Krankenpflege Journal 20050101
[Photodistributed cutaneous drug reaction induced by proton pump inhibitors]. Therapie 20050101
[Assessment of efficacy and safety of two modes of maintenance therapy with rabeprazole in patients with gastroesophageal reflux disease (GERD) of degrees 0 and 1]. Eksperimental'naia i klinicheskaia gastroenterologiia = Experimental & clinical gastroenterology 20050101
The effect of omeprazole pre-treatment on rafts formed by reflux suppressant tablets containing alginate. The Journal of international medical research 20050101
Pancreatitis due to codeine. Allergologia et immunopathologia 20050101
Regression of EI2-stage low-grade gastric MALT-lymphoma after H. pylori eradication. Hepato-gastroenterology 20050101
Heal the damage: prescription drug consumer advertisements and relative choices. Journal of health law 20050101
Simultaneous determination of pantoprazole and its two metabolites in dog plasma by HPLC. Journal of chromatographic science 20050101
Development of a liquid chromatography/tandem mass spectrometry assay for the quantification of rabeprazole in human plasma. Rapid communications in mass spectrometry : RCM 20050101
[Pharmacogenomical aspects of gastroesophageal reflux disease]. Vestnik Rossiiskoi akademii meditsinskikh nauk 20050101
[Comparison of gastric aspirate volume after intubation in patients with and without symptoms of gastroesophageal reflux disease]. Revista espanola de anestesiologia y reanimacion 20050101
An unusual adverse drug reaction? Allergologia et immunopathologia 20050101
Pediatric management problems. GERD. Pediatric nursing 20050101
Combined use of omeprazole and a novel antioxidative cytoprotectant for the treatment of peptic ulcer. Facilitation of ulcer healing in experimental animals. Arzneimittel-Forschung 20050101
[Antisecretory therapy as a component of hemostasis in acute gastroduodenal ulcer bleedings]. Khirurgiia 20050101
HIV drug interactions in 2005. Positively aware : the monthly journal of the Test Positive Aware Network 20050101
On-demand therapy with pantoprazole 20 mg as effective long-term management of reflux disease in patients with mild GERD: the ORION trial. Digestion 20050101
State of the art: extraesophageal manifestations of gastroesophageal reflux disease. Reviews in gastroenterological disorders 20050101
Helicobacter pylori eradication using tetracycline and furazolidone versus amoxicillin and azithromycin in lansoprazole based triple therapy: an open randomized clinical trial. Arquivos de gastroenterologia 20050101
Omeprazole absorption from a compounded transdermal formulation in healthy volunteers. Journal of the American Pharmacists Association : JAPhA 20050101
Omeprazole affects neither electroconvulsive threshold nor anticonvulsant activity of diphenylhydantoin and carbamazepine in mice. Pharmacological reports : PR 20050101
A flow-injection biamperometric method for determination of pantoprazole in pharmaceutical tablets. Journal of AOAC International 20050101
Validation of a capillary electrophoresis method for analysis of rabeprazole sodium in a pharmaceutical dosage form. Journal of AOAC International 20050101
[Eradication of Helicobacter pylori]. Krankenpflege Journal 20050101
Haemorrhagic gastritis and bleeding following rofecoxib administration. Clinical and experimental rheumatology 20050101
Dual effects of rabeprazole on solid-phase gastric emptying assessed by the 13C-octanoate breath test. Digestion 20050101
Lansoprazole-induced subacute cutaneous lupus erythematosus: two cases. Acta dermato-venereologica 20050101
Influence of Helicobacter pylori and omeprazole on celecoxib-induced gastroduodenal mucosal injury. Indian journal of gastroenterology : official journal of the Indian Society of Gastroenterology 20050101
Lansoprazole: in the treatment of gastro-oesophageal reflux disease in children and adolescents. Drugs 20050101
The effect of aging on the relationship between the cytochrome P450 2C19 genotype and omeprazole pharmacokinetics. Clinical pharmacokinetics 20050101
Participation of vanilloid/capsaicin receptors, calcitonin-gene-related peptide and substance P in gastric protection of omeprazole and omeprazole-like compounds. Inflammopharmacology 20050101
A novel gastric lesion model induced in rats by partial gastric vascular ligation. Inflammopharmacology 20050101
Lansoprazole binding to the neutrophils in dextran sulfate sodium-induced rat colitis. Inflammopharmacology 20050101
Effect of pantoprazole administered subcutaneously on the healing of sutured gastric incisions in rats. European surgical research. Europaische chirurgische Forschung. Recherches chirurgicales europeennes 20050101
Primary antibiotic resistance and effectiveness of Helicobacter pylori triple therapy in ulcero-inflammatory pathologies of the upper digestive tract. Acta gastro-enterologica Belgica 20050101
Helicobacter pylori eradication for the treatment of dyspeptic symptoms in chronic renal failure. Annals of Saudi medicine 20050101
Voice disorders and gastroesophageal reflux. Logopedics, phoniatrics, vocology 20050101
Different roles for K+ channels in cisplatin-resistant cell lines argue against a critical role for these channels in cisplatin resistance. Anticancer research 20050101
Sporadic fundic gland polyps: clinico-pathologic features and associated diseases. Polish journal of pathology : official journal of the Polish Society of Pathologists 20050101
What is potent acid inhibition, and how can it be achieved? Drugs 20050101
Intravenous proton pump inhibitor therapy: a rationale for use. Reviews in gastroenterological disorders 20050101
Gastroesophageal reflux disease and extraesophageal disease. Reviews in gastroenterological disorders 20050101
[Efficacy of the drinking magnesium-calcium sulfate mineral water in the combined treatment of duodenal ulcer comorbid with gastroesophageal reflux]. Voprosy kurortologii, fizioterapii, i lechebnoi fizicheskoi kultury 20050101
[Oral cavity manifestations of gastroesophageal reflux disease]. Klinicheskaia meditsina 20050101
Metabolism of omeprazole after two oral doses in children 1 to 9 months old. Proceedings of the Western Pharmacology Society 20050101
Surgical management of acute perforation of peptic ulcers. A single centre experience. Acta chirurgica Belgica 20050101
[Comparison of the effectiveness of tri- and quadricomponent eradication therapy in patients with peptic ulcer]. Klinicheskaia meditsina 20050101
[Reflux therapy in the elderly]. Krankenpflege Journal 20050101
[Gastroesophageal reflux involvement in ENT disorders]. Revista medico-chirurgicala a Societatii de Medici si Naturalisti din Iasi 20050101
[Gastrin-17 level in the omeprazole treatment of duodenal ulcer]. Eksperimental'naia i klinicheskaia gastroenterologiia = Experimental & clinical gastroenterology 20050101
[Upper gastrointestinal bleeding after cardiac surgery and invasive cardiology procedures--prophylaxis and therapy]. Khirurgiia 20050101
Direct injection, column switching-liquid chromatographic technique for the estimation of rabeprazole in bioequivalence study. Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20041225
Intravenous pantoprazole versus ranitidine for prevention of rebleeding after endoscopic hemostasis of bleeding peptic ulcers. World journal of gastroenterology 20041215
Selective induction of apoptosis with proton pump inhibitor in gastric cancer cells. Clinical cancer research : an official journal of the American Association for Cancer Research 20041215
Conversion of the HIV protease inhibitor nelfinavir to a bioactive metabolite by human liver CYP2C19. Drug metabolism and disposition: the biological fate of chemicals 20041201
Acute colchicine intoxication during clarithromycin administration. The Annals of pharmacotherapy 20041201
Differences in binding properties of two proton pump inhibitors on the gastric H+,K+-ATPase in vivo. Biochemical pharmacology 20041201
A randomized crossover study investigating the influence of ranitidine or omeprazole on the pharmacokinetics of cephalexin monohydrate. Journal of clinical pharmacology 20041201
The use of subcutaneous omeprazole in the treatment of dyspepsia in palliative care patients. Journal of pain and symptom management 20041201
Less acid + less bleeding = better outcomes and more money! Canadian journal of gastroenterology = Journal canadien de gastroenterologie 20041201
Frequency analyses of gastric pH in control and gastro-oesophageal reflux disease subjects treated with a proton-pump inhibitor. Alimentary pharmacology & therapeutics 20041201
Pharmacogenetics and herb-drug interactions: experience with Ginkgo biloba and omeprazole. Pharmacogenetics 20041201
Effects of Helicobacter pylori eradication on platelet activation and disease recurrence in patients with acute coronary syndromes. Helicobacter 20041201
Synthesis of novel 2-[2-(substituted amino)phenethyl]-1 H-benzimidazoles; 3,4-dihydro and 1,2,3,4,-tetrahydropyrimido[1,6-a]-benzimidazoles as potential antiulcer agents. Die Pharmazie 20041201
Comparison of one week and two weeks of triple therapy for the eradication of Helicobacter pylori in a Sri Lankan population: a randomised, controlled study. The Ceylon medical journal 20041201
Bacteriostatic and bactericidal activity of rabeprazole against Helicobacter pylori. Journal of chemotherapy (Florence, Italy) 20041201
Comparison of the pharmacokinetics of lansoprazole 15- and 30-mg sachets for suspension versus intact capsules. Clinical therapeutics 20041201
Recent success of pantoprazole -or lansoprazole- based clarithromycin plus amoxicillin treatment in the eradication of Helicobacter pylori. The Turkish journal of gastroenterology : the official journal of Turkish Society of Gastroenterology 20041201
The effect of rabeprazole alone or in combination with H2 receptor blocker on intragastric pH: a pilot study. The Turkish journal of gastroenterology : the official journal of Turkish Society of Gastroenterology 20041201
Effect of proton pump inhibitor pretreatment on resistance of solid tumors to cytotoxic drugs. Journal of the National Cancer Institute 20041117
Pantoprazole provides rapid and sustained symptomatic relief in patients treated for erosive oesophagitis. Alimentary pharmacology & therapeutics 20041115
Classification of dyspepsia and response to treatment with proton-pump inhibitors. Alimentary pharmacology & therapeutics 20041115
Bacillus clausii therapy to reduce side-effects of anti-Helicobacter pylori treatment: randomized, double-blind, placebo controlled trial. Alimentary pharmacology & therapeutics 20041115
[Paradigm change in reflux disease. In reflux patients listening to is often more important than endoscopy]. MMW Fortschritte der Medizin 20041104
[Attention! Cough, asthma and Co. are often caused by reflux]. MMW Fortschritte der Medizin 20041104
Identity and regulation of stored and secreted progastrin-derived peptides in sheep. Endocrinology 20041101
Pharmacokinetic differences between the enantiomers of lansoprazole and its metabolite, 5-hydroxylansoprazole, in relation to CYP2C19 genotypes. European journal of clinical pharmacology 20041101
Development of an intravenously injectable chemically stable aqueous omeprazole formulation using nanosuspension technology. European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V 20041101
Review article: relationship between the metabolism and efficacy of proton pump inhibitors--focus on rabeprazole. Alimentary pharmacology & therapeutics 20041101
Review article: relief of symptoms in gastric acid-related diseases--correlation with acid suppression in rabeprazole treatment. Alimentary pharmacology & therapeutics 20041101
Review article: pH, healing and symptom relief with rabeprazole treatment in acid-related disorders. Alimentary pharmacology & therapeutics 20041101
Effects of fluvoxamine on lansoprazole pharmacokinetics in relation to CYP2C19 genotypes. Journal of clinical pharmacology 20041101
Oesophageal pH monitoring is of limited value in the diagnosis of 'reflux-cough'. The European respiratory journal 20041101
Effects of omeprazole, famotidine, and ranitidine on the enzyme activities of carbonic anhydrase from bovine stomach in vitro and rat erythrocytes in vivo. Biological & pharmaceutical bulletin 20041101
Omeprazole does not reduce gastroesophageal reflux: new insights using multichannel intraluminal impedance technology. Journal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary Tract 20041101
Differential effects of Helicobacter pylori eradication on oxidative DNA damage at the gastroesophageal junction and at the gastric antrum. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 20041101
Long-term effects of eradication of Helicobacter pylori on relapse and histology in gastric ulcer patients: a two-year follow-up study. Scandinavian journal of gastroenterology 20041101
Accuracy of a monoclonal antibody-based stool antigen test in the diagnosis of Helicobacter pylori infection. Scandinavian journal of gastroenterology 20041101
Eradication of Helicobacter pylori induces apoptosis and inhibits proliferation of heterotopic proliferative glands in infected Mongolian gerbils. Cancer science 20041101
Fatal toxic epidermal necrolysis due to lansoprazole. Clinical and experimental dermatology 20041101
A 10-day levofloxacin-based therapy in patients with resistant Helicobacter pylori infection: a controlled trial. Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association 20041101
Patent expiration for lansoprazole. American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists 20041101
[Evaluation of the efficacy of an Helicobacter pylori eradication treatment for idiopathic thrombocytopenic purpura patients]. Nihon Shokakibyo Gakkai zasshi = The Japanese journal of gastro-enterology 20041101
Second-line treatment for Helicobacter pylori infection in Japan: proton pump inhibitor-based amoxicillin and metronidazole regimen. Journal of gastroenterology 20041101
Treatment of gastric hemorrhage by pulverized omeprazole and antacid--concomitant administration via a nasogastric tube. International journal of clinical pharmacology and therapeutics 20041101
[The best strategies against reflux disease. Acid stomach and the sequelae]. MMW Fortschritte der Medizin 20041028
[Choice of proton pump inhibitors--does it play any role?]. Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke 20041021
[The effect of Helicobacter pylori eradication on prokinetic treatment on the quality of life in functional dyspepsia]. Orvosi hetilap 20041017
Intravenous and oral lansoprazole are equivalent in suppressing stimulated acid output in patient volunteers with erosive oesophagitis. Alimentary pharmacology & therapeutics 20041015
Effect of low-dose rabeprazole and omeprazole on gastric acidity: results of a double blind, randomized, placebo-controlled, three-way crossover study in healthy subjects. Alimentary pharmacology & therapeutics 20041015
[Galactorrhea induced by lansoprazole]. Atencion primaria 20041015
Effect of omeprazole on gastric adenosine A1 and A2A receptor gene expression and function. The Journal of pharmacology and experimental therapeutics 20041001
Monocyte chemotactic protein-1 regulates leukocyte recruitment during gastric ulcer recurrence induced by tumor necrosis factor-alpha. American journal of physiology. Gastrointestinal and liver physiology 20041001
Lansoprazole ameliorates intestinal mucosal damage induced by ischemia-reperfusion in rats. World journal of gastroenterology 20041001
Elevated quetiapine serum concentrations in a patient treated concomitantly with doxepin, lorazepam, and pantoprazole. Journal of clinical psychopharmacology 20041001
Esomeprazole 40 mg provides more effective intragastric acid control than lansoprazole 30 mg, omeprazole 20 mg, pantoprazole 40 mg and rabeprazole 20 mg in patients with gastro-oesophageal reflux symptoms. European journal of clinical pharmacology 20041001
Effects of Helicobacter pylori eradication among adults with intellectual disability. Journal of intellectual disability research : JIDR 20041001
Open, randomized multicenter comparative trial of rabeprazole, ofloxacin and amoxicillin therapy for Helicobacter pylori eradication: 7 vs. 14 day treatment. Helicobacter 20041001
On-demand PPI requirements in patients with endoscopy-negative GERD. Journal of clinical gastroenterology 20041001
The effect of Helicobacter pylori eradication on gastroesophageal reflux disease. Journal of clinical gastroenterology 20041001
Influence of gastritis on cyclooxygenase-2 expression before and after eradication of Helicobacter pylori infection. European journal of gastroenterology & hepatology 20041001
Ranitidine-bismuth citrate, tetracycline and metronidazole followed by triple therapy as alternative strategy for Helicobacter pylori treatment: a pilot study. European journal of gastroenterology & hepatology 20041001
Patients with chest pain and occult gastroesophageal reflux demonstrate visceral pain hypersensitivity which may be partially responsive to acid suppression. The American journal of gastroenterology 20041001
Improvement in clinical course and laryngeal appearance in selected patients with chronic laryngitis after eight weeks of therapy with rabeprazole. Medical science monitor : international medical journal of experimental and clinical research 20041001
Clinical strategies -- interactive case discussions. Alimentary pharmacology & therapeutics 20041001
Effect of rabeprazole on MDR1-mediated transport of Rhodamine 123 in Caco-2 and Hvr100-6 cells. Biological & pharmaceutical bulletin 20041001
Proton pump inhibitor therapy for chronic laryngo-pharyngitis: a randomized placebo-control trial. Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery 20041001
Different dosage regimens of rabeprazole for nocturnal gastric acid inhibition in relation to cytochrome P450 2C19 genotype status. Clinical pharmacology and therapeutics 20041001
Lewis and Secretor status and Helicobacter pylori eradication. Epidemiology and infection 20041001
Recurrent anaphylaxis linked to pantoprazole. The Journal of allergy and clinical immunology 20041001
Celecoxib versus diclofenac plus omeprazole in high-risk arthritis patients: results of a randomized double-blind trial. Gastroenterology 20041001
COX-2-specific inhibitor or proton pump inhibitor plus traditional NSAID: is either approach sufficient for patients at highest risk of NSAID-induced ulcers? Gastroenterology 20041001
Effect of lansoprazole for an idiopathic thrombocytopenic purpura patient with Helicobacter pylori infection who did not respond to prednisolone treatment. Clinical and laboratory haematology 20041001
Helicobacter pylori infection and the prevention of peptic ulcer with proton pump inhibitors in elderly subjects taking low-dose aspirin. Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver 20041001
Effect of water intake on pharmacokinetics of lansoprazole from fast disintegrating tablet in human subjects. Drug metabolism and pharmacokinetics 20041001
Efficacy of metronidazole for the treatment of clarithromycin-resistant Helicobacter pylori infection in a Japanese population. Journal of gastroenterology 20041001
Excretion of pantoprazole in human breast. The Journal of reproductive medicine 20041001
Gastrointestinal uptake of FDG after N-butylscopolamine or omeprazole treatment in the rat. Annals of nuclear medicine 20041001
Ulcer recurrence in high-risk patients receiving nonsteroidalanti-inflammatory drugs plus low-dose aspirin: results of a post HOC subanalysis. Clinical therapeutics 20041001
Effect of Helicobacter pylori eradication on platelet recovery in patients with chronic idiopathic thrombocytopenic purpura. Archives of internal medicine 20040927
Determination of lansoprazole in pharmaceutical capsules by flow injection analysis using UV-detection. Journal of pharmaceutical and biomedical analysis 20040921
Therapeutic choices in reflux disease: defining the criteria for selecting a proton pump inhibitor. The American journal of medicine 20040906
Management of acid-related disorders in patients with dysphagia. The American journal of medicine 20040906
A simplified analytical method for a phenotyping cocktail of major CYP450 biotransformation routes. Journal of pharmaceutical and biomedical analysis 20040903
Factors predicting progression of gastric intestinal metaplasia: results of a randomised trial on Helicobacter pylori eradication. Gut 20040901
Lack of weight-based dose dependency and intraindividual variability of omeprazole for CYP2C19 phenotyping. Journal of clinical pharmacology 20040901
Altered pharmacokinetics of omeprazole in cystic fibrosis knockout mice relative to wild-type mice. Drug metabolism and disposition: the biological fate of chemicals 20040901
Resolution of Helicobacter pylori associated granulomatous gastritis in a child after eradication therapy. Journal of pediatric gastroenterology and nutrition 20040901
Symptomatic response to Helicobacter pylori eradication in children with recurrent abdominal pain: double blind randomized placebo-controlled trial. Journal of clinical gastroenterology 20040901
Review article: efficacy and safety of rabeprazole in treating gastroesophageal reflux disease. Journal of gastroenterology and hepatology 20040901
Genetic polymorphism of cytochrome P450 2C19 in healthy Malaysian subjects. British journal of clinical pharmacology 20040901
Suppression of gastric acid production may improve the course of angina pectoris and the results of treadmill stress test in patients with coronary artery disease. Medical science monitor : international medical journal of experimental and clinical research 20040901
A pilot study on duodenal acid exposure and its relationship to symptoms in functional dyspepsia with prominent nausea. The American journal of gastroenterology 20040901
Prevention of erosive oesophagitis relapse with pantoprazole. Alimentary pharmacology & therapeutics 20040901
Clinical inquiries. Is the long-term use of proton pump inhibitors safe? The Journal of family practice 20040901
CYP2C19 polymorphism is a major predictor of treatment failure in white patients by use of lansoprazole-based quadruple therapy for eradication of Helicobacter pylori. Clinical pharmacology and therapeutics 20040901
[Efficacy of 14 day OBMT therapy as a second-line treatment for Helicobacter pylori infection]. The Korean journal of gastroenterology = Taehan Sohwagi Hakhoe chi 20040901
Omeprazole treatment of Korean patients: effects on gastric pH and gastrin release in relation to CYP2C19 geno- and phenotypes. Basic & clinical pharmacology & toxicology 20040901
Proton pump inhibitors and iron deficiency: is the connection real? Southern medical journal 20040901
Effect of omeprazole on oral iron replacement in patients with iron deficiency anemia. Southern medical journal 20040901
Description of prescribing practices in patients with upper gastrointestinal bleeding receiving intravenous proton pump inhibitors: a multicentre evaluation. Canadian journal of gastroenterology = Journal canadien de gastroenterologie 20040901
Pantoprazole for sleepiness associated with acid reflux and obstructive sleep disordered breathing. The Laryngoscope 20040901
Pachydermia is not diagnostic of active laryngopharyngeal reflux disease. The Laryngoscope 20040901
Crohn's disease with isolated esophagus and gastric involvement. The Turkish journal of gastroenterology : the official journal of Turkish Society of Gastroenterology 20040901
Serum cholinesterase inhibition by omeprazole and lansoprazole. Die Pharmazie 20040901
[The effect of rabeprazole on gastric pH in patients with gastric ulcer]. Zhonghua nei ke za zhi 20040901
[Study on changes in physiological [18F]fluorodeoxyglucose accumulation in the digestive tube caused by drug treatment]. [Hokkaido igaku zasshi] The Hokkaido journal of medical science 20040901
Results of triple eradication therapy in Japanese children: a retrospective multicenter study. Journal of gastroenterology 20040901
Does hormone therapy increase allergic reactions and upper gastrointestinal problems? Results from a population-based study of Swedish woman. The women's health in the Lund area (WHILA) study. Maturitas 20040820
A novel option in proton pump inhibitor dosing: lansoprazole orally disintegrating tablet dispersed in water and administered via nasogastric tube. Alimentary pharmacology & therapeutics 20040815
The role of acid suppression in patients with endoscopy-negative reflux disease: the effect of treatment with esomeprazole or omeprazole. Alimentary pharmacology & therapeutics 20040815
Identifying response to acid suppressive therapy in functional dyspepsia using a random starting day trial--is gastro-oesophageal reflux important? Alimentary pharmacology & therapeutics 20040815
Treatment of gastro-oesophageal reflux disease with rabeprazole in primary and secondary care: does Helicobacter pylori infection affect proton pump inhibitor effectiveness? Alimentary pharmacology & therapeutics 20040815
Mechanism of the pharmacokinetic interaction between methotrexate and benzimidazoles: potential role for breast cancer resistance protein in clinical drug-drug interactions. Cancer research 20040815
Acidic duodenal pH alters gene expression in the cystic fibrosis mouse pancreas. American journal of physiology. Gastrointestinal and liver physiology 20040801
Pantoprazole treatment does not invoke anti-inflammatory properties in vivo. International immunopharmacology 20040801
The tautomerism of Omeprazole in solution: a 1H and 13C NMR study. Magnetic resonance in chemistry : MRC 20040801
Comparison of inhibitory effects of the proton pump-inhibiting drugs omeprazole, esomeprazole, lansoprazole, pantoprazole, and rabeprazole on human cytochrome P450 activities. Drug metabolism and disposition: the biological fate of chemicals 20040801
Total family unit Helicobacter pylori eradication and pediatric re-infection rates. Helicobacter 20040801
Dual vs. triple therapy for childhood Helicobacter pylori gastritis: a double-blind randomized multicentre trial. Helicobacter 20040801
Helicobacter pylori eradication in children and adolescents by a once daily 6-day treatment with or without a proton pump inhibitor in a double-blind randomized trial. Alimentary pharmacology & therapeutics 20040801
Reproducibility of a symptom response to omeprazole therapy in functional dyspepsia evaluated by a random-starting-day trial design. Alimentary pharmacology & therapeutics 20040801
Healing rate of EMR-induced ulcer in relation to the duration of treatment with omeprazole. Gastrointestinal endoscopy 20040801
Effect of lansoprazole and rabeprazole on tacrolimus pharmacokinetics in healthy volunteers with CYP2C19 mutations. The Journal of pharmacy and pharmacology 20040801
Pharmacokinetics of lansoprazole in Chinese healthy subjects in relation to CYP2C19 genotypes. Acta pharmacologica Sinica 20040801
One on one. I often have heartburn. Is it safe to use Prilosec OTC long term? Mayo Clinic women's healthsource 20040801
Triple therapy with pantoprazole, clarithromycin and amoxicillin for eradication in patients with Helicobacter pylori positive duodenal ulcers. Saudi medical journal 20040801
The efficacy, safety and tolerability of pantoprazole-based one-week triple therapy in H. pylori eradication and duodenal ulcer healing. Current medical research and opinion 20040801
Effect of omeprazole paste on intragastric pH in clinically normal neonatal foals. American journal of veterinary research 20040801
[Significance of PPI-test in the diagnosis of GERD]. Nihon rinsho. Japanese journal of clinical medicine 20040801
[Test of refractory gastroesophageal reflux disease]. Nihon rinsho. Japanese journal of clinical medicine 20040801
[Primary care for GEDR]. Nihon rinsho. Japanese journal of clinical medicine 20040801
[Evaluation of the efficacy and the cost-effectiveness of maintenance treatment of gastroesophageal reflux disease: proton pump inhibitor versus histamine-2-receptor antagonist]. Nihon rinsho. Japanese journal of clinical medicine 20040801
[PPI: new strategies for GERD]. Nihon rinsho. Japanese journal of clinical medicine 20040801
Chiral separation of omeprazole and several related benzimidazoles using supercritical fluid chromatography. Journal of separation science 20040801
Utility of proton pump inhibitors in the treatment of gastrointestinal hemorrhage. Connecticut medicine 20040801
Comparison of the efficacy of 250 mg and 500 mg clarithromycin used with lansoprazole and amoxicillin in eradication regimens for Helicobacter pylori infection. Wiener klinische Wochenschrift 20040731
[Effects of different triple therapies on duodenal ulcer-associated Helicobacter pylori infection and a one-year follow-up study]. Zhonghua yi xue za zhi 20040717
Six-month trial of on-demand rabeprazole 10 mg maintains symptom relief in patients with non-erosive reflux disease. Alimentary pharmacology & therapeutics 20040715
[Chronic upper abdominal pain without improvement after using proton pump inhibitors]. Deutsche medizinische Wochenschrift (1946) 20040709
Do procalcitonin and C-reactive protein levels have a place in the diagnosis and follow-up of Helicobacter pylori infections? Journal of medical microbiology 20040701
Complete remission of cyclic thrombocytopenia after Helicobacter pylori eradication. Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis 20040701
Effect of Helicobacter pylori eradication on anti-thrombotic dose aspirin-induced gastroduodenal mucosal injury. Journal of gastroenterology and hepatology 20040701
Esomeprazole versus omeprazole for the eradication of Helicobacter pylori infection: results of a randomized controlled study. Journal of clinical gastroenterology 20040701
Seven-day therapy for Helicobacter pylori in the United States. Alimentary pharmacology & therapeutics 20040701
Masking of 13C urea breath test by proton pump inhibitors is dependent on type of medication: comparison between omeprazole, pantoprazole, lansoprazole and esomeprazole. Alimentary pharmacology & therapeutics 20040701
A randomized study of the safety of outpatient care for patients with bleeding peptic ulcer treated by endoscopic injection. Gastrointestinal endoscopy 20040701
Voltammetric behaviour of rabeprazole at a glassy carbon electrode and its determination in tablet dosage form. Farmaco (Societa chimica italiana : 1989) 20040701
Use of intravenous proton pump inhibitors in community practice: an explanation for the shortage? The American journal of gastroenterology 20040701
Second opinion. I have tried the new over-the-counter drug Prilosec for my heartburn, and it was very helpful. The package says I should take it for only two weeks and that if my heartburn comes back after that, I should see my doctor. If Prilosec helps, why can't I keep taking it? Mayo Clinic health letter (English ed.) 20040701
Phosphodiesterase type IV inhibitors prevent ischemia-reperfusion-induced gastric injury in rats. Journal of pharmacological sciences 20040701
DNA typing for Helicobacter pylori isolates from eradication-failed patients: comparison of the isolates before and after therapy. Alimentary pharmacology & therapeutics 20040701
Second-line treatment of Helicobacter pylori infection after dilution agar methods and PCR-RFLP analysis. Alimentary pharmacology & therapeutics 20040701
Helicobacter pylori eradication decreases blood neutrophil and monocyte counts. Alimentary pharmacology & therapeutics 20040701
Evaluation of treatment for gastro-oesophageal reflux disease with a proton pump inhibitor, and relationship between gastro-oesophageal reflux disease and Helicobacter pylori infection in Japan. Alimentary pharmacology & therapeutics 20040701
[Prospective comparative study on protective effect of the proton pump inhibitor and the prostaglandin analog on H. pylori-negative gastric mucosa of healthy subjects against low-dose aspirin]. [Hokkaido igaku zasshi] The Hokkaido journal of medical science 20040701
Wyeth found guilty of paying to boost use of a specific medicine. BMJ (Clinical research ed.) 20040626
[New-generation proton pump inhibitors: progress in the treatment of peptic acid diseases?]. Presse medicale (Paris, France : 1983) 20040619
The importance of the level of metronidazole resistance for the success of Helicobacter pylori eradication. Alimentary pharmacology & therapeutics 20040615
Re: Cost-effectiveness of aspirin chemoprevention for Barrett's esophagus. Journal of the National Cancer Institute 20040602
Drug-induced tubulo-interstitial nephritis secondary to proton pump inhibitors: experience from a single UK renal unit. Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 20040601
Empirical treatment followed by a test-and-treat strategy is more cost-effective in comparison with prompt endoscopy or radiography in patients with dyspeptic symptoms: a randomized trial in a primary care setting. Family practice 20040601
H pylori infection and reflux oesophagitis. Gut 20040601
Lansoprazole in the treatment of functional dyspepsia: two double-blind, randomized, placebo-controlled trials. The American journal of medicine 20040601
Omeprazole as a CYP2C19 marker in Chinese subjects: assessment of its gene-dose effect and intrasubject variability. Journal of clinical pharmacology 20040601
Influence of omeprazole on bioavailability of bismuth following administration of a triple capsule of bismuth biskalcitrate, metronidazole, and tetracycline. Journal of clinical pharmacology 20040601
Helicobacter pylori: antibiotic resistance and eradication rates in Suffolk, UK, 1991-2001. Journal of medical microbiology 20040601
Use of imidazole-based eradication regimens for Helicobacter pylori should be abandoned in North India regardless of in vitro antibiotic sensitivity. Journal of gastroenterology and hepatology 20040601
Long-term effect of Helicobacter pylori eradication on the reversibility of acid secretion in profound hypochlorhydria. Alimentary pharmacology & therapeutics 20040601
A novel option for dosing of proton pump inhibitors: dispersion of lansoprazole orally disintegrating tablet in water via oral syringe. Alimentary pharmacology & therapeutics 20040601
Maastricht II treatment scheme and efficacy of different proton pump inhibitors in eradicating Helicobacter pylori. World journal of gastroenterology 20040601
Efficacy of two rabeprazole/gatifloxacin-based triple therapies for Helicobacter pylori infection. Helicobacter 20040601
Empiric treatment with high and standard dose of omeprazole in general practice: two-week randomized placebo-controlled trial and 12-month follow-up of health-care consumption. The American journal of gastroenterology 20040601
Treat the patients' main dyspepsia complaint, not the ROME criteria. The American journal of gastroenterology 20040601
Effect of antibacterial therapy and salivary secretion on the efficacy of Helicobacter pylori eradication in duodenal ulcer patients. Oral surgery, oral medicine, oral pathology, oral radiology, and endodontics 20040601
Proton pump inhibitors for acute upper GI bleeding. Drug and therapeutics bulletin 20040601
Over-expression of inducible heat shock protein 70 in the gastric mucosa of partially sleep-deprived rats. Scandinavian journal of gastroenterology 20040601
Retrospective evaluation of the effect of omeprazole on clozapine metabolism. Pharmacy world & science : PWS 20040601
Twice daily (mid-day and evening) quadruple therapy for H. pylori infection in the United States. Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver 20040601
[Long-term therapeutic effect of triple therapy consisted of omeperazole, clarithromycin and amoxycillin in children with Helicobacter pylori infection and approach to re-treatment after failure of the treatment]. Zhonghua er ke za zhi = Chinese journal of pediatrics 20040601
On-demand therapy with rabeprazole in nonerosive and erosive gastroesophageal reflux disease in clinical practice: effectiveness, health-related quality of life, and patient satisfaction. Digestive diseases and sciences 20040601
Significance of non-erosive minimal esophageal lesions in gastro-esophageal reflux disorder. The Korean journal of internal medicine 20040601
The influence of pretreatment on cure rates of Helicobacter pylori eradication. The Netherlands journal of medicine 20040601
Evaluation of fast disintegrating lansoprazole tablet in human subjects. Drug metabolism and pharmacokinetics 20040601
[Home-care warning: Christmas Eve in September? Omeprazole and the appearance of auditory hallucinations]. Atencion primaria 20040531
[Prevention of ulcer lesions under non-steroid antirheumatic agents. For each patient the appropriate stomach protection]. MMW Fortschritte der Medizin 20040527
Simultaneous determination of lansoprazole enantiomers and their metabolites in plasma by liquid chromatography with solid-phase extraction. Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20040525
Management options for patients with ulcer hemorrhage. Annals of internal medicine 20040518
Health-related quality of life in patients with cardiovascular disease--the effect of upper gastrointestinal symptom treatment. Alimentary pharmacology & therapeutics 20040515
Evaluation of the pharmacokinetics and pharmacodynamics of intravenous lansoprazole. Alimentary pharmacology & therapeutics 20040515
The effect of an empirical trial of high-dose lansoprazole on symptom response of patients with non-cardiac chest pain--a randomized, double-blind, placebo-controlled, crossover trial. Alimentary pharmacology & therapeutics 20040515
Pharmacokinetic interactions between omeprazole/pantoprazole and clarithromycin in health volunteers. Pharmacological research 20040501
Lansoprazole-tacrolimus interaction in Japanese transplant recipient with CYP2C19 polymorphism. The Annals of pharmacotherapy 20040501
Mucosal concentration of basic fibroblast growth factor in the healing process in human giant gastric ulcers. Journal of gastroenterology and hepatology 20040501
Absence of nocturnal acid breakthrough in Helicobacter pylori-positive subjects treated with twice-daily omeprazole. European journal of gastroenterology & hepatology 20040501
Quantitative prediction of the in vivo inhibition of diazepam metabolism by omeprazole using rat liver microsomes and hepatocytes. Drug metabolism and disposition: the biological fate of chemicals 20040501
Effectiveness and pharmaceutical cost of sequential treatment for Helicobacter pylori in patients with non-ulcer dyspepsia. Alimentary pharmacology & therapeutics 20040501
AstraZeneca digs in over advertising criticisms. BMJ (Clinical research ed.) 20040501
Fexofenadine does not affect omeprazole pharmacokinetics: both are putative P-glycoprotein substrates. Basic & clinical pharmacology & toxicology 20040501
Predictors of outcome in an open label, therapeutic trial of high-dose omeprazole in laryngitis. The American journal of gastroenterology 20040501
Effect of proton pump inhibitors and antacid therapy on 13C urea breath tests and stool test for Helicobacter pylori infection. The American journal of gastroenterology 20040501
Persistent acid and bile reflux in asymptomatic patients with Barrett esophagus receiving proton pump inhibitor therapy. Archives of surgery (Chicago, Ill. : 1960) 20040501
By the way, doctor. I've been taking Prilosec for esophageal reflux. My doctor says I may need to take it indefinitely. Is that safe? Harvard women's health watch 20040501
The prolongation of triple therapy for Helicobacter pylori does not allow reaching therapeutic outcome of sequential scheme: a prospective, randomised study. Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver 20040501
[Successful treatment of long-standing iron-deficiency anemia in adults by eradication of Helicobacter pylori]. [Rinsho ketsueki] The Japanese journal of clinical hematology 20040501
Omeprazole and talampanel as two examples of retrometabolic drug design. Die Pharmazie 20040501
[Studies on chiral inversion of dextropantoprazole in human]. Yao xue xue bao = Acta pharmaceutica Sinica 20040501
Identification and relative contributions of human cytochrome P450 isoforms involved in the metabolism of glibenclamide and lansoprazole: evaluation of an approach based on the in vitro substrate disappearance rate. Xenobiotica; the fate of foreign compounds in biological systems 20040501
[Selective cox-2 inhibitors. Better tolerance than NSAID plus antacid]. MMW Fortschritte der Medizin 20040408
The cavity structure for docking the K(+)-competitive inhibitors in the gastric proton pump. The Journal of biological chemistry 20040402
Does eradication of Helicobacter pylori reduce the risk of carcinogenesis in the residual stomach after gastrectomy for early gastric cancer? Comparison of mucosal lesions in the residual stomach before and after Helicobacter pylori eradication. Langenbeck's archives of surgery 20040401
Different inhibitory effect of fluvoxamine on omeprazole metabolism between CYP2C19 genotypes. British journal of clinical pharmacology 20040401
pH probe positioning for 24-hour pH-metry by manometry or pH step-up. European journal of gastroenterology & hepatology 20040401
Influence of azimilide on CYP2C19-mediated metabolism. Journal of clinical pharmacology 20040401
An audit of argon plasma coagulation, epinephrine injection, and proton-pump infusion therapy in the management of bleeding peptic ulcer disease. Endoscopy 20040401
Helicobacter pylori eradication releases prolonged increased acid secretion following omeprazole treatment. Gastroenterology 20040401
Rank order of success favors longer duration of imidazole-based therapy for Helicobacter pylori in duodenal ulcer disease: a randomized pilot study. Helicobacter 20040401
Protein pump inhibitors go over the counter. Home healthcare nurse 20040401
Helicobacter pylori eradication rate and glycemic control in young patients with type 1 diabetes. Journal of pediatric gastroenterology and nutrition 20040401
Application of Maastricht 2-2000 guidelines for the management of Helicobacter pylori among specialists and primary care physicians in israel: are we missing the malignant potential of Helicobacter pylori? Journal of clinical gastroenterology 20040401
The effects of Helicobacter pylori eradication on chemokine production in patients with immune thrombocytopenic purpura. European journal of haematology 20040401
A comparison of the effects of ranitidine and omeprazole on volume and pH of gastric contents in elective surgical patients. European journal of anaesthesiology 20040401
Esomeprazole-based therapy in Helicobacter pylori eradication: a meta-analysis. Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver 20040401
Helicobacter pylori eradication: efficacy of conventional therapy in India. Tropical doctor 20040401
Does the 'test-and-treat' strategy work in primary health care for management of uninvestigated dyspepsia? A prospective two-year follow-up study of 1552 patients. Scandinavian journal of gastroenterology 20040401
Comparison of cetraxate-based and pantoprazole-based triple therapies in the treatment of Helicobacter pylori infection. Journal of the Chinese Medical Association : JCMA 20040401
[Long-term course of reflux symptoms following Helicobacter pylori eradication]. Deutsche medizinische Wochenschrift (1946) 20040326
[Hereditary neuroendocrine gastroenteropancreatic tumors and multiple endocrine neoplasia type 1]. Deutsche medizinische Wochenschrift (1946) 20040326
The role of protein tyrosine kinases in CYP1A1 induction by omeprazole and thiabendazole in rat hepatocytes. Life sciences 20040319
[Stubborn reflux pain, inconspicuous esophagus. Which therapy brings the fastest relief?]. MMW Fortschritte der Medizin 20040311
[Graded therapy in reflux disease. 'In severe cases 40 mg., in milder 20 mg.']. MMW Fortschritte der Medizin 20040311
Outcome of laparoscopic Nissen-Rossetti fundoplication in children with gastroesophageal reflux disease and supraesophageal symptoms. Surgical endoscopy 20040301
Low eradication rate of Helicobacter pylori with triple 7-14 days and quadriple therapy in Turkey. World journal of gastroenterology 20040301
Clinical evaluation of four one-week triple therapy regimens in eradicating Helicobacter pylori infection. World journal of gastroenterology 20040301
Gastric antiulcer activity of Syngonanthus arthrotrichus SILVEIRA. Biological & pharmaceutical bulletin 20040301
St John's wort induces both cytochrome P450 3A4-catalyzed sulfoxidation and 2C19-dependent hydroxylation of omeprazole. Clinical pharmacology and therapeutics 20040301
Ventilatory compensation of the alkaline tide during digestion in the snake Boa constrictor. The Journal of experimental biology 20040301
Effect of short-term treatment with low dosages of the proton-pump inhibitor omeprazole on serum chromogranin A levels in man. European journal of endocrinology 20040301
Tableting and stability evaluation of enteric-coated omeprazole pellets. European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V 20040301
[Antisecretor treatment of digestive hemorrhage associated to peptic ulcer: an approximation to the available evidence]. Revista clinica espanola 20040301
[Therapeutic effect of low-dose omeprazole vs. standard-dose ranitidine in mild to moderate reflux esophagitis]. The Korean journal of gastroenterology = Taehan Sohwagi Hakhoe chi 20040301
[Myoclonic encephalopathy associated with proton pump inhibitors]. Revue neurologique 20040301
[Eradication effect of lansoprazole-based triple therapy against H. pylori]. Nihon rinsho. Japanese journal of clinical medicine 20040301
[Effect of proton pump inhibitors (PPIs) on wound healing of gastric mucosal cell injury]. Nihon rinsho. Japanese journal of clinical medicine 20040301
Hair analysis as a novel investigative tool for the detection of historical drug use/misuse in the horse: a pilot study. Equine veterinary journal 20040301
Validation of a brief inventory for diagnosis and monitoring of symptomatic gastro-oesophageal reflux. Scandinavian journal of gastroenterology 20040301
[Electrochemical behaviour of pantoprazole]. Die Pharmazie 20040301
Omeprazole treatment: genotoxicity biomarkers, and potential to induce CYP1A2 activity in humans. Human & experimental toxicology 20040301
Schatzki's ring: to cut or break an unresolved problem. Digestive diseases and sciences 20040301
GERD 2003: issues from the past and a consensus for the future. Drugs of today (Barcelona, Spain : 1998) 20040301
The basis of differentiation of PPIs. Drugs of today (Barcelona, Spain : 1998) 20040301
Understanding NSAID-PPI-COX-2 interrelationships. Drugs of today (Barcelona, Spain : 1998) 20040301
[Effectiveness of omeprazole therapy in children with gastroesophageal reflux diseases(GERD)]. Polski merkuriusz lekarski : organ Polskiego Towarzystwa Lekarskiego 20040301
Treatment with omeprazole, metronidazole, and amoxicillin in captive South African cheetahs (Acinonyx jubatus) with spiral bacteria infection and gastritis. Journal of zoo and wildlife medicine : official publication of the American Association of Zoo Veterinarians 20040301
Quality of life after peptic perforation. The Journal of the Association of Physicians of India 20040301
Sequential treatment for Helicobacter pylori does not share the risk factors of triple therapy failure. Alimentary pharmacology & therapeutics 20040215
The acidity index: a simple approach to the measurement of gastric acidity. Alimentary pharmacology & therapeutics 20040215
Double-blind, randomized controlled study to assess the effects of lansoprazole 30 mg and lansoprazole 15 mg on 24-h oesophageal and intragastric pH in Chinese subjects with gastro-oesophageal reflux disease. Alimentary pharmacology & therapeutics 20040215
Mechanisms of gastroprotection by lansoprazole pretreatment against experimentally induced injury in rats: role of mucosal oxidative damage and sulfhydryl compounds. Toxicology and applied pharmacology 20040215
Adverse events following discharge from the hospital. Annals of internal medicine 20040203
Effect of Helicobacter pylori eradication on treatment of gastro-oesophageal reflux disease: a double blind, placebo controlled, randomised trial. Gut 20040201
Helicobacter pylori eradication does not exacerbate gastro-oesophageal reflux disease. Gut 20040201
The effect of eight weeks of rabeprazole therapy on nitric oxide plasma level and esophageal pH and motility and motility nitric oxide plasma level in patients with erosive esophagitis. Medical science monitor : international medical journal of experimental and clinical research 20040201
Different structural requirements of the ligand binding domain of the aryl hydrocarbon receptor for high- and low-affinity ligand binding and receptor activation. Molecular pharmacology 20040201
High-dose versus low-dose clarithromycin in 1-week triple therapy, including rabeprazole and levofloxacin, for Helicobacter pylori eradication. Journal of clinical gastroenterology 20040201
Pharmacokinetics of omeprazole in healthy adults and in children with gastroesophageal reflux disease. Therapeutic drug monitoring 20040201
Inhibition of the L-dopa transport system in human epidermal Langerhans cells by omeprazole and its analogues. Amino acids 20040201
Cost-minimization analysis of treatment of gastroesophageal reflux disease. Implications of varying holding time on conclusions. European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences 20040201
Eosinophilic infiltration of the esophagus: gastroesophageal reflux versus eosinophilic esophagitis in children--discussion on daily practice. Journal of pediatric surgery 20040201
[Gastric uptake of gallium67 in the human immunodeficiency virus infection]. Anales de medicina interna (Madrid, Spain : 1984) 20040201
Economic evaluation of Helicobacter pylori eradication in the CADET-Hp randomized controlled trial of H. pylori-positive primary care patients with uninvestigated dyspepsia. Alimentary pharmacology & therapeutics 20040201
Clopidogrel plus omeprazole compared with aspirin plus omeprazole for aspirin-induced symptomatic peptic ulcers/erosions with low to moderate bleeding/re-bleeding risk -- a single-blind, randomized controlled study. Alimentary pharmacology & therapeutics 20040201
Investigation into the role of cephalic stimulation of acid secretion on gastric emptying and appetite following a soup meal using the gastric acid inhibitor omeprazole. Appetite 20040201
Omeprazole may delay the diagnosis of pyloric stenosis. Acta paediatrica (Oslo, Norway : 1992) 20040201
Nephritis and proton pump inhibitors. Prescrire international 20040201
Functional mechanism underlying COX-2 expression following administration of indomethacin in rat stomachs: importance of gastric hypermotility. Digestive diseases and sciences 20040201
Early epigastric pain after PPI administration: exacerbation of Helicobacter pylori corpus gastritis? Helicobacter 20040201
[Efficacy of Helicobacter pylori eradication in non-ulcer dyspepsia]. Medicina clinica 20040131
Severe thrombocytopenia as a complication of acute Epstein-Barr virus infection. Wiener klinische Wochenschrift 20040131
Whither surgery in the treatment of gastroesophageal reflux disease (GERD)? CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne 20040120
Immunoproliferative small intestinal disease associated with Campylobacter jejuni. The New England journal of medicine 20040115
Helicobacter pylori eradication to prevent gastric cancer in a high-risk region of China: a randomized controlled trial. JAMA 20040114
Notch activity acts as a sensor for extracellular calcium during vertebrate left-right determination. Nature 20040108
Review of rabeprazole in the treatment of gastro-oesophageal reflux disease. Expert opinion on pharmacotherapy 20040101
Cure of Helicobacter pylori infection in patients with reflux oesophagitis treated with long term omeprazole reverses gastritis without exacerbation of reflux disease: results of a randomised controlled trial. Gut 20040101
Long term outcome of patients with gastric marginal zone B cell lymphoma of mucosa associated lymphoid tissue (MALT) following exclusive Helicobacter pylori eradication therapy: experience from a large prospective series. Gut 20040101
Low-dose furazolidone in triple and quadruple regimens for Helicobacter pylori eradication. Alimentary pharmacology & therapeutics 20040101
Rabeprazole 10 mg twice daily is superior to 20 mg once daily for night-time gastric acid suppression. Alimentary pharmacology & therapeutics 20040101
Beta-lactamase inhibitor enhances Helicobacter pylori eradication rate. Journal of internal medicine 20040101
Divalent cations regulate acidity within the lumen and tubulovesicle compartment of gastric parietal cells. Gastroenterology 20040101
Omeprazole is more effective than a histamine H2-receptor blocker for maintaining a persistent elevation of gastric pH after colon resection for cancer. American journal of surgery 20040101
Evaluation of urine sucrose concentration for detection of gastric ulcers in horses. American journal of veterinary research 20040101
Acute interstitial nephritis due to pantoprazole. The Annals of pharmacotherapy 20040101
Helicobacter pylori eradication and gastric preneoplastic conditions: a randomized, double-blind, placebo-controlled trial. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 20040101
Sensitive sulphur-specific detection of omeprazole metabolites in rat urine by high-performance liquid chromatography/inductively coupled plasma mass spectrometry. Rapid communications in mass spectrometry : RCM 20040101
Quantitative assessment of gastric antrum atrophy shows restitution to normal histology after Helicobacter pylori eradication. Digestion 20040101
The comparative effects of single intravenous doses of omeprazole and famotidine on intragastric pH. Journal of gastroenterology 20040101
Rhabdomyolysis associated with omeprazole. Journal of gastroenterology 20040101
Is an intravenous histamine H2 receptor antagonist superior to an intravenous proton pump inhibitor in acid suppression? Journal of gastroenterology 20040101
Empirical Helicobacter pylori 'rescue' therapy after failure of two eradication treatments. Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver 20040101
Lansoprazole promotes gastric mucosal cell proliferation and migration by activating p44/p42 mitogen-activated protein kinase. Wound repair and regeneration : official publication of the Wound Healing Society [and] the European Tissue Repair Society 20040101
[Effect of CYP2C19 genetic polymorphism on treatment efficacy of Helicobacter pylori infection with rabeprazole-based triple therapy in Chinese]. Zhonghua nei ke za zhi 20040101
Parietal cell density during gastric ulcer healing in the rat. Scandinavian journal of gastroenterology 20040101
Managing gastro-oesophageal reflux disease in children. Digestion 20040101
Lack of benefit of treating Helicobacter pylori infection in patients with functional dyspepsia. Randomized one-year follow-up study. Hepato-gastroenterology 20040101
Poor responders to intravenous omeprazole in patients with peptic ulcer bleeding. Hepato-gastroenterology 20040101
Association of helicobacter pylori infection with nutritional status in hemodialysis patients. Transplantation proceedings 20040101
Self-selection and use patterns of over-the-counter omeprazole for frequent heartburn. Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association 20040101
Polymorphism of interleukin-1beta affects the eradication rates of Helicobacter pylori by triple therapy. Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association 20040101
Inhibition of gastric H,K-ATPase activity and gastric epithelial cell IL-8 secretion by the pyrrolizine derivative ML 3000. BMC gastroenterology 20040101
Flavor and taste of lansoprazole strawberry-flavored delayed-release oral suspension preferred over ranitidine peppermint-flavored oral syrup: in children aged between 5-11 years. Paediatric drugs 20040101
Lanzoprazole promotes gastric carcinogenesis in rats with duodenogastric reflux. Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association 20040101
Effectiveness of peripheral hepatogastrostomy versus hepatojejunostomy in the treatment of obstructive cholestasis: results of an experimental model. Surgery today 20040101
Single-isomer drugs: true therapeutic advances. Clinical pharmacokinetics 20040101
Lack of effect of omeprazole or of an aluminium hydroxide/magnesium hydroxide antacid on the pharmacokinetics of lumiracoxib. Clinical pharmacokinetics 20040101
Efficacy of esomeprazole in patients with acid-peptic disorders. Gastroenterology nursing : the official journal of the Society of Gastroenterology Nurses and Associates 20040101
Tumoral calcinosis in systemic sclerosis. Clinical and experimental rheumatology 20040101
Usefulness of proton pump inhibitor (PPI) maintenance therapy for patients with H. pylori-negative recurrent peptic ulcer after eradication therapy for H. pylori: pathophysiological characteristics of H. pylori-negative recurrent ulcer scars and beyond acid suppression by PPI. Hepato-gastroenterology 20040101
[Cross reactivity among proton pump inhibitors: does it exits?]. Allergologia et immunopathologia 20040101
Pantoprazole based therapies in Helicobacter pylori eradication: a systematic review and meta-analysis. European journal of gastroenterology & hepatology 20040101
[Comparative efficacy of different therapeutic schemes in gastropathies induced by nonsteroid anti-inflammatory drugs]. Terapevticheskii arkhiv 20040101
The heat shock response is dependent on the external environment and on rapid ionic balancing by pharmacological agents in Saccharomyces cerevisiae. Journal of applied microbiology 20040101
Stress ulcer prophylaxis in critically ill patients: a randomized controlled trial. Hepato-gastroenterology 20040101
An extensive metabolizer with recurrent ulcer responding to high dose of lansoprazole. Hepato-gastroenterology 20040101
Enhanced gastric emptying of a liquid gastric load in mice lacking cholecystokinin-B receptor: a study of CCK-A,B, and AB receptor gene knockout mice. Journal of gastroenterology 20040101
Serum IL-8 as a possible marker for determining the status of Helicobacter pylori infection in patients with untreated and treated peptic ulcer. Advances in therapy 20040101
Bioequivalence study of rabeprazole sodium on healthy human volunteers. Journal of the Indian Medical Association 20040101
[Acute interstitial nephritis associated with omeprazole therapy]. Nefrologia : publicacion oficial de la Sociedad Espanola Nefrologia 20040101
Bioequivalence evaluation of two rabeprazole enteric coated formulations in healthy Chinese volunteers. European journal of drug metabolism and pharmacokinetics 20040101
Omeprazole/antacid-powder suspension--Santarus: Acitrel, Rapinex Powder for oral suspension, SAN 05. Drugs in R&D 20040101
Determination of pantoprazole in human plasma by LC-MS-MS using lansoprazole as internal standard. Arzneimittel-Forschung 20040101
[Regression of primary low-grade gastric mucosa-associated lymphoma by eradication of Helicobacter pylori infection: case report]. Annali italiani di chirurgia 20040101
Omeprazole is more effective than famotidine for preventing acute gastritis in rats. Surgery today 20040101
[Investigation of the effects of efflux pump inhibitors on ciprofloxacin MIC values of high level fluoroquinolone resistant Escherichia coli clinical isolates]. Mikrobiyoloji bulteni 20040101
New liquid chromatographic method for determination of rabeprazole sodium in coated tablets. Journal of AOAC International 20040101
Efficacy and safety of pantoprazole versus ranitidine in the treatment of patients with symptomatic gastroesophageal reflux disease. Digestion 20040101
Treatment of gastroesophageal reflux disease: pills, knife or scope. Tropical gastroenterology : official journal of the Digestive Diseases Foundation 20040101
Delayed-release lansoprazole plus naproxen. Drugs 20040101
Triple therapy using two dosages of metronidazole along with amoxicillin and omeprazole to eradicate Helicobacter pylori infection: a randomized, open study. Indian journal of gastroenterology : official journal of the Indian Society of Gastroenterology 20040101
Intravenous lansoprazole: in erosive oesophagitis. Drugs 20040101
Perforated duodenal ulcer at seven years after heart-renal transplantation: a case report. Hepato-gastroenterology 20040101
Evaluation of the effects of Helicobacter pylori eradication therapy on gastric antral epithelial hyperproliferation: a prospective six-month follow-up study. Hepato-gastroenterology 20040101
The effect of H2-receptor antagonist and proton pump inhibitor on microbial proliferation in the stomach. Hepato-gastroenterology 20040101
Churg-Strauss syndrome (allergic granulomatous angiitis) associated with T lymphoblastic lymphoma. In vivo (Athens, Greece) 20040101
Effects on the cost and utilization of proton pump inhibitors from adding over-the counter omeprazole to drug benefit coverage in a state employee health plan. Journal of managed care pharmacy : JMCP 20040101
OTC omeprazole for your heartburn--enormous value-for-money opportunity. Journal of managed care pharmacy : JMCP 20040101
Pantoprazole-induced acute interstitial nephritis. Journal of nephrology 20040101
Extra-esophageal disorders in gastroesophageal reflux disease. Digestive diseases (Basel, Switzerland) 20040101
Omeprazole induces apoptosis in jurkat cells. International journal of immunopathology and pharmacology 20040101
[Particular features of application of proton pump inhibitors (Rabeprazole) in children with the gastroesophageal reflux disease]. Eksperimental'naia i klinicheskaia gastroenterologiia = Experimental & clinical gastroenterology 20040101
Do proton pump inhibitors increase the incidence of nosocomial pneumonia and related infectious complications when compared with histamine-2 receptor antagonists in critically ill trauma patients? Current surgery 20040101
[Efficacy of the dosing regimen of pantoprazole 40 mg, amoxicillin 1000 mg and clarithromycin 500 mg, twice daily for 7 days, in the eradication of Helicobacter pylori in patients with peptic ulcer]. Arquivos de gastroenterologia 20040101
Direct injection of 96-well organic extracts onto a hydrophilic interaction chromatography/tandem mass spectrometry system using a silica stationary phase and an aqueous/organic mobile phase. Rapid communications in mass spectrometry : RCM 20040101
[Erosion caused by gastric reflux in children. Discussion of etiology, clinical appearance and therapy in two cases]. Schweizer Monatsschrift fur Zahnmedizin = Revue mensuelle suisse d'odonto-stomatologie = Rivista mensile svizzera di odontologia e stomatologia 20040101
[Selecting variants of drug treatment of non-complicated duodenal ulcer (based on a study of results of Rabeprazole efficiency)]. Eksperimental'naia i klinicheskaia gastroenterologiia = Experimental & clinical gastroenterology 20040101
[Proton pump inhibitors as the basis of anti-helicobacter therapeutic schemes]. Eksperimental'naia i klinicheskaia gastroenterologiia = Experimental & clinical gastroenterology 20040101
[Some comparative aspects of treating the gastroesophageal reflux disease eradication]. Eksperimental'naia i klinicheskaia gastroenterologiia = Experimental & clinical gastroenterology 20040101
Omeprazole/Antacid-powder suspension-Santarus: omeprazole/sodium bicarbonate powder-Santarus, SAN 05. Drugs in R&D 20040101
[Effect of H2-blockers and proton pump inhibitors on intragastric acidity and intraesophageal pH in patients with gastroesophageal reflux disease]. Eksperimental'naia i klinicheskaia gastroenterologiia = Experimental & clinical gastroenterology 20040101
[Problems of excretory insufficiency of the pancreas]. Eksperimental'naia i klinicheskaia gastroenterologiia = Experimental & clinical gastroenterology 20040101
[Clinical and pharmacoeconomic aspects of the antisecretory therapy of gastroesophageal refluxed disease]. Eksperimental'naia i klinicheskaia gastroenterologiia = Experimental & clinical gastroenterology 20040101
Comparison of efficacy of pantoprazole alone versus pantoprazole plus mosapride in therapy of gastroesophageal reflux disease: a randomized trial. Diseases of the esophagus : official journal of the International Society for Diseases of the Esophagus 20040101
Effectiveness of proton pump inhibitors: beyond cost. Reviews in gastroenterological disorders 20040101
[Peptic ulcer disease etiology, diagnosis and treatment]. Polski merkuriusz lekarski : organ Polskiego Towarzystwa Lekarskiego 20040101
Paroxysmal laryngospasm: a typical but underrecognized supraesophageal manifestation of gastroesophageal reflux? Digestive diseases and sciences 20040101
Gastric acid and salivary bicarbonate. Is there a relationship in duodenal ulcer patients? Roczniki Akademii Medycznej w Bialymstoku (1995) 20040101
A pharmacokinetic interaction study between omeprazole and the H2-receptor antagonist ranitidine. Drug metabolism and drug interactions 20040101
Warning: do not combine Reyataz and Prilosec. AIDS treatment news 20040101
[Evaluation of the symptomatology and quality of life in functional dyspepsia before and after Helicobacter pylori eradication treatment]. Revista de gastroenterologia de Mexico 20040101
In vivo and in vitro research on the biological effects of deuterium-depleted water: 1. Influence of deuterium-depleted water on cultured cell growth. Romanian journal of physiology : physiological sciences 20040101
Treatment for patients with gastroesophageal reflux disease. Director (Cincinnati, Ohio) 20040101
Enantiomeric determination of the plasma levels of omeprazole by direct plasma injection using high-performance liquid chromatography with achiral-chiral column-switching. Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20031225
[The proton pump especially steady in grip. Fast help for nightly reflux complaints]. MMW Fortschritte der Medizin 20031218
[Drug treatment of gastro-esophageal reflux disease in pregnant women: consensus guidelines of gastroenterologists and gynaecologists]. Nederlands tijdschrift voor geneeskunde 20031213
Demonstration of a functional apical sodium hydrogen exchanger in isolated rat gastric glands. American journal of physiology. Gastrointestinal and liver physiology 20031201
A 100 kDa vanadate and lanzoprazole-sensitive ATPase from Streptococcus mutans membrane. Archives of oral biology 20031201
Diagnostic and therapeutic options in the management of nonvariceal upper gastrointestinal bleeding. Current gastroenterology reports 20031201
Study of Mimusops elengi bark in experimental gastric ulcers. Journal of ethnopharmacology 20031201
Secondary eradication of Helicobacter pylori was effective against refractory idiopathic thrombocytopenic purpura. Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis 20031201
Effect of omeprazole on the steady-state pharmacokinetics of voriconazole. British journal of clinical pharmacology 20031201
Differential pulse anodic voltammetric determination of pantoprazole in pharmaceutical dosage forms and human plasma using glassy carbon electrode. Analytical biochemistry 20031201
Eradication of Helicobacter pylori by 7-day triple-therapy regimens combining pantoprazole with clarithromycin, metronidazole, or amoxicillin in patients with peptic ulcer disease: results of two double-blind, randomized studies. Helicobacter 20031201
Nutcracker oesophagus: a double-blind, placebo-controlled, cross-over study of the effects of lansoprazole. Alimentary pharmacology & therapeutics 20031201
Effect of omeprazole 10 mg on intragastric pH in three different CYP2C19 genotypes, compared with omeprazole 20 mg and lafutidine 20 mg, a new H2-receptor antagonist. Alimentary pharmacology & therapeutics 20031201
Retreatment of H. pylori with dual therapy using high doses of rabeprazole or lansoprazole can be effective. Alimentary pharmacology & therapeutics 20031201
Effect of omeprazole on the anticoagulant activity and the pharmacokinetics of warfarin enantiomers in rats. European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences 20031201
Symptom relief in patients with reflux esophagitis: comparative study of omeprazole, lansoprazole, and rabeprazole. Journal of gastroenterology and hepatology 20031201
Stomach myoelectrical response of patients with gastroesophageal reflux disease receiving omeprazole treatment. Journal of gastroenterology and hepatology 20031201
Gastric acid control with esomeprazole, lansoprazole, omeprazole, pantoprazole, and rabeprazole: a five-way crossover study. The American journal of gastroenterology 20031201
Intragastric pH during continuous infusion with pantoprazole in patients with bleeding peptic ulcer. The American journal of gastroenterology 20031201
Dosage of intravenous pantoprazole. The American journal of gastroenterology 20031201
The Weber-curve pitfall: effects of a forced introduction on reporting rates and reported adverse reaction profiles. Pharmacy world & science : PWS 20031201
Efficacy of triple therapy with rabeprazole for Helicobacter pylori infection in relation to CYP2C19 genotype. The Korean journal of gastroenterology = Taehan Sohwagi Hakhoe chi 20031201
Effect of a gastrin/cholecystokinin B receptor antagonist, S-0509, on the omeprazole-induced proliferation of gastric mucosa in rats. The Journal of laboratory and clinical medicine 20031201
Sufficient control of heartburn in endoscopy-negative gastro-oesophageal reflux disease trials. Scandinavian journal of gastroenterology 20031201
Endoscopy-negative reflux disease: what is the value of a proton-pump inhibitor test in everyday clinical practice? Scandinavian journal of gastroenterology 20031201
[Efficacy of anti-Helicobacter therapy in children with ulcer-like functional dyspepsia]. Likars'ka sprava 20031201
[Efficacy of controloc in the treatment of acid-dependent diseases]. Likars'ka sprava 20031201
Comparison of rabeprazole-based four- and seven-day triple therapy and omeprazole-based seven-day triple therapy for Helicobacter pylori infection in patients with peptic ulcer. Journal of the Formosan Medical Association = Taiwan yi zhi 20031201
In treatment of active duodenal ulcer and Helicobacter pylori eradication. Hepato-gastroenterology 20031201
Direct effects of proton pump inhibitors on histamine release from rat enterochromaffin-like cells. European journal of pharmacology 20031128
Square-wave adsorptive cathodic stripping voltammetry of pantoprazole. Journal of pharmaceutical and biomedical analysis 20031124
[What treatments can reduce the digestive complications of NSAIDs]. Presse medicale (Paris, France : 1983) 20031122
[Treatment of Helicobacter pylori infection--results and experiences with an Internet-based collaboration trial]. Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke 20031120
Effect of a single oral dose of rabeprazole on nocturnal acid breakthrough and nocturnal alkaline amplitude. World journal of gastroenterology 20031115
Low and high doses of rabeprazole vs. omeprazole for cure of Helicobacter pylori infection. Alimentary pharmacology & therapeutics 20031115
Three-day intravenous triple therapy is not effective for the eradication of Helicobacter pylori infection in patients with bleeding gastro-duodenal ulcer. Alimentary pharmacology & therapeutics 20031115
Proton-pump inhibitors in a Navy hospital after a formulary change. American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists 20031115
Omeprazole, a proton pump inhibitor, improves residual steatorrhoea in cystic fibrosis patients treated with high dose pancreatic enzymes. European journal of pediatrics 20031101
Effect of Helicobacter pylori eradicated therapy on water gastric emptying in patients with active duodenal ulcer. Journal of gastroenterology and hepatology 20031101
CYP2C19- and CYP3A4-dependent omeprazole metabolism in West Mexicans. Journal of clinical pharmacology 20031101
Omeprazole-induced intractable cough. The Annals of pharmacotherapy 20031101
The effect of intravenous pantoprazole and ranitidine for improving preoperative gastric fluid properties in adults undergoing elective surgery. Anesthesia and analgesia 20031101
Immunoelectron microscopic study for histamine in the gastric enterochromaffin-like cells of rats treated with the proton pump inhibitor lansoprazole. Histochemistry and cell biology 20031101
Combined phenotypic assessment of cytochrome p450 1A2, 2C9, 2C19, 2D6, and 3A, N-acetyltransferase-2, and xanthine oxidase activities with the 'Cooperstown 5+1 cocktail'. Clinical pharmacology and therapeutics 20031101
Helicobacter pylori reinfection is common in Peruvian adults after antibiotic eradication therapy. The Journal of infectious diseases 20031101
Gastroprotection by coxibs: what do the Celecoxib Long-Term Arthritis Safety Study and the Vioxx Gastrointestinal Outcomes Research Trial tell us? Rheumatic diseases clinics of North America 20031101
Massive gastrointestinal bleeding in infants with ascariasis. Journal of pediatric surgery 20031101
Comparison of morning and evening administration of rabeprazole for gastro-oesophageal reflux and nocturnal gastric acid breakthrough in patients with reflux disease: a double-blind, cross-over study. Alimentary pharmacology & therapeutics 20031101
The basis for the decreased response to proton pump inhibitors in gastro-oesophageal reflux disease patients without erosive oesophagitis. Alimentary pharmacology & therapeutics 20031101
Banishing bleeding ulcers. Direct treatment helps--and long-term follow-up therapy may be unnecessary. Health news (Waltham, Mass.) 20031101
Lansoprazole-induced hepatic dysfunction. The Annals of pharmacotherapy 20031101
[The effect of proton pump inhibitor on intragastric acidity and it relation to S-mephenytoin hydroxylase genetic polymorphism]. Zhonghua nei ke za zhi 20031101
Interleukin-1beta genetic polymorphism influences the effect of cytochrome P 2C19 genotype on the cure rate of 1-week triple therapy for Helicobacter pylori infection. The American journal of gastroenterology 20031101
[The treatment of Helicobacter pylori infection in upper gastrointestinal disorders]. Nihon Shokakibyo Gakkai zasshi = The Japanese journal of gastro-enterology 20031101
['Mirror, mirror on the wall which is the best proton pump inhibitor of all?']. Zeitschrift fur Gastroenterologie 20031101
Effect of GastroGard and three compounded oral omeprazole preparations on 24 h intragastric pH in gastrically cannulated mature horses. Equine veterinary journal 20031101
Association between nocturnal bruxism and gastroesophageal reflux. Sleep 20031101
Comparable Helicobacter pylori eradication rates obtained with 4- and 7-day rabeprazole-based triple therapy: a preliminary study. Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver 20031101
Manifestations of gastroesophageal reflux and response to omeprazole therapy in patients with chronic posterior laryngitis: an evaluation based on clinical practice. Digestive diseases and sciences 20031101
[Treatment of reflux esophagitis by Xuanfu Daizhe Decoction combined with pantoprazole or omeprazole: a comparative study]. Zhong xi yi jie he xue bao = Journal of Chinese integrative medicine 20031101
[Mastopathy after estradiol and pantoprazol treatment]. Atencion primaria 20031031
Second-line treatment for failure to eradicate Helicobacter pylori: a randomized trial comparing four treatment strategies. Alimentary pharmacology & therapeutics 20031015
Esomeprazole-based one-week triple therapy with clarithromycin and metronidazole is effective in eradicating Helicobacter pylori in the absence of antimicrobial resistance. Alimentary pharmacology & therapeutics 20031015
Randomized study of different 'second-line' therapies for Helicobacter pylori infection after failure of the standard 'Maastricht triple therapy'. Alimentary pharmacology & therapeutics 20031015
Role of antibiotic sensitivity testing before first-line Helicobacter pylori eradication treatments. Alimentary pharmacology & therapeutics 20031015
Lansoprazole reduces ulcer relapse after eradication of Helicobacter pylori in nonsteroidal anti-inflammatory drug users--a randomized trial. Alimentary pharmacology & therapeutics 20031015
Lansoprazole increases testosterone metabolism and clearance in male Sprague-Dawley rats: implications for Leydig cell carcinogenesis. Toxicology and applied pharmacology 20031015
Validation of the spectrophotometric determination of omeprazole and pantoprazole sodium via their metal chelates. Journal of pharmaceutical and biomedical analysis 20031015
[Hyponatremia: an unusual case report]. Praxis 20031008
Simple and efficient method for enantioselective determination of omeprazole in human plasma. Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20031005
Effect of the GABA(B) agonist baclofen in patients with symptoms and duodeno-gastro-oesophageal reflux refractory to proton pump inhibitors. Gut 20031001
Stereoselective metabolism of lansoprazole by human liver cytochrome P450 enzymes. Drug metabolism and disposition: the biological fate of chemicals 20031001
Effects of primary metronidazole and clarithromycin resistance to Helicobacter pylori on omeprazole, metronidazole, and clarithromycin triple-therapy regimen in a region with high rates of metronidazole resistance. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 20031001
Submucosal microinfusion of endothelin and adrenaline mobilizes ECL-cell histamine in rat stomach, and causes mucosal damage: a microdialysis study. British journal of pharmacology 20031001
Formulation study for lansoprazole fast-disintegrating tablet. III. Design of rapidly disintegrating tablets. Chemical & pharmaceutical bulletin 20031001
Impact of Maine's Medicaid drug formulary change on non-Medicaid markets: spillover effects of a restrictive drug formulary. The American journal of managed care 20031001
Treating patients with acute gastrointestinal bleeding or rebleeding. Pharmacotherapy 20031001
Lactoferrin: milking ulcers? Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver 20031001
Use of bovine lactoferrin for Helicobacter pylori eradication. Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver 20031001
Levofloxacin based triple therapy as a second-line treatment after failure of helicobacter pylori eradication with standard triple therapy. Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver 20031001
Proton pump inhibitors in children: a review. Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver 20031001
Inhibitory potency of twice-a-day omeprazole on gastric acidity is enhanced by eradication of H. pylori in duodenal ulcer patients. Digestive diseases and sciences 20031001
Sildenafil, a phosphodiesterase-5 inhibitor, delays gastric emptying and gastrointestinal transit of liquid in awake rats. Digestive diseases and sciences 20031001
Asthma-like syndrome in a teenager. Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology 20031001
Pharmacokinetics of omeprazole in patients with liver cirrhosis and extrahepatic portal venous obstruction. Methods and findings in experimental and clinical pharmacology 20031001
[Modern approach to the therapy of gastroesophageal reflux disease]. Voenno-meditsinskii zhurnal 20031001
[Heartburn without esophagitis. Symptoms more important than the finding?]. MMW Fortschritte der Medizin 20030925
Maintenance treatment is not necessary after Helicobacter pylori eradication and healing of bleeding peptic ulcer: a 5-year prospective, randomized, controlled study. Archives of internal medicine 20030922
One-day quadruple therapy compared with 7-day triple therapy for Helicobacter pylori infection. Archives of internal medicine 20030922
Long-term persistence of resistant Enterococcus species after antibiotics to eradicate Helicobacter pylori. Annals of internal medicine 20030916
Summaries for patients. Effects of antibiotic treatment for Helicobacter pylori on normal bowel bacteria. Annals of internal medicine 20030916
Helicobacter pylori eradication is beneficial in the treatment of functional dyspepsia. Alimentary pharmacology & therapeutics 20030915
Sequential treatment for Helicobacter pylori eradication in duodenal ulcer patients: improving the cost of pharmacotherapy. Alimentary pharmacology & therapeutics 20030915
Meta-analysis: comparative efficacy of different proton-pump inhibitors in triple therapy for Helicobacter pylori eradication. Alimentary pharmacology & therapeutics 20030915
A new furoxan NO-donor rabeprazole derivative and related compounds. Chembiochem : a European journal of chemical biology 20030905
Different effect of antiulcer agents on rat cysteamine-induced duodenal ulcer after sialoadenectomy, but not gastrectomy. European journal of pharmacology 20030905
Comparison of the effect on intragastric pH of a single dose of omeprazole or rabeprazole: which is suitable for on-demand therapy? Journal of gastroenterology and hepatology 20030901
Post-cholecystectomy alkaline reactive gastritis: a randomized trial comparing sucralfate versus rabeprazole or no treatment. European journal of gastroenterology & hepatology 20030901
Minimal surgery for treatment of GERD. The Medical letter on drugs and therapeutics 20030901
Formulation study for lansoprazole fast-disintegrating tablet. II. Effect of triethyl citrate on the quality of the products. Chemical & pharmaceutical bulletin 20030901
Step-down from multiple- to single-dose proton pump inhibitors (PPIs): a prospective study of patients with heartburn or acid regurgitation completely relieved with PPIs. The American journal of gastroenterology 20030901
Absence of symptomatic benefit of lansoprazole, clarithromycin, and amoxicillin triple therapy in eradication of Helicobacter pylori positive, functional (nonulcer) dyspepsia. The American journal of gastroenterology 20030901
Current consensus on the diagnosis and treatment of H. pylori-associated gastroduodenal disease. The Keio journal of medicine 20030901
A randomized trial comparing seven-day ranitidine bismuth citrate and clarithromycin dual therapy to seven-day omeprazole, clarithromycin and amoxicillin triple therapy for the eradication of Helicobacter pylori. Canadian journal of gastroenterology = Journal canadien de gastroenterologie 20030901
On-demand therapy for Los Angeles grade A and B reflux esophagitis: esomeprazole versus omeprazole. Journal of the Formosan Medical Association = Taiwan yi zhi 20030901
[Treatment of reflux disease. An international consensus conference put things in its place]. Revue medicale de la Suisse romande 20030901
The effect of endoscopic therapy in patients receiving omeprazole for bleeding ulcers with nonbleeding visible vessels or adherent clots: a randomized comparison. Annals of internal medicine 20030819
Treatment of patients at high risk for recurrent bleeding from a peptic ulcer. Annals of internal medicine 20030819
Summaries for patients. Combination treatment for peptic ulcers at high risk for recurrent bleeding. Annals of internal medicine 20030819
Medical management of patients with esophageal or supraesophageal gastroesophageal reflux disease. The American journal of medicine 20030818
First-order UV-derivative spectrophotometry in the analysis of omeprazole and pantoprazole sodium salt and corresponding impurities. Journal of pharmaceutical and biomedical analysis 20030808
Over-the-counter omeprazole (prilosec OTC). The Medical letter on drugs and therapeutics 20030804
The impact of gastroesophageal reflux disease on quality of life. Surgical endoscopy 20030801
Pantoprazole rapidly improves health-related quality of life in patients with heartburn: a prospective, randomized, double blind comparative study with nizatidine. Journal of clinical gastroenterology 20030801
Photodynamic therapy for Barrett's esophagus with dysplasia and/or early stage carcinoma: long-term results. Gastrointestinal endoscopy 20030801
The effect of ethinyloestradiol and levonorgestrel on the CYP2C19-mediated metabolism of omeprazole in healthy female subjects. British journal of clinical pharmacology 20030801
A screening study on the liability of eight different female sex steroids to inhibit CYP2C9, 2C19 and 3A4 activities in human liver microsomes. Pharmacology & toxicology 20030801
Sodium pentobarbital anesthesia transiently enhances the severity of infection following intragastric, but not intravenous, inoculation of Listeria monocytogenes in mice. Microbial pathogenesis 20030801
Odds of moderate or severe gastric ulceration in racehorses receiving antiulcer medications. Journal of the American Veterinary Medical Association 20030801
Formulation study for lansoprazole fast-disintegrating tablet. I. Effect of compression on dissolution behavior. Chemical & pharmaceutical bulletin 20030801
Gastric juice, gastric tissue and blood antibiotic concentrations following omeprazole, amoxicillin and clarithromycin triple therapy. Helicobacter 20030801
Salvage therapy after two or more prior Helicobacter pylori treatment failures: the super salvage regimen. Helicobacter 20030801
A prospective, randomized study of quadruple therapy and high-dose dual therapy for treatment of Helicobacter pylori resistant to both metronidazole and clarithromycin. Helicobacter 20030801
Omeprazole disposition in children following single-dose administration. Journal of clinical pharmacology 20030801
Double-blind placebo-controlled trial of omeprazole in irritable infants with gastroesophageal reflux. The Journal of pediatrics 20030801
The evaluation and treatment of gastrointestinal disease in children with cystinosis receiving cysteamine. The Journal of pediatrics 20030801
[A prospective study on rabeprazole-based triple therapy for Helicobacter pylori eradication in patients with peptic ulcer]. The Korean journal of gastroenterology = Taehan Sohwagi Hakhoe chi 20030801
Childhood Helicobacter pylori infection, clinical presentations, endoscopic, histologic features and results of treatment. Journal of the Medical Association of Thailand = Chotmaihet thangphaet 20030801
[References for reflux therapy. Preventing nocturnal acid recurrence]. MMW Fortschritte der Medizin 20030724
Density of Helicobacter pylori may affect the efficacy of eradication therapy and ulcer healing in patients with active duodenal ulcers. World journal of gastroenterology 20030715
Economic analysis of celecoxib versus diclofenac plus omeprazole for the treatment of arthritis in patients at risk of ulcer disease. Alimentary pharmacology & therapeutics 20030715
The long-term effect of Helicobacter pylori eradication therapy on symptoms in dyspeptic patients with fundic atrophic gastritis. Alimentary pharmacology & therapeutics 20030715
[Pantoprazole-induced hepatitis]. Deutsche medizinische Wochenschrift (1946) 20030704
Evidence-based analysis: postoperative gastric bleeding: etiology and prevention. Surgical oncology 20030701
Effect of different doses of furazolidone with amoxicillin and omeprazole on eradication of Helicobacter pylori. Journal of gastroenterology and hepatology 20030701
Rabeprazole in a one-week eradication therapy of Helicobacter pylori: comparison of different dosages. Journal of gastroenterology and hepatology 20030701
Rabeprazole treatment attenuated Helicobacter pylori-associated gastric mucosal lesion formation in Mongolian gerbils. Journal of gastroenterology and hepatology 20030701
Mortality study of 18 000 patients treated with omeprazole. Gut 20030701
Histopathology of the gastric oxyntic mucosa in two different patient groups during long-term treatment with omeprazole. European journal of gastroenterology & hepatology 20030701
Determination of pantoprazole by adsorptive stripping voltammetry at carbon paste electrode. Farmaco (Societa chimica italiana : 1989) 20030701
Effects of inhibition gastric acid secretion on arterial acid-base status during digestion in the toad Bufo marinus. Comparative biochemistry and physiology. Part A, Molecular & integrative physiology 20030701
Helicobacter pylori eradication and peptic ulcer healing: the impact of deleting the proton pump inhibitor and using a once-daily treatment. Alimentary pharmacology & therapeutics 20030701
High-dose rabeprazole-amoxicillin versus rabeprazole-amoxicillin-metronidazole as second-line treatment after failure of the Japanese standard regimen for Helicobacter pylori infection. Alimentary pharmacology & therapeutics 20030701
Proton-pump inhibitor therapy for acetylsalicylic acid associated upper gastrointestinal symptoms: a randomized placebo-controlled trial. Alimentary pharmacology & therapeutics 20030701
Is it possible to predict treatment response to a proton pump inhibitor in functional dyspepsia? Alimentary pharmacology & therapeutics 20030701
Heartburn severity can predict pathologic oesophageal reflux in gastro-oesophageal reflux disease patients treated with a proton-pump inhibitor. Alimentary pharmacology & therapeutics 20030701
Low frequency of upper gastrointestinal complications in a cohort of high-risk patients taking low-dose aspirin or NSAIDS and omeprazole. Scandinavian journal of gastroenterology 20030701
Adverse reactions to pantoprazole. Scandinavian journal of gastroenterology 20030701
Efficacy of a paste formulation of omeprazole for the treatment of naturally occurring gastric ulcers in training standardbred racehorses in Canada. The Canadian veterinary journal = La revue veterinaire canadienne 20030701
Oral bioavailability of pantoprazole suspended in sodium bicarbonate solution. American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists 20030701
Assessment of potential digoxin-rabeprazole interaction after formulary conversion of proton-pump inhibitors. American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists 20030701
[Helicobacter pylori eradication based upon a drug sensitivity test effectively increased platelet count in a patient with refractory idiopathic thrombocytopenic purpura]. [Rinsho ketsueki] The Japanese journal of clinical hematology 20030701
Low dose, one-week triple therapy (lanzoprazole, amoxycillin, clarithromycin) for eradication of Helicobacter pylori infection. Journal of the Medical Association of Thailand = Chotmaihet thangphaet 20030701
Pretreatment antimicrobial susceptibility testing is cost saving in the eradication of Helicobacter pylori. Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association 20030701
Prilosec, nexium and stereoisomers. The Medical letter on drugs and therapeutics 20030623
[All proton pump inhibitors are equally efficacious in standard dosages]. Lakartidningen 20030619
Rat stomach ECL cells: mode of activation of histidine decarboxylase. Regulatory peptides 20030615
Antralization at the edge of proximal gastric ulcers: does Helicobacter pylori infection play a role? World journal of gastroenterology 20030615
Acid inhibition on the first day of dosing: comparison of four proton pump inhibitors. Alimentary pharmacology & therapeutics 20030615
Long-term observation of reflux oesophagitis developing after Helicobacter pylori eradication therapy. Alimentary pharmacology & therapeutics 20030615
The efficacy of omeprazole twice daily with supplemental H2 blockade at bedtime in the suppression of nocturnal oesophageal and gastric acidity. Alimentary pharmacology & therapeutics 20030615
Celecoxib versus diclofenac and omeprazole to prevent recurrent ulcer bleeding. The New England journal of medicine 20030612
Celecoxib versus diclofenac and omeprazole to prevent recurrent ulcer bleeding. The New England journal of medicine 20030612
Bioactivation of cyclophosphamide: the role of polymorphic CYP2C enzymes. European journal of clinical pharmacology 20030601
CD63 expression by flow cytometry in the in vitro diagnosis of allergy to omeprazole. Allergy 20030601
Eradication of dysplastic Barrett's oesophagus using photodynamic therapy: long-term follow-up. Endoscopy 20030601
Review article: test and treat or treat and test in reflux disease? Alimentary pharmacology & therapeutics 20030601
One-week triple therapy with esomeprazole, clarithromycin and metronidazole provides effective eradication of Helicobacter pylori infection. Alimentary pharmacology & therapeutics 20030601
Short- and long-term therapy for reflux oesophagitis in the elderly: a multi-centre, placebo-controlled study with pantoprazole. Alimentary pharmacology & therapeutics 20030601
Time-dependent amplified pharmacokinetic and pharmacodynamic responses of rabeprazole in cytochrome P450 2C19 poor metabolizers. Pharmacotherapy 20030601
Effect of short-term treatment with regular or high doses of omeprazole on the detection of Helicobacter pylori in bleeding peptic ulcer patients. Scandinavian journal of gastroenterology 20030601
The effects of mebendazole on P4501A activity in rat hepatocytes and HepG2 cells. Comparison with tiabendazole and omeprazole. The Journal of pharmacy and pharmacology 20030601
How can the current strategies for Helicobacter pylori eradication therapy be improved? Canadian journal of gastroenterology = Journal canadien de gastroenterologie 20030601
Comparison of four-day and seven-day pantoprazole-based quadruple therapy as a routine treatment for Helicobacter pylori infection. The Netherlands journal of medicine 20030601
Empirical prescribing for dyspepsia: randomised controlled trial of test and treat versus omeprazole treatment. BMJ (Clinical research ed.) 20030524
Effects of antireflux treatment on bronchial hyper-responsiveness and lung function in asthmatic patients with gastroesophageal reflux disease. World journal of gastroenterology 20030515
Type 2 diabetes mellitus affects eradication rate of Helicobacter pylori. World journal of gastroenterology 20030515
Meta-analysis: proton pump inhibitor or H2-receptor antagonist for Helicobacter pylori eradication. Alimentary pharmacology & therapeutics 20030515
The selection of triple therapy for Helicobacter pylori eradication in chronic renal insufficiency. Alimentary pharmacology & therapeutics 20030515
[Proton pump inhibitors and chronic requirement]. Lakartidningen 20030515
Structural and functional characterization of gastric mucosa and central nervous system in histamine H2 receptor-null mice. European journal of pharmacology 20030502
Diarrhea associated with lansoprazole. Journal of gastroenterology and hepatology 20030501
Lansoprazole overutilization: methods for step-down therapy. The American journal of managed care 20030501
Globus sensation and gastroesophageal reflux. European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery 20030501
Rabeprazole is superior to omeprazole for the inhibition of peptone meal-stimulated gastric acid secretion in Helicobacter pylori-negative subjects. Alimentary pharmacology & therapeutics 20030501
Helicobacter pylori eradication and gastric ulcer healing--comparison of three pantoprazole-based triple therapies. Alimentary pharmacology & therapeutics 20030501
Validation of the GSFQ, a self-administered symptom frequency questionnaire for patients with gastroesophageal reflux disease. Canadian journal of gastroenterology = Journal canadien de gastroenterologie 20030501
Nodular gastritis in adults is caused by Helicobacter pylori infection. Digestive diseases and sciences 20030501
A proton-pump inhibitor, rabeprazole, improves ventilatory function in patients with asthma associated with gastroesophageal reflux. Scandinavian journal of gastroenterology 20030501
Effect of pantoprazole on the course of reflux-associated laryngitis: a placebo-controlled double-blind crossover study. Scandinavian journal of gastroenterology 20030501
Do Japanese and Swedish peptic ulcer patients respond differently to Helicobacter pylori eradication therapies and what are their histological features? Scandinavian journal of gastroenterology 20030501
The comparison of an empiric proton pump inhibitor trial vs 24-hour double-probe Ph monitoring in laryngopharyngeal reflux. The Journal of laryngology and otology 20030501
Omeprazole reduces clozapine plasma concentrations. A case report. Pharmacopsychiatry 20030501
Studies regarding the mechanism of false negative urea breath tests with proton pump inhibitors. The American journal of gastroenterology 20030501
The clinical role of cytochrome p450 genotypes in Helicobacter pylori management. The American journal of gastroenterology 20030501
Acute hyperkalemia associated with intravenous omeprazole therapy. The American journal of gastroenterology 20030501
Differential drug-induced mRNA expression of human CYP3A4 compared to CYP3A5, CYP3A7 and CYP3A43. European journal of pharmacology 20030411
[When sour does not make merry at all . Fast relief for patients with reflux]. MMW Fortschritte der Medizin 20030410
[A new interesting study on coxib]. Lakartidningen 20030403
Omeprazole plus azithromycin and either amoxicillin or tinidazole for eradication of Helicobacter pylori infection. Journal of clinical gastroenterology 20030401
Clinical and pathological implications of IgG antibody responses to Helicobacter pylori and its virulence factors in non-ulcer dyspepsia. Alimentary pharmacology & therapeutics 20030401
Meal-stimulated gastric acid secretion and integrated gastric acidity in gastro-oesophageal reflux disease. Alimentary pharmacology & therapeutics 20030401
Determination of the reduction in gastric acidity necessary to prevent pathological oesophageal reflux in patients with gastro-oesophageal reflux disease treated with a proton pump inhibitor. Alimentary pharmacology & therapeutics 20030401
The effects of lansoprazole on erosive reflux oesophagitis are influenced by CYP2C19 polymorphism. Alimentary pharmacology & therapeutics 20030401
Esophageal Crohn disease in children: a clinical spectrum. Journal of pediatric gastroenterology and nutrition 20030401
Treatment of Helicobacter pylori gastritis improves dyspeptic symptoms in Turkish children. Journal of pediatric gastroenterology and nutrition 20030401
Recent use of proton pump inhibitor-based triple therapies for the eradication of H pylori: a broad data review. Helicobacter 20030401
Lafutidine, a novel histamine H2-receptor antagonist, vs lansoprazole in combination with amoxicillin and clarithromycin for eradication of Helicobacter pylori. Helicobacter 20030401
Sequence diversity and functional characterization of the 5'-regulatory region of human CYP2C19. Pharmacogenetics 20030401
[Inmediate antphylactic shock after the administration of intravenous omeprazol]. Revista clinica espanola 20030401
Anodic voltammetric assay of lansoprazole and omeprazole on a carbon paste electrode. Journal of pharmaceutical and biomedical analysis 20030401
A summary of Food and Drug Administration-reported adverse events and drug interactions occurring during therapy with omeprazole, lansoprazole and pantoprazole. Alimentary pharmacology & therapeutics 20030401
Reflux symptoms in general practice: diagnostic evaluation of the Carlsson-Dent gastro-oesophageal reflux disease questionnaire. Alimentary pharmacology & therapeutics 20030401
Safety and efficacy of 7-day rabeprazole- and omeprazole-based triple therapy regimens for the eradication of Helicobacter pylori in patients with documented peptic ulcer disease. Alimentary pharmacology & therapeutics 20030401
Treatment of Waldenstrom's macroglobulinemia with clarithromycin, low-dose thalidomide, and dexamethasone. Seminars in oncology 20030401
[A case of gastric fundic polyps during long-term treatment of reflux esophagitis with omeprazole]. Nihon Shokakibyo Gakkai zasshi = The Japanese journal of gastro-enterology 20030401
Smoking and polymorphisms of fucosyltransferase gene Le affect success of H. pylori eradication with lansoprazole, amoxicillin, and clarithromycin. Epidemiology and infection 20030401
Nonoperative treatment of laryngeal granuloma. Ear, nose, & throat journal 20030401
One-week esomeprazole treatment: an effective confirmatory test in patients with suspected gastroesophageal reflux disease. Scandinavian journal of gastroenterology 20030401
Helicobacter pylori stimulates inducible nitric oxide synthase in diverse topographical patterns in various gastroduodenal disorders. Digestive diseases and sciences 20030401
Reductions in symptom distress reported by patients with moderately severe, nonerosive gastroesophageal reflux disease treated with rabeprazole. Digestive diseases and sciences 20030401
A third-line levofloxacin-based rescue therapy for Helicobacter pylori eradication. Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver 20030401
Gastric myoelectrical activity in patients with recurrent gastric or duodenal ulcers. Journal of smooth muscle research = Nihon Heikatsukin Gakkai kikanshi 20030401
A novel antioxidant and antiapoptotic role of omeprazole to block gastric ulcer through scavenging of hydroxyl radical. The Journal of biological chemistry 20030328
[Pantoprazole-induced hepatitis]. Deutsche medizinische Wochenschrift (1946) 20030321
Systematic review: Rabeprazole-based therapies in Helicobacter pylori eradication. Alimentary pharmacology & therapeutics 20030315
Eradication of Helicobacter pylori increases nocturnal intragastric acidity during dosing with rabeprazole, omeprazole, lansoprazole and placebo. Alimentary pharmacology & therapeutics 20030315
Update on prescribing information for pantoprazole. American family physician 20030315
Helicobacter pylori hiccup. Internal medicine journal 20030301
Different contribution of CYP2C19 in the in vitro metabolism of three proton pump inhibitors. Biological & pharmaceutical bulletin 20030301
Impact of upper endoscopy on satisfaction in patients with previously uninvestigated dyspepsia. Gastrointestinal endoscopy 20030301
Extragastric mucosa-associated lymphoid tissue lymphoma showing the regression by Helicobacter pylori eradication therapy. British journal of haematology 20030301
Long-term results of a randomized prospective study comparing medical and surgical treatment of Barrett's esophagus. Annals of surgery 20030301
Chronic cough and gastroesophageal reflux disease: experience with specific therapy for diagnosis and treatment. Chest 20030301
mRNA and protein expression of dog liver cytochromes P450 in relation to the metabolism of human CYP2C substrates. Xenobiotica; the fate of foreign compounds in biological systems 20030301
Intravenous proton-pump inhibitors versus H2-antagonists for treatment of GI bleeding. The Annals of pharmacotherapy 20030301
The prophylactic use of a proton pump inhibitor before food and alcohol. Alimentary pharmacology & therapeutics 20030301
High eradication rates of Helicobacter pylori with a new sequential treatment. Alimentary pharmacology & therapeutics 20030301
Rabeprazole-based therapy in the management of symptomatic gastroesophageal reflux disease. The American journal of gastroenterology 20030301
Nocturnal acid breakthrough: clinical significance and correlation with esophageal acid exposure. The American journal of gastroenterology 20030301
Bismuth-based quadruple therapy using a single capsule of bismuth biskalcitrate, metronidazole, and tetracycline given with omeprazole versus omeprazole, amoxicillin, and clarithromycin for eradication of Helicobacter pylori in duodenal ulcer patients: a prospective, randomized, multicenter, North American trial. The American journal of gastroenterology 20030301
Antral G cells in rats during dosing with a PPAR alpha agonist: a morphometric and immunocytochemical study. Medical electron microscopy : official journal of the Clinical Electron Microscopy Society of Japan 20030301
Triple eradication therapy counteracts functional impairment associated with Helicobacter pylori infection in Mongolian gerbils. Journal of physiology and pharmacology : an official journal of the Polish Physiological Society 20030301
Complications of medical management of dental erosion. Dental update 20030301
Synthesis or rupture: duration of acid inhibition by proton pump inhibitors. Drugs of today (Barcelona, Spain : 1998) 20030301
Seven-day proton pump inhibitor, amoxicillin and clarithromycin triple therapy. factors that influence Helicobacter pylori eradications success. Revista espanola de enfermedades digestivas : organo oficial de la Sociedad Espanola de Patologia Digestiva 20030301
Oesophageal acid-peptic strictures in the histamine H2 receptor antagonist and proton pump inhibitor era. Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver 20030301
Acid exposure and altered acid clearance in GERD patients treated for Helicobacter pylori infection. Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver 20030301
Helicobacter pylori infection in patients with liver cirrhosis: facts and fictions. Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver 20030301
Spectrophotometric and chromatographic determination of rabeprazole in presence of its degradation products. Journal of pharmaceutical and biomedical analysis 20030226
Omeprazole-induced acute interstitial nephritis. The New Zealand medical journal 20030221
Review article: Esomeprazole--enhanced bio-availability, specificity for the proton pump and inhibition of acid secretion. Alimentary pharmacology & therapeutics 20030215
Randomized controlled study of rabeprazole, levofloxacin and rifabutin triple therapy vs. quadruple therapy as second-line treatment for Helicobacter pylori infection. Alimentary pharmacology & therapeutics 20030215
[Generous treatment with gastric acid blockers. For patients with gastric reflux the proton pump inhibitor power is cost-effective]. MMW Fortschritte der Medizin 20030206
Influence of omeprazole on multidrug resistance protein 3 expression in human liver. The Journal of pharmacology and experimental therapeutics 20030201
Long-term follow up of gastric low-grade mucosa-associated lymphoid tissue lymphoma by endosonography emphasizing the application of a miniature ultrasound probe. Journal of gastroenterology and hepatology 20030201
Influence of lansoprazole, famotidine, roxatidine and rebamipide administration on the urea breath test for the diagnosis of Helicobacter pylori infection. Journal of gastroenterology and hepatology 20030201
Anti-Helicobacter pylori therapy in India: differences in eradication efficiency associated with particular alleles of vacuolating cytotoxin (vacA) gene. Journal of gastroenterology and hepatology 20030201
Efficacy and safety of oral pantoprazole 20 mg given once daily for reflux esophagitis in children. Journal of pediatric gastroenterology and nutrition 20030201
Cost-effectiveness analysis of high-dose omeprazole infusion as adjuvant therapy to endoscopic treatment of bleeding peptic ulcer. Gastrointestinal endoscopy 20030201
An aspirin a day keeps the cardiologist away (but what about the gastroenterologist?). Gastroenterology 20030201
Reflux disease and Barrett's esophagus. Endoscopy 20030201
Review of esomeprazole in the treatment of acid disorders. Expert opinion on pharmacotherapy 20030201
A randomized, double-blind trial of the efficacy and safety of 10 or 20 mg rabeprazole compared with 20 mg omeprazole in the maintenance of gastro-oesophageal reflux disease over 5 years. Alimentary pharmacology & therapeutics 20030201
Comparative pharmacokinetics and safety of lansoprazole oral capsules and orally disintegrating tablets in healthy subjects. Alimentary pharmacology & therapeutics 20030201
Symptomatic response to lansoprazole predicts abnormal acid reflux in endoscopy-negative patients with non-cardiac chest pain. Alimentary pharmacology & therapeutics 20030201
Pharmacokinetics of budesonide controlled-release capsules when taken with omeprazole. Alimentary pharmacology & therapeutics 20030201
Monotherapy with mastic does not eradicate Helicobacter pylori infection from mice. The Journal of antimicrobial chemotherapy 20030201
Antimicrobial activity of esomeprazole versus omeprazole against Helicobacter pylori. The Journal of antimicrobial chemotherapy 20030201
A randomized comparative study to determine the effect of omeprazole on the peak serum concentration of itraconazole oral solution. The Journal of antimicrobial chemotherapy 20030201
A proton-pump inhibitor expedition: the case histories of omeprazole and esomeprazole. Nature reviews. Drug discovery 20030201
Maintenance oral pantoprazole therapy is effective for patients with Zollinger-Ellison syndrome and idiopathic hypersecretion. The American journal of gastroenterology 20030201
Severe colchicine-macrolide interactions. Prescrire international 20030201
Acid inhibitory potency of twice a day omeprazole is not affected by eradication of Helicobacter pylori in healthy volunteers. Helicobacter 20030201
Review article: esomeprazole--the first proton pump inhibitor to be developed as an isomer. Alimentary pharmacology & therapeutics 20030201
Review article: pharmacology of esomeprazole and comparisons with omeprazole. Alimentary pharmacology & therapeutics 20030201
Review article: initial therapy of reflux disease with esomeprazole. Alimentary pharmacology & therapeutics 20030201
Inhibitory effect of troleandomycin on the metabolism of omeprazole is CYP2C19 genotype-dependent. Xenobiotica; the fate of foreign compounds in biological systems 20030201
Long-term follow-up of gastric metaplasia after eradication of Helicobacter pylori. The journal of medical investigation : JMI 20030201
Impact of long-term ranitidine and pantoprazole on accuracy of [13C]urea breath test. Digestive diseases and sciences 20030201
Significant enhancement of gastric mucin content after rabeprazole administration: its potential clinical significance in acid-related disorders. Digestive diseases and sciences 20030201
[Guidelines in the management of Helicobacter pylori infection in Japan]. Nihon rinsho. Japanese journal of clinical medicine 20030201
A pharmacoeconomic comparison of the efficacy and costs of pantoprazole and omeprazole for the treatment of peptic ulcer or gastroesophageal reflux disease in The Netherlands. Clinical therapeutics 20030201
Validation of the 13c-urea breath test for the initial diagnosis of helicobacter pylori infection and to confirm eradication after treatment. Revista espanola de enfermedades digestivas : organo oficial de la Sociedad Espanola de Patologia Digestiva 20030201
Pharyngolaryngeal reflux in outpatient clinical practice: personal experience. Acta otorhinolaryngologica Italica : organo ufficiale della Societa italiana di otorinolaringologia e chirurgia cervico-facciale 20030201
A retrospective study on efficacy of proton-pump inhibitor-based triple therapy for eradication of Helicobacter pylori in patients with chronic renal failure. Singapore medical journal 20030201
Lansoprazole quantification in human plasma by liquid chromatography-electrospray tandem mass spectrometry. Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20030115
Stereospecific analysis of omeprazole in human plasma as a probe for CYP2C19 phenotype. Journal of pharmaceutical and biomedical analysis 20030115
Ablative mucosectomy is the procedure of choice to prevent Barrett's cancer. Gut 20030101
Treatment of Helicobacter pylori in functional dyspepsia resistant to conventional management: a double blind randomised trial with a six month follow up. Gut 20030101
Pantoprazole: an update of its pharmacological properties and therapeutic use in the management of acid-related disorders. Drugs 20030101
Severe esophagitis healed in less than a week with intravenous pantoprazole. Journal of clinical gastroenterology 20030101
Efficacy of triple therapy comprising rabeprazole, amoxicillin and metronidazole for second-line Helicobacter pylori eradication in Japan, and the influence of metronidazole resistance. Alimentary pharmacology & therapeutics 20030101
Once-daily, low-cost, highly effective Helicobacter pylori treatment to family members of gastric cancer patients. Alimentary pharmacology & therapeutics 20030101
Pantoprazole maintenance therapy prevents relapse of erosive oesophagitis. Alimentary pharmacology & therapeutics 20030101
Dissolution test for liquid formulations of omeprazole enteric-coated products. The Annals of pharmacotherapy 20030101
Safety and pharmacokinetics of oral lansoprazole in preadolescent rats exposed from weaning through sexual maturity. Reproductive toxicology (Elmsford, N.Y.) 20030101
What's new: proton pump inhibitors and pediatrics. Pediatrics in review 20030101
Ulcers and nonvariceal bleeding. Endoscopy 20030101
Lansoprazole: in the management of gastroesophageal reflux disease in children. Paediatric drugs 20030101
Gastric heterotopia in the proximal esophagus complicated by stricture. Gastrointestinal endoscopy 20030101
Effect of proton pump inhibitors on the continuous real time (13)C-urea breath test. The American journal of gastroenterology 20030101
A 59-year-old woman with gastroesophageal reflux disease and Barrett esophagus. JAMA 20030101
The pharmacovigilance of pantoprazole: the results of postmarketing surveillance on 11 541 patients in England. Drug safety 20030101
Early events in proton pump inhibitor-associated exacerbation of corpus gastritis. Alimentary pharmacology & therapeutics 20030101
Effect of oral omeprazole in reducing re-bleeding in bleeding peptic ulcers: a prospective, double-blind, randomized, clinical trial. Alimentary pharmacology & therapeutics 20030101
Effective intra-oesophageal acid suppression in patients with gastro-oesophageal reflux disease: lansoprazole vs. pantoprazole. Alimentary pharmacology & therapeutics 20030101
Effect of different proton pump inhibitors, differences in CYP2C19 genotype and antibiotic resistance on the eradication rate of Helicobacter pylori infection by a 1-week regimen of proton pump inhibitor, amoxicillin and clarithromycin. Alimentary pharmacology & therapeutics 20030101
Impact of clarithromycin resistance and CYP2C19 genetic polymorphism on treatment efficacy of Helicobacter pylori infection with lansoprazole- or rabeprazole-based triple therapy in Japan. European journal of gastroenterology & hepatology 20030101
Diagnostic test with omeprazole in patients with posterior laryngitis. Medicina (Kaunas, Lithuania) 20030101
[New triple therapy for Helicobacter pylori infection in Japan]. Nihon rinsho. Japanese journal of clinical medicine 20030101
[Tailor-made medicine in Helicobacter pylori eradication therapy]. Nihon rinsho. Japanese journal of clinical medicine 20030101
Cell kinetics of the oesophageal epithelium in the rat: effects of hypergastrinaemia. Scandinavian journal of gastroenterology 20030101
Prevention and treatment of stress ulcers in critically ill patients. Seminars in gastrointestinal disease 20030101
FDA approves generic drug for persistent heartburn. FDA consumer 20030101
Gene expression of ornithine decarboxylase, cyclooxygenase-2, and gastrin in atrophic gastric mucosa infected with Helicobacter pylori before and after eradication therapy. Digestive diseases and sciences 20030101
Effects of rabeprazole sodium on gastric emptying, electrogastrography, and fullness. Digestive diseases and sciences 20030101
[The diverse etiology of hiccups]. Harefuah 20030101
[Clinical efficacy of combined anti-Helicobacter treatment of patients with duodenal ulcer]. Klinicheskaia meditsina 20030101
[The state of immune system and effects of current therapy and immunomodulators]. Klinicheskaia meditsina 20030101
[Therapeutic tactics for treating patient with duodenal ulcer complicated my hemorrhage]. Eksperimental'naia i klinicheskaia gastroenterologiia = Experimental & clinical gastroenterology 20030101
Utility and limitations of a method for detecting Helicobacter pylori-specific antigens in the stool. Journal of gastroenterology 20030101
Acceleration of gastric ulcer healing by omeprazole in portal hypertensive rats. Is its action mediated by gastrin release and the stimulation of epithelial proliferation? European surgical research. Europaische chirurgische Forschung. Recherches chirurgicales europeennes 20030101
The effect of commonly used drugs on angiogenesis. Anticancer research 20030101
Efficacy of omeprazole for the prevention of exercise-induced gastritis in racing Alaskan sled dogs. Journal of veterinary internal medicine 20030101
[Esomeprazole in treating duodenal ulcer in various modes of anti-Helicobacter therapy]. Terapevticheskii arkhiv 20030101
Triple therapy for 7 days vs. triple therapy for 7 days plus omeprazole for 21 days in treatment of active duodenal ulcer with Helicobacter pylori infection. A double blind placebo controlled trial. Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver 20030101
Lansoprazole fast disintegrating tablet: a new formulation for an established proton pump inhibitor. Digestion 20030101
Comparable efficacy of pantoprazole and omeprazole in patients with moderate to severe reflux esophagitis. Results of a multinational study. Digestion 20030101
Follow-up survey of a large-scale multicenter, double-blind study of triple therapy with lansoprazole, amoxicillin, and clarithromycin for eradication of Helicobacter pylori in Japanese peptic ulcer patients. Journal of gastroenterology 20030101
Isolated granulomatous gastritis successfully treated by Helicobacter pylori eradication: a possible association between granulomatous gastritis and Helicobacter pylori. Journal of gastroenterology 20030101
Eradication therapy of Helicobacter pylori directly induces apoptosis in inflammation-related immunocytes in the gastric mucosa--possible mechanism for cure of peptic ulcer disease and MALT lymphoma with a low-grade malignancy. Hepato-gastroenterology 20030101
Determination of omeprazole in bulk and injectable preparations by liquid chromatography. Journal of AOAC International 20030101
The impact of treatment for gastro-oesophageal reflux disease on health-related quality of life: a literature review. PharmacoEconomics 20030101
Helicobacter pylori eradication therapy for the remnant stomach after gastrectomy. Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association 20030101
[Medico-economic efficacy of eradication schemes in helicobacter infections in patients with duodenal ulcers]. Eksperimental'naia i klinicheskaia gastroenterologiia = Experimental & clinical gastroenterology 20030101
[Effectiveness of eradication anti-helicobacter therapy in patients with duodenal ulcer in different drug dosage regimens]. Klinicheskaia meditsina 20030101
Compartment theory in Helicobacter pylori-associated gastric carcinogenesis. Anticancer research 20030101
[Pharmacotherapy in complex treatment of ulcerous stenosis]. Vestnik khirurgii imeni I. I. Grekova 20030101
Quality of life and cost-effectiveness of combined therapy for reflux esophagitis. Journal of Zhejiang University. Science 20030101
Safety and efficacy of rabeprazole in gastroesophageal reflux disease: report of a multicenter study. Indian journal of gastroenterology : official journal of the Indian Society of Gastroenterology 20030101
Influence of Helicobacter pylori infection and omeprazole treatment on gastric regional CO2. Digestion 20030101
[Prescription, dispensation and sustitution of prescription forms of omeprazole]. Gaceta sanitaria 20030101
Impact of cotherapy with some proton pump inhibitors on medical claims among HMO patients already using other common drugs also cleared by cytochrome P450. American journal of therapeutics 20030101
Switching omeprazole in Sweden and the United States. American journal of therapeutics 20030101
['Visual assessment' does not replace quality control with instrumental methods]. Wiener medizinische Wochenschrift (1946) 20030101
Relaxant effect of omeprazole and lansoprazole in guinea pig gallbladder muscle strips in vitro. Journal of gastroenterology 20030101
[Efficacy of antihelicobacter therapy in NSAID-induced gastropathies]. Klinicheskaia meditsina 20030101
Improving health-related quality of life in gastro-oesophageal reflux disease. Drugs 20030101
[Omeprazole, amoxicillin and clarithromycin in the treatment of helicobacterpylori, in 7 and 10-day regimens]. Revista de gastroenterologia del Peru : organo oficial de la Sociedad de Gastroenterologia del Peru 20030101
The impact of Helicobacter pylori resistance on the efficacy of a short course pantoprazole based triple therapy. Arquivos de gastroenterologia 20030101
[Use of omeprazole and esomeprazole in patients suffering from bronchial asthma with associated gastroesophageal reflux disease]. Eksperimental'naia i klinicheskaia gastroenterologiia = Experimental & clinical gastroenterology 20030101
[Combination therapy of chronic pancreatitis (double-blind, placebo-controlled, pilot studies)]. Eksperimental'naia i klinicheskaia gastroenterologiia = Experimental & clinical gastroenterology 20030101
Nocturnal gastric acid breakthrough during the administration of rabeprazole and ranitidine in Helicobacter pylori-negative subjects: effects of different regimens. Journal of gastroenterology 20030101
Simple closure of chronic duodenal ulcer perforation in the era of Helicobacter pylori: an old procedure, today's solution. Hepato-gastroenterology 20030101
One-week low-dose triple therapy without anti-acid treatment has sufficient efficacy on Helicobacter pylori eradication and ulcer healing. Hepato-gastroenterology 20030101
Improvement in gastric histology following Helicobacter pylori eradication therapy in Japanese peptic ulcer patients. The Journal of international medical research 20030101
[Use of proton pump inhibitors in the treatment of gastroesophageal reflux disease]. Klinicheskaia meditsina 20030101
An overview of proton pump inhibitors. Gastroenterology nursing : the official journal of the Society of Gastroenterology Nurses and Associates 20030101
Influence of anti-ulcer drugs used in Japan on the result of (13)C-urea breath test for the diagnosis of Helicobacter pylori infection. Journal of gastroenterology 20030101
[Evaluation of the efficacy of pariet in patients with gastroesophageal reflux disease with thoracic pain not connected with cardiac disease]. Eksperimental'naia i klinicheskaia gastroenterologiia = Experimental & clinical gastroenterology 20030101
[Therapeutic effect of gastrozolum in stomach ulcers]. Eksperimental'naia i klinicheskaia gastroenterologiia = Experimental & clinical gastroenterology 20030101
[Comparative clinical and economic efficiency of new generation proton pump inhibitors in the treatment of gastroesophageal reflux]. Eksperimental'naia i klinicheskaia gastroenterologiia = Experimental & clinical gastroenterology 20030101
[Therapy with cytokines and thymic factors in a complicated case of common variable immunodeficiency]. Revista alergia Mexico (Tecamachalco, Puebla, Mexico : 1993) 20030101
Health-related quality of life improves with treatment-related GERD symptom resolution after adjusting for baseline severity. Health and quality of life outcomes 20030101
[Antisecretory therapy for prevention of stenoses of bougienage after-burn of esophageal strictures]. Eksperimental'naia i klinicheskaia gastroenterologiia = Experimental & clinical gastroenterology 20030101
[Possible treatment with immune system modulators of patients with pathology of the digestive organs. Informational letter]. Eksperimental'naia i klinicheskaia gastroenterologiia = Experimental & clinical gastroenterology 20030101
Gastroesophageal reflux disease in children: need for long-term medical treatment. Indian journal of gastroenterology : official journal of the Indian Society of Gastroenterology 20030101
[Level of Helicobacter pylori infection of the gastric mucosa in the optimization of a daily dose of antihelicobacter drugs]. Klinicheskaia meditsina 20030101
Alternative dosing for PPI therapy: rationale and options. Reviews in gastroenterological disorders 20030101
Epigastric pain in dyspepsia and reflux disease. Reviews in gastroenterological disorders 20030101
Sleep issues in gastroesophageal reflux disease: beyond simple heartburn control. Reviews in gastroenterological disorders 20030101
The role of proton pump inhibitors in NSAID-associated gastropathy and upper gastrointestinal symptoms. Reviews in gastroenterological disorders 20030101
[Treatment of laryngeal granuloma with anti-extraesophageal reflux medication]. Acta otorrinolaringologica espanola 20030101
Symptomatic and endoscopic outcome of heartburn 3-4.5 years after starting lansoprazole therapy: a prospective study of 142 patients. Journal of gastroenterology 20030101
Proton pump inhibitors in pediatrics: relevant pharmacokinetics and pharmacodynamics. Journal of pediatric gastroenterology and nutrition 20030101
How to eradicate Helicobacter pylori using amoxicillin and omeprazole in the remnant stomach. Hepato-gastroenterology 20030101
Increased risk of rebleeding of peptic ulcer bleeding in patients with comorbid illness receiving omeprazole infusion. Hepato-gastroenterology 20030101
High-dose rabeprazole/amoxicillin therapy as the second-line regimen after failure to eradicate H. pylori by triple therapy with the usual doses of a proton pump inhibitor, clarithromycin and amoxicillin. Hepato-gastroenterology 20030101
Efficacy and tolerability of pantoprazole compared with misoprostol for the prevention of NSAID-related gastrointestinal lesions and symptoms in rheumatic patients. Digestion 20030101
Comparison of H2-receptor antagonist- and proton-pump inhibitor-based triple regimens for the eradication of Helicobacter pylori in Chinese patients with gastritis or peptic ulcer. The Journal of international medical research 20030101
[Results of an open multicenter study of the efficiency of one-week anti-helicobacter therapy using omeprazole, clarithromycin, and amoxicillin in patients with duodenal peptic ulcer]. Terapevticheskii arkhiv 20030101
[Acid-supressing capacity of omeprazole 20 mg tablets vs pantoprazole 20 and 40 mg tablets. A pilot study in volunteers]. Acta gastroenterologica Latinoamericana 20030101
The gastroprotective effect of tannins extracted from duhat (Syzygium cumini Skeels) bark on HCl/ethanol induced gastric mucosal injury in Sprague-Dawley rats. Clinical hemorheology and microcirculation 20030101
[Cost-minimization study on the prescription of intravenous proton pump inhibitors: pantoprazole versus omeprazole]. Farmacia hospitalaria : organo oficial de expresion cientifica de la Sociedad Espanola de Farmacia Hospitalaria 20030101
[Comparative analysis of the effectiveness of two Helicobacter pylori eradication plans based on omeprazole, clarithromycin and amoxicillin in patients with duodenal peptic ulcer: results of a randomized double-blind, controlled study]. Eksperimental'naia i klinicheskaia gastroenterologiia = Experimental & clinical gastroenterology 20030101
[Place and significance of proton pump inhibitors in current treatment of peptic ulcers]. Eksperimental'naia i klinicheskaia gastroenterologiia = Experimental & clinical gastroenterology 20030101
[Clarithromycin--standard component of anti-Helicobacter therapy]. Eksperimental'naia i klinicheskaia gastroenterologiia = Experimental & clinical gastroenterology 20030101
[Secretolytic therapy of acid-dependent diseases of the digestive system from the point of view of a clinician]. Eksperimental'naia i klinicheskaia gastroenterologiia = Experimental & clinical gastroenterology 20030101
[Comparative efficacy of proton pump inhibitors in children]. Eksperimental'naia i klinicheskaia gastroenterologiia = Experimental & clinical gastroenterology 20030101
Not a usual suspect; rabeprazole therapy presenting as a severe neuropsychiatric illness: case report. International journal of psychiatry in medicine 20030101
[Non-erosive gastroesophageal reflux disease. Incidence of clinical forms, characteristics of esophageal exposure to acid and symptomatic correlations]. Revista de gastroenterologia de Mexico 20030101
[Clinical effectiveness of omeprazole, azithromycin and amoxicillin in ulcer healing and eradication of Helicobacter pylori infection]. Medicinski arhiv 20030101
Celecoxib versus diclofenac and omeprazole in reducing the risk of recurrent ulcer bleeding in patients with arthritis. The New England journal of medicine 20021226
NSAIDs, Helicobacter pylori, and Pandora's Box. The New England journal of medicine 20021226
Pharmacogenetics affects dosing, efficacy, and toxicity of cytochrome P450-metabolized drugs. The American journal of medicine 20021215
Efficacy and one year follow up of argon plasma coagulation therapy for ablation of Barrett's oesophagus: factors determining persistence and recurrence of Barrett's epithelium. Gut 20021201
Lansoprazole induces mucosal protection through gastrin receptor-dependent up-regulation of cyclooxygenase-2 in rats. The Journal of pharmacology and experimental therapeutics 20021201
The pharmacology and clinical relevance of proton pump inhibitors. Current gastroenterology reports 20021201
Influence of the urine flow rate on some caffeine metabolite ratios used to assess CYP1A2 activity. Therapeutic drug monitoring 20021201
Comparison of the efficacy of pantoprazole vs. nizatidine in the treatment of erosive oesophagitis: a randomized, active-controlled, double-blind study. Alimentary pharmacology & therapeutics 20021201
Long-term follow-up and factors predictive of recurrence in Barrett's esophagus treated by argon plasma coagulation and acid suppression. Endoscopy 20021201
An update on bimatoprost in glaucoma therapy. Expert opinion on pharmacotherapy 20021201
The effects of nocturnal acid breakthrough on Helicobacter pylori eradication. Helicobacter 20021201
Oxidative stress in gastric mucosa of asymptomatic humans infected with Helicobacter pylori: effect of bacterial eradication. Helicobacter 20021201
Pseudomembranous colitis requiring surgical intervention following triple therapy for Helicobacter pylori eradication. ANZ journal of surgery 20021201
Facial swelling and eosinophilia in a 44-year-old woman. Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology 20021201
Persistent gastroesophageal reflux disease symptoms on standard proton-pump inhibitor therapy. Gastroenterology clinics of North America 20021201
A double blind, randomized, placebo-controlled trial of proton pump inhibitor therapy in patients with uninvestigated dyspepsia. The American journal of gastroenterology 20021201
Low-dose aspirin: protection from the panacea. The American journal of gastroenterology 20021201
Occurrence of ventilator-associated pneumonia in mechanically ventilated pediatric intensive care patients during stress ulcer prophylaxis with sucralfate, ranitidine, and omeprazole. Journal of critical care 20021201
Characteristics of diarrhoea in 10,008 users of lansoprazole in daily practice: which co-factors contribute? Pharmacoepidemiology and drug safety 20021201
Comparison of three triple regimens with omeprazole or ranitidine bismuth citrate for Helicobacter pylori eradication. Scandinavian journal of gastroenterology 20021201
Effect of profound acid suppression in functional dyspepsia: a double-blind, randomized, placebo-controlled trial. Scandinavian journal of gastroenterology 20021201
[Ongoing treatment with omeprazole and appearance of oropharyngeal candidiasis]. Atencion primaria 20021201
[Influence of ion pump-inhibiting drugs on the accumulation of ofloxacin and grepafloxacin in human polymorphonuclear leukocytes]. Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia 20021201
On-demand proton pump inhibitor therapy in patients with gastro-oesophageal reflux disease. Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver 20021201
Transport through liquid membranes containing omeprazole and lansoprazole. Indian journal of biochemistry & biophysics 20021201
Phenotype of CYP2C19 and CYP3A4 by determination of omeprazole and its two main metabolites in plasma using liquid chromatography with liquid-liquid extraction. Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20021125
Lansoprazole for the prevention of recurrences of ulcer complications from long-term low-dose aspirin. The New England journal of medicine 20021114
Spectrophotometric determination of omeprazole, lansoprazole and pantoprazole in pharmaceutical formulations. Journal of pharmaceutical and biomedical analysis 20021107
[A case for proton pump blocker... When cough comes from the stomach]. MMW Fortschritte der Medizin 20021107
Coordinated regulation of gastric chloride secretion with both acid and alkali secretion. American journal of physiology. Gastrointestinal and liver physiology 20021101
Eradication rates of clarithromycin-resistant Helicobacter pylori using either rabeprazole or lansoprazole plus amoxicillin and clarithromycin. Alimentary pharmacology & therapeutics 20021101
Restoration of acid secretion following treatment with proton pump inhibitors. Gastroenterology 20021101
Pharmacokinetics of lansoprazole, amoxicillin and clarithromycin after simultaneous and single administration. The Journal of antimicrobial chemotherapy 20021101
Central Orexin-A stimulates pancreatic exocrine secretion via the vagus. Pancreas 20021101
Lansoprazole-associated microscopic colitis: a case series. The American journal of gastroenterology 20021101
Pantoprazole-induced recurrent anaphylactic shock. The American journal of gastroenterology 20021101
[Microbiological factors that influence the eradication of Helicobacter pylori in adults and children]. Enfermedades infecciosas y microbiologia clinica 20021101
Drug interaction of tacrolimus and proton pump inhibitors in renal transplant recipients with CYP2C19 gene mutation. Transplantation proceedings 20021101
Persistent acid reflux and symptoms in patients with Barrett's oesophagus on proton-pump inhibitor therapy. European journal of gastroenterology & hepatology 20021101
Omeprazole triple therapy versus omeprazole quadruple therapy for healing duodenal ulcer and eradication of Helicobacter pylori infection: a 24-month follow-up study. European journal of gastroenterology & hepatology 20021101
Inducibility of CYP1A2 by omeprazole in vivo related to the genetic polymorphism of CYP1A2. British journal of clinical pharmacology 20021101
Effects of omeprazole and ascorbate on gastric emptying and antioxidant levels in a mouse model of glutathione depletion. Digestive diseases and sciences 20021101
Rabeprazole improves health-related quality of life in patients with erosive gastroesophageal reflux disease. Digestive diseases and sciences 20021101
Iron deficiency anemia: induced by long-term ingestion of omeprazole. Digestive diseases and sciences 20021101
Gastric polyps and nodules in children receiving long-term omeprazole therapy. Journal of pediatric gastroenterology and nutrition 20021101
Factors affecting ammonium uptake by C11 clone of MDCK cells. Pflugers Archiv : European journal of physiology 20021101
[Helicobacter pylori induced gastritis: recent topics on eradication therapy]. Nihon Shokakibyo Gakkai zasshi = The Japanese journal of gastro-enterology 20021101
Seven-day triple therapy with omeprazole, amoxycillin and clarithromycin for Helicobacter pylori infection in haemodialysis patients. Scandinavian journal of gastroenterology 20021101
Hydrogen-potassium ATPase inhibitors induce relaxation on rabbit prostatic strips in vitro. International journal of urology : official journal of the Japanese Urological Association 20021101
Prevention of non-steroidal antiinflammatory drugs-induced gastropathy: follow up of protocol adherence. Revista espanola de enfermedades digestivas : organo oficial de la Sociedad Espanola de Patologia Digestiva 20021101
Might proton pump inhibitors prevent the antiplatelet effects of low- or very low-dose aspirin? Archives of internal medicine 20021028
Ulcer prevention in long-term users of nonsteroidal anti-inflammatory drugs. Archives of internal medicine 20021028
[Patient with increased stomach cancer risk. Helicobacter can cause damage here]. MMW Fortschritte der Medizin 20021024
Randomised controlled trial of pantoprazole versus ranitidine for the treatment of uninvestigated heartburn in primary care. The Medical journal of Australia 20021021
Azithromycin in a triple therapy for H.pylori eradication in active duodenal ulcer. World journal of gastroenterology 20021015
Comparison of paste and suspension formulations of omeprazole in the healing of gastric ulcers in racehorses in active training. Journal of the American Veterinary Medical Association 20021015
[In small steps to far ahead. Diminished risk of interactions as definite advantage]. MMW Fortschritte der Medizin 20021010
Asymmetries in H+/K+-ATPase and cell membrane potentials comprise a very early step in left-right patterning. Cell 20021004
Functional dyspepsia: bye-bye to PPIs. Gut 20021001
Double blind, randomised, placebo controlled study of four weeks of lansoprazole for the treatment of functional dyspepsia in Chinese patients. Gut 20021001
A cell-based reporter gene assay for determining induction of CYP3A4 in a high-volume system. The Journal of pharmacology and experimental therapeutics 20021001
Effects of rabeprazole, lansoprazole and omeprazole on intragastric pH in CYP2C19 extensive metabolizers. Alimentary pharmacology & therapeutics 20021001
Short course of omeprazole: a better first diagnostic approach to noncardiac chest pain than endoscopy, manometry, or 24-hour esophageal pH monitoring. Journal of clinical gastroenterology 20021001
Factors associated with treatment failure of Helicobacter pylori infection in a developing country. Journal of clinical gastroenterology 20021001
Omeprazole-induced relaxation in rat aorta is partly dependent on endothelium. Pharmacological research 20021001
Quantification of Helicobacter pylori resistance in functional and organic dyspepsia. Journal of clinical pharmacy and therapeutics 20021001
Eradication rate of Helicobacter pylori in a Mexican population at high risk for gastric cancer and use of serology to assess cure. The American journal of gastroenterology 20021001
Comparison of azithromycin and clarithromycin in triple therapy regimens for the eradication of Helicobacter pylori. The American journal of gastroenterology 20021001
Sequential eradicating therapy: a treatment that does not discriminate Helicobacter pylori strains in patients with nonulcer dyspepsia? The American journal of gastroenterology 20021001
Effect of cytochrome P4502C19 genotypic differences on cure rates for gastroesophageal reflux disease by lansoprazole. Clinical pharmacology and therapeutics 20021001
Prospective study on the incidence of chronic ear complaints related to gastroesophageal reflux and on the outcome of antireflux therapy. The Annals of otology, rhinology, and laryngology 20021001
Vitamin C and E supplements to lansoprazole-amoxicillin-metronidazole triple therapy may reduce the eradication rate of metronidazole-susceptible Helicobacter pylori infection. Helicobacter 20021001
Medication errors. Liquid lansoprazole: gumming up the works. Nursing 20021001
Effect of Helicobacter pylori infection on fibrinogen level in elderly patients with ischaemic heart disease. Acta cardiologica 20021001
A new serum antibody test kit (E plate) for evaluation of Helicobacter pylori eradication. Internal medicine (Tokyo, Japan) 20021001
[Omeprazole. Antiulcer and gastric anti-secretory agent: one of the most prescribed drugs in France]. Revue de l'infirmiere 20021001
[Antisecretory effect of losec and pariet in peptic ulcer therapy]. Voenno-meditsinskii zhurnal 20021001
[Double blind randomized multicentre study of a seven-day eradication regime of Helicobacter pylori by omeprazole, clarithromycin and ornidazole vs. omeprazole, clarithromycin and metronidazole]. Vnitrni lekarstvi 20021001
[Proton pump inhibitor in reflux disease. Administer for maximum effect from the beginning]. MMW Fortschritte der Medizin 20020926
[Comparison of pantoprazole and omeprazole-based triple therapy regimens in the treatment of Helicobacter pylori infection]. Zhonghua yi xue za zhi 20020925
Randomized comparative study of omeprazole and famotidine in reflux esophagitis. Journal of gastroenterology and hepatology 20020901
Comparison of the efficacy of octreotide, vasopressin, and omeprazole in the control of acute bleeding in patients with portal hypertensive gastropathy: a controlled study. Journal of gastroenterology and hepatology 20020901
Primary prevention of diclofenac associated ulcers and dyspepsia by omeprazole or triple therapy in Helicobacter pylori positive patients: a randomised, double blind, placebo controlled, clinical trial. Gut 20020901
Relative contribution of mucosal injury and Helicobacter pylori in the development of gastroduodenal lesions in patients taking non-steroidal anti-inflammatory drugs. Gut 20020901
Influence of sex and Helicobacter pylori on development and healing of gastroduodenal lesions in non-steroidal anti-inflammatory drug users. Gut 20020901
Comparison of two provocative tests for calcitonin in medullary thyroid carcinoma: omeprazole vs pentagastrin. Clinical chemistry 20020901
Impact of supplement with Lactobacillus- and Bifidobacterium-containing yogurt on triple therapy for Helicobacter pylori eradication. Alimentary pharmacology & therapeutics 20020901
Efficacy of a 1-week course of proton-pump inhibitor-based triple therapy for eradicating Helicobacter pylori in patients with and without chronic renal failure. American journal of kidney diseases : the official journal of the National Kidney Foundation 20020901
Influence of Helicobacter pylori eradication therapy on the occurrence of gastrointestinal events in patients treated with conventional nonsteroidal antiinflammatory drugs combined with omeprazole. The Journal of rheumatology 20020901
Regression of CD5-positive and Helicobacter pylori-negative mucosa-associated lymphoid tissue lymphoma of the rectum after administration of antibiotics: report of a case. Diseases of the colon and rectum 20020901
Effect of H. pylori status on gastric ulcer healing in patients continuing nonsteroidal anti-inflammatory therapy and receiving treatment with lansoprazole or ranitidine. The American journal of gastroenterology 20020901
Motion--Helicobacter pylori worsens GERD: arguments for the motion. Canadian journal of gastroenterology = Journal canadien de gastroenterologie 20020901
Motion--Helicobacter pylori causes or worsens GERD: arguments against the motion. Canadian journal of gastroenterology = Journal canadien de gastroenterologie 20020901
Rabeprazole: pharmacokinetics and pharmacokinetic drug interactions. Die Pharmazie 20020901
Short-term therapeutic trial of proton pump inhibitors in suspected extraesophageal reflux. Journal of voice : official journal of the Voice Foundation 20020901
Thrombocytopenic purpura: an unusual complication of eradication therapy for Helicobacter pylori. Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver 20020901
[Long-term curative effects of suture plus proximal gastric vagotomy or triad-therapy for duodenal ulcer with acute perforation]. Zhonghua wai ke za zhi [Chinese journal of surgery] 20020901
[The short term effect of rabeprazol versus omeprazole on symptom relief of duodenal ulcer]. Zhonghua nei ke za zhi 20020901
[Pharma clinics medication of the month. Esomeprazole]. Revue medicale de Liege 20020901
Treatment and prevention of aspirin-induced gastroduodenal ulcers and gastrointestinal bleeding. Expert opinion on drug safety 20020901
Potential role of endocrine gastrin in the colonic adenoma carcinoma sequence. British journal of cancer 20020827
[Does intake of gastric acid pump inhibitor affect the evaluation of the Lundh test?]. Ugeskrift for laeger 20020826
Minimal residual low-grade gastric MALT-type lymphoma after eradication of Helicobacter pylori. Lancet (London, England) 20020817
Characterization of human CYP1A1/1A2 induction by DNA microarray and alpha-naphthoflavone. Biochemical and biophysical research communications 20020809
Tetany secondary to the use of a proton-pump inhibitor. Annals of internal medicine 20020806
Melatonin protects against gastric ulceration and increases the efficacy of ranitidine and omeprazole in reducing gastric damage. Journal of pineal research 20020801
Gastroprotective effect of fenugreek seeds (Trigonella foenum graecum) on experimental gastric ulcer in rats. Journal of ethnopharmacology 20020801
Effect of Helicobacter pylori eradication on platelet recovery in Japanese patients with chronic idiopathic thrombocytopenic purpura and secondary autoimmune thrombocytopenic purpura. British journal of haematology 20020801
Localization of [14C]clarithromycin in rat gastric tissue when administered with lansoprazole and amoxicillin. The Journal of antimicrobial chemotherapy 20020801
Normalization of phospholipids concentration of the gastric mucosa was observed in patients with peptic ulcer after eradication of Helicobacter pylori. Helicobacter 20020801
Chronic urticaria induced by eradication therapy of Helicobacter pylori: a case report. Helicobacter 20020801
Medical or surgical therapy for erosive reflux esophagitis: cost-utility analysis using a Markov model. Annals of surgery 20020801
Esomeprazole 40 mg and 20 mg is efficacious in the long-term management of patients with endoscopy-negative gastro-oesophageal reflux disease: a placebo-controlled trial of on-demand therapy for 6 months. European journal of gastroenterology & hepatology 20020801
Efficacy of quadruple therapy with pantoprazole, bismuth, tetracycline and metronidazole as rescue treatment for Helicobacter pylori infection. Alimentary pharmacology & therapeutics 20020801
[Prevention and treatment of gastro-duodenal ulcers in elderly--from theory-based toward evidence-based]. Nihon rinsho. Japanese journal of clinical medicine 20020801
[Reflux esophagitis]. Nihon rinsho. Japanese journal of clinical medicine 20020801
[Eradication therapy of Helicobacter pylori for elderly patients in Japan]. Nihon rinsho. Japanese journal of clinical medicine 20020801
[Management of gastrointestinal mucosal damage in patients with cerebrovascular disease]. Nihon rinsho. Japanese journal of clinical medicine 20020801
[Treatment of peptic ulcer related to rheumatic diseases]. Nihon rinsho. Japanese journal of clinical medicine 20020801
[Chronic respiratory disease and gastroesophageal reflux]. Nihon rinsho. Japanese journal of clinical medicine 20020801
[Several points that should be noticed during PPI treatment for peptic ulcers in elderly patients]. Nihon rinsho. Japanese journal of clinical medicine 20020801
Effect of sex and menstrual cycle phase on cytochrome P450 2C19 activity with omeprazole used as a biomarker. Clinical pharmacology and therapeutics 20020801
Short-term omeprazole treatment does not influence biochemical parameters of bone turnover in children. Calcified tissue international 20020801
Bioavailability of lansoprazole granules administered in juice or soft food compared with the intact capsule formulation. Clinical therapeutics 20020801
[Ranitidine-bismuth citrate versus omeprazole plus two antibiotics for seven days for the eradication of Helicobacter pylori: a non-concluding clinical essay]. Anales de medicina interna (Madrid, Spain : 1984) 20020801
Gastric acid secretion in the dog: a mechanism-based pharmacodynamic model for histamine stimulation and irreversible inhibition by omeprazole. Journal of pharmacokinetics and pharmacodynamics 20020801
Induction of aneuploidy in male mouse germ cells detected by the sperm-FISH assay: a review of the present data base. Mutation research 20020725
Esomeprazole: a clinical review. American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists 20020715
Proton pump inhibitors: an update. American family physician 20020715
Impact of safety alerts upon prescribing of cisapride to children in New Zealand. The New Zealand medical journal 20020702
Review article: esomeprazole in the treatment of Helicobacter pylori. Alimentary pharmacology & therapeutics 20020701
Recurrent bleeding from peptic ulcer associated with adherent clot: a randomized study comparing endoscopic treatment with medical therapy. Gastrointestinal endoscopy 20020701
The efficacy of lafutidine in improving preoperative gastric fluid property: a comparison with ranitidine and rabeprazole. Anesthesia and analgesia 20020701
Is omeprazole helpful in the management of children with reflux oesophagitis? Archives of disease in childhood 20020701
Bleeding peptic ulcers: what's new? Gastrointestinal endoscopy 20020701
Effect of omeprazole on oral and intravenous RS-methadone pharmacokinetics and pharmacodynamics in the rat. Journal of pharmaceutical sciences 20020701
Calcium and phosphate plasma levels in dialysis patients after dietary Ca-P overload. Role of gastric acid secretion. Nephron 20020701
Randomized open trial for comparison of proton pump inhibitors in triple therapy for Helicobacter pylori infection in relation to CYP2C19 genotype. Journal of gastroenterology and hepatology 20020701
[Eradication of helicobacter pylori: symptomatic treatment of reflux disease?]. Zeitschrift fur Gastroenterologie 20020701
Optimal dose of omeprazole for CYP2C19 extensive metabolizers in anti-Helicobacter pylori therapy: pharmacokinetic considerations. Biological & pharmaceutical bulletin 20020701
Genotyping of Helicobacter pylori in paraffin-embedded gastric biopsy specimens: relation to histological parameters and effects on therapy. The American journal of gastroenterology 20020701
Comparison of oral omeprazole and endoscopic ethanol injection therapy for prevention of recurrent bleeding from peptic ulcers with nonbleeding visible vessels or fresh adherent clots. The American journal of gastroenterology 20020701
Use of proton pump inhibitors during pregnancy and rates of major malformations: a meta-analysis. Digestive diseases and sciences 20020701
Measuring symptom distress and health-related quality of life in clinical trials of gastroesophageal reflux disease treatment: further validation of the Gastroesophageal Reflux Disease Symptom Assessment Scale (GSAS). Digestive diseases and sciences 20020701
Ranitidine and omeprazole as adjuvant therapy to pancrelipase to improve fat absorption in patients with cystic fibrosis. Journal of pediatric gastroenterology and nutrition 20020701
One-week triple vs. quadruple therapy for Helicobacter pylori infection - a randomized trial. Alimentary pharmacology & therapeutics 20020701
Furazolidone-based triple 'rescue therapy' vs. quadruple 'rescue therapy' for the eradication of Helicobacter pylori resistant to metronidazole. Alimentary pharmacology & therapeutics 20020701
An evaluation of the clinical implications of acid breakthrough in patients on proton pump inhibitor therapy. Alimentary pharmacology & therapeutics 20020701
Dose-dependent inhibition of CYP3A activity by clarithromycin during Helicobacter pylori eradication therapy assessed by changes in plasma lansoprazole levels and partial cortisol clearance to 6beta-hydroxycortisol. Clinical pharmacology and therapeutics 20020701
Enantioselective disposition of lansoprazole in extensive and poor metabolizers of CYP2C19. Clinical pharmacology and therapeutics 20020701
Assessment of the afferent vagal nerve in patients with gastroesophageal reflux. Surgical endoscopy 20020701
[Treatment of NSAID-associated gastric ulcer]. Nihon Shokakibyo Gakkai zasshi = The Japanese journal of gastro-enterology 20020701
Early relief of upper gastrointestinal dyspeptic symptoms: a survey of empirical therapy with pantoprazole in Canadian clinical practice. Canadian journal of gastroenterology = Journal canadien de gastroenterologie 20020701
Impact of proton pump inhibitor utilization patterns on gastroesophageal reflux disease-related costs. Managed care (Langhorne, Pa.) 20020701
Helicobacter pylori and different topographic types of gastritis: treatment response after successful eradication therapy in functional dyspepsia. Scandinavian journal of gastroenterology 20020701
Protective effect of omeprazole against acute gastric mucosal lesions induced by compound 48/80, a mast cell degranulator, in rats. Pharmacological research 20020701
[Allergic vasculitis following ingestion of celecoxib?]. Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete 20020701
The impact of primary antibiotic resistance on the efficacy of ranitidine bismuth citrate- vs. omeprazole-based one-week triple therapies in H. pylori eradication--a randomised controlled trial. Wiener klinische Wochenschrift 20020628
Lansoprazole for the prevention of recurrences of ulcer complications from long-term low-dose aspirin use. The New England journal of medicine 20020627
Drug points: Severe myalgia from an interaction between treatments with pantoprazole and methotrexate. BMJ (Clinical research ed.) 20020622
From the Food and Drug Administration. JAMA 20020612
Upper gastrointestinal complications after renal transplantation: a 3-yr sequential study. Clinical transplantation 20020601
Pharmacologic management of gastroesophageal reflux disease. Current gastroenterology reports 20020601
Helicobacter pylori eradication does not worsen quality of life related to reflux symptoms: a prospective trial. Alimentary pharmacology & therapeutics 20020601
Single vs. double dose of a proton pump inhibitor in triple therapy for Helicobacter pylori eradication: a meta-analysis. Alimentary pharmacology & therapeutics 20020601
Duodenal ulcer healing with 1-week eradication triple therapy followed, or not, by anti-secretory treatment: a multicentre double-blind placebo-controlled trial. Alimentary pharmacology & therapeutics 20020601
Amoxicillin and ampicillin are not transferred to gastric juice irrespective of Helicobacter pylori status or acid blockade by omeprazole. Alimentary pharmacology & therapeutics 20020601
High dose Omeprazole in esophagitis with stenosis after surgical treatment of esophageal atresia. Journal of pediatric surgery 20020601
Additive effect of pronase on the efficacy of eradication therapy against Helicobacter pylori. Helicobacter 20020601
Symptomatic ulceration of an acid-producing oesophageal inlet patch colonized by helicobacter pylori. Endoscopy 20020601
Prevalence of H. pylori-infection in family members of H. pylori positive and its influence on the reinfection rate after successful eradication therapy: a two-year follow-up. Zeitschrift fur Gastroenterologie 20020601
A double-blind, randomized comparison of omeprazole Multiple Unit Pellet System (MUPS) 20 mg, lansoprazole 30 mg and pantoprazole 40 mg in symptomatic reflux oesophagitis followed by 3 months of omeprazole MUPS maintenance treatment: a Dutch multicentre trial. European journal of gastroenterology & hepatology 20020601
Pharmacology of acid suppression in the hospital setting: focus on proton pump inhibition. Critical care medicine 20020601
Stress-related mucosal disease in the critically ill patient: risk factors and strategies to prevent stress-related bleeding in the intensive care unit. Critical care medicine 20020601
Intravenous proton pump inhibitors in the critical care setting. Critical care medicine 20020601
Protection against aspiration with the Proseal laryngeal mask airway. Anaesthesia and intensive care 20020601
Rabeprazole in nonerosive gastroesophageal reflux disease: a randomized placebo-controlled trial. The American journal of gastroenterology 20020601
Daily low-dose versus alternate day full-dose lansoprazole in the maintenance treatment of reflux esophagitis. The American journal of gastroenterology 20020601
Pantoprazole-induced recurrent anaphylactic shock. The American journal of gastroenterology 20020601
Osteoporosis with underlying connective tissue disease: an unusual case. Annals of the New York Academy of Sciences 20020601
On-demand treatment in patients with oesophagitis and reflux symptoms: comparison of lansoprazole and omeprazole. Scandinavian journal of gastroenterology 20020601
Improvement of long-standing iron-deficiency anemia in adults after eradication of Helicobacter pylori infection. Internal medicine (Tokyo, Japan) 20020601
[Changes of rat gastric mucosal barrier under stress conditions]. Zhonghua nei ke za zhi 20020601
[Antibiotic resistance of Helicobacter pylori in Reunion Island: therapeutic consequences]. Bulletin de la Societe de pathologie exotique (1990) 20020601
Influence of aging on gastric ulcer healing activities of cimetidine and omeprazole. European journal of pharmacology 20020531
Nonhealing gastric ulcer caused by chronic alendronate administration. MedGenMed : Medscape general medicine 20020522
[Management of dyspepsia, gastroduodenal ulcer and Helicobacter pylori infection in primary care]. Atencion primaria 20020515
Stability of pantoprazole in an extemporaneously compounded oral liquid. American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists 20020515
Effects of Ostertagia ostertagi and omeprazole treatment on feed intake and gastrin-related responses in the calf. Veterinary parasitology 20020510
Chronic gastric ulcer healing in rats subjected to selective and non-selective cyclooxygenase-2 inhibitors. European journal of pharmacology 20020503
pH-Hp: implications for dyspepsia management. Gut 20020501
Combined analysis of the ORCHID and OCAY studies: does eradication of Helicobacter pylori lead to sustained improvement in functional dyspepsia symptoms? Gut 20020501
The potential role of acid suppression in functional dyspepsia: the BOND, OPERA, PILOT, and ENCORE studies. Gut 20020501
Approaches to uninvestigated dyspepsia. Gut 20020501
Use of antisecretory agents as a trial of therapy. Gut 20020501
A modification of the quininium resin test for assessing gastric acidity. Alimentary pharmacology & therapeutics 20020501
Hiatal hernia is the key factor determining the lansoprazole dosage required for effective intra-oesophageal acid suppression. Alimentary pharmacology & therapeutics 20020501
Lansoprazole-induced thrombocytopenia. The Annals of pharmacotherapy 20020501
Vitamin B(12) deficiency associated with histamine(2)-receptor antagonists and a proton-pump inhibitor. The Annals of pharmacotherapy 20020501
Combination drug therapy for gastroesophageal reflux disease. The Annals of pharmacotherapy 20020501
Discussion on simultaneous intraesophageal impedance and pH measurement of acid and nonacid gastroesophageal reflux: effect of omeprazole. Gastroenterology 20020501
Omeprazole treatment diminishes intra- and extracellular neutrophil reactive oxygen production and bactericidal activity. Critical care medicine 20020501
Proton pump inhibitors and stress ulcer prophylaxis: pause for thought? Critical care medicine 20020501
Pharmacokinetic-pharmacodynamic study of oral lansoprazole in children. Clinical pharmacology and therapeutics 20020501
Proton pump activation in stimulated parietal cells is regulated by gastric acid secretory capacity: a human study. Journal of clinical pharmacology 20020501
Effect of esomeprazole 40 mg vs omeprazole 40 mg on 24-hour intragastric pH in patients with symptoms of gastroesophageal reflux disease. Digestive diseases and sciences 20020501
Evaluation of gene induction of drug-metabolizing enzymes and transporters in primary culture of human hepatocytes using high-sensitivity real-time reverse transcription PCR. Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan 20020501
Primary hyperparathyroidism with duodenal ulcer and H. pylori infection. Internal medicine (Tokyo, Japan) 20020501
Pantoprazole IV (Protonix IV). The Medical letter on drugs and therapeutics 20020429
Treating Helicobacter pylori infection in primary care patients with uninvestigated dyspepsia: the Canadian adult dyspepsia empiric treatment-Helicobacter pylori positive (CADET-Hp) randomised controlled trial. BMJ (Clinical research ed.) 20020427
Esomeprazole for acid peptic disorders. The Annals of pharmacotherapy 20020401
Spontaneous resolution of multiple fundic gland polyps after cessation of treatment with lansoprazole and Nissen fundoplication: a case report. Gastrointestinal endoscopy 20020401
Analysis of the CYP2C19 polymorphism in a North-eastern Thai population. Pharmacogenetics 20020401
One-week omeprazole, furazolidone and amoxicillin rescue therapy after failure of Helicobacter pylori eradication with standard triple therapies. Alimentary pharmacology & therapeutics 20020401
Dose-dependent control of intragastric pH by pantoprazole, 10, 20 or 40 mg, in healthy volunteers. Alimentary pharmacology & therapeutics 20020401
Comparison of lansoprazole and famotidine for gastric acid inhibition during the daytime and night-time in different CYP2C19 genotype groups. Alimentary pharmacology & therapeutics 20020401
Effects of omeprazole and famotidine on fibroblast growth factor-2 during artificial gastric ulcer healing in humans. European journal of gastroenterology & hepatology 20020401
Selective colonization by Helicobacter pylori of the deep gastric glands and intracellular canaliculi of parietal cells in the setting of chronic proton pump inhibitor use. European journal of gastroenterology & hepatology 20020401
Wine stimulates gastric acid secretion in isolated rabbit gastric glands via two different pathways. Alimentary pharmacology & therapeutics 20020401
Omeprazole hydroxylation is inhibited by a single dose of moclobemide in homozygotic EM genotype for CYP2C19. British journal of clinical pharmacology 20020401
Amoxicillin/tetracycline combinations are inadequate as alternative therapies for Helicobacter pylori infection. Helicobacter 20020401
Does reduction in gastric acid secretion in bariatric surgery increase diet-induced thermogenesis? Obesity surgery 20020401
Effect of hypergastrinemia on pancreatic carcinogenesis. American journal of surgery 20020401
Is lansoprazole (Prevacid) or omeprazole (Prilosec) more effective in treating erosive esophagitis? The Journal of family practice 20020401
Molecular and biochemical screening for the diagnosis and management of medullary thyroid carcinoma in multiple endocrine neoplasia type 2A. Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme 20020401
Influence of Helicobacter pylori infection on healing and relapse of acetic acid ulcers in Mongolian gerbils. Digestive diseases and sciences 20020401
Gastroprotective activity of oleanolic acid derivatives on experimentally induced gastric lesions in rats and mice. The Journal of pharmacy and pharmacology 20020401
Role of GERD in chronic resistant sinusitis: a prospective, open label, pilot trial. The American journal of gastroenterology 20020401
Colloidal bismuth subcitrate-based twice-a-day quadruple therapy as primary or salvage therapy for Helicobacter pylori infection. The American journal of gastroenterology 20020401
Laryngeal manifestations of gastroesophageal reflux disease in children. Acta oto-laryngologica 20020401
Localization of antigen-presenting cells in Helicobacter pylori-infected gastric mucosa. Pathology international 20020401
[Regeneration of the gastric epitheliocytes during treatment of duodenal ulcer with pariet]. Voenno-meditsinskii zhurnal 20020401
Effect of pantoprazole versus other proton pump inhibitors on 24-hour intragastric pH and basal acid output in Zollinger-Ellison syndrome. Gastroenterologie clinique et biologique 20020401
Chickenpox oesophagitis and haematemesis in an immunocompetent adult. The Journal of infection 20020401
[Effect of proton pump inhibitors. In vivo is decisive]. MMW Fortschritte der Medizin 20020328
[Practice guidelines for diagnosis and treatment of Helicobacter pylori infections and their application in clinical practice]. Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine 20020320
Determination of omeprazole and its metabolites in human plasma by liquid chromatography-mass spectrometry. Journal of chromatography. A 20020308
Determination and pharmacokinetic profile of omeprazole in rat blood, brain and bile by microdialysis and high-performance liquid chromatography. Journal of chromatography. A 20020308
Review article: rabeprazole-based therapy in Helicobacter pylori eradication. Alimentary pharmacology & therapeutics 20020301
Long-term effect of H2RA therapy on nocturnal gastric acid breakthrough. Gastroenterology 20020301
Acid suppression in healthy subjects following lansoprazole or pantoprazole. Alimentary pharmacology & therapeutics 20020301
Onset of symptom relief with rabeprazole: a community-based, open-label assessment of patients with erosive oesophagitis. Alimentary pharmacology & therapeutics 20020301
Integrated acidity and rabeprazole pharmacology. Alimentary pharmacology & therapeutics 20020301
Over-the-counter H(2)-receptor antagonists do not compromise intragastric pH control with proton pump inhibitors. Alimentary pharmacology & therapeutics 20020301
A randomized, double-blind, comparative study of standard-dose rabeprazole and high-dose omeprazole in gastro-oesophageal reflux disease. Alimentary pharmacology & therapeutics 20020301
The effect of Helicobacter pylori eradication on the natural course of atrophic gastritis with dysplasia. Alimentary pharmacology & therapeutics 20020301
Mono, dual and triple moxifloxacin-based therapies for Helicobacter pylori eradication. Alimentary pharmacology & therapeutics 20020301
Effect of Helicobacter pylori eradication on oesophageal acid exposure in patients with reflux oesophagitis. Alimentary pharmacology & therapeutics 20020301
Different effects of short-term omeprazole, lansoprazole or pantoprazole on the accuracy of the (13)C-urea breath test. Alimentary pharmacology & therapeutics 20020301
The cost-effectiveness of population Helicobacter pylori screening and treatment: a Markov model using economic data from a randomized controlled trial. Alimentary pharmacology & therapeutics 20020301
Effectiveness of two quadruple, tetracycline- or clarithromycin-containing, second-line, Helicobacter pylori eradication therapies. Alimentary pharmacology & therapeutics 20020301
Influence of Helicobacter pylori infection and eradication on blood lipids and fibrinogen. Alimentary pharmacology & therapeutics 20020301
Drugs for bleeding peptic ulcer. Alimentary pharmacology & therapeutics 20020301
Protease-activated receptor-2 (PAR-2) in the rat gastric mucosa: immunolocalization and facilitation of pepsin/pepsinogen secretion. British journal of pharmacology 20020301
Omeprazole and ultrastructural modifications occurring in reflux esophagitis. Gastroenterology 20020301
Omeprazole increases permeability across isolated rat gastric mucosa pre-treated with an acid secretagogue. The Journal of pharmacy and pharmacology 20020301
Gastroprotective activity of solidagenone on experimentally-induced gastric lesions in rats. The Journal of pharmacy and pharmacology 20020301
A comparative study on the activity of lansoprazole, omeprazole and PD-136450 on acidified ethanol- and indomethacin-induced gastric lesions in the rat. Clinical and experimental pharmacology & physiology 20020301
Low daily 10-mg and 20-mg doses of fluvoxamine inhibit the metabolism of both caffeine (cytochrome P4501A2) and omeprazole (cytochrome P4502C19). Clinical pharmacology and therapeutics 20020301
Evaluation of the Helicobacter pylori stool antigen test for monitoring eradication therapy. The American journal of gastroenterology 20020301
An overview of the pharmacology, efficacy, safety and cost-effectiveness of lansoprazole. International journal of clinical practice 20020301
Nizatidine and omeprazole enhance the effect of metronidazole on Helicobacter pylori in vitro. International journal of antimicrobial agents 20020301
Influence of fluconazole on the pharmacokinetics of omeprazole in healthy volunteers. Biopharmaceutics & drug disposition 20020301
Relation between alcohol consumption and the success of Helicobacter pylori eradication therapy using omeprazole, clarithromycin and amoxicillin for 1 week. European journal of gastroenterology & hepatology 20020301
Failure of Helicobacter pylori eradication: is poor compliance the main cause? Gastroenterologie clinique et biologique 20020301
Anti-ulcerogenic and analgesic activities of the leaves of Wilbrandia ebracteata in mice. Phytomedicine : international journal of phytotherapy and phytopharmacology 20020301
Posterior laryngitis: effects of treatment with omeprazole alone. Revista espanola de enfermedades digestivas : organo oficial de la Sociedad Espanola de Patologia Digestiva 20020301
Mutagenic and clastogenic activity of gastric juice in human gastric diseases. Mutation research 20020215
Acute fulminant hepatitis after treatment with rabeprazole and terbinafine: is rabeprazole the culprit? Archives of internal medicine 20020211
Collagenous colitis associated with lansoprazole. Journal of clinical gastroenterology 20020201
Cutaneous leucocytoclastic vasculitis associated with omeprazole. Postgraduate medical journal 20020201
Nonvariceal upper gastrointestinal bleeding. Endoscopy 20020201
Omeprozole therapy in pediatric patients after liver and intestinal transplantation. Journal of pediatric gastroenterology and nutrition 20020201
Does Helicobacter pylori eradication reduce the long-term requirements for acid suppressants in patients with a history of peptic ulcer disease in general practice? Results from a four-year longitudinal study. Scandinavian journal of gastroenterology 20020201
Control of nocturnal gastric acidity: a role for low dose bedtime ranitidine to supplement daily omeprazole. Digestive diseases and sciences 20020201
[Long-term prophylaxis with omeprazol is superior to eradication therapy in H. pylori-positive NSAIDs taking patients]. Zeitschrift fur Gastroenterologie 20020201
Current concepts in the management of Helicobacter pylori infection--the Maastricht 2-2000 Consensus Report. Alimentary pharmacology & therapeutics 20020201
The clinical and economic impact of competing management strategies for gastro-oesophageal reflux disease. Alimentary pharmacology & therapeutics 20020201
Effect of Helicobacter pylori eradication on duodenal ulcer scar in patients with no clinical history of duodenal ulcer. Alimentary pharmacology & therapeutics 20020201
Primary resistance to antibiotics and its clinical impact on the efficacy of Helicobacter pylori lansoprazole-based triple therapies. Alimentary pharmacology & therapeutics 20020201
Minor effects of Helicobacter pylori on gastric secretion and dose of lansoprazole during long-term treatment in ZE and non-ZE acid hypersecretors. Alimentary pharmacology & therapeutics 20020201
High rate of post-therapeutic resistance after failure of macrolide-nitroimidazole triple therapy to cure Helicobacter pylori infection: impact of two second-line therapies in a randomized study. Alimentary pharmacology & therapeutics 20020201
Impact of esophageal acid exposure on the endoscopic reversal of Barrett's esophagus. The American journal of gastroenterology 20020201
Conservative treatment of primary gastric low-grade B-cell lymphoma of mucosa-associated lymphoid tissue: predictive factors of response and outcome. The American journal of gastroenterology 20020201
Resolution of collagenous colitis after treatment for Helicobacter pylori. The American journal of gastroenterology 20020201
In support of 'step-up therapy' for gastroesophageal reflux disease. The American journal of gastroenterology 20020201
The effect of immobilization stress on the pharmacokinetics of omeprazole in rats. Acta medica Okayama 20020201
Critical effect of Helicobacter pylori infection on the effectiveness of omeprazole for prevention of gastric or duodenal ulcers among chronic NSAID users. Helicobacter 20020201
[Acquisition of secondary resistance after failure of a first treatment of Helicobacter pylori infection in children]. Archives de pediatrie : organe officiel de la Societe francaise de pediatrie 20020201
Protonix. First i.v. proton pump inhibitor approved. Nursing 20020201
Hepatic lysosomal enzymes activity and liver morphology after short-time omeprazole administration. Experimental and toxicologic pathology : official journal of the Gesellschaft fur Toxikologische Pathologie 20020201
Proton pump inhibitors or surgery for gastro-oesophageal reflux disease. Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver 20020201
Laparoscopic fundoplication versus lansoprazole for gastro-oesophageal reflux disease. A pH-metric comparison. Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver 20020201
Nonallergic anaphylaxis to pantoprazole. Allergy 20020201
[The outline of medical treatment of peptic ulcer]. Nihon rinsho. Japanese journal of clinical medicine 20020201
[Guidelines for the management of Helicobacter pylori infection in Japan]. Nihon rinsho. Japanese journal of clinical medicine 20020201
[Guidelines of Helicobacter pylori eradication in children]. Nihon rinsho. Japanese journal of clinical medicine 20020201
[New triple therapy for Helicobacter pylori infection]. Nihon rinsho. Japanese journal of clinical medicine 20020201
[Dual therapy for Helicobacter pylori resistance to anti microbial agents]. Nihon rinsho. Japanese journal of clinical medicine 20020201
[Proton pump inhibitor-based quadruple therapy regimen for Helicobacter pylori infection]. Nihon rinsho. Japanese journal of clinical medicine 20020201
[Effect of PPI/AM re-treatment regimen for the patients with Helicobacter pylori infection after failure of first line eradication therapy by PPI/AC regimens]. Nihon rinsho. Japanese journal of clinical medicine 20020201
[High dose dual PPI/AMPC therapy for the treatment of Helicobacter pylori infection after failure of usual standard triple PPI/AMPC/CAM therapy: CYP2C19 polymorphism]. Nihon rinsho. Japanese journal of clinical medicine 20020201
[Second line treatment regimen of PPI + AMPC + MNZ for patients with clarithromycin-resistant Helicobacter pylori infection]. Nihon rinsho. Japanese journal of clinical medicine 20020201
[Minocycline-containing eradication therapy for patients with clarithromycin-resistant Helicobacter pylori infection]. Nihon rinsho. Japanese journal of clinical medicine 20020201
[Triple therapy with faropenem, proton pump inhibitor (PPI), and amoxicillin for clarithromycin-resistant H. pylori eradication]. Nihon rinsho. Japanese journal of clinical medicine 20020201
[Ecabet sodium (ECA) + PPI + AMPC therapy for clarithromycin-resistant Helicobacter pylori infections]. Nihon rinsho. Japanese journal of clinical medicine 20020201
[Eradication therapy for clarithromycin-resistant and metronidazole-resistant Helicobacter pylori infection]. Nihon rinsho. Japanese journal of clinical medicine 20020201
[Adverse effects of H. pylori eradication therapy and its measure]. Nihon rinsho. Japanese journal of clinical medicine 20020201
[Acute mucosal lesion of the upper-gastrointestinal tract observed after H. pylori-eradication]. Nihon rinsho. Japanese journal of clinical medicine 20020201
[H. pylori eradication therapy and natural history of peptic ulcer]. Nihon rinsho. Japanese journal of clinical medicine 20020201
[Continuation of acid suppression therapy after H. pylori eradication]. Nihon rinsho. Japanese journal of clinical medicine 20020201
[Treatment of NSAIDs induced ulcers]. Nihon rinsho. Japanese journal of clinical medicine 20020201
[Prophylaxis against non-steroidal anti-inflammatory drug-associated ulcers and erosions]. Nihon rinsho. Japanese journal of clinical medicine 20020201
[Intractable ulcer]. Nihon rinsho. Japanese journal of clinical medicine 20020201
[Gastroduodenal ulcer in childhood]. Nihon rinsho. Japanese journal of clinical medicine 20020201
[Peptic ulcer in the elderly]. Nihon rinsho. Japanese journal of clinical medicine 20020201
[Proton pump inhibitors: Omeprazole]. Nihon rinsho. Japanese journal of clinical medicine 20020201
[Proton pump inhibitors: Efficacy of lansoprazole in eradicating Helicobacter pylori]. Nihon rinsho. Japanese journal of clinical medicine 20020201
[Proton pump inhibitors: Rabeprazole]. Nihon rinsho. Japanese journal of clinical medicine 20020201
[Proton pump inhibitors: Tenatoprazole (TU-199)]. Nihon rinsho. Japanese journal of clinical medicine 20020201
[Proton pump inhibitors: Pantoprazole]. Nihon rinsho. Japanese journal of clinical medicine 20020201
[Amoxicillin (AMPC)]. Nihon rinsho. Japanese journal of clinical medicine 20020201
[Sucralfate]. Nihon rinsho. Japanese journal of clinical medicine 20020201
[Plaunotol]. Nihon rinsho. Japanese journal of clinical medicine 20020201
[Sofalcone]. Nihon rinsho. Japanese journal of clinical medicine 20020201
[Ecabet sodium]. Nihon rinsho. Japanese journal of clinical medicine 20020201
[Polaprezinc]. Nihon rinsho. Japanese journal of clinical medicine 20020201
[Non-ulcer dyspepsia and H. pylori]. Nihon rinsho. Japanese journal of clinical medicine 20020201
[Cause and prevention of nocturnal gastric acid breakthrough]. Nihon rinsho. Japanese journal of clinical medicine 20020201
[Helicobacter heilmannii-associated gastritis]. Nihon rinsho. Japanese journal of clinical medicine 20020201
[Clinical management of reflux laryngitis]. HNO 20020201
Life cycle of a block buster drug: discovery and development of omeprazole (Prilosec). Molecular interventions 20020201
Conformational analysis: a new approach by means of chemometrics. Journal of computational chemistry 20020130
Clinical outcome and influencing factors of a new short-term quadruple therapy for Helicobacter pylori eradication: a randomized controlled trial (MACLOR study). Archives of internal medicine 20020128
Ulcer prevention in long-term users of nonsteroidal anti-inflammatory drugs: results of a double-blind, randomized, multicenter, active- and placebo-controlled study of misoprostol vs lansoprazole. Archives of internal medicine 20020128
Effects of lansoprazole and rabeprazole on tacrolimus blood concentration: case of a renal transplant recipient with CYP2C19 gene mutation. Transplantation 20020127
[Omeprazole-induced interstitial nephritis: a reversible cause of acute renal failure]. Medicina clinica 20020119
[Dyspepsia and Helicobacter pylori infection in employees of a large industry. Results of a prospective BASF Helicobacter pylori prevention campaign]. Medizinische Klinik (Munich, Germany : 1983) 20020115
Very early detection of RET proto-oncogene mutation is crucial for preventive thyroidectomy in multiple endocrine neoplasia type 2 children: presence of C-cell malignant disease in asymptomatic carriers. Cancer 20020115
Use of a proton-pump inhibitor for metabolic disturbances associated with anorexia nervosa. The New England journal of medicine 20020110
Eradication of Helicobacter pylori and risk of peptic ulcers in patients starting long-term treatment with non-steroidal anti-inflammatory drugs: a randomised trial. Lancet (London, England) 20020105
Enantiomeric determination of pantoprazole in human plasma by multidimensional high-performance liquid chromatography. Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20020105
Noncardiac chest pain. Journal of clinical gastroenterology 20020101
The novel use of an intravenous proton pump inhibitor in a patient with short bowel syndrome. Journal of clinical gastroenterology 20020101
Hypergastrinemia in response to gastric inflammation suppresses somatostatin. American journal of physiology. Gastrointestinal and liver physiology 20020101
Effect of multipolar electrocoagulation on EUS findings in Barrett's esophagus. Gastrointestinal endoscopy 20020101
Visual disorders associated with omeprazole and their relation to CYP2C19 polymorphism. Pharmacogenetics 20020101
Genetic or chemical hypochlorhydria is associated with inflammation that modulates parietal and G-cell populations in mice. Gastroenterology 20020101
Interaction of sleep disturbances and gastroesophageal reflux in chronic laryngitis. American journal of otolaryngology 20020101
Acute necrotizing gastritis by Escherichia coli in a severely neutropenic patient. Haematologica 20020101
[Progress of tailor-made treatment of peptic ulcer]. Nihon rinsho. Japanese journal of clinical medicine 20020101
Drug combinations with amoxycillin reduce selection of clarithromycin resistance during Helicobacter pylori eradication therapy. International journal of antimicrobial agents 20020101
Regression of low-grade gastric mucosa-associated lymphoid tissue lymphoma after eradication of Helicobacter pylori: possible association with p16 hypermethylation. Journal of gastroenterology 20020101
[Treatment of perforated gastroduodenal ulcer by simple suture followed by Helicobacter pylori eradication]. Annales de chirurgie 20020101
Therapeutic effects of antibacterial treatment for intractable skin diseases in Helicobacter pylori-positive Japanese patients. The Journal of dermatology 20020101
[Duodenal ulcer]. Nihon rinsho. Japanese journal of clinical medicine 20020101
Acute manic psychosis induced by triple therapy for H. pylori. The Journal of the American Board of Family Practice 20020101
[Piracetam in combined pathogenetic therapy of recurrent duodenal ulcer]. Klinicheskaia meditsina 20020101
Lansoprazole vs. omeprazole for gastro-oesophageal reflux disease: a pH-metric comparison. Alimentary pharmacology & therapeutics 20020101
Efficacy of low-dose clarithromycin triple therapy and tinidazole-containing triple therapy for Helicobacter pylori eradication. Alimentary pharmacology & therapeutics 20020101
Low-dose lansoprazole and clarithromycin plus metronidazole vs. full-dose lansoprazole and clarithromycin plus amoxicillin for eradication of Helicobacter pylori infection. Alimentary pharmacology & therapeutics 20020101
Treatment with a proton pump inhibitor promotes corpus gastritis in patients with Helicobacter pylori-infected antrum-predominant gastritis. Alimentary pharmacology & therapeutics 20020101
Pre and post eradication gastric inflammation in Helicobacter pylori-associated duodenal ulcer. Indian journal of gastroenterology : official journal of the Indian Society of Gastroenterology 20020101
[Circadian monitoring of intragastric pH in evaluation of efficiency of antisecretory therapy of duodenal ulcer]. Klinicheskaia meditsina 20020101
[Pharma-clinics medication of the month. Rabeprazole (Pariet)]. Revue medicale de Liege 20020101
Regression of duodenal gastric metaplasia in Helicobacter pylori positive patients with duodenal ulcer disease. Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver 20020101
The effects of rabeprazole on parietal cells and enterochromaffin-like cells in rats: a comparison with omeprazole. Journal of gastroenterology 20020101
Rabeprazole: quest for the best PPI. Journal of gastroenterology 20020101
Dual versus triple therapy in eradication of Helicobacter pylori. Hepato-gastroenterology 20020101
Efficacy of trimebutine therapy in patients with gastroesophageal reflux disease and irritable bowel syndrome. Hepato-gastroenterology 20020101
[Various mechanisms of cytoprotective effect of omeprazole and low intensity laser radiation on the gastroduodenal mucosa in the treatment of patients with duodenal ulcer]. Likars'ka sprava 20020101
Cost effectiveness of proton pump inhibitors in gastro-oesophageal reflux disease without oesophagitis: comparison of on-demand esomeprazole with conventional omeprazole strategies. PharmacoEconomics 20020101
Cost effectiveness of esomeprazole compared with omeprazole in the acute treatment of patients with reflux oesophagitis in the UK. PharmacoEconomics 20020101
Atypical and aggressive upper gastrointestinal ulceration associated with aspirin abuse. Journal of clinical gastroenterology 20020101
Prolonged use of proton pump inhibitors, CagA status, and the outcome of Helicobacter pylori gastritis. Journal of clinical gastroenterology 20020101
One-week quadruple therapy is an effective salvage regimen for Helicobacter pylori infection in patients after failure of standard triple therapy. Journal of clinical gastroenterology 20020101
Effect of omeprazole on regional and temporal variations in intragastric acidity. Digestion 20020101
Esomeprazole: a review of its use in the management of acid-related disorders in the US. Drugs 20020101
Determinants of headache in lansoprazole users in The Netherlands: results from a nested case-control study. Drug safety 20020101
Helicobacter pylori infection in skin diseases: a critical appraisal. American journal of clinical dermatology 20020101
Lansoprazole for maintenance of remission of erosive oesophagitis. Drugs 20020101
Gastric MALT-lymphoma, gastrin and cyclooxygenases. Acta gastro-enterologica Belgica 20020101
[Microflora of gastric juice in patients after eradication of Helicobacter pylori and treatment with a proton pump inhibitor]. Wiadomosci lekarskie (Warsaw, Poland : 1960) 20020101
[The gastric mucigenous function in the treatment of patients with ulcer with various antisecretory preparations]. Eksperimental'naia i klinicheskaia gastroenterologiia = Experimental & clinical gastroenterology 20020101
[Treatment of patients with ulcer associated with Helicobacter pylori (experience with a triple therapy regimen]. Eksperimental'naia i klinicheskaia gastroenterologiia = Experimental & clinical gastroenterology 20020101
[Inhibitors of proton pump in the treatment of non-ulcer functional dyspepsia of the reflux-like type]. Eksperimental'naia i klinicheskaia gastroenterologiia = Experimental & clinical gastroenterology 20020101
[Regeneration of the esophagus epitheliocytes. Evaluation of pariet efficacy in the treatment of patients with reflux esophagitis]. Eksperimental'naia i klinicheskaia gastroenterologiia = Experimental & clinical gastroenterology 20020101
Gastric neuroendocrine tumors in a 2-year oncogenicity study with CD-1 mice. Toxicologic pathology 20020101
Efficacy and tolerability of pantoprazole versus ranitidine in the treatment of reflux esophagitis and the influence of Helicobacter pylori infection on healing rate. Diseases of the esophagus : official journal of the International Society for Diseases of the Esophagus 20020101
[Intravenous 3-day Helicobacter pylori eradication therapy is highly effective in patients with bleeding peptic ulcer]. Gastroenterologia y hepatologia 20020101
Rabeprazole. Journal of postgraduate medicine 20020101
Esomeprazole: a review of its use in the management of acid-related disorders. Drugs 20020101
[Treatment of gastritis-associated Helicobacter pylori infection in children]. Revista de gastroenterologia del Peru : organo oficial de la Sociedad de Gastroenterologia del Peru 20020101
Long-term clinical outcome of elderly patients with reflux esophagitis: a six-month to three-year follow-up study. American journal of therapeutics 20020101
[Effect of various antisecretory drugs on morphological changes in rat gastric mucosa in experimental stomach ulcers]. Fiziolohichnyi zhurnal (Kiev, Ukraine : 1994) 20020101
Efficacy and tolerability of ranitidine bismuth citrate plus amoxycillin and clarithromycin as first- or second-line therapy to cure Helicobacter pylori infection. Hepato-gastroenterology 20020101
Low efficacy of an ultra-short term, once-daily dose triple therapy with omeprazole, azithromycin, and secnidazole for Helicobacter pylori eradication in peptic ulcer. Revista do Hospital das Clinicas 20020101
[Evaluation of efficacy, safety and tolerability rabeprazole in treatment of acid-peptic diseases ]. Arquivos de gastroenterologia 20020101
[Reactive polyarthritis and painful dermatographism caused by Helicobacter pylori]. Revista alergia Mexico (Tecamachalco, Puebla, Mexico : 1993) 20020101
Pharmacokinetics of omeprazole given by continuous intravenous infusion to patients with varying degrees of hepatic dysfunction. Clinical pharmacokinetics 20020101
The role of triple therapy, age, gender and smoking on the genotoxic effects of Helicobacter pylori infection. The Journal of international medical research 20020101
Polymorphism of CYP2C19 and gastric emptying in patients with proton pump inhibitor-resistant gastric ulcers. The Journal of international medical research 20020101
Long-term effect of Helicobacter pylori eradication on quality of life, body mass index, and newly developed diseases in Japanese patients with peptic ulcer disease. Hepato-gastroenterology 20020101
Patients have treatment preferences: a multicentre, double-blind, crossover study comparing rabeprazole and omeprazole. Current medical research and opinion 20020101
[Effectiveness of pariet (rabeprazole) in the treatment of gastroesophageal reflux disease (at the reflux-esophagitis stage)]. Eksperimental'naia i klinicheskaia gastroenterologiia = Experimental & clinical gastroenterology 20020101
[Seven-day antihelicobacter therapy of duodenal ulcer associated with Helicobacter pylori and prospects for treating patients]. Eksperimental'naia i klinicheskaia gastroenterologiia = Experimental & clinical gastroenterology 20020101
[Pariet in eradication therapy plans]. Eksperimental'naia i klinicheskaia gastroenterologiia = Experimental & clinical gastroenterology 20020101
[Submicroscopic aspects of the mechanism of inhibitors of H+/K+-ATPase in gastric parietal cells]. Eksperimental'naia i klinicheskaia gastroenterologiia = Experimental & clinical gastroenterology 20020101
[Clinico-functional evaluation of the efficacy of treating gastroesophageal reflux disease combined with bronchial asthma with omeprazole]. Terapevticheskii arkhiv 20020101
[Fromilid (clarithromycin) in eradication patients in patients with duodenal ulcer associated with Helicobacter pylori (comparison of two treatment variations)]. Terapevticheskii arkhiv 20020101
[Fromilide (clarithromycin) in eradication of Helicobacter pylori in patients with duodenal ulcer]. Antibiotiki i khimioterapiia = Antibiotics and chemoterapy [sic] 20020101
Efficacy of the eradication of Helicobacter pylori infection in patients with chronic urticaria. A placebo-controlled double blind study. Allergologia et immunopathologia 20020101
[Results of pre- and postoperative treatment of complicated duodenal ulcers with proton pump inhibitors ]. Klinicheskaia meditsina 20020101
[Concerning the discussion article by I. A. Morozov 'Choice of the gastroenterologist']. Klinicheskaia meditsina 20020101
Mixed infection due to leptospira and dengue. Indian journal of gastroenterology : official journal of the Indian Society of Gastroenterology 20020101
Interaction between lansoprazole and bromocriptine in a patient with Parkinson's disease. Therapie 20020101
Long-term effects of Helicobacter pylori eradication in Mongolian gerbils. Journal of gastroenterology 20020101
The clinical importance of proton pump inhibitor pharmacokinetics. Digestion 20020101
Omeprazole, furazolidone, and tetracycline: an eradication treatment for resistant H. pylori in Brazilian patients with peptic ulcer disease. Revista do Hospital das Clinicas 20020101
Presence on human chromosome 10 of omeprazole-sensitivity gene whose product mediates CYP1A1 induction. Cytogenetic and genome research 20020101
[Microcirculation in gastric mucosa as related to its secretory activity in patients with peptic ulcer]. Likars'ka sprava 20020101
Tenatoprazole. Benatoprazole, TU 199. Drugs in R&D 20020101
Anaphylaxis to proton pump inhibitors. Allergologia et immunopathologia 20020101
[Typical and atypical symptoms of laryngopharyngeal reflux disease]. Medicina (Kaunas, Lithuania) 20020101
Does chemoprevention of Barrett's esophagus using acid suppression and/or COX-2 inhibition prevent neoplastic progression? Reviews in gastroenterological disorders 20020101
Eradication therapy with rabeprazole versus omeprazole in the treatment of active duodenal ulcer. Digestion 20020101
Esomeprazole: update and clinical review. Reviews in gastroenterological disorders 20020101
[Esophageal epithelial cells renewal in evaluation of the pariet efficacy in the treatment of patients with reflux esophagitis]. Eksperimental'naia i klinicheskaia gastroenterologiia = Experimental & clinical gastroenterology 20020101
[A case of the successful treatment of the esophageal leukoplakia with rabeprazole]. Eksperimental'naia i klinicheskaia gastroenterologiia = Experimental & clinical gastroenterology 20020101
[Acid-base blood balance in patients with ulcer under treatment by the gastric secretion inhibitors and antacids]. Eksperimental'naia i klinicheskaia gastroenterologiia = Experimental & clinical gastroenterology 20020101
[Visual documentation of the stability of intravenous solutions of omeprazole (Losec) and pantoprazole (Pantoloc)]. Wiener medizinische Wochenschrift (1946) 20020101
Modulation of the phototoxic effect of hypericin in human leukemia CEM cell line by N-ethylmaleimide, amiloride and omeprazole. Physiological research 20020101
Interaction between various resistance modifiers and apoptosis inducer 12H-benzo[alpha]phenothiazine. Anticancer research 20020101
ATPase inhibitors suppress actinomycin D-induced apoptosis in leukemia cells. Anticancer research 20020101
Effect of omeprazole on plasma zinc levels after oral zinc administration. Indian journal of gastroenterology : official journal of the Indian Society of Gastroenterology 20020101
In vitro study on capsule formulations of omeprazole containing enteric coated granules. Bollettino chimico farmaceutico 20020101
Safety of lansoprazole in the treatment of gastroesophageal reflux disease in children. Journal of pediatric gastroenterology and nutrition 20020101
Efficacy of lansoprazole in the treatment of gastroesophageal reflux disease in children. Journal of pediatric gastroenterology and nutrition 20020101
Pharmacokinetics and pharmacodynamics of lansoprazole in children with gastroesophageal reflux disease. Journal of pediatric gastroenterology and nutrition 20020101
Lansoprazole in adolescents with gastroesophageal reflux disease: pharmacokinetics, pharmacodynamics, symptom relief efficacy, and tolerability. Journal of pediatric gastroenterology and nutrition 20020101
Assessment of effectiveness of different dosage regimens of pantoprazole in controlling symptoms and healing esophageal lesions of patients with mild erosive esophagitis. Arquivos de gastroenterologia 20020101
[Clinical aspects of using pariet in treating chronic pancreatitis]. Eksperimental'naia i klinicheskaia gastroenterologiia = Experimental & clinical gastroenterology 20020101
[Rhabdomyolysis during treatment with rabeprazole (Pariel), a proton pump inhibitor combined with domperidone (Peridys)]. Therapie 20020101
[Changes in the ultrastructure of the stomach mucous membrane parietal cells caused by inhibitors of hydrochloric acid secretion]. Arkhiv patologii 20020101
Amoxycillin, clarithromycin and either sucralfate or pantoprazole for eradication of Helicobacter pylori in duodenal ulcer (a randomized controlled trial). Wiener klinische Wochenschrift 20011217
Duodenal mucosa-associated lymphoid tissue lymphoma treated by eradication of Helicobacter pylori: report of 2 cases including EUS findings. Gastrointestinal endoscopy 20011201
Localization of [14C]amoxicillin in rat gastric tissue when administered with lansoprazole and clarithromycin. The Journal of antimicrobial chemotherapy 20011201
Effect of inhibition of gastric acid secretion on antropyloroduodenal motor activity and duodenal acid hypersensitivity in functional dyspepsia. Alimentary pharmacology & therapeutics 20011201
Effects of CYP2C19 genotypic differences in the metabolism of omeprazole and rabeprazole on intragastric pH. Alimentary pharmacology & therapeutics 20011201
Helicobacter pylori eradication is superior to ulcer healing with or without maintenance therapy to prevent further ulcer haemorrhage. Alimentary pharmacology & therapeutics 20011201
Rabeprazole-based 3-day and 7-day triple therapy vs. omeprazole-based 7-day triple therapy for the treatment of Helicobacter pylori infection. Alimentary pharmacology & therapeutics 20011201
Gastro-duodenal protection in an era of cyclo-oxygenase-2-selective nonsteroidal anti-inflammatory drugs. European journal of gastroenterology & hepatology 20011201
One week of treatment with esomeprazole-based triple therapy eradicates Helicobacter pylori and heals patients with duodenal ulcer disease. European journal of gastroenterology & hepatology 20011201
[Long-term therapy of gastrooesophageal reflux disease: Medical treatment or anti-reflux surgery?]. Zeitschrift fur Gastroenterologie 20011201
Transfer of clarithromycin to gastric juice is enhanced by omeprazole in Helicobacter pylori-infected individuals. Scandinavian journal of gastroenterology 20011201
Regular-dose versus high-dose omeprazole in peptic ulcer bleeding: a prospective randomized double-blind study. Scandinavian journal of gastroenterology 20011201
The influence of commonly prescribed synthetic drugs for peptic ulcer on the pharmacokinetic fate of glycyrrhizin from Shaoyao-Gancao-tang. Biological & pharmaceutical bulletin 20011201
Pretreatment gastric histology is helpful to predict the symptomatic response after H. pylori eradication in patients with nonulcer dyspepsia. Digestive diseases and sciences 20011201
Interaction of omeprazole, lansoprazole and pantoprazole with P-glycoprotein. Naunyn-Schmiedeberg's archives of pharmacology 20011201
Clinical efficacy of proton pump inhibitor therapy in neurologically impaired children with gastroesophageal reflux: prospective study. Hong Kong medical journal = Xianggang yi xue za zhi 20011201
Oral pantoprazole for acid suppression in the treatment of patients with Zollinger-Ellison syndrome. Canadian journal of gastroenterology = Journal canadien de gastroenterologie 20011201
Replacement of oral proton pump inhibitors with intravenous pantoprazole to effectively control gastric acid hypersecretion in patients with Zollinger-Ellison syndrome. The American journal of gastroenterology 20011201
Acute interstitial nephritis due to omeprazole. The American journal of gastroenterology 20011201
Proton pump inhibitors and gastric acid secretion. The American journal of gastroenterology 20011201
Omeprazole versus ranitidine in the medical treatment of acute upper gastrointestinal bleeding: assessment by early repeat endoscopy. International journal of clinical practice 20011201
Pharmacological regulation of gastric acid secretion in the apical membrane of parietal cells; a new target for antisecretory drugs. Journal of physiology and pharmacology : an official journal of the Polish Physiological Society 20011201
Meta-analysis of proton pump inhibitors in treatment of bleeding peptic ulcers. The Annals of pharmacotherapy 20011201
Gastroesophageal reflux and obstructive sleep apnea. The Laryngoscope 20011201
Evaluation of omeprazole in the treatment of reflux laryngitis: a prospective, placebo-controlled, randomized, double-blind study. The Laryngoscope 20011201
[Medical treatment of hemorrhaging ulcer]. Presse medicale (Paris, France : 1983) 20011201
[Successful treatment of refractory idiopathic thrombocytopenic purpura by eradication of Helicobacter pylori]. [Rinsho ketsueki] The Japanese journal of clinical hematology 20011201
Role of CYP3A4 and CYP2C19 in the stereoselective metabolism of lansoprazole by human liver microsomes. European journal of clinical pharmacology 20011201
Helicobacter pylori eradication: do we have another ace up our sleeve? Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver 20011201
Absence of platelet response after eradication of Helicobacter pylori infection in patients with chronic idiopathic thrombocytopenic purpura. British journal of haematology 20011201
Problems associated with the clinical use of proton pump inhibitors. Pharmacology & toxicology 20011201
[Helicobacter pylori increases the antisecretory activity of omeprazole in the parietal cell and the proton pump]. Gastroenterologie clinique et biologique 20011201
A systematic gene expression screen of Caenorhabditis elegans cytochrome P450 genes reveals CYP35 as strongly xenobiotic inducible. Archives of biochemistry and biophysics 20011115
Prospective study of Helicobacter pylori eradication therapy in stage I(E) high-grade mucosa-associated lymphoid tissue lymphoma of the stomach. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20011115
Intravenous omeprazole after endoscopic treatment of bleeding peptic ulcers. Gut 20011101
Duodenal fat intensifies the perception of heartburn. Gut 20011101
Helicobacter pylori eradication does not exacerbate reflux symptoms in gastroesophageal reflux disease. Gastroenterology 20011101
Systematic review of proton pump inhibitors for the acute treatment of reflux oesophagitis. Alimentary pharmacology & therapeutics 20011101
Evaluation of the cost-effectiveness of Helicobacter pylori eradication triple therapy vs. conventional therapy for ulcers in Japan. Alimentary pharmacology & therapeutics 20011101
A randomized comparison of four omeprazole-based triple therapy regimens for the eradication of Helicobacter pylori in patients with non-ulcer dyspepsia. Alimentary pharmacology & therapeutics 20011101
Long-term lansoprazole control of gastric acid and pepsin secretion in ZE and non-ZE hypersecretors: a prospective 10-year study. Alimentary pharmacology & therapeutics 20011101
A comparison of simplified lansoprazole suspension administered nasogastrically and pantoprazole administered intravenously: effects on 24-h intragastric pH. Alimentary pharmacology & therapeutics 20011101
Long-term lansoprazole treatment for gastro-oesophageal reflux disease: clinical efficacy and influence on gastric mucosa. Alimentary pharmacology & therapeutics 20011101
Efficacy of medical therapy and antireflux surgery to prevent Barrett's metaplasia in patients with gastroesophageal reflux disease. Annals of surgery 20011101
Regression of primary high-grade gastric B-cell lymphoma following Helicobacter pylori eradication. European journal of gastroenterology & hepatology 20011101
Resolution of granulomatous rosacea after eradication of Helicobacter pylori with clarithromycin, metronidazole and pantoprazole. European journal of gastroenterology & hepatology 20011101
Helicobacter pylori-induced reduction of acute levodopa absorption in Parkinson's disease patients. Annals of neurology 20011101
Fundic gland polyps are not induced by proton pump inhibitor therapy. American journal of clinical pathology 20011101
Omeprazole combined with amoxicillin and clarithromycin in the eradication of Helicobacter pylori in children with gastritis: A prospective randomized double-blind trial. The Journal of pediatrics 20011101
Health-Related quality-of-life and quality-days incrementally gained in symptomatic nonerosive GERD patients treated with lansoprazole or ranitidine. Digestive diseases and sciences 20011101
Clarithromycin resistance, but not CYP2C-19 polymorphism, has a major impact on treatment success in 7-day treatment regimen for cure of H. pylori infection: a multiple logistic regression analysis. Digestive diseases and sciences 20011101
Assessment of cytochrome P450 activity by a five-drug cocktail approach. Clinical pharmacology and therapeutics 20011101
Effect of high-dose lansoprazole on intragastic pH in subjects who are homozygous extensive metabolizers of cytochrome P4502C19. Clinical pharmacology and therapeutics 20011101
Comparing lansoprazole and omeprazole in onset of heartburn relief: results of a randomized, controlled trial in erosive esophagitis patients. The American journal of gastroenterology 20011101
Effect of long-term omeprazole treatment on antral G and D cells in children. Journal of pediatric gastroenterology and nutrition 20011101
Antiulcerogenic effect of Hippophae rhamnoides L. Phytotherapy research : PTR 20011101
Fine-needle aspiration biopsy of an intra-abdominal inflammatory mass secondary to a penetrating duodenal ulcer mimicking neoplasm. Diagnostic cytopathology 20011101
Pill-induced esophagitis caused by lansoprazole. Journal of gastroenterology 20011101
Effects of CYP2C19 gene polymorphism on cure rates for Helicobacter pylori infection by triple therapy with proton pump inhibitor (omeprazole or rabeprazole), amoxycillin and clarithromycin in Japan. Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver 20011101
Two new treatment regimens for Helicobacter pylori eradication: a randomised study. Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver 20011101
Changes in gastric mucosa and luminal environment during acid-suppressive therapy: a review in depth. Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver 20011101
Improving opportunities for effective management of gastro-oesophageal reflux disease. Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver 20011101
Treatment of erosive oesophagitis with omeprazole: a comparison with different delivery system. Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver 20011101
Correlation between omeprazole hydroxylase and CYP2C19 genotype in North Indians. European journal of clinical pharmacology 20011101
Laryngospasm: an atypical manifestation of severe gastroesophageal reflux disease (GERD). The Laryngoscope 20011101
In vitro study of the interaction between omeprazole and the metal ions Zn(II), Cu(II), and Co(II). Die Pharmazie 20011101
[Lansoprazole-associated collagenous colitis]. Gastroenterologie clinique et biologique 20011101
Cluster headache without autonomic symptoms? Cephalalgia : an international journal of headache 20011101
Vitamin C inhibits corpus gastritis in Helicobacter pylori-infected patients during acid-suppressive therapy. Journal of gastroenterology and hepatology 20011101
Influence of Helicobacter pylori infection and cetraxate on gastric mucosal blood flow during healing of endoscopic mucosal resection-induced ulcers. Journal of gastroenterology and hepatology 20011101
Effect of omeprazole-induced achlorhydria on trefoil peptide expression in the rat stomach. Journal of gastroenterology and hepatology 20011101
The stomach divalent ion-sensing receptor scar is a modulator of gastric acid secretion. The Journal of biological chemistry 20011026
Ticlopidine as a selective mechanism-based inhibitor of human cytochrome P450 2C19. Biochemistry 20011009
Intragastric pH regulates conversion from net acid to net alkaline secretion by the rat stomach. American journal of physiology. Gastrointestinal and liver physiology 20011001
The cost of long term therapy for gastro-oesophageal reflux disease: a randomised trial comparing omeprazole and open antireflux surgery. Gut 20011001
Prediction of human hepatic clearance from in vivo animal experiments and in vitro metabolic studies with liver microsomes from animals and humans. Drug metabolism and disposition: the biological fate of chemicals 20011001
Does the widespread use of proton pump inhibitors mask, complicate and/or delay the diagnosis of Zollinger-Ellison syndrome? Alimentary pharmacology & therapeutics 20011001
Pharmacokinetics and pharmacodynamics of esomeprazole, the S-isomer of omeprazole. Alimentary pharmacology & therapeutics 20011001
Comparable clinical efficacy and tolerability of 20 mg pantoprazole and 20 mg omeprazole in patients with grade I reflux oesophagitis. Alimentary pharmacology & therapeutics 20011001
Prevention and treatment of gastrointestinal symptoms and complications due to NSAIDs. Best practice & research. Clinical gastroenterology 20011001
Black esophagus: an unusual finding during routine endoscopy. Endoscopy 20011001
Intravenous omeprazole in critically ill patients: a randomized, crossover study comparing 40 with 80 mg plus 8 mg/hour on intragastric pH. Critical care medicine 20011001
Long-term omeprazole treatment suppresses body weight gain and bone mineralization in young male rats. Scandinavian journal of gastroenterology 20011001
Proton pump inhibitor resistance in the treatment of laryngopharyngeal reflux. Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery 20011001
Ultrashort regimen of lansoprazole-amoxicillin-azithromycin for eradicating Helicobacter pylori. American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists 20011001
Recrudescence and reinfection with Helicobacter pylori after eradication therapy in Bangladeshi adults. Gastroenterology 20011001
First successful treatment of a primary high-grade gastric MALT lymphoma by eradication therapy for Helicobacter pylori. Gastroenterology 20011001
What is the best pharmacologic approach to managing moderate to severe heartburn? The Journal of family practice 20011001
[GERD (gastroesophageal reflux disease)]. Nihon rinsho. Japanese journal of clinical medicine 20011001
Clinical relevance of genetic polymorphisms in the human CYP2C subfamily. British journal of clinical pharmacology 20011001
[Pharmacological study on the pathological changes of the gastric mucosa in Helicobacter pylori-infected Mongolian gerbils]. Nihon yakurigaku zasshi. Folia pharmacologica Japonica 20011001
Endogenous gastrin stimulates regeneration of remnant pancreas after partial pancreatectomy. Digestive diseases and sciences 20011001
Bioequivalence between omeprazole MUPS 20 mg as tablet and omeprazole MUPS 20 mg as tablet encapsulated in a hard gelatine capsule. International journal of clinical pharmacology and therapeutics 20011001
A bioavailability/bioequivalence study of two oral lansoprazole formulations after single administration to healthy volunteers. Die Pharmazie 20011001
Heartburn. The new purple pill is it any better? Harvard health letter 20011001
The role of treatment with proton pump inhibitors and anti-Helicobacter therapy in functional dyspepsia. The American journal of gastroenterology 20011001
Helicobacter pylori eradication and standardized 3-month omeprazole therapy in functional dyspepsia. The American journal of gastroenterology 20011001
Quantitative assessment of gastric corpus atrophy in subjects using omeprazole: a randomized follow-up study. The American journal of gastroenterology 20011001
Symptom relief in gastroesophageal reflux disease: a randomized, controlled comparison of pantoprazole and nizatidine in a mixed patient population with erosive esophagitis or endoscopy-negative reflux disease. The American journal of gastroenterology 20011001
Effects of acid inhibition on somatostatin-producing cells in the rat gastric fundus. Acta histochemica 20011001
[Laryngeal manifestations of gastroesophageal reflux disease (GERD) in pediatric patients: the usefulness of therapeutic (proton pump inhibitor (PPI)) trials]. Nihon Jibiinkoka Gakkai kaiho 20011001
Effect of aggressive therapy on laryngeal symptoms and voice characteristics in patients with gastroesophageal reflux. Acta oto-laryngologica 20011001
Gastroesophageal reflux in infants and children. When to reassure and when to go further. Canadian family physician Medecin de famille canadien 20011001
Optimizing acid-suppression therapy. Managed care (Langhorne, Pa.) 20011001
[Modern means of anti-Helicobacter therapy]. Voenno-meditsinskii zhurnal 20011001
Clinical pharmacology and safety profile of esomeprazole, the first enantiomerically pure proton pump inhibitor. Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver 20011001
Lansoprazole: pharmacokinetics, pharmacodynamics and clinical uses. Expert opinion on pharmacotherapy 20011001
Cervical osteophyte induced dysphagia. The Journal of the Association of Physicians of India 20011001
Effects of CCK2 receptor blockade on growth parameters in gastrointestinal tract and pancreas in rats. Pharmacology & toxicology 20011001
Noninvasive Helicobacter pylori testing for the 'test-and-treat' strategy: a decision analysis to assess the effect of past infection on test choice. Archives of internal medicine 20010924
Clinical and ethical concerns about switching patient treatment to 'therapeutically interchangeable' medications. Archives of internal medicine 20010924
[Comparative study of proton pump inhibitors]. Orvosi hetilap 20010909
Does short-term treatment with proton pump inhibitors cause rebound aggravation of symptoms? Journal of clinical gastroenterology 20010901
Gastric leptin and Helicobacter pylori infection. Gut 20010901
Drug treatments in upper gastrointestinal bleeding: value of endoscopic findings as surrogate end points. Gut 20010901
Intragastric volatile N-nitrosamines, nitrite, pH, and Helicobacter pylori during long-term treatment with omeprazole. Gastroenterology 20010901
High-dose omeprazole in esophagitis with stenosis after surgical treatment of esophageal atresia. Journal of pediatric surgery 20010901
Decreasing oesophageal acid exposure in patients with GERD: a comparison of rabeprazole and omeprazole. Alimentary pharmacology & therapeutics 20010901
Influence of pantoprazole on oesophageal motility, and bile and acid reflux in patients with oesophagitis. Alimentary pharmacology & therapeutics 20010901
Lansoprazole in children: pharmacokinetics and efficacy in reflux oesophagitis. Alimentary pharmacology & therapeutics 20010901
Influence of anti-Helicobacter triple-therapy with metronidazole, omeprazole and clarithromycin on intestinal microflora. Alimentary pharmacology & therapeutics 20010901
Efficacy of triple therapy with rabeprazole for Helicobacter pylori infection and CYP2C19 genetic polymorphism. Alimentary pharmacology & therapeutics 20010901
Intragastric distribution of Helicobacter pylori during short-term omeprazole therapy: study using Carnoy's fixation and immunohistochemistry for detection of bacteria. Alimentary pharmacology & therapeutics 20010901
[Progress in study for mechanism of gastric mucosal injury]. Nihon rinsho. Japanese journal of clinical medicine 20010901
Review article: long-term use of proton pump inhibitors in GORD--help or hindrance? Alimentary pharmacology & therapeutics 20010901
Review article: tackling the 'dyspeptic problem'. Alimentary pharmacology & therapeutics 20010901
Review article: managing the dyspeptic patient--an interactive discussion. Alimentary pharmacology & therapeutics 20010901
Omeprazole as adjuvant therapy to endoscopic combination injection sclerotherapy for treating bleeding peptic ulcer. The American journal of medicine 20010901
Disappearance of both MALT lymphoma and hyperplastic polyps in the stomach after eradication of Helicobacter pylori. The American journal of gastroenterology 20010901
Bismuth-based quadruple therapy with bismuth subcitrate, metronidazole, tetracycline and omeprazole in the eradication of Helicobacter pylori. Canadian journal of gastroenterology = Journal canadien de gastroenterologie 20010901
Impairment of gastric secretion modulation in duodenal ulcer and in long-term PPI treatment: quantitative morphologic findings and pathophysiologic implications. Digestive diseases and sciences 20010901
Remission of a high-grade gastric mucosa associated lymphoid tissue (MALT) lymphoma following Helicobacter pylori eradication and highly active antiretroviral therapy in a patient with AIDS. The American journal of medicine 20010901
Effects of therapy with lansoprazole on intestinal permeability and inflammation in young cystic fibrosis patients. Journal of pediatric gastroenterology and nutrition 20010901
Are children with cystic fibrosis who are treated with a proton-pump inhibitor at risk for vitamin B(12) deficiency? Journal of pediatric gastroenterology and nutrition 20010901
Involvement of heat shock proteins in the healing of acetic acid-induced gastric ulcers in rats. Journal of physiology and pharmacology : an official journal of the Polish Physiological Society 20010901
Clarithromycin resistance of Helicobacter pylori has a major impact on the efficacy of the omeprazole-amoxicillin-clarithromycin therapy. Pathologie-biologie 20010901
[Comparative antisecretory activity of famotidine, omeprazole, and rabeprazole (pariet) in ulcer disease based on daily pH-monitoring]. Voenno-meditsinskii zhurnal 20010901
A multicenter, double-blind study on triple therapy with lansoprazole, amoxicillin and clarithromycin for eradication of Helicobacter pylori in Japanese peptic ulcer patients. Helicobacter 20010901
Comparison of the kinetic disposition of and serum gastrin change by lansoprazole versus rabeprazole during an 8-day dosing scheme in relation to CYP2C19 polymorphism. European journal of clinical pharmacology 20010901
[Complementary observational study of the efficacy, tolerance and safety of lansoprazole 15 mg as maintenance therapy of reflux esophagitis in daily medical practice in Belgium (record RU49749/R002]. Revue medicale de Liege 20010901
Resolution of Menetrier's disease after Helicobacter pylori eradication therapy. The New Zealand medical journal 20010824
Comparative pharmacokinetics and pharmacodynamics of lansoprazole oral capsules and suspension in healthy subjects. American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists 20010815
Membrane potential changes after infection of monocytes by Toxoplasma gondii. International journal for parasitology 20010801
The effectiveness of one-week triple eradication therapy for perforated duodenal ulcer patients treated with simple closure. Journal of clinical gastroenterology 20010801
SODA (severity of dyspepsia assessment): a new effective outcome measure for dyspepsia-related health. Journal of clinical epidemiology 20010801
Efficacy of ecabet sodium for Helicobacter pylori eradication triple therapy in comparison with a lansoprazole-based regimen. Alimentary pharmacology & therapeutics 20010801
Relaxation induced by omeprazole does not change in diabetic rabbit corpus cavernosum. BJU international 20010801
Effect of acid secretion blockade by omeprazole on the relative bioavailability of orally administered furazolidone in healthy volunteers. British journal of clinical pharmacology 20010801
Effect of grapefruit juice on the disposition of omeprazole. British journal of clinical pharmacology 20010801
High-dose proton-pump inhibitors as a diagnostic test of gastro-oesophageal reflux disease in endoscopic-negative patients. Scandinavian journal of gastroenterology 20010801
A study of 13 patients with gastric tube in place after esophageal resection: use of omeprazole to decrease gastric acidity and volume. Journal of clinical anesthesia 20010801
Disappearance of antiphospholipid antibodies syndrome after Helicobacter pylori eradication. The American journal of medicine 20010801
The relationship between gastric-oral Helicobacter pylori and oral hygiene in patients with vitamin B12-deficiency anemia. Oral surgery, oral medicine, oral pathology, oral radiology, and endodontics 20010801
No clinical benefit of adding cisapride to pantoprazole for treatment of gastro-oesophageal reflux disease. European journal of gastroenterology & hepatology 20010801
Famotidine versus omeprazole, in combination with amoxycillin and tinidazole, for eradication of Helicobacter pylori infection. European journal of gastroenterology & hepatology 20010801
A randomised controlled trial of four management strategies for dyspepsia: relationships between symptom subgroups and strategy outcome. The British journal of general practice : the journal of the Royal College of General Practitioners 20010801
Strategies for diagnosis and short and long term treatment: respondent overview. The American journal of gastroenterology 20010801
Helicobacter pylori eradication treatment does not benefit patients with nonulcer dyspepsia. The American journal of gastroenterology 20010801
[Administration of proton pump inhibitor caused esophageal stenosis in two patients with severe reflux esophagitis]. Nihon Shokakibyo Gakkai zasshi = The Japanese journal of gastro-enterology 20010801
Pharmacokinetics of pantoprazole in patients with moderate and severe hepatic dysfunction. Clinical therapeutics 20010801
Intravenous omeprazole in children: pharmacokinetics and effect on 24-hour intragastric pH. Journal of pediatric gastroenterology and nutrition 20010801
Remission of idiopathic thrombocytopenic purpura by eradicating Helicobacter pylori after omeprazole monotherapy. International journal of hematology 20010801
Key topics in Helicobacter pylori eradication in the management of the dyspeptic patient: a panel discussion. European journal of gastroenterology & hepatology 20010801
Helicobacter pylori eradication in functional dyspepsia: new evidence for symptomatic benefit. European journal of gastroenterology & hepatology 20010801
Diagnostic methods for detecting forms and strains of Helicobacter pylori and evaluation of its eradication. Bulletin of experimental biology and medicine 20010801
Cost-effectiveness of proton-pump inhibitors for maintenance therapy of erosive reflux esophagitis. American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists 20010715
Acute fulminant hepatitis after treatment with rabeprazole and terbinafine. Archives of internal medicine 20010709
Preventing upper gastrointestinal bleeding in patients with Helicobacter pylori infection. The New England journal of medicine 20010705
Anticonvulsant activity of omeprazole in rats. Epilepsy research 20010701
ClC-2 Cl- channels in human lung epithelia: activation by arachidonic acid, amidation, and acid-activated omeprazole. American journal of physiology. Cell physiology 20010701
The pharmacological effect of omeprazole on water gastric emptying: A study based on an impedance measure. Pharmacology 20010701
Pathological documentation of complete elimination of Barrett's metaplasia following endoscopic multipolar electrocoagulation therapy. Gut 20010701
Increasing concerns about chronic proton pump inhibitor use. Journal of clinical gastroenterology 20010701
Effect of long-term, continuous versus alternate-day omeprazole therapy on serum gastrin in patients treated for reflux esophagitis. Journal of clinical gastroenterology 20010701
Ranitidine bismuth citrate-based triple therapies after failure of the standard 'Maastricht triple therapy': a promising alternative to the quadruple therapy? Alimentary pharmacology & therapeutics 20010701
Predictors of failure of Helicobacter pylori eradication with the standard 'Maastricht triple therapy'. Alimentary pharmacology & therapeutics 20010701
Cure of Helicobacter pylori infection in elderly patients: comparison of low versus high doses of clarithromycin in combination with amoxicillin and pantoprazole. Alimentary pharmacology & therapeutics 20010701
Is a one-week course of triple anti-Helicobacter pylori therapy sufficient to control active duodenal ulcer? Alimentary pharmacology & therapeutics 20010701
Modified seven-day, quadruple therapy as a first line Helicobacter pylori treatment. Alimentary pharmacology & therapeutics 20010701
Potential gastrointestinal effects of long-term acid suppression with proton pump inhibitors. Alimentary pharmacology & therapeutics 20010701
Quadruple therapy for symptomatic spontaneous duodenal ulcer disease. Postgraduate medical journal 20010701
Regression of primary lymphoma of the ampulla of Vater after eradication of Helicobacter pylori. Gastrointestinal endoscopy 20010701
Follow-up of Barrett's epithelium after ablation by endoscopic argon plasma coagulation. Gastrointestinal endoscopy 20010701
Noninvasive stool antigen assay can effectively screen Helicobacter pylori Infection and assess success of eradication therapy in hemodialysis patients. American journal of kidney diseases : the official journal of the National Kidney Foundation 20010701
A prospective study of a one-week nonbismuth quadruple therapy for childhood Helicobacter pylori infection. Journal of pediatric surgery 20010701
Seriate histomorphometry of whole rat stomach: an accurate and reliable method for quantitative analysis of mucosal damage. Toxicology and applied pharmacology 20010701
Neuroendocrine-specific and gastrin-dependent expression of a chromogranin A-luciferase fusion gene in transgenic mice. Gastroenterology 20010701
Pooled analysis on the efficacy of the second-line treatment regimens for Helicobacter pylori infection. Scandinavian journal of gastroenterology 20010701
Helicobacter pylori and iron deficiency anaemia in children. Scandinavian journal of gastroenterology 20010701
A randomized open trial for comparison of proton pump inhibitors, omeprazole versus rabeprazole, in dual therapy for Helicobacter pylori infection in relation to CYP2C19 genetic polymorphism. Journal of gastroenterology and hepatology 20010701
Effect of intravenous omeprazole on recurrent bleeding after endoscopic treatment of bleeding peptic ulcers. Gastrointestinal endoscopy 20010701
Chronic middle ear disease and gastroesophageal reflux disease: a causal relation? Otology & neurotology : official publication of the American Otological Society, American Neurotology Society [and] European Academy of Otology and Neurotology 20010701
Effects on 24-hour intragastric pH: a comparison of lansoprazole administered nasogastrically in apple juice and pantoprazole administered intravenously. The American journal of gastroenterology 20010701
Relapse prevention in reflux oesophagitis with regard to Helicobacter pylori status: a double-blind, randomized, multicentre trial to compare the efficacy of pantoprazole versus ranitidine. European journal of gastroenterology & hepatology 20010701
Impact of a formulary change in proton pump inhibitors on health care costs and patients' symptoms. Digestive diseases and sciences 20010701
Effectiveness of acid suppression in preventing gastroesophageal reflux disease (GERD) after successful treatment of Helicobacter pylori infection. Digestive diseases and sciences 20010701
Pseudomembranous colitis without diarrhoea following Helicobacter pylori eradication therapy. Hospital medicine (London, England : 1998) 20010701
Possible phototoxicity with subsequent progression to discoid lupus following pantoprazole administration. Clinical and experimental dermatology 20010701
Short-term changes in Helicobacter pylori gastritis and bulbitis during and after 2 weeks of treatment with omeprazole and amoxicillin in duodenal ulcer patients. Zeitschrift fur Gastroenterologie 20010701
Healing and relapse rates in gastroesophageal reflux disease treated with the newer proton-pump inhibitors lansoprazole, rabeprazole, and pantoprazole compared with omeprazole, ranitidine, and placebo: evidence from randomized clinical trials. Clinical therapeutics 20010701
[Comparative study of the eradication of Helicobacter pylori: ranitidine bismuth citrate versus omeprazole plus two antibiotics for seven days]. Anales de medicina interna (Madrid, Spain : 1984) 20010701
Pharmacoeconomic issues of the treatment of gastroesophageal reflux disease. Expert opinion on pharmacotherapy 20010701
Efficacy of a nitroimidazole containing tripletherapy regime in Singapore. Singapore medical journal 20010701
Inhibitor effect of omeprazole in isolated human myometrial smooth muscle. Life sciences 20010615
High-performance liquid chromatographic assay for the simultaneous determination of lansoprazole enantiomers and metabolites in human liver microsomes. Journal of chromatography. B, Biomedical sciences and applications 20010605
Helicobacter pylori and symptomatic relapse of gastro-oesophageal reflux disease: a randomised controlled trial. Lancet (London, England) 20010602
Helicobacter pylori eradication therapy for high-grade mucosa-associated lymphoid tissue lymphomas of the stomach with analysis of p53 and K-ras alteration and microsatellite instability. International journal of oncology 20010601
Proton pump inhibitors: a study of GPs' prescribing. Family practice 20010601
Acid regulates inflammatory response in a rat model of induction of gastric ulcer recurrence by interleukin 1beta. Gut 20010601
Preferential repair by squamous epithelium of thermal induced injury to the proximal stomach in patients undergoing ablation of Barrett's esophagus. Gastrointestinal endoscopy 20010601
Simultaneous intraesophageal impedance and pH measurement of acid and nonacid gastroesophageal reflux: effect of omeprazole. Gastroenterology 20010601
Effect of Helicobacter pylori eradication on cyclooxygenase 2 (COX-2) and inducible nitric oxide synthase (iNOS) expression during gastric adaptation to aspirin (ASA) in humans. Microscopy research and technique 20010601
Omeprazole determination using HPLC with coulometric detection. Journal of pharmaceutical and biomedical analysis 20010601
Eradication of Helicobacter pylori infection in patients with duodenal ulcer and non-ulcer dyspepsia and analysis of one-year reinfection rates. Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas 20010601
Pharmacodynamic effects and kinetic disposition of rabeprazole in relation to CYP2C19 genotypes. Alimentary pharmacology & therapeutics 20010601
Three-day lansoprazole quadruple therapy for Helicobacter pylori-positive duodenal ulcers: a randomized controlled study. Alimentary pharmacology & therapeutics 20010601
Fish oil (Eicosapen) is less effective than metronidazole, in combination with pantoprazole and clarithromycin, for Helicobacter pylori eradication. Alimentary pharmacology & therapeutics 20010601
Pantoprazole. American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists 20010601
Laryngopharyngeal reflux symptoms improve before changes in physical findings. The Laryngoscope 20010601
Proton-pump inhibitors for acute peptic ulcer bleeding. The Annals of pharmacotherapy 20010601
Treatment of gastroesophageal reflux disease: to step or not to step. The American journal of gastroenterology 20010601
Management of heartburn in a large, randomized, community-based study: comparison of four therapeutic strategies. The American journal of gastroenterology 20010601
Pantoprazole therapy in the long-term management of severe acid peptic disease: clinical efficacy, safety, serum gastrin, gastric histology, and endocrine cell studies. The American journal of gastroenterology 20010601
Surgery versus medical therapy for gastroesophageal reflux disease. The American journal of gastroenterology 20010601
Discoloured tongue: a new cause? The British journal of dermatology 20010601
Helicobacter pylori and early duodenal ulcer status post-treatment: a review. Helicobacter 20010601
Inhibitory action of a novel proton pump inhibitor, rabeprazole, and its thioether derivative against the growth and motility of clarithromycin-resistant Helicobacter pylori. Helicobacter 20010601
Is eradication of Helicobacter pylori with colloidal bismuth subcitrate quadruple therapy safe? Helicobacter 20010601
Strategy for retreatment of therapeutic failure of eradication of Helicobacter pylori infection. Journal of gastroenterology and hepatology 20010601
Clarithromycin-based triple therapy for non-resistant Helicobacter pylori infection. How long should it be given? Scandinavian journal of gastroenterology 20010601
Effects of omeprazole and pirenzepine on enterochromaffin-like cells and parietal cells in rat stomach. Journal of gastroenterology 20010601
An intervention trial to inhibit the progression of precancerous gastric lesions: compliance, serum micronutrients and S-allyl cysteine levels, and toxicity. European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation (ECP) 20010601
Effects of genotypic differences in CYP2C19 status on cure rates for Helicobacter pylori infection by dual therapy with rabeprazole plus amoxicillin. Pharmacogenetics 20010601
The AMOR study: a randomized, double-blinded trial of omeprazole versus ranitidine together with amoxycillin and metronidazole for eradication of Helicobacter pylori. European journal of gastroenterology & hepatology 20010601
Long-term management of gastro-eosophageal reflux disease with omeprazole or open antireflux surgery. European journal of gastroenterology & hepatology 20010601
Inhibition of hyphal growth of Candida albicans by activated lansoprazole, a novel benzimidazole proton pump inhibitor. Medical mycology 20010601
Is untargeted outreach visiting in primary care effective? A pragmatic randomized controlled trial. Journal of public health medicine 20010601
Factors associated with non-response in proton pump inhibitor users: a study of lansoprazole therapy. Pharmacy world & science : PWS 20010601
CYP2C19 genotype and pharmacokinetics of three proton pump inhibitors in healthy subjects. Pharmaceutical research 20010601
Eradication rates of Helicobacter pylori between metronidazole-sensitive and metronidazole-resistant strains with metronidazole containing regimen in Thai patients with peptic ulcer disease. Journal of the Medical Association of Thailand = Chotmaihet thangphaet 20010601
Analysis of variation in plasma concentrations of nelfinavir and its active metabolite M8 in HIV-positive patients. AIDS (London, England) 20010525
Editorial comment on Analysis of variation in plasma concentrations of nelfinavir and its active metabolite M8 in HIV-positive patients. AIDS (London, England) 20010525
Species comparison in P450 induction: effects of dexamethasone, omeprazole, and rifampin on P450 isoforms 1A and 3A in primary cultured hepatocytes from man, Sprague-Dawley rat, minipig, and beagle dog. Chemico-biological interactions 20010516
Use of omeprazole during pregnancy--no hazard demonstrated in 955 infants exposed during pregnancy. European journal of obstetrics, gynecology, and reproductive biology 20010501
Antibiotic resistance and antibiotic sensitivity based treatment in Helicobacter pylori infection: advantages and outcome. Archives of disease in childhood 20010501
Effective and safe endoscopic reversal of nondysplastic Barrett's esophagus with thermal electrocoagulation combined with high-dose acid inhibition: a multicenter study. Gastrointestinal endoscopy 20010501
Mobilization of rat stomach ECL-cell histamine in response to short- or long-term treatment with omeprazole and/or YF 476 studied by gastric submucosal microdialysis in conscious rats. British journal of pharmacology 20010501
Control of intragastric pH with omeprazole 20 mg, omeprazole 40 mg and lansoprazole 30 mg. Alimentary pharmacology & therapeutics 20010501
Impact of Helicobacter pylori resistance to clarithromycin on the efficacy of the omeprazole-amoxicillin-clarithromycin therapy. Alimentary pharmacology & therapeutics 20010501
The safety of proton pump inhibitors. Alimentary pharmacology & therapeutics 20010501
The association between antiulcer medication and initiation of cobalamin replacement in older persons. Journal of clinical epidemiology 20010501
Eradication of Helicobacter pylori from the stomach and duodenum of patients with duodenal ulcers. International journal of antimicrobial agents 20010501
Reversible pheripheral edema in female patients taking proton pump inhibitors for peptic acid diseases. Digestive diseases and sciences 20010501
Low incidence of Helicobacter pylori infection in patients with duodenal ulcer and chronic liver disease. Scandinavian journal of gastroenterology 20010501
Helicobacter pylori-negative duodenal ulcers: prevalence, clinical characteristics, and prognosis--results from a randomized trial with 2-year follow-up. The American journal of gastroenterology 20010501
Long-term omeprazole treatment and fundic gland polyps: a very authoritative proof against a link? The American journal of gastroenterology 20010501
Erythrodermia induced by omeprazole. International journal of clinical pharmacology and therapeutics 20010501
Impact of different therapeutic regimens on the outcome of patients with Crohn's disease of the upper gastrointestinal tract. Inflammatory bowel diseases 20010501
Asthma and gastro-oesophageal reflux: can the response to anti-reflux therapy be predicted? Respiratory medicine 20010501
A review of omeprazole use in the treatment of acid-related disorders in children. Clinical therapeutics 20010501
Lansoprazole-based triple therapy versus ranitidine bismuth citrate-based dual therapy in the eradication of Helicobacter pylori in patients with duodenal ulcer: a multicenter, randomized, double-dummy study. Clinical therapeutics 20010501
Proton pump inhibitors and their drug interactions: an evidence-based approach. European journal of gastroenterology & hepatology 20010501
Restoration of enamel and dentin erosion due to gastroesophageal reflux disease: a case report. Practical procedures & aesthetic dentistry : PPAD 20010501
An optimized methodology for combined phenotyping and genotyping on CYP2D6 and CYP2C19. European journal of clinical pharmacology 20010501
Lansoprazole triple therapy for Turkish children with Helicobacter pylori infections. Journal of pediatric gastroenterology and nutrition 20010501
Shortcomings of the first-generation proton pump inhibitors. European journal of gastroenterology & hepatology 20010501
New-generation proton pump inhibitors: overcoming the limitations of early-generation agents. European journal of gastroenterology & hepatology 20010501
Physicochemical characterization and evaluation of buccal adhesive tablets containing omeprazole. Drug development and industrial pharmacy 20010501
CYP2C19 genotype related effect of omeprazole on intragastric pH and antimicrobial stability. Pharmaceutical research 20010501
[Safety profile of pariet clinical use (a literature review)]. Voenno-meditsinskii zhurnal 20010501
Assay of omeprazole and omeprazole sulfone by semi-microcolumn liquid chromatography with mixed-function precolumn. Journal of chromatography. B, Biomedical sciences and applications 20010425
Omeprazole, its isomers, and the carcinoid question. Lancet (London, England) 20010421
Omeprazole isomer approved by FDA. American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists 20010415
Pharmacokinetic comparison of omeprazole capsules and a simplified omeprazole suspension. American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists 20010415
[H2 receptor antagonists and proton pump inhibitors: principles and rules of use]. La Revue du praticien 20010415
Helicobacter pylori and gastric cancer:current status of the Austrain Czech German gastric cancer prevention trial (PRISMA Study). World journal of gastroenterology 20010415
From the Food and Drug Administration. JAMA 20010404
Effect of the treatment of Helicobacter pylori infection on gastric emptying and its influence on the glycaemic control in type 1 diabetes mellitus. Diabetes research and clinical practice 20010401
Effects of lansoprazole, clarithromycin and pH gradient on uptake of [14C]amoxycillin into rat gastric tissue. The Journal of antimicrobial chemotherapy 20010401
Complete remission of primary high-grade B-cell gastric lymphoma after cure of Helicobacter pylori infection. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20010401
Nitrofurantoin quadruple therapy for Helicobacter pylori infection: effect of metronidazole resistance. Alimentary pharmacology & therapeutics 20010401
Maximal acid reflux control for Barrett's oesophagus: feasible and effective. Alimentary pharmacology & therapeutics 20010401
Pantoprazole and cyclosporine or tacrolimus. Alimentary pharmacology & therapeutics 20010401
Antireflux surgery in children suffering from reflux-associated respiratory disease? Pediatric pulmonology 20010401
Which patients with ulcer- or reflux-like dyspepsia will respond favorably to omeprazole? The Journal of family practice 20010401
Effect of omeprazole on the pharmacokinetics of moclobemide according to the genetic polymorphism of CYP2C19. Clinical pharmacology and therapeutics 20010401
Intragastric acidification reduces the occurrence of false-negative urea breath test results in patients taking a proton pump inhibitor. The American journal of gastroenterology 20010401
Stability of gastric secretory inhibition during 6-month treatment with omeprazole in patients with gastroesophageal reflux disease. The American journal of gastroenterology 20010401
Lansoprazole treatment of patients with chronic idiopathic laryngitis: a placebo-controlled trial. The American journal of gastroenterology 20010401
Does gastric juice pH influence tonometric PCO2 measured by automated air tonometry? American journal of respiratory and critical care medicine 20010401
Prevalence of gastric myoelectrical abnormalities in patients with nonulcer dyspepsia and H. pylori infection: resolution after H. pylori eradication. Digestive diseases and sciences 20010401
Intragastric nitric oxide/nitrite in Helicobacter pylori-infected subjects. Scandinavian journal of gastroenterology 20010401
Effects of pirenzepine, omeprazole, lansoprazole, and rabeprazole on human neutrophil functions. Canadian journal of anaesthesia = Journal canadien d'anesthesie 20010401
4-day triple therapy with rabeprazole, amoxicillin and clarithromycin in the eradication of Helicobacter pylori in patients with peptic ulcer disease--A pilot study. Zeitschrift fur Gastroenterologie 20010401
Relative contributions of CYP2C9 and 2C19 to phenytoin 4-hydroxylation in vitro: inhibition by sulfaphenazole, omeprazole, and ticlopidine. European journal of clinical pharmacology 20010401
Recurrent severe bleeding from gastrointestinal angiodysplasia in a patient with von Willebrand's disease, controlled with recombinant factor VIIa. Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis 20010401
[Pariet in current patterns of eradication of Helicobacter pylori infection]. Voenno-meditsinskii zhurnal 20010401
Omeprazole and excessive sweating. Prescrire international 20010401
[Adsorptive voltammetric behavior of omeprazole and its application]. Yao xue xue bao = Acta pharmaceutica Sinica 20010401
Preventing recurrent upper gastrointestinal bleeding in patients with Helicobacter pylori infection who are taking low-dose aspirin or naproxen. The New England journal of medicine 20010329
[Gynecomastia associated with the simultaneous use of cisapride and lansoprazole]. Medicina clinica 20010324
Haloperidol-stomach lesions attenuation by pentadecapeptide BPC 157, omeprazole, bromocriptine, but not atropine, lansoprazole, pantoprazole, ranitidine, cimetidine and misoprostol in mice. Life sciences 20010309
[Heartburn. Only a harmless symptom?]. MMW Fortschritte der Medizin 20010308
Improvement in atrophic gastritis and intestinal metaplasia in patients in whom Helicobacter pylori was eradicated. Annals of internal medicine 20010306
Predictive factors for regression of gastric MALT lymphoma after anti-Helicobacter pylori treatment. Gut 20010301
Esomeprazole 20 mg maintains symptom control in endoscopy-negative gastro-oesophageal reflux disease: a controlled trial of 'on-demand' therapy for 6 months. Alimentary pharmacology & therapeutics 20010301
One-week ranitidine bismuth citrate-based triple therapy for the eradication of Helicobacter pylori in Hong Kong with high prevalence of metronidazole resistance. Alimentary pharmacology & therapeutics 20010301
Clarithromycin vs. furazolidone in quadruple therapy regimens for the treatment of Helicobacter pylori in a population with a high metronidazole resistance rate. Alimentary pharmacology & therapeutics 20010301
Five-day proton pump inhibitor-based quadruple therapy regimen is more effective than 7-day triple therapy regimen for Helicobacter pylori infection. Alimentary pharmacology & therapeutics 20010301
Bioequivalence evaluation of lansoprazole 30-mg capsules (Lanfast and Lanzor) in healthy volunteers. European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V 20010301
A case of gastric plasmacytoma associated with Helicobacter pylori infection: improvement of abnormal endoscopic and EUS findings after H. pylori eradication. Gastrointestinal endoscopy 20010301
Stereoselective pharmacokinetics of pantoprazole, a proton pump inhibitor, in extensive and poor metabolizers of S-mephenytoin. Clinical pharmacology and therapeutics 20010301
Effect of genotypic differences in CYP2C19 on cure rates for Helicobacter pylori infection by triple therapy with a proton pump inhibitor, amoxicillin, and clarithromycin. Clinical pharmacology and therapeutics 20010301
Pharmacokinetic differences between lansoprazole enantiomers and contribution of cytochrome P450 isoforms to enantioselective metabolism of lansoprazole in dogs. Biological & pharmaceutical bulletin 20010301
Pharmacodynamic modeling of lansoprazole using an indirect irreversible response model. Journal of clinical pharmacology 20010301
Efficacy and safety of esomeprazole compared with omeprazole in GERD patients with erosive esophagitis: a randomized controlled trial. The American journal of gastroenterology 20010301
Electrochemical studies and differential pulse polarographic analysis of lansoprazole in pharmaceuticals. The Analyst 20010301
The effect of culture results for Helicobacter pylori on the choice of treatment following failure of initial eradication. The Israel Medical Association journal : IMAJ 20010301
[Long-term results of conservative management of reflux esophagitis]. Therapeutische Umschau. Revue therapeutique 20010301
Gastroprotective effect of aparisthman, a diterpene isolated from Aparisthmium cordatum, on experimental gastric ulcer models in rats and mice. Phytomedicine : international journal of phytotherapy and phytopharmacology 20010301
Peptic ulcer occurrence in follow-up of chronic gastritis in patients with treated and not eradicated CagA-positive Helicobacter pylori infection. Digestive diseases and sciences 20010301
Efficacy of rabeprazole once daily for acid-related disorders. Digestive diseases and sciences 20010301
Functionally impaired, hypertrophic ECL cells accumulate vacuoles and lipofuscin bodies. An ultrastructural study of ECL cells isolated from hypergastrinemic rats. Cell and tissue research 20010301
Ranitidine bismuth citrate or omeprazole-based triple therapy for Helicobacter pylori eradication in Helicobacter pylori-infected non-ulcer dyspepsia. Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver 20010301
Randomised study of the efficacy of omeprazole and clarithromycin with either amoxycillin or metronidazole in the eradication of Helicobacter pylori in screened primary care patients. Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver 20010301
Pantoprazole versus lansoprazole in French patients with reflux esophagitis. Gastroenterologie clinique et biologique 20010301
Analysis of gastrin receptor gene expression in proliferating cells in the neck zone of gastric fundic glands using laser capture microdissection. FEBS letters 20010202
The effect of oral administration of Lactobacillus GG on antibiotic-associated gastrointestinal side-effects during Helicobacter pylori eradication therapy. Alimentary pharmacology & therapeutics 20010201
Eradication of Helicobacter pylori prevents ulcer development in patients with ulcer-like functional dyspepsia. Alimentary pharmacology & therapeutics 20010201
The prescribing of acid suppressants prior to the endoscopic diagnosis of Barrett's oesophagus and oesophagitis. Alimentary pharmacology & therapeutics 20010201
Meta-analysis of randomized controlled trials comparing standard clinical doses of omeprazole and lansoprazole in erosive oesophagitis. Alimentary pharmacology & therapeutics 20010201
Helicobacter pylori augments the acid inhibitory effect of omeprazole on parietal cells and gastric H(+)/K(+)-ATPase. Gut 20010201
CYP3A4 is the major CYP isoform mediating the in vitro hydroxylation and demethylation of flunitrazepam. Drug metabolism and disposition: the biological fate of chemicals 20010201
Relaxation induced by omeprazole does not change in diabetic rabbit corpus cavernosum. BJU international 20010201
Antibiotic-resistance patterns of Helicobacter pylori in Croatia: cohort study. Croatian medical journal 20010201
Pharmacodynamic modeling of pantoprazole's irreversible effect on gastric acid secretion in humans and rats. Journal of clinical pharmacology 20010201
[Recent guidelines for the management of Helicobacter pylori infection]. Nihon rinsho. Japanese journal of clinical medicine 20010201
[Selection of antibiotics and planning of eradication for H. pylori infection]. Nihon rinsho. Japanese journal of clinical medicine 20010201
[Usefulness of new triple therapy containing PPI]. Nihon rinsho. Japanese journal of clinical medicine 20010201
[A strategy for second-line anti-Helicobacter pylori therapy in patients with previously failed treatment]. Nihon rinsho. Japanese journal of clinical medicine 20010201
Continued (5-year) followup of a randomized clinical study comparing antireflux surgery and omeprazole in gastroesophageal reflux disease. Journal of the American College of Surgeons 20010201
Aggressive acid control: minimizing progression of Barrett's esophagus. The American journal of managed care 20010201
Early stage gastric MALT lymphoma with high-grade component cured by Helicobacter pylori eradication. Journal of gastroenterology 20010201
Comparison of the efficacy and safety of different formulations of omeprazole-based triple therapies in the treatment of Helicobacter pylori-positive peptic ulcer. Journal of gastroenterology 20010201
Increased acid and bile reflux in Barrett's esophagus compared to reflux esophagitis, and effect of proton pump inhibitor therapy. The American journal of gastroenterology 20010201
Do some patients with Helicobacter pylori infection benefit from an extension to 2 weeks of a proton pump inhibitor-based triple eradication therapy? The American journal of gastroenterology 20010201
A randomized, pharmacokinetic and pharmacodynamic, cross-over study of duodenal or jejunal administration compared to nasogastric administration of omeprazole suspension in patients at risk for stress ulcers. The American journal of gastroenterology 20010201
Recurrent ulcer bleeding: is intravenous omeprazole the solution? The American journal of gastroenterology 20010201
Re: Ammonia cannot explain the effect of H. pylori on omeprazole-induced acid suppression. The American journal of gastroenterology 20010201
[Suppressive effect of lansoprazole on anti-Candida activity of murine macrophages]. Kansenshogaku zasshi. The Journal of the Japanese Association for Infectious Diseases 20010201
Gastroesophageal reflux disease and Barrett's esophagus. Endoscopy 20010201
Improved high performance liquid chromatographic analysis of omeprazole in human plasma. Journal of pharmaceutical and biomedical analysis 20010201
Protective effect of famotidine, omeprazole, and melatonin against acetylsalicylic acid-induced gastric damage in rats. Digestive diseases and sciences 20010201
Omeprazole maintenance therapy for gastroesophageal reflux disease after failure of fundoplication. Journal of pediatric gastroenterology and nutrition 20010201
Pharmacokinetics and pharmacodynamics of antiulcer agents in llama. Journal of veterinary pharmacology and therapeutics 20010201
Detection of Helicobacter pylori colonization in dental plaques and tongue scrapings of patients with chronic gastritis. Quintessence international (Berlin, Germany : 1985) 20010201
Propylene glycol toxicosis in a llama. Journal of the American Veterinary Medical Association 20010115
Hypergastrinemia promotes adenoma progression in the APC(Min-/+) mouse model of familial adenomatous polyposis. Cancer research 20010115
[Ulcer therapy with a new proton pump inhibitor. One week of treatment is enough]. MMW Fortschritte der Medizin 20010111
Helicobacter pylori and nonsteroidal anti-inflammatory drugs: interaction with proton pump inhibitor therapy for prevention of nonsteroidal anti-inflammatory drug ulcers and ulcer complications--future research needs. The American journal of medicine 20010108
Current approaches to reducing gastrointestinal toxicity of low-dose aspirin. The American journal of medicine 20010108
Biochemical properties of a newly synthesized H(+)/K(+) ATPase inhibitor, 1-(2-methyl-4-methoxyphenyl)-4-. European journal of pharmacology 20010105
Pharmacological properties of a newly synthesized H(+)/K(+) ATPase inhibitor, 1-(2-methyl-4-methoxyphenyl)-4-. European journal of pharmacology 20010105
Accuracy of the stool antigen test in the diagnosis of Helicobacter pylori infection before treatment and in patients on omeprazole therapy. Alimentary pharmacology & therapeutics 20010101
A multicentre study on eradication of Helicobacter pylori using four 1-week triple therapies in China. Alimentary pharmacology & therapeutics 20010101
Helicobacter pylori effects on gastritis, gastrin and enterochromaffin-like cells in Zollinger-Ellison syndrome and non-Zollinger-Ellison syndrome acid hypersecretors treated long-term with lansoprazole. Alimentary pharmacology & therapeutics 20010101
Duration of effect of lansoprazole on gastric pH and acid secretion in normal male volunteers. Alimentary pharmacology & therapeutics 20010101
Switching between intravenous and oral pantoprazole. Journal of clinical gastroenterology 20010101
Long-term follow-up and serologic assessment after triple therapy with omeprazole or lansoprazole of Helicobacter-associated duodenal ulcer. Journal of clinical gastroenterology 20010101
Allergic contact dermatitis due to lansoprazole, a proton pump inhibitor. Contact dermatitis 20010101
Does pantoprazole alleviate mouth dryness in patients with Sjögren's syndrome? Rheumatology (Oxford, England) 20010101
Effect of Lactobacillus GG supplementation on antibiotic-associated gastrointestinal side effects during Helicobacter pylori eradication therapy: a pilot study. Digestion 20010101
Changes in pulmonary hyperinflation and bronchial hyperresponsiveness following treatment with lansoprazole in children with cystic fibrosis. Pediatric pulmonology 20010101
c-myc gene mutation in gastric mucosa-associated lymphoid tissue (MALT) lymphoma and diffuse large B-cell lymphoma. Oncology reports 20010101
Microsatellite instability at D18S61 is associated with no regression of gastric mucosa-associated lymphoid tissue lymphoma after Helicobacter pylori eradication. Oncology reports 20010101
Esomeprazole once daily for 6 months is effective therapy for maintaining healed erosive esophagitis and for controlling gastroesophageal reflux disease symptoms: a randomized, double-blind, placebo-controlled study of efficacy and safety. The American journal of gastroenterology 20010101
Randomized study of two 'rescue' therapies for Helicobacter pylori-infected patients after failure of standard triple therapies. The American journal of gastroenterology 20010101
Effect of polaprezinc on impaired healing of chronic gastric ulcers in adjuvant-induced arthritic rats--role of insulin-like growth factors (IGF)-1. Medical science monitor : international medical journal of experimental and clinical research 20010101
Level of malondialdehyde after short-time omeprazole administration. Medical science monitor : international medical journal of experimental and clinical research 20010101
Clinical onset of the Crohn's disease after eradication therapy of Helicobacter pylori infection. Does Helicobacter pylori infection interact with natural history of inflammatory bowel diseases? Medical science monitor : international medical journal of experimental and clinical research 20010101
Management of GERD: medical versus surgical. Seminars in gastrointestinal disease 20010101
Gastroesophageal reflux disease: extraesophageal manifestations and therapy. Seminars in gastrointestinal disease 20010101
Approach to the patient with unexplained chest pain. Seminars in gastrointestinal disease 20010101
Study of the electrospray ionization mass spectrometry of the proton pump inhibiting drug Omeprazole. Rapid communications in mass spectrometry : RCM 20010101
[Prevalence and treatment of Helicobacter pylori in gastro-duodenal ulcers. An experience in Liege]. Revue medicale de Liege 20010101
Omeprazole therapy and salivary flow rate in duodenal ulcer patients. Medical science monitor : international medical journal of experimental and clinical research 20010101
Effects of IY-81149, a newly developed proton pump inhibitor, on gastric acid secretion in vitro and in vivo. Arzneimittel-Forschung 20010101
Drug interaction: omeprazole and phenprocoumon. BMC gastroenterology 20010101
Inhibition of drug metabolism in human liver microsomes by nizatidine, cimetidine and omeprazole. Xenobiotica; the fate of foreign compounds in biological systems 20010101
[Relations of acid-base balance and gastric secretion of hydrogen carbonate ions in patients with peptic ulcer]. Terapevticheskii arkhiv 20010101
Comparison of pantoprazole 20 mg to ranitidine 150 mg b.i.d. in the treatment of mild gastroesophageal reflux disease. Digestion 20010101
Delayed healing of gastric ulcers in adjuvant arthritis rats: role of acid secretion and basic fibroblast growth factor. Digestion 20010101
Factors affecting Helicobacter pylori eradication using a seven-day triple therapy with a proton pump inhibitor, tinidazole and clarithromycin, in Brazilian patients with peptic ulcer. Revista do Hospital das Clinicas 20010101
The suitability of hepatocyte culture models to study various aspects of drug metabolism. ALTEX 20010101
Complete regression of primary gastric MALT-lymphoma after double eradication Helicobacter pylori therapy: role and importance of endoscopic ultrasonography. Anticancer research 20010101
Effect of omeprazole on the pharmacokinetics of sustained-release carbamazepine in healthy male volunteers. Methods and findings in experimental and clinical pharmacology 20010101
Bioavailability of a crushed pantoprazole tablet after buffering with sodium hydrogencarbonate or magaldrate relative to the intact enteric coated pantoprazole tablet. Methods and findings in experimental and clinical pharmacology 20010101
Adenocarcinoma of the rat esophagus in the presence of a proton pump inhibitor: a pilot study. Diseases of the esophagus : official journal of the International Society for Diseases of the Esophagus 20010101
Pseudomembranous colitis after eradication of Helicobacter pylori infection with a triple therapy. Medical science monitor : international medical journal of experimental and clinical research 20010101
Effects of lansoprazole on human gastric lipase secretion and intragastric lipolysis in healthy human volunteers. Digestion 20010101
Drugs versus diets: disillusions with Dutch health care. Acta biotheoretica 20010101
A randomized comparison of triple therapy Helicobacter pylori eradication regimens in children with peptic ulcers. The Journal of international medical research 20010101
Effects of eradication therapy on gastric emptying in patients with Helicobacter pylori-positive duodenal ulcers. The Journal of international medical research 20010101
Pharmacokinetic studies with esomeprazole, the (S)-isomer of omeprazole. Clinical pharmacokinetics 20010101
[Efficacy and safety of intravenously administered pantoprazole in the treatment of gastrinoma]. Recenti progressi in medicina 20010101
[A new blocker of proton pump pariet: pharmacological properties and effectiveness of clinical application]. Klinicheskaia meditsina 20010101
A 3-day anti-Helicobacter pylori therapy is a good alternative for bleeding peptic ulcer patients with Helicobacter pylori infection. Hepato-gastroenterology 20010101
Sporadic fundic gland polyps, GERD and omeprazole usage: is there a little piece of information missed? Polish journal of pathology : official journal of the Polish Society of Pathologists 20010101
[Omeprazole and misoprostol for NSAID-induced gastropathies: comparative efficiency of their short-term treatment]. Klinicheskaia meditsina 20010101
Drug interaction studies with esomeprazole, the (S)-isomer of omeprazole. Clinical pharmacokinetics 20010101
[Current principles of the use of laparoscopic surgery in gastroduodenal ulcer]. Khirurgiia 20010101
[The effectiveness of 7-day combined Helicobacter eradication therapy in patients with peptic ulcer and chronic gastritis]. Klinicheskaia meditsina 20010101
[Experience in the use of losek (omeprazole) in gastroenterology]. Terapevticheskii arkhiv 20010101
A randomized trial of lansoprazole, amoxycillin, and clarithromycin versus lansoprazole, bismuth, metronidazole and tetracycline in the retreatment of patients failing initial Helicobacter pylori therapy. Digestive diseases (Basel, Switzerland) 20010101
Resolution of Ménétrier's disease after Helicobacter pylori eradicating therapy. Digestive diseases (Basel, Switzerland) 20010101
Advantage of expressing the variations in some digestive parameters as a function of gastric emptying instead of time. Digestion 20010101
[Results of child observation during 3 years after the eradication treatment]. Rossiiskii gastroenterologicheskii zhurnal : ezhekvartalnyi nauchno-prakticheskii zhurnal 20010101
The treatment of gastroesophageal reflux disease with proton-pump inhibitors and its implications on managed care--pharmacoeconomics and its application to antisecretory drugs: a case study. Managed care interface 20010101
[Changes in ultra rapid urease test and histopathological examination for Helicobacter pylori by antisecretory drugs]. Arquivos de gastroenterologia 20010101
Gastroesophageal reflux disease presenting as xerophthalmia. Journal of pediatric ophthalmology and strabismus 20010101
Lung lesions and anti-ulcer agents beneficial effect: anti-ulcer agents pentadecapeptide BPC 157, ranitidine, omeprazole and atropine ameliorate lung lesion in rats. Journal of physiology, Paris 20010101
Gastric mucosal changes induced by long term infection with Helicobacter pylori in Mongolian gerbils: effects of bacteria eradication. Journal of physiology, Paris 20010101
Gastroesophageal reflux in the patients with asthma. Allergologia et immunopathologia 20010101
Randomized trial of a quadruple-drug regimen and a triple-drug regimen for eradication of Helicobacter pylori: long-term follow-up study. Indian journal of gastroenterology : official journal of the Indian Society of Gastroenterology 20010101
Are twelve days of omeprazole, amoxicillin and clarithromycin better than six days for treating H. pylori infection in peptic ulcer and in non-ulcer dyspepsia? Hepato-gastroenterology 20010101
[Helicobacter pylori, non-steroidal anti-inflammatory drugs and aspirin: a new piece of the puzzle]. Gastroenterologie clinique et biologique 20010101
Lansoprazole: an update of its place in the management of acid-related disorders. Drugs 20010101
Helicobacter pylori eradication therapy in gastric high grade non Hodgkin's lymphoma (NHL). Annals of hematology 20010101
Relative efficacies of gastric proton-pump inhibitors on a milligram basis: desired and undesired SH reactions. Impact of chirality. Scandinavian journal of gastroenterology. Supplement 20010101
A practice-based approach for converting from proton pump inhibitors to less costly therapy. Effective clinical practice : ECP 20010101
Rabeprazole: an update of its use in acid-related disorders. Drugs 20010101
Has the incidence of perforated peptic ulcer decreased over the last decade? Digestive surgery 20010101
Helicobacter pylori eradication with beta carotene, ascorbic acid and allicin. Acta medica (Hradec Kralove) 20010101
Is Helicobacter pylori eradication useful in non-ulcer dyspepsia? Indian journal of gastroenterology : official journal of the Indian Society of Gastroenterology 20010101
Helicobacter pylori eradication after duodenal ulcer perforation. Indian journal of gastroenterology : official journal of the Indian Society of Gastroenterology 20010101
Effects of very long (up to 10 years) proton pump blockade on human gastric mucosa. Digestion 20010101
Second-line Helicobacter pylori eradication with a furazolidone-based regimen in patients who have failed a metronidazole-based regimen. Digestion 20010101
Quality of life in chronic NSAID users: a comparison of the effect of omeprazole and misoprostol. Scandinavian journal of rheumatology 20010101
The incidence of non ulcer dyspepsia and its response to treatment. Journal of Ayub Medical College, Abbottabad : JAMC 20010101
Triple therapy with clarithromycin, amoxicillin and omeprazole for Helicobacter pylori eradication in children and adolescents. Arquivos de gastroenterologia 20010101
Pediatric management problems. Pediatric nursing 20010101
[Gastroesophageal reflux disease in pregnancy]. Revista medico-chirurgicala a Societatii de Medici si Naturalisti din Iasi 20010101
Esomeprazole magnesium (Nexium). Reviews in gastroenterological disorders 20010101
Evaluation of the effects of omeprazole on physiological indices of performance of horses during incremental treadmill exercise. Veterinary therapeutics : research in applied veterinary medicine 20010101
Lansoprazole in the treatment of gastro-oesophageal reflux disease in childhood. Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver 20001101
The rates of common adverse events reported during treatment with proton pump inhibitors used in general practice in England: cohort studies. British journal of clinical pharmacology 20001001
Hypercalcaemia and acute interstitial nephritis associated with omeprazole therapy. Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 20000901
Reversible renal failure after treatment with omeprazole. The Netherlands journal of medicine 20000801
Esomeprazole provides improved acid control vs. omeprazole In patients with symptoms of gastro-oesophageal reflux disease. Alimentary pharmacology & therapeutics 20000701
How do we offer clinical relief to patients with gastro-oesophageal reflux disease? European journal of gastroenterology & hepatology 20000601
Affinities at the verapamil binding site of MDR1-encoded P-glycoprotein: drugs and analogs, stereoisomers and metabolites. International journal of clinical pharmacology and therapeutics 20000401
Prevention and healing of experimental indomethacin-induced gastric lesions: effects of ebrotidine, omeprazole and ranitidine. European journal of gastroenterology & hepatology 20000301
Ultrasonographic evaluation of lansoprazole-induced improvement of submucosal injury in patients with gastroesophageal reflux. The American journal of gastroenterology 20000201
Omeprazole-induced delirium. Journal of neurology 20000101
[Mental confusion from interaction of a proton-pump inhibitor with benzodiazepines: 3 cases]. Therapie 20000101
Peptic ulcer recurrence during maintenance therapy with H2-receptor antagonist following first-line therapy with proton pump inhibitor. Journal of gastroenterology 20000101
Fluorometric screening for metabolism-based drug--drug interactions. Journal of pharmacological and toxicological methods 20000101
Comparison of IY81149 with omeprazole in rat reflux oesophagitis. Journal of autonomic pharmacology 20000101
Standard-dose lansoprazole is more effective than high-dose ranitidine in achieving endoscopic healing and symptom relief in patients with moderately severe reflux oesophagitis. The Dutch Lansoprazole Study Group. Alimentary pharmacology & therapeutics 19991201
Rational prescribing: practice audit and drug switch in dyspepsia management. International journal of clinical practice 19991201
Omeprazole-induced acute interstitial nephritis. The American journal of gastroenterology 19991101
Double-blind comparison of lansoprazole 15 mg, lansoprazole 30 mg and placebo as maintenance therapy in patients with healed duodenal ulcers resistant to H2-receptor antagonists. Alimentary pharmacology & therapeutics 19990701
Role of endothelin-1 and constitutive nitric oxide synthase in gastric mucosal resistance to indomethacin injury: effect of antiulcer agents. Scandinavian journal of gastroenterology 19990501
[Losec was probably the cause of interstitial nephritis]. Lakartidningen 19990407
Characterization of antisecretory and antiulcer activity of CR 2945, a new potent and selective gastrin/CCK(B) receptor antagonist. European journal of pharmacology 19990312
Anaphylaxis to omeprazole. Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology 19990101
Prostacyclin analog prevents stress-induced expression of immediate early genes and gastric mucosal lesions in the rat stomach. Life sciences 19990101
Effect of chronic duodenal ulceration and its treatment with lanzoprazole or sucralfate on gastroduodenal mucosal protein turnover and TGF-alpha, bFGF, and EGF receptor expression in humans. Digestive diseases and sciences 19981201
Effects of different antisecretory drugs on gastric potential difference in the rat: comparison with sucralfate. Pharmacological research 19981201
[Interstitial nephritis caused by omeprazole]. Anales de medicina interna (Madrid, Spain : 1984) 19981101
Lansoprazole and omeprazole in the prevention of relapse of reflux oesophagitis: a long-term comparative study. Alimentary pharmacology & therapeutics 19981001
Acute hepatitis induced by omeprazole. The American journal of emergency medicine 19980901
An evaluation of the cytochrome P450 induction potential of pantoprazole in primary human hepatocytes. Chemico-biological interactions 19980703
Pyrexia, anaemia and acute renal failure secondary to omeprazole. Postgraduate medical journal 19980701
[Polyneuropathy caused by vitamin B12 deficiency secondary to chronic atrophic gastritis and giardiasis]. Revista de neurologia 19980601
[Hemolytic anemia and thrombocytopenia associated with anti-omeprazole antibody]. [Rinsho ketsueki] The Japanese journal of clinical hematology 19980601
Effect of long-term gastric acid suppressive therapy on serum vitamin B12 levels in patients with Zollinger-Ellison syndrome. The American journal of medicine 19980501
Effects of a proton-pump inhibitor in cystic fibrosis. Acta paediatrica (Oslo, Norway : 1992) 19980501
The management of acid-related dyspepsia in general practice: a comparison of an omeprazole versus an antacid-alginate/ranitidine management strategy. Compete Research Group [corrected]. Alimentary pharmacology & therapeutics 19980301
Lansoprazole triple therapy for Helicobacter pylori--is 5 days enough? Alimentary pharmacology & therapeutics 19980301
Bismuth-containing single-antibiotic 1-week triple therapy for Helicobacter pylori eradication. Alimentary pharmacology & therapeutics 19980301
Kinetic characterization and identification of the enzymes responsible for the hepatic biotransformation of adinazolam and N-desmethyladinazolam in man. The Journal of pharmacy and pharmacology 19980301
Neuromyopathy secondary to omeprazole treatment. Muscle & nerve 19980201
Possible lansoprazole-induced eosinophilic syndrome. The Annals of pharmacotherapy 19980201
Immunoallergic granulomatous interstitial nephritis following treatment with omeprazole. American journal of nephrology 19980101
Iron absorption in patients with Zollinger-Ellison syndrome treated with long-term gastric acid antisecretory therapy. Alimentary pharmacology & therapeutics 19980101
Long-term extracorporeal bilirubin elimination: A case report on cascade resin plasmaperfusion. Blood purification 19980101
The role of endogenous gastrin in the development of enterochromaffin-like cell carcinoid tumors in Mastomys natalensis: a study with the specific gastrin receptor antagonist AG-041R. The Yale journal of biology and medicine 19980101
Signal transduction-mediated activation of the aryl hydrocarbon receptor in rat hepatoma H4IIE cells. The Journal of biological chemistry 19971212
One week triple therapy for Helicobacter pylori: does high-dose clarithromycin confer additional benefit? Helicobacter 19971201
Central nervous system side effects after proton pump inhibitor treatment. Journal of clinical gastroenterology 19971201
The plasma membrane H(+)-ATPase of fungi. A candidate drug target? Annals of the New York Academy of Sciences 19971103
A prospective follow-up study of 5669 users of lansoprazole in daily practice. Alimentary pharmacology & therapeutics 19971001
Bismuth subsalicylate instead of metronidazole with lansoprazole and clarithromycin for Helicobacter pylori infection: a randomized trial. The American journal of gastroenterology 19970901
Omeprazole-induced interstitial nephritis. Journal of clinical gastroenterology 19970901
Ocular damage associated with proton pump inhibitors. BMJ (Clinical research ed.) 19970621
Regulation of dioxin receptor function by omeprazole. The Journal of biological chemistry 19970509
Effects of pantoprazole on xenobiotic metabolizing enzymes in rat liver microsomes: a comparison with other proton pump inhibitors. Drug metabolism and disposition: the biological fate of chemicals 19970501
[Lansoprazole-induced hepatitis]. Medicina clinica 19970419
Stereoselective 4'-hydroxylation of phenytoin: relationship to (S)-mephenytoin polymorphism in Japanese. British journal of clinical pharmacology 19970401
Lansoprazole heals erosive reflux esophagitis resistant to histamine H2-receptor antagonist therapy. The American journal of gastroenterology 19970301
Lethargy with omeprazole. BMJ (Clinical research ed.) 19970215
Lansoprazole heals erosive reflux oesophagitis in patients with Barrett's oesophagus. Alimentary pharmacology & therapeutics 19970201
Effects of benzimidazole derivatives on cytochrome P450 1A1 expression in a human hepatoma cell line. Xenobiotica; the fate of foreign compounds in biological systems 19970101
Omeprazole-induced acute interstitial nephritis. Renal failure 19970101
Genetic polymorphism of CYP2C19 and lansoprazole pharmacokinetics in Japanese subjects. European journal of clinical pharmacology 19970101
Lansoprazole compared with histamine2-receptor antagonists in healing gastric ulcers: a meta-analysis. Clinical therapeutics 19970101
[A case of hemolysis induced by lansoprazole]. [Rinsho ketsueki] The Japanese journal of clinical hematology 19961201
[Effects of lansoprazole on indomethacin-induced gastric bleeding and mucosal lesions in rats]. Nihon yakurigaku zasshi. Folia pharmacologica Japonica 19961201
[Effects of intravenous lansoprazole on acute gastric mucosal lesions and acid secretion]. Nihon yakurigaku zasshi. Folia pharmacologica Japonica 19961201
Double-blind, multicenter evaluation of lansoprazole and amoxicillin dual therapy for the cure of Helicobacter pylori infection. Helicobacter 19961201
Seven-day triple therapy with lansoprazole, clarithromycin, and metronidazole for the cure of Helicobacter pylori infection: a short report. Helicobacter 19961201
Differences in inducibility of CYP1A1-mRNA by benzimidazole compounds between human and mouse cells: evidences of a human-specific signal transduction pathway for CYP1A1 induction. Archives of biochemistry and biophysics 19961015
Metabolic interactions of the proton-pump inhibitors lansoprazole, omeprazole and pantoprazole with other drugs. European journal of gastroenterology & hepatology 19961001
Lansoprazole prevents recurrence of erosive reflux esophagitis previously resistant to H2-RA therapy. The Lansoprazole Maintenance Study Group. The American journal of gastroenterology 19960901
Hyponatremia with consciousness disturbance caused by omeprazole administration. A case report and literature review. Digestive diseases and sciences 19960801
A trial of lansoprazole in refractory gastric ulcer. Alimentary pharmacology & therapeutics 19960601
Erythema nodosum caused by omeprazole. Cutis 19960601
Identification of the human P450 enzymes involved in lansoprazole metabolism. The Journal of pharmacology and experimental therapeutics 19960501
Induction of CYP1A1 gene by benzimidazole derivatives during Caco-2 cell differentiation. Evidence for an aryl-hydrocarbon receptor-mediated mechanism. European journal of biochemistry 19960501
Effects of long-term omeprazole treatment on adult rat gastric mucosa--enhancement of the epithelial cell proliferation and suppression of its differentiation. Biochemical and biophysical research communications 19950925
Acute interstitial nephritis due to omeprazole. Clinical nephrology 19950801
Mechanism for species-specific induction of Leydig cell tumors in rats by lansoprazole. Fundamental and applied toxicology : official journal of the Society of Toxicology 19950701
Meta-analysis of randomized clinical trials comparing lansoprazole with ranitidine or famotidine in the treatment of acute duodenal ulcer. European journal of gastroenterology & hepatology 19950701
Effect of gastrin receptor blockade on gastrin and histidine decarboxylase gene expression in rats during achlorhydria. Scandinavian journal of gastroenterology 19950601
Gynecomastia and sexual disorders after the administration of omeprazole. The American journal of gastroenterology 19950601
Treatment of erosive reflux esophagitis resistant to H2-receptor antagonist therapy. Lansoprazole, a new proton pump inhibitor. Digestive diseases and sciences 19950301
Oxidative metabolism of lansoprazole by human liver cytochromes P450. Molecular pharmacology 19950201
Influence of lansoprazole on intragastric 24-hour pH, meal-stimulated gastric acid secretion, and concentrations of gastrointestinal hormones and enzymes in serum and gastric juice in healthy volunteers. Digestion 19950101
Increased immunoreactivity and concentration of basic fibroblast growth factor in lansoprazole-treated gastric mucosa. Journal of clinical gastroenterology 19950101
Arthralgias and omeprazole. BMJ (Clinical research ed.) 19941217
Acute interstitial nephritis due to omeprazole. Lancet (London, England) 19941008
Protective action of omeprazole against gastric mucosal injury induced by hemorrhagic shock in rats. Digestive diseases and sciences 19941001
Recurrent acute interstitial nephritis on rechallenge with omeprazole. Lancet (London, England) 19940820
Is omeprazole helpful in inflammatory bowel disease? Journal of clinical gastroenterology 19940601
Omeprazole and lansoprazole are mixed inducers of CYP1A and CYP3A in human hepatocytes in primary culture. The Journal of pharmacology and experimental therapeutics 19940401
Hepatitis following treatments with famotidine and then cimetidine. The Annals of pharmacotherapy 19940101
Angioedema and urticaria associated with omeprazole confirmed by drug rechallenge. Pharmacotherapy 19940101
Treatment of reflux esophagitis resistant to H2-receptor antagonists with lansoprazole, a new H+/K(+)-ATPase inhibitor: a controlled, double-blind study. Lansoprazole Study Group. The American journal of gastroenterology 19930801
Omeprazole-induced acute interstitial nephritis. The American journal of medicine 19930801
Differential control of somatostatin messenger RNA in rat gastric corpus and antrum. Role of acid, food, and capsaicin-sensitive afferent neurons. The Journal of clinical investigation 19930101
Acute interstitial nephritis due to omeprazole. The American journal of medicine 19921001
Subacute myopathy during omeprazole therapy. Lancet (London, England) 19920912
Endocrine adverse effects of omeprazole. BMJ (Clinical research ed.) 19920822
Fulminant hepatic failure related to omeprazole. The American journal of gastroenterology 19920401
[Proton pump inhibitors in the treatment of peptic ulcers resistant to H2-receptor antagonists]. Nihon rinsho. Japanese journal of clinical medicine 19920101
[Evaluation of the effect of proton pump inhibitors on stomal ulcer]. Nihon rinsho. Japanese journal of clinical medicine 19920101
Painful gynaecomastia during omeprazole therapy. Lancet (London, England) 19911102
Differences in the antisecretory actions of the proton pump inhibitor AG-1749 (lansoprazole) and the histamine H2-receptor antagonist famotidine in rats and dogs. Japanese journal of pharmacology 19910401
Hemolytic anemia associated with the use of omeprazole. The American journal of gastroenterology 19910201
H2-receptor antagonist-refractory ulcer: its pathophysiology and treatment. Journal of clinical gastroenterology 19910101
Catatonic reaction to omeprazole and disulfiram in a patient with alcohol dependence. CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne 19901201
An unusual side effect of omeprazole: case report. The British journal of general practice : the journal of the Royal College of General Practitioners 19900901
Synthesis of (aryloxy)alkylamines. 1. Novel antisecretory agents with H+K+-ATPase inhibitory activity. Journal of medicinal chemistry 19880901

Related Products

© 2019 Angene International Limited. All rights Reserved.